OBO_ID (LABEL):	GO_0042571 (immunoglobulin complex, circulating)

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
BMJ_2012_Jan_30_344_e184	1/2012	S14-BMJ_2012_Jan_30_344_e184	['Arachidonic Acid gives rise to Eicosanoids such as Prostaglandin E2, which can enhance the synthesis of T Helper type 2 cytokines and Immunoglobulin e Antibodies—the hallmark of Atopic Responses To Allergens.']	N/A	N/A	[('CHEBI_15843', 'arachidonic acid', 0, 'Arachidonic acid'), ('CHEBI_36744', 'guaiane sesquiterpenoid', 31, 'eicosanoids'), ('CHEBI_15551', 'prostaglandin E2', 51, 'prostaglandin E2'), ('CL_0002061', 'T-helper 9 cell', 104, 'T helper'), ('GO_0019814', 'immunoglobulin complex', 134, 'immunoglobulin'), ('GO_0042571', 'immunoglobulin complex, circulating', 151, 'antibodies'), ('GO_1990375', 'baculum development', 178, 'atopic responses to allergens'), ('CHEBI_33663', 'cyclic hydrocarbon', 198, 'allergens')]
PMC1184067	7/2005	S58-PMC1184067	['caption (table-wrap): table 1\n\nPreconception care interventionsservicesinterventionfolic Acid supplementationadvise 0.4 mg of Folic Acid daily (4 mg if previous Pregnancy with Neural Tube defect) three months prior to Conception.smoking cessationeducate about the risks of smoking during Pregnancy and counsel about smoking cessation.anemia screencheck hematocrit/cbc and recommend Iron Supplement if anemia is detected.testing for rubella Antibodycheck Igg rubella Antibody before Conception.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 31, 'Preconception'), ('CHEBI_37527', 'acid', 89, 'acid'), ('CHEBI_30751', 'formic acid', 126, 'folic acid'), ('GO_0007565', 'female pregnancy', 161, 'pregnancy'), ('UBERON_0001049', 'neural tube', 176, 'neural tube'), ('GO_0007620', 'copulation', 218, 'conception'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy'), ('CHEBI_76528', "2-acyl-sn-glycero-3-phospho-(1'-sn-glycerol)(1-)", 382, 'iron supplement'), ('GO_0044225', 'apical pole of neuron', 440, 'antibodyCheck'), ('GO_0071735', 'IgG immunoglobulin complex', 454, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 466, 'antibody'), ('GO_0007620', 'copulation', 482, 'conception')]
PMC1184067	7/2005	S75-PMC1184067	["caption (table-wrap): table 3\n\njapanese family physicians' experiences in Preconception education during medical school and residency training (n = 268)n(%)smoking cessation191(71.3)testing for anemia172(64.2)Blood testing for rubella Antibody156(58.2)use of basal body temperature monitoring125(46.6)restricting Alcohol intake120(44.8)increasing calcium intake86(32.1)restricting Caffeine intake52(19.4)exercise during Pregnancy48(17.9)timing of Intercourse to maximize chances of Conception38(14.2)Folic Acid supplementation31(11.6)\nPreconception care practices of the respondents are depicted in table4."]	N/A	N/A	[('GO_0007565', 'female pregnancy', 74, 'preconception'), ('UBERON_0000178', 'blood', 209, 'Blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 235, 'antibody156'), ('CHEBI_30879', 'alcohol', 313, 'alcohol'), ('CHEBI_27732', 'caffeine', 381, 'caffeine'), ('GO_0007565', 'female pregnancy', 420, 'pregnancy48'), ('GO_0006954', 'inflammatory response', 447, 'intercourse'), ('GO_0007631', 'feeding behavior', 482, 'conception38'), ('CHEBI_30751', 'formic acid', 500, 'Folic acid'), ('GO_0007565', 'female pregnancy', 535, 'Preconception')]
PMC1184067	7/2005	S80-PMC1184067	['about two thirds of participants reported their willingness to provide preconception care about such topics as Calcium intake (70%), Blood testing for rubella Antibody (69%), and restricting Caffeine intake (64%).']	N/A	N/A	[('CHEBI_22313', 'alkaline earth metal atom', 111, 'calcium'), ('UBERON_0000178', 'blood', 133, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 159, 'antibody'), ('CHEBI_27732', 'caffeine', 191, 'caffeine')]
PMC1280409	9/2005	S55-PMC1280409	['typically, Seroconversion is characterized as a 4-fold rise in Antibody titers taken in serial samples.']	N/A	N/A	[('GO_0097577', 'sequestering of iron ion', 11, 'seroconversion'), ('GO_0042571', 'immunoglobulin complex, circulating', 63, 'antibody')]
PMC2409299	5/2008	S43-PMC2409299	['caption (table-wrap): table 1\n\ngeometric mean absolute and percentage Lymphocyte subpopulation counts at each age and overall, according to season of Birth (values adjusted for gender, Gestation, Birth weight and monoclonal Antibody source; overall values also adjusted for age at measurement).absolute counts (× 109/l)percentage countsweekdry season birthwet season birthp-valuedry season birthwet season birthp-valuecd3+ 02.302.530.4151.850.50.7083.574.350.02958.758.20.77164.105.260.01457.759.00.66523.323.720.2660.961.90.71all3.403.850.0157.156.20.47 Cd4+ 01.451.730.1735.033.80.6582.492.730.2640.837.00.017162.803.280.0539.137.40.34522.072.190.5538.436.70.27all2.262.410.1537.835.10.0017 Cd8+ 01.291.440.4427.227.70.8280.981.470.01116.319.00.055161.341.650.09318.718.70.97521.121.280.2220.921.60.60all1.161.420.000720.421.40.18 Cd19+ 00.780.730.6817.414.60.08481.881.940.7932.730.70.37161.972.500.03432.934.70.39521.501.510.9527.725.50.32all1.541.660.2327.525.90.12 Cd56+ 00.840.780.6819.116.00.1480.270.350.0954.85.40.34160.250.330.0284.14.50.38520.210.290.00523.94.70.036all0.330.420.00146.16.50.17 cd4/cd8 ratio 01.31.20.7082.51.90.018162.12.00.69521.81.70.32all1.91.60.013\n\nage-related changes\ngeometric mean absolute and percentage Lymphocyte counts were highest at 16 weeks and significantly lower at 52 weeks (p = 0.0056 and p ≤ 0.0001 respectively).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 70, 'lymphocyte'), ('GO_0007567', 'parturition', 150, 'birth'), ('GO_0007565', 'female pregnancy', 185, 'gestation'), ('GO_0007567', 'parturition', 196, 'birth'), ('GO_0042571', 'immunoglobulin complex, circulating', 224, 'antibody'), ('PR_000001204', 'C-C chemokine receptor type 8', 555, 'CD4'), ('PR_000005170', 'CD37 molecule', 693, 'CD8'), ('PR_000001309', 'CD70 molecule', 833, 'CD19'), ('PR_000001309', 'CD70 molecule', 971, 'CD56'), ('CL_0000542', 'lymphocyte', 1242, 'lymphocyte')]
PMC2409299	5/2008	S129-PMC2409299	['location of the Lymphocyte gate, and freedom from Monocyte contamination, were assessed using monoclonal Antibodies to cd14+ and Cd45+.']	N/A	N/A	[('CL_0000542', 'lymphocyte', 16, 'lymphocyte'), ('CL_0000576', 'monocyte', 50, 'monocyte'), ('GO_0042571', 'immunoglobulin complex, circulating', 105, 'antibodies'), ('PR_000001309', 'CD70 molecule', 129, 'CD45')]
PMC2685772	4/2009	S55-PMC2685772	['Estradiol and Progesterone levels were assessed using the beckman coulter (formerly dsl) – dsl-4400 Estradiol double Antibody kit and siemens (formerly dpc) – Tkpg2 kit, respectively.']	N/A	N/A	[('CHEBI_4856', 'esmolol', 0, 'Estradiol'), ('CHEBI_17026', 'progesterone', 14, 'progesterone'), ('CHEBI_23965', 'estradiol', 100, 'estradiol'), ('GO_0042571', 'immunoglobulin complex, circulating', 117, 'antibody'), ('PR_000016373', 'transducin-like enhancer protein 2', 159, 'TKPG2')]
PMC2685772	4/2009	S56-PMC2685772	['the Antibodies used have high affinity for Estradiol and Progesterone, respectively, and low cross-reactivity to other naturally-occurring hormones.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'antibodies'), ('CHEBI_23965', 'estradiol', 43, 'estradiol'), ('CHEBI_17026', 'progesterone', 57, 'progesterone')]
PMC2704503	6/2007	S40-PMC2704503	['C-Reactive Protein and Antinuclear Antibody were normal.']	N/A	N/A	[('PR_000005890', 'crooked neck-like protein 1', 0, 'C-reactive protein'), ('GO_0005642', 'annulate lamellae', 23, 'antinuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibody')]
PMC2721967	7/2009	S169-PMC2721967	['in filipino adolescents (1) and pakistani Adults (2,3), for example, a weaker Antibody response to vaccination with Polysaccharide Antigens was observed in subjects Born with a lower Birth weight.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 42, 'adults'), ('GO_0042571', 'immunoglobulin complex, circulating', 78, 'antibody'), ('CHEBI_18154', 'polysaccharide', 116, 'polysaccharide'), ('CHEBI_59132', 'antigen', 131, 'antigens'), ('GO_0007567', 'parturition', 165, 'born'), ('GO_0007567', 'parturition', 183, 'birth')]
PMC2726293	9/2009	S64-PMC2726293	['briefly, a one-in-four series of Forebrain sections from each Animal was incubated in primary Fos Antibody (48\xa0h; 1:10,000; Rabbit polyclonal; santa cruz biotechnology, santa cruz, ca), then in secondary Antibody (2\xa0h; 1:200; biotinylated anti-Rabbit; vector laboratories, burlingame ca) and in an avidin–Biotin horseradish peroxidase (hrp) Complex (1\xa0h; vector elite kit, vector).']	N/A	N/A	[('UBERON_0001890', 'forebrain', 33, 'forebrain'), ('NCBITaxon_33208', 'Metazoa', 62, 'animal'), ('PR_000007705', 'galactoside alpha-(1,2)-fucosyltransferase 2', 94, 'Fos'), ('GO_0042571', 'immunoglobulin complex, circulating', 98, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 124, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 204, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 244, 'rabbit'), ('CHEBI_15956', 'biotin', 305, 'biotin'), ('GO_0032991', 'protein-containing complex', 341, 'complex')]
PMC2756957	10/2009	S281-PMC2756957	['Plasma leptin concentrations (ng.ml−1) were determined using a validated double-Antibody ria as previously reported[18],[63].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('GO_0042571', 'immunoglobulin complex, circulating', 80, 'antibody')]
PMC2756957	10/2009	S282-PMC2756957	['samples were assayed in triplicate (200 µl) using a Rabbit anti-ovine leptin primary Antibody, iodinated ovine leptin and Sheep anti-Rabbit secondary Antibody.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 52, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 85, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 122, 'sheep'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 133, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 150, 'antibody')]
PMC2777012	4/2009	S35-PMC2777012	['his Thyroid Antibodies were negative.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 4, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibodies')]
PMC2825514	1/2010	S56-PMC2825514	['radiolabeled Insulin was purified on sephadex g50 column and a fraction corresponding to the top of the radioactive peak was collected and used as tracer to test Rabbit Antibodies.']	N/A	N/A	[('PR_000045358', 'insulin family protein', 13, 'insulin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 162, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 169, 'antibodies')]
PMC2850511	4/2010	S55-PMC2850511	['because the Rbcs of a rhesus d negative Pregnant female do not possess the rhesus d Antigen, maternal anti-d (Igg) Antibodies are created in response to detection of fetal Rbcs in the maternal Blood Stream [48].']	N/A	N/A	[('CL_0000232', 'erythrocyte', 12, 'RBCs'), ('GO_0007565', 'female pregnancy', 40, 'pregnant'), ('CHEBI_59132', 'antigen', 84, 'antigen'), ('GO_0071735', 'IgG immunoglobulin complex', 110, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 115, 'antibodies'), ('CL_0000232', 'erythrocyte', 172, 'RBCs'), ('UBERON_0001969', 'blood plasma', 193, 'blood stream')]
PMC2850511	4/2010	S56-PMC2850511	['these Antibodies destroy the fetal Rbcs in the maternal Blood Stream, cross the Placenta, and destroy fetal Rbcs.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 6, 'antibodies'), ('CL_0000232', 'erythrocyte', 35, 'RBCs'), ('UBERON_0001969', 'blood plasma', 56, 'blood stream'), ('UBERON_0001987', 'placenta', 80, 'placenta'), ('CL_0000232', 'erythrocyte', 108, 'RBCs')]
PMC2880107	5/2010	S48-PMC2880107	['Antibodies from santa cruz biotechnology (ca, usa) were used for the detection of Myostatin (1:3000 dilution; goat polyclonal Gdf-8 (f-13), sc-34781) and Fstl-3 (1:5000 dilution; Goat polyclonal flrg (n-18), sc-21302) in conjunction with a secondary polyclonal Rabbit anti Igg/hrp Antibody (1:10000 dilution).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('PR_000010404', 'MICAL-like protein 2', 82, 'myostatin'), ('PR_000007939', 'glial fibrillary acidic protein', 126, 'GDF-8'), ('PR_000007690', 'ferritin heavy chain', 154, 'FSTL-3'), ('NCBITaxon_10088', 'Mus <genus>', 179, 'Goat'), ('NCBITaxon_10088', 'Mus <genus>', 261, 'Rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 273, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 281, 'antibody')]
PMC2888390	6/2010	S48-PMC2888390	['the samples were then fractionated by Sds-page fractionation followed by semi-dry transfer to Polyvinylidene Difluoride membrane, blocked with 5% dry milk and 0.05% Tween 20 (pbs-T), and rocked overnight at 4 °c in primary Antibody.']	N/A	N/A	[('CHEBI_8984', 'sodium dodecyl sulfate', 38, 'SDS'), ('CHEBI_53245', 'poly(vinylpyridine)', 94, 'polyvinylidene difluoride'), ('CHEBI_53424', 'polysorbate 20', 165, 'Tween 20'), ('CHEBI_53424', 'polysorbate 20', 179, 'T'), ('GO_0042571', 'immunoglobulin complex, circulating', 223, 'antibody')]
PMC2888390	6/2010	S49-PMC2888390	['Antibodies were Rabbit polyclonal 5009 or 4964 (Α4) and 4842 or 305 (Β2) as described elsewhere (9,14).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 16, 'rabbit'), ('PR_000002123', 'C-C motif chemokine 3', 48, 'α4'), ('PR_000001884', 'macrophage receptor MARCO', 69, 'β2')]
PMC2888390	6/2010	S50-PMC2888390	['blots were washed, incubated at room temperature for 1 h in blocking Solution containing peroxidase-conjugated secondary Antibody, washed again, and the bands detected on film after developing with the enhanced chemiluminescence system (perkinelmer life sciences).']	N/A	N/A	[('CHEBI_75958', 'solution', 69, 'solution'), ('GO_0042571', 'immunoglobulin complex, circulating', 121, 'antibody')]
PMC2945165	10/2010	S37-PMC2945165	['Serum samples were tested for cml (4g9 monoclonal Antibody; alteon, northvale, nj) and for Methylglyoxal derivatives, such as mg-h1 (mg3d11 monoclonal Antibody) by enzyme-linked immunosorbent assays (elisas), based on standards characterized by high-performance liquid chromatography and gas-liquid chromatography-mass spectrometry, as described (18).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody'), ('CHEBI_17158', 'methylglyoxal', 91, 'methylglyoxal'), ('GO_0042571', 'immunoglobulin complex, circulating', 151, 'antibody')]
PMC2999828	3/2009	S12-PMC2999828	['classification and mechanism\nhypersensitivity against Allergens can be mediated by either Antibodies or T Lymphocytes.']	N/A	N/A	[('CHEBI_33663', 'cyclic hydrocarbon', 54, 'allergens'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibodies'), ('CL_0000084', 'T cell', 104, 'T lymphocytes')]
PMC2999828	3/2009	S15-PMC2999828	['the sensitization process involves the Production of Allergen-specific Immunoglobulin e (Ige) Antibodies, which are fixed to Mast Cells via their high-affinity receptor, Fc Epsilon Receptor I (Fc Ε Ri).']	N/A	N/A	[('GO_0007128', 'meiotic prophase I', 39, 'production'), ('CHEBI_50904', 'allergen', 53, 'allergen'), ('GO_0019814', 'immunoglobulin complex', 71, 'immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 89, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 94, 'antibodies'), ('CL_0000097', 'mast cell', 125, 'mast cells'), ('PR_000001453', 'frizzled-10', 170, 'Fc epsilon receptor I'), ('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 193, 'Fc ε RI')]
PMC2999828	3/2009	S16-PMC2999828	['on a subsequent encounter with the Allergen, Bridging of 2 or more Ige Antibodies leads to Degranulation Of the Mast Cell with release of preformed Mediators such as Histamine, Serotonin, tryptase, chymase, kininogenase, and Heparin.']	N/A	N/A	[('CHEBI_50904', 'allergen', 35, 'allergen'), ('GO_0030674', 'protein-macromolecule adaptor activity', 45, 'bridging'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 67, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 71, 'antibodies'), ('GO_0032497', 'detection of lipopolysaccharide', 91, 'degranulation of ... cell'), ('CL_0000097', 'mast cell', 112, 'mast cell'), ('CHEBI_35222', 'inhibitor', 148, 'mediators'), ('CHEBI_18295', 'histamine', 166, 'histamine'), ('CHEBI_28790', 'serotonin', 177, 'serotonin'), ('CHEBI_28304', 'heparin', 225, 'heparin')]
PMC3028350	2/2011	S92-PMC3028350	['all primary Antibodies used in this study were purchased either from cell signaling technology or santa cruz biotechnology.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibodies')]
PMC3104165	6/2011	S53-PMC3104165	['immunocytochemistry\nProgesterone Receptor (Pr) Antibody (Rabbit anti-Human Pr, recognizes both forms of Pr; dako, denmark), and Estrogen Receptor Alpha (Erα) Antibody (monoclonal Mouse anti-Human Er; dako, denmark) were used for immunohistochemistry.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 20, 'Progesterone'), ('PR_000001658', 'prostaglandin E2 receptor EP2 subtype', 20, 'Progesterone receptor'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 43, 'PR'), ('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 57, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 69, 'human'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 75, 'PR'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 104, 'PR'), ('CHEBI_50114', 'estrogen', 128, 'estrogen'), ('PR_000007200', 'endothelial cell-specific molecule 1', 128, 'estrogen receptor alpha'), ('PR_000007120', 'ephrin type-A receptor 1', 153, 'ERα'), ('GO_0042571', 'immunoglobulin complex, circulating', 158, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 179, 'mouse'), ('NCBITaxon_9606', 'Homo sapiens', 190, 'human'), ('GO_0005783', 'endoplasmic reticulum', 196, 'ER'), ('PR_000007204', 'estrogen receptor', 196, 'ER')]
PMC3104165	6/2011	S58-PMC3104165	['Pr (1:400) and Erα (1:200) Antibodies were diluted in pbs with 3% Bovine Serum Albumin containing 0.05% Tween.']	N/A	N/A	[('PR_000001904', 'platelet endothelial cell adhesion molecule', 0, 'PR'), ('PR_000007120', 'ephrin type-A receptor 1', 15, 'ERα'), ('GO_0042571', 'immunoglobulin complex, circulating', 27, 'antibodies'), ('NCBITaxon_33208', 'Metazoa', 66, 'bovine'), ('PR_000003918', 'albumin', 73, 'serum albumin'), ('UBERON_0001977', 'blood serum', 73, 'serum'), ('CHEBI_53422', 'polysorbate', 104, 'Tween')]
PMC3104165	6/2011	S59-PMC3104165	['the sections were incubated with primary Antibodies overnight at +4℃, washed with pbs, and incubated with horseradish peroxidase conjugated dako envisiontm systems (dako, denmark) for 30 min.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 41, 'antibodies')]
PMC3104165	6/2011	S77-PMC3104165	['Uterine sections not receiving primary Antibody showed no staining.']	N/A	N/A	[('UBERON_0000995', 'uterus', 0, 'Uterine'), ('GO_0042571', 'immunoglobulin complex, circulating', 39, 'antibody')]
PMC3156909	9/2011	S47-PMC3156909	['paraffin embedded ldlrko Mice Gastrocnemius Muscle samples were sectioned (4 µm) and incubated 2 h at 37°c with 1/200 diluted Rabbit polyclonal anti-Cd36 Antibody (novus biologicals, inc. littleton, co, usa).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 25, 'mice'), ('UBERON_0001388', 'gastrocnemius', 30, 'gastrocnemius muscle'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 126, 'rabbit'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 149, 'CD36'), ('GO_0042571', 'immunoglobulin complex, circulating', 154, 'antibody')]
PMC3156909	9/2011	S48-PMC3156909	['immunostaining was via a fluorescent secondary Antibody, goat anti-Rabbit Alexa 568 (invitrogen, basel, switzerland).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 67, 'rabbit'), ('CHEBI_51766', 'Alexa Fluor 568', 74, 'Alexa 568')]
PMC3156909	9/2011	S49-PMC3156909	['for Cd36 quantification by immunoblotting, 4 µg and 6 µg of Cytosolic and Membrane extracts, respectively, were loaded and probed with 1/1000 Rabbit polyclonal anti-Cd36 Antibody (novus biologicals, inc. littleton, co, usa).']	N/A	N/A	[('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 4, 'CD36'), ('GO_0005829', 'cytosol', 60, 'cytosolic'), ('GO_0016020', 'membrane', 74, 'membrane'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 142, 'rabbit'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 165, 'CD36'), ('GO_0042571', 'immunoglobulin complex, circulating', 170, 'antibody')]
PMC3156909	9/2011	S54-PMC3156909	['Rat anti-F4/80 Antibody (abcam, cambridge, uk) was used to stain Adipose Tissue Macrophages and the immunostaining was revealed by an anti-Rat hrp (invitrogen, basel, switzerland).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rat'), ('PR_000001900', 'neuropilin-1', 9, 'F4/80'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('CL_0002617', 'adipocyte of breast', 65, 'adipose tissue macrophages'), ('UBERON_0001013', 'adipose tissue', 65, 'adipose tissue'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 139, 'rat')]
PMC3156909	9/2011	S66-PMC3156909	['Rat monoclonal anti-Vascular Cell Adhesion Molecule 1 (Vcam1) and anti-Cd68 Antibodies, and Rabbit polyclonal anti-Α Smooth Muscle Actin (Αsma) Antibody (abcam, cambridge, uk) were used on frozen sections of Antenatal-treated Aortic Roots.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rat'), ('CL_0000568', 'amine precursor uptake and decarboxylation cell', 20, 'vascular cell'), ('PR_000001881', 'lymphocyte activation gene 3 protein', 20, 'vascular cell adhesion molecule 1'), ('GO_0000328', 'fungal-type vacuole lumen', 29, 'cell adhesion molecule'), ('CHEBI_36357', 'polyatomic entity', 43, 'molecule'), ('PR_000001970', 'vascular cell adhesion protein 1', 55, 'VCAM1'), ('PR_000001309', 'CD70 molecule', 71, 'CD68'), ('GO_0042571', 'immunoglobulin complex, circulating', 76, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 92, 'rabbit'), ('PR_000003669', 'acyl-coenzyme A synthetase ACSM5, mitochondrial', 115, 'α smooth muscle actin'), ('UBERON_0001135', 'smooth muscle tissue', 117, 'smooth muscle'), ('PR_000003669', 'acyl-coenzyme A synthetase ACSM5, mitochondrial', 138, 'αSMA'), ('GO_0042571', 'immunoglobulin complex, circulating', 144, 'antibody'), ('UBERON_0001760', 'frontal sinus', 208, 'antenatal'), ('UBERON_0002109', 'pair of nares', 226, 'aortic roots')]
PMC3156909	9/2011	S67-PMC3156909	['the immunostaining was revealed by a fluorescent secondary Antibody, goat anti-Rat/Rabbit Alexa 568 (invitrogen, basel, switzerland).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 59, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 79, 'rat'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 83, 'rabbit'), ('CHEBI_51766', 'Alexa Fluor 568', 90, 'Alexa 568')]
PMC3192420	7/2011	S78-PMC3192420	['after migration and electrical protein transfer, Nitrocellulose membranes were blocked overnight and blotted with Antibodies for either Ampkα, phospho-Ampkα (catalog no.']	N/A	N/A	[('CHEBI_53325', 'nitrocellulose', 49, 'nitrocellulose'), ('GO_0042571', 'immunoglobulin complex, circulating', 114, 'antibodies'), ('PR_000004510', 'ataxin-7-like protein 2', 136, 'AMPKα'), ('PR_000004510', 'ataxin-7-like protein 2', 151, 'AMPKα')]
PMC3192420	7/2011	S86-PMC3192420	['briefly, slides are heated and stained as follows: 5 min on a Peroxide block, 15 min with primary Antibody, 8 min with secondary Antibody, 10 min with 3,3-Diaminobenzidine, and 5-min counterstaining with Hematoxylin and eosin.']	N/A	N/A	[('CHEBI_44785', 'peroxide', 62, 'peroxide'), ('GO_0042571', 'immunoglobulin complex, circulating', 98, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 129, 'antibody'), ('CHEBI_51595', 'chloro(subphthalocyaninato)boron', 151, '3,3-diaminobenzidine'), ('CHEBI_51686', 'haematoxylin', 204, 'hematoxylin')]
PMC3192420	7/2011	S87-PMC3192420	['negative slides were run in parallel, with the exclusion of the primary Antibody.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 72, 'antibody')]
PMC3208550	11/2011	S74-PMC3208550	['the membranes were blocked in 5% non-fat milk for 1.5 h at room temperature and then blotted with a primary Antibody to gr or actin (santa cruz, california, usa) at 1∶250 dilution overnight at 4°c.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 108, 'antibody')]
PMC3208550	11/2011	S75-PMC3208550	['after being washed four times (10 min/wash) in pbst buffer at room temperature, the membrane was incubated with the second Antibody for 1 h and immunoreactive bands were visualized using chemiluminescence.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 123, 'antibody')]
PMC3264579	1/2012	S69-PMC3264579	['the membranes were then incubated 48 h at 4°c with the primary Antibody: Rabbit anti-Phospho-Stat3 (tyr 705) (1∶1000), Rabbit anti-Phospho-mtor (1∶500), Rabbit anti-phospho Akt (1∶1000) (cell signaling technology for all Antibodies, ozyme, st quentin en yvelines).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 63, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 73, 'rabbit'), ('CHEBI_32958', 'phosphate group', 85, 'phospho'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 93, 'STAT3'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 119, 'rabbit'), ('CHEBI_32958', 'phosphate group', 131, 'phospho'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 153, 'rabbit'), ('PR_000003888', 'A-kinase anchor protein 14', 173, 'AKT'), ('GO_0042571', 'immunoglobulin complex, circulating', 221, 'antibodies')]
PMC3264579	1/2012	S70-PMC3264579	['after washing in tbs/T, the membranes were incubated for 1 hour at room temperature with secondary Antibody conjugated with horseradish peroxidase (goat anti-Rabbit, 1∶20000, jackson immunuresearch, interchim, montluçon).']	N/A	N/A	[('CHEBI_53424', 'polysorbate 20', 21, 'T'), ('GO_0042571', 'immunoglobulin complex, circulating', 99, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 158, 'rabbit')]
PMC3264579	1/2012	S72-PMC3264579	['after detection of the phosphorylated protein, Membranes were stripped using a Tris ph 6.8 50 mm, 2-Mercaptoethanol 100 mm and Sds 2% Solution and re-blotted with the Rabbit anti-Stat3 (1∶1000), and Rabbit anti-mtor (1∶1000), Rabbit anti-Akt (1∶2000) (cell signaling technology for all Antibodies, ozyme, st quentin en yvelines).']	N/A	N/A	[('GO_0016020', 'membrane', 47, 'membranes'), ('CHEBI_9754', 'tris', 79, 'Tris'), ('CHEBI_41218', 'mercaptoethanol', 98, '2-mercaptoethanol'), ('CHEBI_8984', 'sodium dodecyl sulfate', 127, 'SDS'), ('CHEBI_75958', 'solution', 134, 'solution'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 167, 'rabbit'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 179, 'STAT3'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 199, 'rabbit'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 226, 'rabbit'), ('PR_000003888', 'A-kinase anchor protein 14', 238, 'AKT'), ('GO_0042571', 'immunoglobulin complex, circulating', 286, 'antibodies')]
PMC3264579	1/2012	S74-PMC3264579	['blots were systematically analyzed with an actin Antibody (anti-Mouse anti-Β-Actin Antibody, 1/5000, sigma-aldrich, st louis, mo, usa) to verify if proteins were evenly loaded between samples.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 64, 'mouse'), ('PR_000003676', 'actin, cytoplasmic 1', 75, 'β-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 83, 'antibody')]
PMC3268605	8/2011	S42-PMC3268605	['sentinel Animals were housed under the same conditions and regularly monitored for infections by Nematodes, pathogenic bacteria, and Antibodies for rodent viral pathogens (international council for laboratory Animal science, nijmegen, netherlands).']	N/A	N/A	[('NCBITaxon_33208', 'Metazoa', 9, 'animals'), ('NCBITaxon_33208', 'Metazoa', 97, 'nematodes'), ('GO_0042571', 'immunoglobulin complex, circulating', 133, 'antibodies'), ('NCBITaxon_33208', 'Metazoa', 209, 'Animal')]
PMC3268605	8/2011	S66-PMC3268605	['either α-Mouse (l36a) or α-Rabbit (actin) hrp-conjugated secondary Antibodies (ge healthcare, #nxa931 and na934) were used at a dilution of 1:5000 in tbst for 20\u2009min at rt.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 9, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 27, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies')]
PMC3268605	8/2011	S137-PMC3268605	['western blot analysis was performed on Kidneys lysates from 2\u2009day and 2 week control and Molsidomine fhh Rats of both genders using an Antibody against Ribosomal Protein L36A (upper panel).']	N/A	N/A	[('UBERON_0002113', 'kidney', 39, 'kidneys'), ('CHEBI_30629', 'diethylenetriamine', 89, 'molsidomine'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 105, 'rats'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibody'), ('GO_0005840', 'ribosome', 152, 'ribosomal'), ('PR_000014178', 'ribulose-phosphate 3-epimerase', 152, 'ribosomal protein L36a')]
PMC3273459	2/2012	S82-PMC3273459	['the concentration of Plasma leptin was analyzed by a double Antibody enzyme immunoassay as described by sauerwein et al.[16].']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 21, 'plasma'), ('GO_0042571', 'immunoglobulin complex, circulating', 60, 'antibody')]
PMC3276895	11/2011	S48-PMC3276895	['the assay system utilized one monoclonal anti-Ige Antibody and goat anti-Ige Antibody in the Antibody-enzyme (horseradish peroxidase) conjugate Solution.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 46, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 73, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibody'), ('CHEBI_75958', 'solution', 144, 'solution')]
PMC3299317	2/2012	S9-PMC3299317	['most Allergens elicit Ige Antibodies, which bind to Mast Cells; when cross-linked, the Mast Cell releases Inflammatory Mediators that cause bronchospasm and Mucus Formation [1].']	N/A	N/A	[('CHEBI_33663', 'cyclic hydrocarbon', 5, 'allergens'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 22, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 26, 'antibodies'), ('CL_0000097', 'mast cell', 52, 'mast cells'), ('CL_0000097', 'mast cell', 87, 'mast cell'), ('CHEBI_64668', 'geranylgeranyl-chlorophyll a', 106, 'inflammatory mediators'), ('GO_0000024', 'maltose biosynthetic process', 157, 'mucus formation'), ('UBERON_0000912', 'mucus', 157, 'mucus')]
PMC3304528	2/2012	S21-PMC3304528	['on the one hand there are methods such as that used in the current study in which the methylated portion of the Genome is captured using Antibodies against methylated dna and subsequently quantified using microarrays or next-generation sequencing.']	N/A	N/A	[('SO_0001026', 'genome', 112, 'genome'), ('GO_0042571', 'immunoglobulin complex, circulating', 137, 'antibodies')]
PMC3321448	3/2012	S59-PMC3321448	['proteins were transferred to Nitrocellulose membrane (hybond-c extra, amersham bioscience) for probing with Antibodies to Β1-Ar (affinity bioreagents; Rabbit polyclonal raised against a synthetic peptide corresponding to residues 394–408 of Mouse/Rat Β1-Ar), Β2-Ar (abcam; Rabbit polyclonal raised against against residues 1–100 of Human Β2-Ar), g stimulatory protein (santa cruz g α s (k-20): sc-823), and g inhibitory protein (santa cruz g Α I-3 (c10): sc262).']	N/A	N/A	[('CHEBI_53325', 'nitrocellulose', 29, 'nitrocellulose'), ('GO_0042571', 'immunoglobulin complex, circulating', 108, 'antibodies'), ('PR_000001244', 'long-wave-sensitive opsin 1', 122, 'β1-AR'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 151, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 247, 'rat'), ('PR_000001244', 'long-wave-sensitive opsin 1', 251, 'β1-AR'), ('PR_000001144', 'melanin-concentrating hormone receptor 1', 259, 'β2-AR'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 273, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 332, 'human'), ('PR_000001144', 'melanin-concentrating hormone receptor 1', 338, 'β2-AR'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 442, 'α i-3')]
PMC3321448	3/2012	S60-PMC3321448	['Membranes were incubated in blocking Solution (5% dried skimmed milk in tbs with 1% Tween 20) prior to incubation with primary Antibodies.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_75958', 'solution', 37, 'solution'), ('CHEBI_53424', 'polysorbate 20', 84, 'Tween 20'), ('GO_0042571', 'immunoglobulin complex, circulating', 127, 'antibodies')]
PMC3321448	3/2012	S61-PMC3321448	['horseradish peroxidise secondary Antibody conjugated to Rabbit Igg was used at a working concentration of 1\u2009:\u20095000 (ge healthcare, amersham, uk).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 33, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 56, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 63, 'IgG')]
PMC3321454	3/2012	S64-PMC3321454	['the sections were incubated with primary Antibodies for 90 minutes at room temperature.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 41, 'antibodies')]
PMC3321454	3/2012	S65-PMC3321454	['the secondary Antibodies (either antimouse Rat adsorbed or antirabbit biotinylated) were incubated for 30 minutes, followed by abc (sigma) for a further 30 minutes and dab (sigma) for approximately 6 minutes.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 43, 'rat')]
PMC3321454	3/2012	S106-PMC3321454	['western blotting\nExpression of Ucp2 (primary Antibody; calbiochem, cat.']	N/A	N/A	[('GO_0010467', 'gene expression', 17, 'Expression'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 31, 'UCP2'), ('GO_0042571', 'immunoglobulin complex, circulating', 45, 'antibody')]
PMC3321454	3/2012	S107-PMC3321454	['number 662047) and Atp Synthetase Β -Subunit (primary Antibody; sigma cat.']	N/A	N/A	[('PR_000004106', 'AP-3 complex subunit delta-1', 19, 'ATP synthetase β -subunit'), ('GO_0042571', 'immunoglobulin complex, circulating', 54, 'antibody')]
PMC3325178	4/2012	S302-PMC3325178	['80 µg of protein was run on a 5–15% Sds-page gradient gel at 50 v overnight at 4°c and transferred to Pvdf membranes by electroblotting overnight at 20 v. following blocking membranes were incubated with primary polyclonal Antibody (Rabbit) α-Peg3 at 1/24,000[67], followed by a 1/5000 poly-clonal anti-Rabbit hrp-conjugated secondary Antibody (dako denmark) and developed using an ecl plus western blotting detection system (amersham, ge healthcare).']	N/A	N/A	[('CHEBI_8984', 'sodium dodecyl sulfate', 36, 'SDS'), ('CHEBI_53250', 'poly(vinylene fluoride)', 102, 'PVDF'), ('GO_0042571', 'immunoglobulin complex, circulating', 223, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 233, 'rabbit'), ('PR_000012522', 'all trans-polyprenyl-diphosphate synthase PDSS2', 243, 'Peg3'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 303, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 335, 'antibody')]
PMC3350070	1/2011	S55-PMC3350070	['anticardiolipin Antibody was “low to medium positive” at 23.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 16, 'antibody')]
PMC3350070	1/2011	S56-PMC3350070	['the remainder of the Prothrombotic workup on the mother was normal including Antinuclear Antigen, testing for Factor V leiden thrombophilia (activated protein c resistance assay and factor v Gene dna analysis), prothrombin Gene dna analysis, protein c, Homocysteine, Immunoglobulin g (Igg) and m (Igm) Antibodies to cardiolipin, and Phosphatidylserine.']	N/A	N/A	[('GO_0006508', 'proteolysis', 21, 'prothrombotic'), ('GO_0005642', 'annulate lamellae', 77, 'antinuclear'), ('CHEBI_59132', 'antigen', 89, 'antigen'), ('PR_000007319', 'fatty acid desaturase 3', 110, 'factor V'), ('SO_0000704', 'gene', 191, 'gene'), ('SO_0000704', 'gene', 223, 'gene'), ('CHEBI_17088', 'monoacyl-sn-glycerol 3-phosphate', 253, 'homocysteine'), ('GO_0019814', 'immunoglobulin complex', 267, 'immunoglobulin'), ('GO_0071735', 'IgG immunoglobulin complex', 285, 'IgG'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 297, 'IgM'), ('GO_0042571', 'immunoglobulin complex, circulating', 302, 'antibodies'), ('CHEBI_18303', 'phosphatidyl-L-serine', 333, 'phosphatidylserine')]
PMC3357266	6/2012	S98-PMC3357266	['Insulin and leptin were quantified by enzyme-linked immunosorbent assays using Rat standards and anti-Rat Insulin or leptin Antibodies (linco research, st. charles, mo) (sensitivity: Insulin = 0.2 ng/ml, leptin = 0.04 ng/ml using 10-μl sample).']	N/A	N/A	[('PR_000045358', 'insulin family protein', 0, 'Insulin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 79, 'rat'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 102, 'rat'), ('PR_000045358', 'insulin family protein', 106, 'insulin'), ('GO_0042571', 'immunoglobulin complex, circulating', 124, 'antibodies'), ('PR_000045358', 'insulin family protein', 183, 'insulin')]
PMC3366289	7/2011	S48-PMC3366289	['laboratory investigations\n\nFerritin, soluble Transferrin Receptor, C-Reactive Protein and α-1 Glycoprotein\nSerum ferritin (sf) and soluble Transferrin Receptor (Stfr), as indicators for iron status, and the Acute Phase proteins C-Reactive Protein (Crp) and Α-1 Glycoprotein (Agp) were measured by elisa using polyclonal (dako, finland: sf, crp, agp) and monoclonal (hytest, finland: Stfr) Antibodies [11].']	N/A	N/A	[('CHEBI_80820', 'Eucarvone', 27, 'Ferritin'), ('PR_000001679', 'trace amine-associated receptor 5', 45, 'transferrin receptor'), ('PR_000005890', 'crooked neck-like protein 1', 67, 'C-reactive protein'), ('CHEBI_17089', 'glycoprotein', 94, 'glycoprotein'), ('UBERON_0001977', 'blood serum', 107, 'Serum'), ('PR_000001679', 'trace amine-associated receptor 5', 139, 'transferrin receptor'), ('PR_000015619', 'sorcin', 161, 'sTfR'), ('GO_0006953', 'acute-phase response', 207, 'acute phase'), ('PR_000005890', 'crooked neck-like protein 1', 228, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 248, 'CRP'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 257, 'α-1 glycoprotein'), ('CHEBI_17089', 'glycoprotein', 261, 'glycoprotein'), ('PR_000003830', 'angiogenic factor with G patch and FHA domains 1', 275, 'AGP'), ('PR_000015619', 'sorcin', 383, 'sTfR'), ('GO_0042571', 'immunoglobulin complex, circulating', 389, 'antibodies')]
PMC3373516	6/2012	S25-PMC3373516	['Pregnant women with hiv-1 who were ≥18 years of age had hiv-1 confirmed by enzyme-linked immunosorbant assay (elisa), Hsv-2 Antibodies, and cd4 count.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 0, 'Pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 118, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 118, 'HSV-2'), ('GO_0042571', 'immunoglobulin complex, circulating', 124, 'antibodies')]
PMC3382418	6/2012	S90-PMC3382418	['Hormone levels were measured in duplicate by specific radioimmunoassays using commercially available kits: Insulin Antibody coated tubes for immunoreactive Insulin (iri) measurements (Insulin-ct; cis bio international, saclay, france) with Rat Insulin as standard (novo, copenhagen, denmark), a Rat Ghrelin kit (rk-031-31; phoenix europe gmbh, karlsruhe, germany), and a Rat leptin kit (rl-83\u2009k; linco, st charles, usa).']	N/A	N/A	[('CHEBI_5762', 'hordatine A', 0, 'Hormone'), ('PR_000045358', 'insulin family protein', 107, 'insulin'), ('GO_0042571', 'immunoglobulin complex, circulating', 115, 'antibody'), ('PR_000045358', 'insulin family protein', 156, 'insulin'), ('PR_000045358', 'insulin family protein', 184, 'Insulin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 240, 'rat'), ('PR_000045358', 'insulin family protein', 244, 'insulin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 295, 'rat'), ('CHEBI_69086', 'glycyrin', 299, 'ghrelin'), ('PR_000007988', 'gastric inhibitory polypeptide receptor', 299, 'ghrelin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 371, 'rat')]
PMC3404662	4/2012	S286-PMC3404662	['2005immune toxicityimmunosuppressiondecreased dth and Antibody productionatrazine (Gestational exposure to Rats)Triazinerooney et al.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 54, 'antibody'), ('GO_0007565', 'female pregnancy', 83, 'gestational'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 107, 'rats'), ('CHEBI_63624', 'telbivudine', 112, 'TriazineRooney')]
PMC3411795	8/2012	S39-PMC3411795	['th-positive cells were visualized by Alexa555-conjugated secondary goat anti-Mouse Antibody (invitrogen).']	N/A	N/A	[('CHEBI_52673', 'Alexa Fluor 555', 37, 'Alexa555'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 83, 'antibody')]
PMC3411795	8/2012	S46-PMC3411795	['transferred membranes were blocked in 10% skim Milk with 1× pbst at room temperature for 1 h and incubated with the same Mouse monoclonal anti-th Antibody used in immunohistochemical studies (1∶1,000, millipore) at 4°c overnight.']	N/A	N/A	[('UBERON_0001913', 'milk', 47, 'milk'), ('NCBITaxon_10088', 'Mus <genus>', 121, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 146, 'antibody')]
PMC3411795	8/2012	S47-PMC3411795	['Membranes were then washed with 1× pbst and incubated with Alexa 680 conjugated goat anti-Mouse Antibody (1∶20,000, invitrogen) at room temperature for 1 h. Membranes were washed again with 1× pbst for 3 times and then scanned under odyssey imager (li-cor bioscience, usa).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_51766', 'Alexa Fluor 568', 59, 'Alexa 680'), ('NCBITaxon_10088', 'Mus <genus>', 90, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 96, 'antibody'), ('GO_0016020', 'membrane', 157, 'Membranes')]
PMC3415211	5/2012	S84-PMC3415211	['for staining, sections were mounted on superfrost plus gold slides permeabilized and stained with either anti-peripherin (1:100; emd millipore billerica, ma ab1530) and Fitc, Alexa Fluor 488 secondary Antibodies (jackson immunoresearch, west grove, pa).']	N/A	N/A	[('CHEBI_37926', 'fluorescein isothiocyanate', 169, 'FITC'), ('CHEBI_52661', 'Alexa Fluor 488', 175, 'Alexa Fluor 488'), ('GO_0042571', 'immunoglobulin complex, circulating', 201, 'antibodies')]
PMC3415211	5/2012	S175-PMC3415211	['d : a section through the same Embryo stained with Antibodies to neural marker peripherin.']	N/A	N/A	[('UBERON_0000922', 'embryo', 31, 'embryo'), ('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibodies')]
PMC3415261	7/2012	S151-PMC3415261	['in addition its functionality can be measured by the number of cells producing Antibodies and by the transition from predominance of Igm- to Iga-Secreting cells.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 79, 'antibodies'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 133, 'IgM'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 141, 'IgA'), ('GO_0046903', 'secretion', 145, 'secreting')]
PMC3420688	5/2012	S91-PMC3420688	['eculizumab, a humanized monoclonal Antibody against C5, acts as a terminal Complement Inhibitor and is effective in targeting classical manifestations of pnh including Complement-Mediated Hemolysis and Thromboses [12].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibody'), ('PR_000004904', 'complement C5', 52, 'C5'), ('CHEBI_75293', 'methyltrioctylammonium', 75, 'complement'), ('CHEBI_35222', 'inhibitor', 86, 'inhibitor'), ('GO_0000911', 'cytokinesis by cell plate formation', 168, 'complement-mediated hemolysis'), ('GO_0007596', 'blood coagulation', 202, 'thromboses')]
PMC3424155	8/2012	S74-PMC3424155	['after blocking, the Membranes were incubated with the follow Antibodies: a) polyclonal Antibody against Rabbit anti-Human At1 Receptor (At1R 306; 43 kda; sc-579; 1∶1000; santa cruz biotechnology); b) monoclonal Antibody against Mouse Renin (A-1; 38–46 kda; sc-137252; 1∶1000; santa cruz biotechnology); c) polyclonal Antibody against Rabbit anti-Human Podocin (h-130; 42 kda; sc-21009; 1∶1000; santa cruz biotechnology); and d) polyclonal Antibody against Rabbit anti-Human Wt1 (c-19; 52 kda; sc-192; 1∶500; santa cruz biotechnology).']	N/A	N/A	[('GO_0016020', 'membrane', 20, 'membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 61, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 87, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 104, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 116, 'human'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 122, 'AT1 receptor'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 136, 'AT1r'), ('GO_0042571', 'immunoglobulin complex, circulating', 211, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 228, 'mouse'), ('PR_000014368', 'RuvB-like 1', 234, 'renin'), ('PR_000004100', 'AP-2 complex subunit alpha-2', 241, 'A-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 317, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 334, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 346, 'human'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 352, 'podocin'), ('GO_0042571', 'immunoglobulin complex, circulating', 439, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 456, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 468, 'human'), ('PR_000017450', 'protein Wnt-8a', 474, 'WT1')]
PMC3424155	8/2012	S75-PMC3424155	['the membranes were washed and incubated with anti-Mouse (1∶5000 for Renin) or anti-Rabbit (1∶8000 for Podocin and At1R; 1∶5000 for wt1) secondary Antibodies.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 50, 'mouse'), ('PR_000014368', 'RuvB-like 1', 68, 'renin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 83, 'rabbit'), ('PR_000012775', 'polycystic kidney disease 2-like 2 protein', 102, 'podocin'), ('PR_000029299', 'B-cell CLL/lymphoma 7 protein family member A', 114, 'AT1r'), ('GO_0042571', 'immunoglobulin complex, circulating', 146, 'antibodies')]
PMC3424155	8/2012	S142-PMC3424155	['average values were measured and equal protein loading was confirmed by probing blots with Beta-Actin Antibody and is expressed as a percentage of the sc counterpart.']	N/A	N/A	[('PR_000004692', 'Bcl-2-related protein A1', 91, 'beta-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 102, 'antibody')]
PMC3424155	8/2012	S144-PMC3424155	['the average values were measured and equal protein loading was confirmed by probing blots with Beta-Actin Antibody and is expressed as a percentage of the sc counterpart.']	N/A	N/A	[('PR_000004692', 'Bcl-2-related protein A1', 95, 'beta-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 106, 'antibody')]
PMC3424155	8/2012	S154-PMC3424155	['the average values were measured and equal protein loading was confirmed by probing blots with Beta-Actin Antibody and is expressed as a percentage of the sc counterpart.']	N/A	N/A	[('PR_000004692', 'Bcl-2-related protein A1', 95, 'beta-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 106, 'antibody')]
PMC3424155	8/2012	S161-PMC3424155	['the average values were measured and equal protein loading was confirmed by probing blots with Beta-Actin Antibody and is expressed into a percentage of the sc counterpart.']	N/A	N/A	[('PR_000004692', 'Bcl-2-related protein A1', 95, 'beta-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 106, 'antibody')]
PMC3458940	9/2012	S46-PMC3458940	['left panels showed positive staining of specific Antibodies, whereas right panels showed negative controls of cells stained with the respective non-immune Iggs.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibodies'), ('GO_0071735', 'IgG immunoglobulin complex', 155, 'IgGs')]
PMC3458940	9/2012	S176-PMC3458940	['cells were then permeabilized with 0.1% Triton x-100 for 3 min and washed with three changes of pbs, 5 min each wash. after fixation and permeabilization, cells were incubated with 1% bsa for 2 h at room temperature to reduce non-specific Antibody binding, followed by 1 h incubation of Rabbit anti-Aqp2 Igg (dilution 1∶150, millipore, watford, uk), or Mouse anti-E-Cad Igg2A (dilution 1∶50, bd biosciences, oxford, uk), at room temperature.']	N/A	N/A	[('CHEBI_29236', 'protium atom', 40, 'Triton'), ('GO_0042571', 'immunoglobulin complex, circulating', 239, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 287, 'rabbit'), ('PR_000004182', 'aquaporin-2', 299, 'AQP2'), ('GO_0071735', 'IgG immunoglobulin complex', 304, 'IgG'), ('NCBITaxon_10088', 'Mus <genus>', 353, 'mouse'), ('PR_000001447', 'cadherin-1', 364, 'E-cad'), ('GO_0071735', 'IgG immunoglobulin complex', 370, 'IgG2a')]
PMC3458940	9/2012	S179-PMC3458940	['at the end of secondary Antibody incubation, cells were washed with three changes of pbs, 5 min each wash. one milliliter of fresh pbs was then pipetted onto the cell monolayer and fluorescence microscopy was performed immediately.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 24, 'antibody')]
PMC3471827	10/2012	S33-PMC3471827	['for additional confirmation of Homology we tested for anti-Human ttp cross reactivity using a new Antibody to Human ttp, cw201p that also recognizes Mouse ttp.']	N/A	N/A	[('SO_0000857', 'homologous', 31, 'homology'), ('NCBITaxon_9606', 'Homo sapiens', 59, 'human'), ('GO_0042571', 'immunoglobulin complex, circulating', 98, 'antibody'), ('NCBITaxon_9606', 'Homo sapiens', 110, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mouse')]
PMC3471827	10/2012	S34-PMC3471827	['Adult Zebrafish Liver homogenate reacted with the Antibody with a single band at 33 kd, the expected size of the Zebrafish protein (left lane, figure 1b ); the Antibody reacted with Mouse ttp, but not with homogenate from a ttp−/− Mouse Liver (middle and right lanes, figure 1b ).10.1371/journal.pone.0047402.g001\n\ncaption (fig): figure 1\nthe Zebrafish Α-Tocopherol transfer protein.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 0, 'Adult'), ('NCBITaxon_7955', 'Danio rerio', 6, 'zebrafish'), ('UBERON_0002107', 'liver', 16, 'liver'), ('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody'), ('NCBITaxon_7955', 'Danio rerio', 113, 'zebrafish'), ('GO_0042571', 'immunoglobulin complex, circulating', 160, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mouse'), ('NCBITaxon_10088', 'Mus <genus>', 231, 'mouse'), ('UBERON_0002107', 'liver', 237, 'liver'), ('NCBITaxon_7955', 'Danio rerio', 343, 'zebrafish'), ('CHEBI_16199', 'urea', 353, 'α-'), ('CHEBI_27013', 'tocopherol', 355, 'tocopherol')]
PMC3471827	10/2012	S42-PMC3471827	['b. anti-Human ttp Antibody cross-reacts with ttp from Adult Zebrafish Liver homogenate.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibody'), ('UBERON_0007023', 'adult organism', 54, 'adult'), ('NCBITaxon_7955', 'Danio rerio', 60, 'zebrafish'), ('UBERON_0002107', 'liver', 70, 'liver')]
PMC3471827	10/2012	S151-PMC3471827	['lysates were immunoblotted for endogenous ttp using a Rabbit polyclonal cw201p Antibody and a secondary hrp-conjugated Rabbit Antibody in combination with supersignal west dura substrate (thermo fisher scientific, inc., rockford, il) for visualization.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 54, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 79, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 119, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 126, 'antibody')]
PMC3471827	10/2012	S152-PMC3471827	['Rabbit anti-Human ttp Antibody (cw201p)\nrecombinant wildtype Human ttp was Expressed in bacteria as described and purified as described[11],[33].']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 12, 'human'), ('GO_0042571', 'immunoglobulin complex, circulating', 22, 'Antibody'), ('NCBITaxon_9606', 'Homo sapiens', 61, 'human'), ('GO_0010467', 'gene expression', 75, 'expressed')]
PMC3471827	10/2012	S154-PMC3471827	['for Antibody preparation, purified ttp was dialyzed into phosphate-buffered saline; 2 Rabbits were injected with the protein (250 µg at 1 mg/ml) (covance, denver, pa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 86, 'rabbits')]
PMC3471827	10/2012	S156-PMC3471827	['the Antibody was purified from crude Serum using protein g sepharose and stored at −20°c until use.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'antibody'), ('UBERON_0001977', 'blood serum', 37, 'serum')]
PMC3471827	10/2012	S157-PMC3471827	['for western blotting, Antibody was diluted 1∶1000 with pbs, 2% Bovine Serum Albumin.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 22, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 63, 'bovine'), ('PR_000003918', 'albumin', 70, 'serum albumin'), ('UBERON_0001977', 'blood serum', 70, 'serum')]
PMC3476426	8/2012	S4-PMC3476426	['methods\nSerum levels of 25-Hydroxy Vitamin D and anti-mag auto-Antibodies were measured in 50 autistic children, aged between 5 and 12 years, and 30 healthy-matched children.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 8, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 24, '25-hydroxy vitamin D'), ('GO_0042571', 'immunoglobulin complex, circulating', 63, 'antibodies')]
PMC3476426	8/2012	S51-PMC3476426	['assessment of Serum anti-Myelin Associated Glycoprotein (anti-mag) Antibodies\nthis assay employs the quantitative sandwich-type enzyme immunoassay (eia) technique (buhlmann laboratories ag, baselstrasse 55, ch-4124 schonenbuch, switzerland).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 14, 'serum'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 25, 'myelin associated glycoprotein'), ('UBERON_0000345', 'myelin', 25, 'myelin'), ('CHEBI_17089', 'glycoprotein', 43, 'glycoprotein'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies')]
PMC3476426	8/2012	S53-PMC3476426	['calibrators and patient Sera were incubated for in the microtiter wells and any anti-Mag auto-Antibodies present were bound by the immobilized Human Mag.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 24, 'sera'), ('PR_000010050', 'transcription factor MafG', 85, 'MAG'), ('GO_0042571', 'immunoglobulin complex, circulating', 94, 'antibodies'), ('NCBITaxon_9606', 'Homo sapiens', 143, 'human'), ('PR_000010050', 'transcription factor MafG', 149, 'MAG')]
PMC3476426	8/2012	S54-PMC3476426	['after washing away any unbound substances, horseradish peroxidase labeled Antibodies against Human Igm were added to the wells and incubated.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 74, 'antibodies'), ('NCBITaxon_9606', 'Homo sapiens', 93, 'human'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 99, 'IgM')]
PMC3476426	8/2012	S56-PMC3476426	['the color developed in proportion to the amount of anti-mag Antibodies bound in the initial step was stopped by adding an Acidic stop Solution.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 60, 'antibodies'), ('CHEBI_37527', 'acid', 122, 'acidic'), ('CHEBI_75958', 'solution', 134, 'solution')]
PMC3476426	8/2012	S67-PMC3476426	['two sd above the mean value of Serum anti-mag auto-Antibodies of healthy controls, 1983.45 buhlmann titre unit (btu), were considered to be elevated in autistic patients.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibodies')]
PMC3476426	8/2012	S76-PMC3476426	['caption (table-wrap): table 2\n\nSerum levels of 25-Hydroxy Vitamin D and anti-Mag auto-Antibodies in relation to the severity of autism\xa0 patients with mild to moderate autism (\u2009 n \u2009= 18)patients with severe autism (\u2009 n \u2009= 32)z/t (\u2009 p \u2009value) Serum 25-Hydroxy Vitamin D (ng/ml) (median (iqr))20.5 (16)14.5 (15)1.82 (0.06)Serum anti-mag (btu) (mean ± sd)1827.5 ± 349.92525.5 ± 529.65.6 (<0.001)\nanti-mag, anti-Myelin-Associated Glycoprotein Antibodies.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 31, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 47, '25-hydroxy vitamin D'), ('PR_000010050', 'transcription factor MafG', 77, 'MAG'), ('GO_0042571', 'immunoglobulin complex, circulating', 86, 'antibodies'), ('UBERON_0001977', 'blood serum', 241, 'Serum'), ('CHEBI_67825', '17beta,21beta-epoxyhopan-3-one', 250, 'hydroxy vitamin D'), ('UBERON_0001977', 'blood serum', 319, 'Serum'), ('UBERON_0000345', 'myelin', 407, 'myelin'), ('PR_000002201', 'dynein light chain', 414, 'associated'), ('CHEBI_17089', 'glycoprotein', 425, 'glycoprotein'), ('GO_0042571', 'immunoglobulin complex, circulating', 438, 'antibodies')]
PMC3476426	8/2012	S79-PMC3476426	['Serum levels of anti-mag auto-Antibodies in autistic patients and healthy children\nautistic children had significantly higher Serum levels of anti-mag auto-Antibodies (2274.22 ± 578.32 btu) than healthy children (1468.57 ± 302.89 btu), p< 0.001 (figure2).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 30, 'antibodies'), ('UBERON_0001977', 'blood serum', 126, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 156, 'antibodies')]
PMC3476426	8/2012	S81-PMC3476426	['caption (fig): figure 2\n\nSerum levels of anti-mag auto-Antibodies in the studied children.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 25, 'Serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 55, 'antibodies')]
PMC3476426	8/2012	S82-PMC3476426	['anti-mag, anti-Myelin-Associated Glycoprotein Antibodies; btu, buhlmann titre unit.']	N/A	N/A	[('UBERON_0000345', 'myelin', 15, 'myelin'), ('PR_000004593', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3', 21, '-associated'), ('CHEBI_17089', 'glycoprotein', 33, 'glycoprotein'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies')]
PMC3476426	8/2012	S83-PMC3476426	['patients with severe autism had significantly higher Serum anti-mag auto-Antibodies than children with mild to moderate autism, p< 0.001 (table2).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 53, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibodies')]
PMC3476426	8/2012	S84-PMC3476426	['in addition, children with severe autism had significantly higher frequency of seropositivity of anti-mag auto-Antibodies (90.6%) than autistic patients with mild to moderate autism (33.3%), p< 0.001.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 111, 'antibodies')]
PMC3476426	8/2012	S88-PMC3476426	['caption (fig): figure 3\n\nnegative correlations between Serum levels of 25-Hydroxy Vitamin D and anti-Mag auto-Antibodies in children with autism.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 71, '25-hydroxy vitamin D'), ('PR_000010050', 'transcription factor MafG', 101, 'MAG'), ('GO_0042571', 'immunoglobulin complex, circulating', 110, 'antibodies')]
PMC3476426	8/2012	S89-PMC3476426	['anti-mag, anti-Myelin-Associated Glycoprotein Antibodies; btu, buhlmann titre unit.']	N/A	N/A	[('UBERON_0000345', 'myelin', 15, 'myelin'), ('PR_000004593', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3', 21, '-associated'), ('CHEBI_17089', 'glycoprotein', 33, 'glycoprotein'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies')]
PMC3478561	11/2012	S81-PMC3478561	['blots were blocked with 5% nonfat dry Milk for 2 h. pstat3, Stat3, phospho-Amp–activated protein kinase (pampk), ampk, phospho-Acetyl Coa carboxylase (pacc), and acc were determined using corresponding Antibodies (cell signaling, beverly, ma; millipore).']	N/A	N/A	[('UBERON_0001913', 'milk', 38, 'milk'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 60, 'STAT3'), ('CHEBI_16027', "adenosine 5'-monophosphate", 75, 'AMP'), ('CHEBI_15513', 'acryloyl-CoA', 127, 'acetyl CoA'), ('GO_0042571', 'immunoglobulin complex, circulating', 202, 'antibodies')]
PMC3496584	7/2012	S132-PMC3496584	['as mentioned earlier, Brain specific auto-Antibodies are present in the Plasma of many asd Individuals [112,164,165].']	N/A	N/A	[('UBERON_0000955', 'brain', 22, 'brain'), ('GO_0042571', 'immunoglobulin complex, circulating', 42, 'antibodies'), ('UBERON_0001969', 'blood plasma', 72, 'plasma'), ('NCBITaxon_1', 'root', 91, 'individuals')]
PMC3496584	7/2012	S133-PMC3496584	['in a cohort of egyptian autistic children, 54.5% had antineuronal Antibodies [166].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 66, 'antibodies')]
PMC3496584	7/2012	S155-PMC3496584	['laboratory studies\nintroduction of Human systemic lupus erythematosus auto-Antibodies to Pregnant Mice led to Cortical impairment in their offspring [199].']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 35, 'human'), ('GO_0042571', 'immunoglobulin complex, circulating', 75, 'antibodies'), ('GO_0007565', 'female pregnancy', 89, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 98, 'mice'), ('UBERON_0001851', 'cortex', 110, 'cortical')]
PMC3501517	11/2012	S71-PMC3501517	['all slides were then incubated with Rabbit-anti-Rat secondary Antibody (1∶300 dilution, vector laboratories, burlingame, ca), stained with dab, and counterstained with Hematoxylin.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rabbit'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 48, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 62, 'antibody'), ('CHEBI_51686', 'haematoxylin', 168, 'hematoxylin')]
PMC3501517	11/2012	S85-PMC3501517	['Cxcr2 positive cells were defined as having fluorescent intensity greater than 95% of cells labeled with isotype control Antibody.']	N/A	N/A	[('PR_000001209', 'C-X-C chemokine receptor type 5', 0, 'CXCR2'), ('GO_0042571', 'immunoglobulin complex, circulating', 121, 'antibody')]
PMC3503401	11/2012	S31-PMC3503401	['at the same time Thyroid function tests, Thyroid Antibodies, and Urinary Iodine concentrations were measured.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 17, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 41, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibodies'), ('UBERON_0001088', 'urine', 65, 'urinary'), ('CHEBI_24859', 'iodine atom', 73, 'iodine')]
PMC3513828	11/2012	S29-PMC3513828	['the following tests were negative: hepatitis a Igm, hepatitis b surface Antigen, hepatitis b core Antibody [total & Igm], hepatitis c Antibody, hepatitis e Antibody, cytomegalovirus (Cmv) Igm, epstein-barr virus Igm, human immunodeficiency virus Antibodies, herpes simplex virus (Hsv) Igm, varicella Igm, Antinuclear Antibodies, Antimitochondrial Antibodies, and antismooth muscle Antibodies.']	N/A	N/A	[('GO_0071754', 'IgM immunoglobulin complex, circulating', 47, 'IgM'), ('CHEBI_59132', 'antigen', 72, 'antigen'), ('GO_0042571', 'immunoglobulin complex, circulating', 98, 'antibody'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 116, 'IgM'), ('GO_0042571', 'immunoglobulin complex, circulating', 134, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 156, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 183, 'CMV'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 188, 'IgM'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 212, 'IgM'), ('GO_0042571', 'immunoglobulin complex, circulating', 246, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 280, 'HSV'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 285, 'IgM'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 300, 'IgM'), ('GO_0005642', 'annulate lamellae', 305, 'antinuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 317, 'antibodies'), ('GO_0043079', 'antipodal cell nucleus', 329, 'antimitochondrial'), ('GO_0042571', 'immunoglobulin complex, circulating', 347, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 381, 'antibodies')]
PMC3527219	11/2012	S85-PMC3527219	['immunofluorescence double staining for flow cytometry was performed by incubating 200 μl of the pbmc suspension (1\u2009×\u2009106cells) with 10 μl of Fluorescein Isothiocyanate (Fitc)-conjugated Mouse-anti-Porcine Cd4Α (Igg2B isotype) and 10 μl R-Phycoerythrin (rpe)-conjugated Mouse-anti-Porcine Cd8Α (Igg2A isotype) monoclonal Antibodies (abd serotec, oxford, uk) in the dark at room temperature for 30 min.']	N/A	N/A	[('CHEBI_37926', 'fluorescein isothiocyanate', 141, 'fluorescein isothiocyanate'), ('CHEBI_37926', 'fluorescein isothiocyanate', 169, 'FITC'), ('NCBITaxon_10088', 'Mus <genus>', 186, 'mouse'), ('NCBITaxon_10088', 'Mus <genus>', 197, 'porcine'), ('PR_000001200', 'C-C chemokine receptor type 4', 205, 'CD4α'), ('GO_0071735', 'IgG immunoglobulin complex', 211, 'IgG2b'), ('CHEBI_8735', 'R', 236, 'R'), ('CHEBI_36311', 'corphinoid', 238, 'phycoerythrin'), ('NCBITaxon_10088', 'Mus <genus>', 269, 'mouse'), ('NCBITaxon_10088', 'Mus <genus>', 280, 'porcine'), ('PR_000001200', 'C-C chemokine receptor type 4', 288, 'CD8α'), ('GO_0071735', 'IgG immunoglobulin complex', 294, 'IgG2a'), ('GO_0042571', 'immunoglobulin complex, circulating', 320, 'antibodies')]
PMC3527219	11/2012	S86-PMC3527219	['excess Antibodies were removed by washing plates twice with pbs/1% fetal Bovine Serum (fbs) and centrifuging at 180\u2009×\u2009g for 5 min at 20°c.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 7, 'antibodies'), ('NCBITaxon_33208', 'Metazoa', 73, 'bovine'), ('UBERON_0001977', 'blood serum', 80, 'serum')]
PMC3527219	11/2012	S91-PMC3527219	['to estimate the specific binding of Mouse monoclonal Antibodies to Cell Surface Of Lymphocytes Mouse-Igg2B negative control-Fitc and Mouse-Igg2A negative control-rpe (serotec, oxford, uk) were used.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 36, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibodies'), ('GO_0009504', 'cell plate', 67, 'cell surface of ...'), ('CL_0000542', 'lymphocyte', 83, 'lymphocytes'), ('NCBITaxon_10088', 'Mus <genus>', 95, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 101, 'IgG2b'), ('CHEBI_37926', 'fluorescein isothiocyanate', 124, 'FITC'), ('NCBITaxon_10088', 'Mus <genus>', 133, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 139, 'IgG2a')]
PMC3534399	10/2012	S9-PMC3534399	['the primary outcome measures of this study are Thymic Development during infancy, and Antibody response to vaccination.']	N/A	N/A	[('GO_0048538', 'thymus development', 47, 'thymic development'), ('UBERON_0002370', 'thymus', 47, 'thymic'), ('GO_0042571', 'immunoglobulin complex, circulating', 86, 'antibody')]
PMC3534399	10/2012	S125-PMC3534399	['at 12, 24 and 52 weeks of age, a Venous Blood sample is collected from infants for the assessment of Antibody response to vaccination, Micronutrient status, with residual aliquots biobanked for further biomarker measurements.']	N/A	N/A	[('UBERON_0001638', 'vein', 33, 'venous'), ('UBERON_0000178', 'blood', 40, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 135, 'micronutrient')]
PMC3534399	10/2012	S126-PMC3534399	['Cord Blood and samples from 12 and 24 week bleeds will be used to assess anti-diphtheria, tetanus Toxoid, haemophilus b influenzae, opv and hepatitis b Antibody titres will be measured.']	N/A	N/A	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('CHEBI_29238', 'tritium atom', 98, 'toxoid'), ('GO_0042571', 'immunoglobulin complex, circulating', 152, 'antibody')]
PMC3534399	10/2012	S127-PMC3534399	['in Cord, 24 week and 52 week samples, Measles Antibody levels will be assessed.']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 3, 'cord'), ('PR_000010211', 'protein max', 38, 'measles'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibody')]
PMC3534399	10/2012	S138-PMC3534399	['secondary outcomes include (i) Antibody response to vaccination and (ii) detailed cellular immunology (on a subset of infants only).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 31, 'antibody')]
PMC3568875	1/2013	S29-PMC3568875	['she was known to have circulating anti-e Antibodies at a stable 1\u2009:\u20092 titer level.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 41, 'antibodies')]
PMC3568875	1/2013	S47-PMC3568875	['transfusion Medicine was consulted, and 2 units of type-specific Blood screened for multiple Antibodies were Transfused (table 1).']	N/A	N/A	[('CHEBI_6807', 'methadone', 12, 'medicine'), ('UBERON_0000178', 'blood', 65, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibodies'), ('GO_0009293', 'transduction', 109, 'transfused')]
PMC3568875	1/2013	S52-PMC3568875	['Cmv, babesia , direct and indirect coombs, Antinuclear Antibodies, and G6Pd deficiency testing all returned negative.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'CMV'), ('GO_0005642', 'annulate lamellae', 43, 'antinuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 55, 'antibodies'), ('PR_000008060', 'glycine N-acyltransferase-like protein 1', 71, 'G6PD')]
PMC3577465	2/2013	S63-PMC3577465	['samples were incubated with a primary Antibody against Smooth Muscle specific Α-actin (Α-Sma, clone: 1a4, dako) overnight, followed by secondary goat Antibody (hrp Polymer) for 30 minutes at 37°c.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibody'), ('UBERON_0001135', 'smooth muscle tissue', 55, 'smooth muscle'), ('PR_000010051', 'transcription factor MafK', 62, 'muscle'), ('PR_000004770', 'Polycomb complex protein BMI-1', 78, 'α-'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 87, 'α-SMA'), ('GO_0042571', 'immunoglobulin complex, circulating', 150, 'antibody'), ('CHEBI_33839', 'macromolecule', 164, 'polymer')]
PMC3577465	2/2013	S75-PMC3577465	['the pvec positively labeled with the magnetic microbeads linked to Pecam-1 Antibody were selected with the separation unit, and kept at −80°c until use.']	N/A	N/A	[('PR_000001900', 'neuropilin-1', 67, 'PECAM-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 75, 'antibody')]
PMC3577465	2/2013	S80-PMC3577465	['Membranes were incubated with a primary Antibody against Α-Sma and Et-1 overnight at 4°c and with a peroxidase-conjugated secondary Antibody for 60 minutes at room temperature.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibody'), ('PR_000003664', 'acyl-coenzyme A synthetase ACSM1, mitochondrial', 57, 'α-SMA'), ('PR_000007222', 'protein C-ets-2', 67, 'ET-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 132, 'antibody')]
PMC3577465	2/2013	S93-PMC3577465	['aliquots were incubated overnight at 4°c with one of the following Antibodies: 5 μl anti-acetylaled Histone H3 (06–599, millipore), 5 μl anti-acetylated Histone H3 (lys9/18) (H3K9/18, 07–593, millipore), 5 μl anti-acetylaled Histone H4 (06–866, millipore), anti-Hypoxia Inducible Factor 1 Α (mab5382, millipore).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies'), ('CHEBI_15358', 'histone', 100, 'Histone'), ('PR_000008608', 'hexokinase-1', 100, 'Histone H3'), ('CHEBI_15358', 'histone', 153, 'Histone'), ('PR_000008608', 'hexokinase-1', 153, 'Histone H3'), ('SO_0001735', 'H3K79_methylation_site', 175, 'H3K9'), ('CHEBI_15358', 'histone', 225, 'Histone'), ('PR_000008608', 'hexokinase-1', 225, 'Histone H4'), ('PR_000008489', 'histidine decarboxylase', 262, 'Hypoxia Inducible Factor 1 α')]
PMC3578836	2/2013	S60-PMC3578836	['Ccr2 (abcam, ma), levels in cell extracts was detected using the respective primary and secondary Antibodies and detected using the chemiluminescent horseradish peroxidase system (pierce, il) as described previously[19].']	N/A	N/A	[('PR_000001204', 'C-C chemokine receptor type 8', 0, 'CCR2'), ('GO_0042571', 'immunoglobulin complex, circulating', 98, 'antibodies')]
PMC3578836	2/2013	S64-PMC3578836	['briefly, Splenocytes were stained with Fitc-conjugated anti-cd3 and percp-Cy5.5-conjugated anti-Cd11B Antibodies or Fitc and percp-Cy5.5 isotype Rat Igg2B,k, respectively (bd biosciences, ca), then fixed in cytofix/cytoperm (bd) and permeabilized using pbs supplemented with 0.1% Saponin, 1% fbs, and 0.1% Sodium Azide.']	N/A	N/A	[('CL_0000017', 'spermatocyte', 9, 'splenocytes'), ('CHEBI_37926', 'fluorescein isothiocyanate', 39, 'FITC'), ('CHEBI_37989', 'Cy5 dye', 74, 'Cy5'), ('PR_000001309', 'CD70 molecule', 96, 'CD11b'), ('GO_0042571', 'immunoglobulin complex, circulating', 102, 'antibodies'), ('CHEBI_37926', 'fluorescein isothiocyanate', 116, 'FITC'), ('CHEBI_37989', 'Cy5 dye', 131, 'Cy5'), ('NCBITaxon_10088', 'Mus <genus>', 145, 'Rat'), ('GO_0071735', 'IgG immunoglobulin complex', 149, 'IgG2b'), ('CHEBI_26605', 'saponin', 280, 'saponin'), ('CHEBI_28341', '2-hydroxyacetophenone', 306, 'sodium azide')]
PMC3578836	2/2013	S66-PMC3578836	['cells were exposed to anti-5-Methylcytidine (acris Antibodies, germany) in permeabilization buffer, washed, then incubated with pe-anti-Mouse Igg1 or pe-isotype Rat-Igg1Κ, (bd).']	N/A	N/A	[('CHEBI_20607', '5-methylcytidine', 27, '5-methylcytidine'), ('GO_0042571', 'immunoglobulin complex, circulating', 51, 'Antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 136, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 142, 'IgG1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 161, 'rat'), ('GO_0071735', 'IgG immunoglobulin complex', 165, 'IgG1κ')]
PMC3578836	2/2013	S119-PMC3578836	['ms f1 T Cells are hypermethylated relative to control Mice\nwe quantified T-Cell and Monocytic Dna Methylation with an unbiased, Antibody-based flow cytometric method as shown infigure 3.']	N/A	N/A	[('CL_0000084', 'T cell', 6, 'T cells'), ('NCBITaxon_10088', 'Mus <genus>', 54, 'Mice'), ('CL_0000084', 'T cell', 73, 'T-cell'), ('CL_0000576', 'monocyte', 84, 'monocytic'), ('GO_0006306', 'DNA methylation', 94, 'DNA methylation'), ('GO_0042571', 'immunoglobulin complex, circulating', 128, 'antibody')]
PMC3578836	2/2013	S127-PMC3578836	['cd3+ T Cells ( a ) or Cd11B+ cells ( b ) isolated from 17 wk or 28 wk old f1 Apoe−/−Mice were stained with anti-Methylcytidine Antibody and subjected to facs analysis.']	N/A	N/A	[('CL_0000084', 'T cell', 5, 'T cells'), ('PR_000001309', 'CD70 molecule', 22, 'CD11b'), ('PR_000004155', 'apolipoprotein E', 77, 'ApoE'), ('NCBITaxon_10088', 'Mus <genus>', 84, 'mice'), ('CHEBI_25347', 'methyluridine', 112, 'methylcytidine'), ('GO_0042571', 'immunoglobulin complex, circulating', 127, 'antibody')]
PMC3581200	3/2013	S52-PMC3581200	['Antibodies specific for total and phosphorylated Akt (ser473) and Glycogen Synthase Kinase 3Β (Gsk3Β) (ser9) were purchased from cell signaling (danvers, ma), and Antibodies against Pepck and glucokinase (gk) were gifts from d. k. granner and m. shiota, respectively (vanderbilt school of medicine, nashville, tn).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 49, 'Akt'), ('CHEBI_24384', 'glycogens', 66, 'glycogen'), ('PR_000007939', 'glial fibrillary acidic protein', 66, 'glycogen synthase kinase 3β'), ('PR_000008288', 'glycogen synthase kinase-3 beta', 95, 'GSK3β'), ('GO_0042571', 'immunoglobulin complex, circulating', 163, 'antibodies'), ('PR_000012564', 'peroxisomal biogenesis factor 3', 182, 'PEPCK')]
PMC3599765	2/2013	S65-PMC3599765	['cellularity and vascularity\nparaffin-embedded Tissues were sectioned at 4\xa0μm, and stained for a Cellular Proliferation marker using the Mouse anti-Proliferating Nuclear Cell Antigen (Pcna) primary Antibody (chemicon international, temecula, ca) and detected with a biotinylated secondary Antibody (Horse anti-Mouse Igg, vectastain; vector laboratories, burlingame, ca) and the avidin-biotin complex system (vectastain; vector laboratories).']	N/A	N/A	[('UBERON_0000479', 'tissue', 46, 'tissues'), ('GO_0008283', 'cell proliferation', 96, 'cellular proliferation'), ('NCBITaxon_10088', 'Mus <genus>', 136, 'mouse'), ('GO_0008283', 'cell proliferation', 147, 'proliferating'), ('PR_000001908', 'platelet glycoprotein Ib beta chain', 147, 'proliferating nuclear cell antigen'), ('GO_0005634', 'nucleus', 161, 'nuclear'), ('CHEBI_59132', 'antigen', 174, 'antigen'), ('PR_000012421', 'proliferating cell nuclear antigen', 183, 'PCNA'), ('GO_0042571', 'immunoglobulin complex, circulating', 197, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 288, 'antibody'), ('NCBITaxon_1', 'root', 298, 'horse'), ('NCBITaxon_10088', 'Mus <genus>', 309, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 315, 'IgG')]
PMC3599765	2/2013	S69-PMC3599765	['vascularity staining was performed using an Antibody to Factor Viii, a specific Endothelial Cell marker, as previously described by our laboratory [15] and counter-stained with using Periodic Acid-schiff’s staining procedures to provide contrast to the vascular Tissue, as previously described [7,16,17]; figure\xa01.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 44, 'antibody'), ('PR_000007440', 'Fc receptor-like protein 1', 56, 'Factor VIII'), ('CL_0000115', 'endothelial cell', 80, 'endothelial cell'), ('UBERON_0001986', 'endothelium', 80, 'endothelial'), ('CHEBI_29149', 'periodic acid', 183, 'periodic acid'), ('UBERON_0000479', 'tissue', 262, 'tissue')]
PMC3603018	12/2012	S18-PMC3603018	['[4]\nthe typical case is a women in the first Trimester of Pregnancy who is referred with a high tsh value with the free Thyroid Hormones in the low normal range or with frank hypothyroidism and in certain instances with biochemical euthyroxinemia with Tpo Antibody positivity.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 45, 'trimester'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_26935', 'tetraterpenoid', 120, 'thyroid hormones'), ('UBERON_0002046', 'thyroid gland', 120, 'thyroid'), ('PR_000016585', 'tripeptidyl-peptidase 1', 252, 'TPO'), ('GO_0042571', 'immunoglobulin complex, circulating', 256, 'antibody')]
PMC3610650	3/2013	S69-PMC3610650	['Formalin-fixed paraffin embedded sections were processed in a pressure cooker for 5 min at 125°c, blocked with 3% H2O2In Methanol and 10% goat Serum (dako, x0907), and incubated with Rabbit anti-hypoxyprobe primary Antibody (1∶500, pab2627) overnight at 4°c.']	N/A	N/A	[('CHEBI_16842', 'formaldehyde', 0, 'Formalin'), ('CHEBI_42471', 'forskolin', 114, 'H2O2in'), ('CHEBI_17790', 'methanol', 121, 'methanol'), ('UBERON_0001977', 'blood serum', 143, 'serum'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 183, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 215, 'antibody')]
PMC3610650	3/2013	S70-PMC3610650	['bound primary Antibody was detected by sequentially incubating the samples with goat anti-Rabbit biotinylated Igg’s (1∶400, dako, e0432) and streptavidin/horseradish peroxidase (1∶400, dako, p0397) for 30 min at rt.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 90, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 110, 'IgG')]
PMC3610650	3/2013	S79-PMC3610650	['immunoblotting was performed using the following Antibodies: Hif-2Α (nb100–122) novus biologicals; dcytb (dcytb11-a, alpha diagnostics), Dmt1[31],[32], Hsc70 (sc-7298), ccs (sc-20141), Ferritin H (sc-14416) santa cruz and Β-Actin (a5316) sigma.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibodies'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 61, 'HIF-2α'), ('PR_000006606', 'DNA (cytosine-5)-methyltransferase 1', 137, 'DMT1'), ('PR_000008806', 'heat shock 70 kDa protein 1-like', 152, 'Hsc70'), ('CHEBI_69271', 'Inflatin B', 185, 'Ferritin H'), ('PR_000007443', 'Fc receptor-like protein 4', 185, 'Ferritin'), ('PR_000003676', 'actin, cytoplasmic 1', 222, 'β-actin')]
PMC3613945	2/2013	S283-PMC3613945	['rheumatic fever\nrheumatic fever is a systemic inflammatory illness characterized by excessive B Cell activity leading to an over-Production Of Antibody to group a streptococcus.']	N/A	N/A	[('CL_0000236', 'B cell', 94, 'B cell'), ('GO_0019230', 'proprioception', 129, 'production of antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 143, 'antibody')]
PMC3614838	9/2011	S70-PMC3614838	['the primary Antibody was omitted for method controls.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibody')]
PMC3616124	4/2013	S82-PMC3616124	['Sds page was followed by western blotting with primary (1∶5,000, polyclonal Rabbit anti-Human haptoglobin, dakocytomation, carpinteria, ca) and secondary (1∶25,000, Goat anti-Rabbit Igg horseradish peroxidase, millipore) Antibodies.']	N/A	N/A	[('CHEBI_8984', 'sodium dodecyl sulfate', 0, 'SDS'), ('NCBITaxon_10088', 'Mus <genus>', 76, 'Rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 88, 'Human'), ('NCBITaxon_10088', 'Mus <genus>', 165, 'Goat'), ('NCBITaxon_10088', 'Mus <genus>', 175, 'Rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 182, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 221, 'antibodies')]
PMC3635901	4/2013	S26-PMC3635901	['by contrast, self-reactive Antibodies against self-reactive or cross-reactive dna co-engage Antigen receptors and tlrs, leading to a continuous activation of these auto-reactive B Cells and the development of Autoimmune disease [12].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 27, 'antibodies'), ('CHEBI_59132', 'antigen', 92, 'antigen'), ('CL_0000236', 'B cell', 178, 'B cells'), ('UBERON_0001442', 'skeleton of manus', 209, 'autoimmune')]
PMC3642194	5/2013	S68-PMC3642194	['methylated dna was immunoprecipitated using 0.15 ul of magnetic beads coated with anti-5Methylcytidine Antibody (diagenode) or Mouse pre-immune Serum.']	N/A	N/A	[('CHEBI_23916', 'enoyl group', 87, '5methylcytidine'), ('GO_0042571', 'immunoglobulin complex, circulating', 103, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 127, 'mouse'), ('UBERON_0001977', 'blood serum', 144, 'serum')]
PMC3653849	5/2013	S166-PMC3653849	['pre-cleared protein a/g plus-Agarose (sc-2003, santa cruz) was used to immunoprecipitate the Antibody/dna Complexes, and the medip dna was purified.']	N/A	N/A	[('CHEBI_2511', 'agarose', 29, 'Agarose'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibody'), ('GO_0032991', 'protein-containing complex', 106, 'complexes')]
PMC3653849	5/2013	S169-PMC3653849	['hrp-conjugated anti-Rabbit Antibody (star54, univ-bio, 1∶8000) and hrp-anti-Mouse Antibody (star86p, univ-bio, 1∶8000) were used as secondary Antibodies.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 20, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 27, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 76, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 82, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 142, 'antibodies')]
PMC3653849	5/2013	S177-PMC3653849	['after pre-clearance of the resulting Chromatin with salmon Sperm dna-protein a/g Agarose (50% slurry), the immunoprecipitation was performed with 2 µg of a specific gr Antibody (sc-1004x, santa cruz) or normal Igg (12–370, millipore) as control overnight at 4°c.']	N/A	N/A	[('GO_0000785', 'chromatin', 37, 'chromatin'), ('CL_0000019', 'sperm', 59, 'sperm'), ('CHEBI_2511', 'agarose', 81, 'agarose'), ('GO_0042571', 'immunoglobulin complex, circulating', 168, 'antibody'), ('GO_0071735', 'IgG immunoglobulin complex', 210, 'IgG')]
PMC3654972	5/2013	S71-PMC3654972	['blots were probed with the following anti-Rat Antibodies: tfr diluted 1:1000 (serotec) for both fetal Liver and Placental samples, ferroportin (alpha diagnostics) diluted 1:30,000 for Placental samples and 1:700 for fetal Liver samples, Tubulin (abcam, uk) diluted 1:60,000 for both fetal Liver and Placental samples.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 42, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies'), ('UBERON_0002107', 'liver', 102, 'liver'), ('UBERON_0001987', 'placenta', 112, 'placental'), ('UBERON_0001987', 'placenta', 184, 'placental'), ('UBERON_0002107', 'liver', 222, 'liver'), ('PR_000016845', 'twinfilin-2', 237, 'Tubulin'), ('UBERON_0002107', 'liver', 289, 'liver'), ('UBERON_0001987', 'placenta', 299, 'placental')]
PMC3654972	5/2013	S72-PMC3654972	['blots were developed using ecl Reagents and treated with goat anti-Rabbit (ferroportin and Tubulin) or Sheep anti-Mouse (tfr) Horse radish peroxidise linked secondary Antibody (ge healthcare).']	N/A	N/A	[('CHEBI_33893', 'reagent', 31, 'reagents'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 67, 'rabbit'), ('PR_000028799', 'tubulin', 91, 'tubulin'), ('NCBITaxon_10088', 'Mus <genus>', 103, 'sheep'), ('NCBITaxon_10088', 'Mus <genus>', 114, 'mouse'), ('NCBITaxon_1', 'root', 126, 'horse'), ('GO_0042571', 'immunoglobulin complex, circulating', 167, 'antibody')]
PMC3657451	4/2013	S3-PMC3657451	['women with hypothyroidism and having anti-thyroglobulin (atg) and anti-Thyroid peroxidase (anti-Tpo) Antibodies were assigned as group i, women with hypothyroidism who did not have Autoantibodies were assigned as group ii, and women without Thyroid problems were assigned as group iii.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 71, 'thyroid'), ('PR_000016585', 'tripeptidyl-peptidase 1', 96, 'TPO'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibodies'), ('GO_0044308', 'axonal spine', 181, 'autoantibodies'), ('UBERON_0002046', 'thyroid gland', 241, 'thyroid')]
PMC3657451	4/2013	S110-PMC3657451	['none of the infants of mothers with elevated anti-tg Antibodies had elevated Serum anti-tg levels.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibodies'), ('UBERON_0001977', 'blood serum', 77, 'serum')]
PMC3675032	6/2013	S62-PMC3675032	['after the ponceau s staining, the Membranes were divided at 60 kda to facilitate incubation with multiple Antibodies.']	N/A	N/A	[('GO_0016020', 'membrane', 34, 'membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 106, 'antibodies')]
PMC3675032	6/2013	S63-PMC3675032	['Membranes were blocked in 5% skimmed milk prior to incubation with other Antibodies and subsequently incubated overnight with the Antibodies against Pkcζ (sc-216, santa cruz, ca, usa; see information s3, s5, and s6 for band specificity and quality), Insulin Receptor Beta Subunit ( Insrβ )(sc-711, santa cruz; see information s3, s5, and s6 for band specificity and quality), Phosphoinositide 3 Kinase-P85 Regulatory Subunit ( Pi3K-P85 )(06–195, millipore, billerica, ma, usa; see information s4 for band specificity and quality), and Phosphoinositide 3 Kinase-P110 Catabolic Subunit ( Pi3K-P110 )(sc-602, santa cruz; see information s4 for band specificity and quality), or were incubated with the Antibody against Glut4 (ab37445, abcam, cambridge, uk; see information s3, s5, and s6 for band specificity and quality).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 130, 'antibodies'), ('PR_000003059', 'protein kinase C beta type', 149, 'PKCζ'), ('PR_000002050', 'interferon regulatory factor 8', 250, 'insulin receptor beta subunit'), ('PR_000009020', "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase", 282, 'INSRβ'), ('CHEBI_18179', 'phosphoinositide', 376, 'phosphoinositide'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 376, 'phosphoinositide 3 kinase-'), ('PR_000013030', 'NADPH--cytochrome P450 reductase', 402, 'p85 regulatory subunit'), ('GO_0065007', 'biological regulation', 406, 'regulatory'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 427, 'PI3K-'), ('PR_000001245', 'rhodopsin', 432, 'p85'), ('CHEBI_18179', 'phosphoinositide', 535, 'phosphoinositide'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 535, 'phosphoinositide 3 kinase-'), ('PR_000004100', 'AP-2 complex subunit alpha-2', 561, 'p110 catabolic subunit'), ('PR_000014702', 'plasminogen activator inhibitor 1', 586, 'PI3K'), ('PR_000000035', 'BMP receptor type-1A', 591, 'p110'), ('GO_0042571', 'immunoglobulin complex, circulating', 699, 'antibody'), ('PR_000015065', 'solute carrier family 2, facilitated glucose transporter member 3', 716, 'GLUT4')]
PMC3675032	6/2013	S64-PMC3675032	['subsequently, Membranes were incubated with horseradish peroxidase-conjugated anti-Rabbit Antibodies (#7074, cell signalling technology).']	N/A	N/A	[('GO_0016020', 'membrane', 14, 'membranes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 83, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibodies')]
PMC3675032	6/2013	S67-PMC3675032	['assay linearity between signal and protein quantity was verified for each Antibody and for the ponceau s staining.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 74, 'antibody')]
PMC3728489	7/2013	S149-PMC3728489	['in Human Milk the main Antibody is Iga, which constitutes part of the Mucosal Immune System that Controls Epithelial colonization of microorganisms and inhibits penetration of harmful substances (brandtzaeg,2011).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 3, 'human'), ('UBERON_0001913', 'milk', 9, 'milk'), ('GO_0042571', 'immunoglobulin complex, circulating', 23, 'antibody'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 35, 'IgA'), ('UBERON_0000344', 'mucosa', 70, 'mucosal'), ('UBERON_0002405', 'immune system', 78, 'immune system'), ('GO_0065007', 'biological regulation', 97, 'controls'), ('UBERON_0000483', 'epithelium', 106, 'epithelial')]
PMC3728489	7/2013	S153-PMC3728489	['Food-derived Antigens are transferred through the Placenta into the Amniotic Fluid and cause Prenatal formation of Antigen-specific Ige Antibodies (kondo et al.,1992).']	N/A	N/A	[('CHEBI_33290', 'food', 0, 'Food'), ('CHEBI_59132', 'antigen', 13, 'antigens'), ('UBERON_0001987', 'placenta', 50, 'placenta'), ('UBERON_0000173', 'amniotic fluid', 68, 'amniotic fluid'), ('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_59132', 'antigen', 115, 'antigen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 132, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 136, 'antibodies')]
PMC3728489	7/2013	S212-PMC3728489	['altered or poorer Adaptive Immunity was measured from humoral Immunity, indexed by reduced hepatitis b Antibody titers following immunization ( in vivo ), and cell-Mediated Immunity, indexed by increased Il-4 and decreased Ifn-Γ responder cell frequencies to Antigen ( in vitro ).']	N/A	N/A	[('GO_0051866', 'general adaptation syndrome', 18, 'adaptive immunity'), ('GO_0007566', 'embryo implantation', 62, 'immunity'), ('GO_0042571', 'immunoglobulin complex, circulating', 103, 'antibody'), ('GO_0010222', 'stem vascular tissue pattern formation', 164, 'mediated immunity'), ('PR_000001470', 'interleukin-28B', 204, 'IL-4'), ('PR_000008920', 'interferon alpha-7', 223, 'IFN-γ'), ('CHEBI_59132', 'antigen', 259, 'antigen')]
PMC3740243	8/2013	S112-PMC3740243	['similarly, Adult Rats undernourished during Lactation showed no change in Immune parameters after an Immune challenge either under control conditions or after being subjected to footshock, while control Rats (normal diet during Lactation) had elevated Leukocyte counts and Antibody titers (barreto-medeiros et al.,2007).']	N/A	N/A	[('UBERON_0007023', 'adult organism', 11, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 17, 'rats'), ('GO_0007595', 'lactation', 44, 'lactation'), ('UBERON_0002405', 'immune system', 74, 'immune'), ('UBERON_0002405', 'immune system', 101, 'immune'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 203, 'rats'), ('GO_0007595', 'lactation', 228, 'lactation'), ('CL_0000738', 'leukocyte', 252, 'leukocyte'), ('GO_0042571', 'immunoglobulin complex, circulating', 273, 'antibody')]
PMC3742769	8/2013	S52-PMC3742769	['sections were subjected to three 10-min washes in pbs with 0.3% Triton-x with 10 min between each wash. nonspecific epitopes were blocked with 1% Serum for 30 min at rt, and were incubated overnight at 4°c with either Brdu (1∶100; bd pharmingen, franklin lakes, nj, usa) or Cleaved Caspase-3 (1∶1,000; cell signaling, danvers, ma, usa) Antibody in pbs and 1% Serum.']	N/A	N/A	[('CHEBI_70359', '3-acetyleriocasin C, (rel)-', 64, 'Triton-'), ('UBERON_0001977', 'blood serum', 146, 'serum'), ('CHEBI_472552', "5-bromo-2'-deoxyuridine", 218, 'BrdU'), ('PR_000005833', 'cleavage and polyadenylation specificity factor subunit 6', 274, 'cleaved caspase-3'), ('GO_0042571', 'immunoglobulin complex, circulating', 336, 'antibody'), ('UBERON_0001977', 'blood serum', 359, 'serum')]
PMC3742769	8/2013	S53-PMC3742769	['on day 2, the sections were incubated with the appropriate secondary fluorescent Antibodies (Alexa Fluor 488, 1∶200; invitrogen, carlsbad, ca, usa) for 2 h at rt, followed by three 5-min washes in pbs.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibodies'), ('CHEBI_52661', 'Alexa Fluor 488', 93, 'Alexa Fluor 488')]
PMC3742769	8/2013	S62-PMC3742769	['the blots were incubated overnight at 4°c with a polyclonal anti-Cleaved Caspase-3 Antibody, and then incubated with a Rabbit anti-Mouse polyclonal horseradish peroxidase-conjugated secondary Antibody (1∶5,000; epitomics, hangzhou, zhejiang province, china) at rt for 1 h. protein signals were detected using an enhanced chemiluminescence detection system (pierce biotechnology).']	N/A	N/A	[('PR_000005833', 'cleavage and polyadenylation specificity factor subunit 6', 65, 'cleaved caspase-3'), ('GO_0042571', 'immunoglobulin complex, circulating', 83, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 119, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 131, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 192, 'antibody')]
PMC3742769	8/2013	S63-PMC3742769	['a Β-Actin Antibody (1∶1,000; santa cruz biotechnology, santa cruz, ca, usa) was used to normalize sample loading and transfer.']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 2, 'β-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibody')]
PMC3749995	8/2013	S92-PMC3749995	['approximately 50 µg protein was probed with an Antibody raised against 11Β Hydroxysteroid Dehydrogenase Type Ii (abnova, ca, usa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibody'), ('CHEBI_37983', 'sulfur-35 atom', 71, '11β'), ('PR_000003753', 'adenylate cyclase type 2', 71, '11β hydroxysteroid dehydrogenase type II')]
PMC3756974	8/2013	S74-PMC3756974	['the membrane was washed twice with 40 mm Tris–Hcl buffer (ph 7.4), 0.9% Nacl, and 0.3% Tween 20, and then exposed to the diluted primary Antibody.']	N/A	N/A	[('CHEBI_9754', 'tris', 41, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 46, 'HCl'), ('CHEBI_26710', 'sodium chloride', 72, 'NaCl'), ('CHEBI_53422', 'polysorbate', 87, 'Tween'), ('GO_0042571', 'immunoglobulin complex, circulating', 137, 'antibody')]
PMC3756974	8/2013	S75-PMC3756974	['Amp-activated protein kinase (ampk) Antibody, thr172-phosphorylated ampk Antibody, Endothelial Isoform of Nitric Oxide synthase (Enos) Antibody, phosphorylated Enos Antibody, P53 Antibody (cell signaling technology, usa), and Β-Actin Antibody (abcam, japan) were incubated with the blot in a 1% blocking Solution that contained 40 mm Tris–Hcl buffer (ph7.4), 0.9% Nacl, 0.3% Tween 20, and 1% blocking Reagent or odyssey blocking buffer.']	N/A	N/A	[('CHEBI_16027', "adenosine 5'-monophosphate", 0, 'AMP'), ('GO_0042571', 'immunoglobulin complex, circulating', 36, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibody'), ('UBERON_0001986', 'endothelium', 83, 'endothelial'), ('SO_0001060', 'sequence_variant', 95, 'isoform'), ('CHEBI_16480', 'nitric oxide', 106, 'nitric oxide'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 129, 'eNOS'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibody'), ('PR_000007020', 'ETS-related transcription factor Elf-1', 160, 'eNOS'), ('GO_0042571', 'immunoglobulin complex, circulating', 165, 'antibody'), ('PR_000003035', 'cellular tumor antigen p53', 175, 'p53'), ('GO_0042571', 'immunoglobulin complex, circulating', 179, 'antibody'), ('PR_000003676', 'actin, cytoplasmic 1', 226, 'β-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 234, 'antibody'), ('CHEBI_75958', 'solution', 304, 'solution'), ('CHEBI_9754', 'tris', 334, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 339, 'HCl'), ('CHEBI_26710', 'sodium chloride', 364, 'NaCl'), ('CHEBI_53424', 'polysorbate 20', 375, 'Tween 20'), ('CHEBI_33893', 'reagent', 401, 'reagent')]
PMC3756974	8/2013	S76-PMC3756974	['again, the membrane was washed for 3 times for 3 min in 40 mm Tris–Hcl buffer (ph 7.4), 0.9% Nacl, 0.3% Tween 20, and then exposed to the secondary Antibody: anti-Rabbit Igg irdye 680 or anti-Mouse Igg irdye 800 (m & s techno systems, japan), diluted 1500 times in 1% blocking Solution.']	N/A	N/A	[('CHEBI_9754', 'tris', 62, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 67, 'HCl'), ('CHEBI_26710', 'sodium chloride', 93, 'NaCl'), ('CHEBI_53424', 'polysorbate 20', 104, 'Tween 20'), ('GO_0042571', 'immunoglobulin complex, circulating', 148, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 163, 'Rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 170, 'IgG'), ('NCBITaxon_10088', 'Mus <genus>', 192, 'Mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 198, 'IgG'), ('CHEBI_75958', 'solution', 277, 'solution')]
PMC3773919	9/2013	S401-PMC3773919	['the infants were followed prospectively for 2 years regarding development of Eczema and sensitization as defined by a positive skin prick test and/or circulating Allergen-specific Ige Antibodies at 6, 12, and 24 months of age [44].']	N/A	N/A	[('GO_0000278', 'mitotic cell cycle', 77, 'eczema'), ('CHEBI_50904', 'allergen', 162, 'allergen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 180, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 184, 'antibodies')]
PMC3794936	10/2013	S68-PMC3794936	['frozen sections of Liver (5 μm) were stained with oil red o for Lipids or anti-cidea Antibody (santa cruz) for if labeling of cidea proteins.']	N/A	N/A	[('UBERON_0002107', 'liver', 19, 'liver'), ('CHEBI_18059', 'lipid', 64, 'lipids'), ('GO_0042571', 'immunoglobulin complex, circulating', 85, 'antibody')]
PMC3794936	10/2013	S78-PMC3794936	['primary Antibodies for Pparα, Pparγ, C/Ebpβ (santa cruz), Fsp27 (abcam), and α-Tubulin (sigma) were used.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 8, 'antibodies'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 23, 'PPARα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 30, 'PPARγ'), ('PR_000004967', 'calbindin', 37, 'C/EBPβ'), ('PR_000007690', 'ferritin heavy chain', 58, 'FSP27'), ('PR_000028799', 'tubulin', 79, 'tubulin')]
PMC3794936	10/2013	S81-PMC3794936	['immunoprecipitation was performed with ∼3 µg anti-H3K4Me3, H3K9Me3 and h3k27me3 (abcam) Antibodies and Rabbit Igg (sigma).']	N/A	N/A	[('SO_0001734', 'H3K4_methylation_site', 50, 'H3K4me3'), ('SO_0001707', 'H3K9_trimethylation_site', 59, 'H3K9me3'), ('GO_0042571', 'immunoglobulin complex, circulating', 88, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 103, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 110, 'IgG')]
PMC3820434	12/2012	S47-PMC3820434	['obese, Insulin-resistant Mice treated with either anti-Cxcl5 neutralizing Antibodies or with antagonists of the chemokine (c-x-c motif) Receptor (Cxcr)-2, which is the Cxcl5 receptor, were protected against ir, as were Cxcr2−/− Mice [25].']	N/A	N/A	[('PR_000045358', 'insulin family protein', 7, 'insulin'), ('NCBITaxon_10088', 'Mus <genus>', 25, 'mice'), ('PR_000006069', 'C-X-C motif chemokine 2', 55, 'CXCL5'), ('GO_0042571', 'immunoglobulin complex, circulating', 74, 'antibodies'), ('PR_000014368', 'RuvB-like 1', 136, 'receptor'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 146, 'CXCR)-2'), ('PR_000006069', 'C-X-C motif chemokine 2', 168, 'CXCL5'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 219, 'Cxcr2'), ('NCBITaxon_10088', 'Mus <genus>', 228, 'mice')]
PMC3820434	12/2012	S116-PMC3820434	['Lox-1 Expression was increased when Macrophages were incubated with an adiponectin-neutralizing Antibody [56].']	N/A	N/A	[('PR_000009880', 'Lon protease, mitochondrial', 0, 'LOX-1'), ('GO_0010467', 'gene expression', 6, 'expression'), ('CL_0000235', 'macrophage', 36, 'macrophages'), ('GO_0042571', 'immunoglobulin complex, circulating', 96, 'antibody')]
PMC3829803	11/2013	S78-PMC3829803	['(h) u937 cells were Infected with Muv at an moi of 0.01 and treated with 1\xa0μm Atra or Dmso and isotype control Antibody or Ifnar2 Antibody.']	N/A	N/A	[('GO_0007631', 'feeding behavior', 20, 'infected'), ('NCBITaxon_10088', 'Mus <genus>', 34, 'MuV'), ('CHEBI_17033', 'biliverdin', 78, 'ATRA'), ('CHEBI_34018', '(S)-AMPA', 86, 'DMSO'), ('GO_0042571', 'immunoglobulin complex, circulating', 111, 'antibody'), ('PR_000008920', 'interferon alpha-7', 123, 'IFNAR2'), ('GO_0042571', 'immunoglobulin complex, circulating', 130, 'antibody')]
PMC3829803	11/2013	S274-PMC3829803	['for experiments in which Antibodies were used to block type i ifn signalling, an rneasy mini kit was used to extract rna (qiagen, mississauga, on).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 25, 'antibodies')]
PMC3829803	11/2013	S286-PMC3829803	['blocking Antibody\nsupernatants were collected from tws and used to treat fresh u937 cells.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 9, 'antibody')]
PMC3829803	11/2013	S287-PMC3829803	['these fresh cells were treated with anti-Ifnar2 blocking Antibody (20\xa0μg/μl, pbl biomedical laboratories, piscataway, nj) or isotype control Antibody for one hour before infection and for the subsequent 24-hour incubation with the conditioned media.']	N/A	N/A	[('PR_000008920', 'interferon alpha-7', 41, 'IFNAR2'), ('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 141, 'antibody')]
PMC3829803	11/2013	S291-PMC3829803	['the membranes were incubated in 5% non-fat milk or 5% bsa for 1\xa0hour and incubated overnight at 4°c with primary Antibody.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 113, 'antibody')]
PMC3829803	11/2013	S292-PMC3829803	['primary Antibodies used were against Phospho-Stat1 (y701) (1/1000, bd bioscience), total Stat1 (1/1000, bd bioscience) and Β-Actin (1/10000, sigma).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 8, 'antibodies'), ('CHEBI_32958', 'phosphate group', 37, 'phospho'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 45, 'STAT1'), ('PR_000015700', 'alpha-2,8-sialyltransferase 8F', 89, 'STAT1'), ('PR_000003676', 'actin, cytoplasmic 1', 123, 'β-actin')]
PMC3829803	11/2013	S293-PMC3829803	['following overnight incubation, membranes were washed three times for 10\xa0minutes in tbs/0.1% Tween, incubated with secondary Antibody (1/10000, ge healthcare) at room temperature for 30\xa0minutes, and washed three times for 10\xa0minutes.']	N/A	N/A	[('CHEBI_53422', 'polysorbate', 93, 'Tween'), ('GO_0042571', 'immunoglobulin complex, circulating', 125, 'antibody')]
PMC3829803	11/2013	S294-PMC3829803	['the peroxidase-conjugated secondary Antibodies were developed using a chemiluminescence kit according to the manufacturer’s instructions (ge healthcare).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 36, 'antibodies')]
PMC3857567	12/2013	S181-PMC3857567	['sections were permeabilized in 0.2% Tritonx-100 in pbs for 15′, blocked in 10% goat Serum/5% bsa in pbs, and incubated with α-ki67 Antibody (abcam, 1:250), α-Pten (cell signaling technology 1:200), α-phospho (ser380) Pten (cell signaling technology, 1:200), α-Akt (cell signaling technology, 1:200), or α-phospho (ser473) Akt (cell signaling technology, 1:200) overnight at 4°c (all Antibodies were raised in Rabbit).']	N/A	N/A	[('CHEBI_9750', 'Triton X-100', 36, 'TritonX-100'), ('UBERON_0001977', 'blood serum', 84, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 131, 'antibody'), ('PR_000012582', 'ATP-dependent 6-phosphofructokinase, liver type', 158, 'Pten'), ('PR_000012582', 'ATP-dependent 6-phosphofructokinase, liver type', 217, 'Pten'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 260, 'Akt'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 322, 'Akt'), ('GO_0042571', 'immunoglobulin complex, circulating', 383, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 409, 'rabbit')]
PMC3857567	12/2013	S182-PMC3857567	['slides were washed in pbs and incubated for 1\u2005hour at room temperature in either hrp- (santa cruz biotechnology, 1:2500) or Alexa Fluor 488/568-conjugated (molecular probes,1:1000) secondary Antibodies raised in goat.']	N/A	N/A	[('CHEBI_52661', 'Alexa Fluor 488', 124, 'Alexa Fluor 488'), ('GO_0042571', 'immunoglobulin complex, circulating', 191, 'antibodies')]
PMC3857567	12/2013	S194-PMC3857567	['slides were washed in pbs and labeled with Alexa Fluor 488 secondary Antibody (life technologies, 1:100) for 30′ at room temperature, and to-Pro-3 Iodide 642 (life technologies, 1:500) was applied for 5′ at room temperature.']	N/A	N/A	[('CHEBI_52661', 'Alexa Fluor 488', 43, 'Alexa Fluor 488'), ('GO_0042571', 'immunoglobulin complex, circulating', 69, 'antibody'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 141, 'PRO-3'), ('CHEBI_37972', 'phosphorus-32 atom', 145, '3'), ('CHEBI_16382', 'iodide', 147, 'iodide')]
PMC3857567	12/2013	S204-PMC3857567	['Membranes were incubated in primary Antibody overnight at 4°c in heat-sealed bags.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 36, 'antibody')]
PMC3857567	12/2013	S205-PMC3857567	['primary Antibodies were the same as used above; all were diluted 1:1000.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 8, 'antibodies')]
PMC3857567	12/2013	S206-PMC3857567	['Membranes were washed and incubated with hrp-conjugated secondary Antibodies (santa cruz, 1:10,000) for 1\u2005hour at room temperature.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 66, 'antibodies')]
PMC3869952	12/2013	S50-PMC3869952	['hiv status is determined by Antibody testing with a broad-based hiv-1/hiv-2 enzyme-linked immunosorbent assay (elisa; vironostika, organon teknika, boxtel, the netherlands) followed by a confirmatory elisa (gac-elisa; abbott, abbott park, illinois, usa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 28, 'antibody')]
PMC3898607	1/2014	S220-PMC3898607	['Tissues were incubated overnight with primary Antibody at 4°c, followed by a 2\xa0hr incubation with secondary Antibodies at room temperature the next day.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissues'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 108, 'antibodies')]
PMC3898607	1/2014	S221-PMC3898607	['the following Antibodies were used: Mouse α-futsch (22c10, developmental studies hybridoma bank; 1:10), goat α-green fluorescent protein (gfp) (abcam, 1:2,000), Rabbit α-ilp7 (miguel-aliaga et\xa0al., 2008; 1:5,000), Mouse anti-Pdf propeptide (Pdf c7, developmental studies hybridoma bank; 1:50) and Mouse anti-dsrf Antibody (active motif, 1:10).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 36, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 161, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 214, 'mouse'), ('PR_000012208', 'polyadenylate-binding protein 4', 225, 'Pdf'), ('PR_000012208', 'polyadenylate-binding protein 4', 241, 'Pdf'), ('NCBITaxon_10088', 'Mus <genus>', 297, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 313, 'antibody')]
PMC3898607	1/2014	S223-PMC3898607	['Fitc-, Cy3-, and Cy5-conjugated secondary Antibodies were obtained from jackson immunolabs and used at 1:200 (1:100 for the Cy5-conjugated Antibody).']	N/A	N/A	[('CHEBI_37926', 'fluorescein isothiocyanate', 0, 'FITC'), ('CHEBI_82427', 'orange G', 7, 'Cy3-,'), ('CHEBI_37989', 'Cy5 dye', 17, 'Cy5'), ('GO_0042571', 'immunoglobulin complex, circulating', 42, 'antibodies'), ('CHEBI_37989', 'Cy5 dye', 124, 'Cy5'), ('GO_0042571', 'immunoglobulin complex, circulating', 139, 'antibody')]
PMC3925765	9/2013	S86-PMC3925765	['Nitrotyrosine (nt) histology\n5 µm Liver paraffin sections were immunostained using methods that have been described previously in detail(25) with affinity-purified Mouse monoclonal Antibody anti-Nt (sc-101358) 1:1000 dilution, abc elite kit, vector laboratories and visualized using 2.5% Nickel Sulfate sith 0.02% dab Chromogen in 0.175 m Sodium Acetate.']	N/A	N/A	[('CHEBI_50692', 'mifepristone', 0, 'Nitrotyrosine'), ('UBERON_0002107', 'liver', 34, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 164, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 181, 'antibody'), ('PR_000011508', 'nuclear pore complex protein Nup153', 195, 'NT'), ('CHEBI_53001', 'nickel sulfate', 288, 'nickel sulfate'), ('CHEBI_76201', 'clonixin lysine salt', 318, 'chromogen'), ('CHEBI_32954', 'sodium acetate', 339, 'sodium acetate')]
PMC3926113	1/2014	S75-PMC3926113	['Antibody specificity of Cleaved Caspase-3 was tested by pre-absorption with equal volume of the blocking peptide (#1050, cell signaling technology, danvers, ma, usa) and specificity of anti-Nitrotyrosine was tested by pre-absorption of 0.5\xa0µg/ml primary Antibody with 15\xa0mm free Nt (#89540, cayman chemical, ann arbor, mi, usa) with respective controls (#9663 Caspase-3 Control Cell Signalling technology, danver, ma, usa); (#12–354, nt immunoblotting control, chemicon, temecula, ca, usa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody'), ('PR_000005833', 'cleavage and polyadenylation specificity factor subunit 6', 24, 'cleaved caspase-3'), ('CHEBI_50654', 'but-2-enoate ester', 190, 'nitrotyrosine'), ('GO_0042571', 'immunoglobulin complex, circulating', 254, 'antibody'), ('CHEBI_13389', 'NAD', 279, 'NT'), ('PR_000002319', 'catenin beta-1 isoform 1', 360, 'Caspase-3'), ('GO_0065007', 'biological regulation', 370, 'control'), ('GO_0007267', 'cell-cell signaling', 378, 'Cell signalling')]
PMC3926113	1/2014	S76-PMC3926113	['Membranes were incubated with primary Antibody overnight at 4\xa0°c (1:1000, Cleaved Caspase-3 or 0.5\xa0µg/ml anti-nt or 1:2000 anti-Hne), followed by secondary Antibody(anti-Rabbit Igg-hrp, 7074, cell signaling technology, danvers, ma, usa) 1: 1000, 1:6000 and 1:2000 for anti-Caspase-3, anti-nt and anti-hne proteins respectively.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibody'), ('PR_000005833', 'cleavage and polyadenylation specificity factor subunit 6', 74, 'cleaved caspase-3'), ('CHEBI_17759', 'cholesta-5,7-dien-3beta-ol', 128, 'HNE'), ('GO_0042571', 'immunoglobulin complex, circulating', 156, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 170, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 177, 'IgG'), ('PR_000002319', 'catenin beta-1 isoform 1', 273, 'caspase-3')]
PMC3926113	1/2014	S79-PMC3926113	['Cleaved Caspase-3 bands were located by an additional protein standard (ecl dualvue western blotting markers, rpn810, amersham biosciences) with a specific secondary Antibody (1:10000, hrp-s) diluted together with the secondary Antibody.']	N/A	N/A	[('PR_000005444', 'chondrolectin', 0, 'Cleaved caspase-3'), ('GO_0042571', 'immunoglobulin complex, circulating', 166, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 228, 'antibody')]
PMC3926113	1/2014	S81-PMC3926113	['target bands of Cleaved Caspase-3 or lanes in case of nt and hne blots were normalized to the loading control, detected by anti-Mouse Igg-hrp secondary Antibody (1:10000, sc-2005, santa cruz biotechnology, ca, usa).']	N/A	N/A	[('PR_000005833', 'cleavage and polyadenylation specificity factor subunit 6', 16, 'cleaved caspase-3'), ('NCBITaxon_10088', 'Mus <genus>', 128, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 134, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 152, 'antibody')]
PMC3926113	1/2014	S111-PMC3926113	['pre-absorption of primary Antibody with blocking peptide abolished the specific bands from guinea pig Brain lysate and the positive control confirming the specificity of the Antibody (data not shown).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 26, 'antibody'), ('UBERON_0000955', 'brain', 102, 'brain'), ('GO_0042571', 'immunoglobulin complex, circulating', 174, 'antibody')]
PMC3994635	8/2010	S54-PMC3994635	['albumin was measured with nephelometry by using anti-Human Albumin Antibody (diasorin).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 53, 'human'), ('PR_000005908', 'alpha-crystallin B chain', 59, 'albumin'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibody')]
PMC4006733	5/2014	S164-PMC4006733	['Antibodies used: Rabbit anti-Histone H3 total (1∶1000, ab1791 abcam), Rabbit anti-Histone tri-methylated (1∶1000, ab8580 abcam), and Mouse anti-actin (1∶5000 , mp biomedicals).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 17, 'rabbit'), ('CHEBI_15358', 'histone', 29, 'Histone'), ('PR_000008608', 'hexokinase-1', 29, 'Histone H3'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 70, 'rabbit'), ('CHEBI_15358', 'histone', 82, 'Histone'), ('PR_000027594', 'histone H3', 82, 'Histone'), ('NCBITaxon_10088', 'Mus <genus>', 133, 'mouse')]
PMC4006733	5/2014	S165-PMC4006733	['blots were visualized with peroxidase-conjugated secondary Antibodies and ecl western blotting substrate (thermo scientific).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 59, 'antibodies')]
PMC4034700	5/2014	S189-PMC4034700	['conditioned medium from hr explants induced er stress in jeg-3 cells, which was abolished by an Et-1 neutralizing Antibody (jain et al., 2012).']	N/A	N/A	[('PR_000007222', 'protein C-ets-2', 96, 'ET-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 114, 'antibody')]
PMC4037583	5/2014	S63-PMC4037583	['this was followed by incubation for 1\u2009hr with Antibodies against Gr Α at a 1\u2009:\u2009200 dilution in 1% bsa/pbs.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 65, 'GR α')]
PMC4037583	5/2014	S64-PMC4037583	['cells were then washed with pbs prior to an incubation with a Tritc-conjugated secondary Antibody (santa cruz biotechnology, usa) for 1\u2009hr.']	N/A	N/A	[('CHEBI_63746', 'TRIBOA', 62, 'TRITC'), ('GO_0042571', 'immunoglobulin complex, circulating', 89, 'antibody')]
PMC4037583	5/2014	S70-PMC4037583	['after three washes with tbs-0.1% Tween-20, the Nitrocellulose membranes were incubated with primary Antibodies against Gr Α / β (abcam, ab3580, uk) and gapdh (sigma-aldrich, uk).']	N/A	N/A	[('CHEBI_53424', 'polysorbate 20', 33, 'Tween-20'), ('CHEBI_53325', 'nitrocellulose', 47, 'nitrocellulose'), ('GO_0042571', 'immunoglobulin complex, circulating', 100, 'antibodies'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 119, 'GR α')]
PMC4089555	5/2014	S130-PMC4089555	['these Igg Antibodies can cross the Placenta and are the most common cause of congenital hyperthyroidism [31,32,81].']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 6, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibodies'), ('UBERON_0001987', 'placenta', 35, 'placenta')]
PMC4090150	7/2014	S73-PMC4090150	["western blot analyses\ntotal cellular proteins from individual newborn pups' whole Cerebral Hemispheres (n\u200a=\u200a2/gender/group) were used, and the detection of targeted proteins were accomplished by incubating with primary Antibodies overnight at 4°c (anti-Slc17A7 1∶500, anti-Vgll2 1∶250) followed by horseradish peroxidase (hrp)−conjugated secondary Antibody."]	N/A	N/A	[('UBERON_0014644', 'cerebrocerebellum', 82, 'cerebral hemispheres'), ('GO_0042571', 'immunoglobulin complex, circulating', 219, 'antibodies'), ('PR_000014968', 'vesicular acetylcholine transporter', 253, 'Slc17a7'), ('PR_000017279', 'testis-specific basic protein Y 1', 273, 'Vgll2'), ('GO_0042571', 'immunoglobulin complex, circulating', 348, 'antibody')]
PMC4090150	7/2014	S155-PMC4090150	['the blot was probed with Slc17A7P Antibody ( a , b ) or with vgll2p Antibody ( c , d ).']	N/A	N/A	[('PR_000014968', 'vesicular acetylcholine transporter', 25, 'Slc17a7p'), ('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 68, 'antibody')]
PMC4090150	7/2014	S156-PMC4090150	['to confirm equal protein loading, the Membranes were re-probed with gapdh/Β-Tubulin Antibodies.']	N/A	N/A	[('GO_0016020', 'membrane', 38, 'membranes'), ('PR_000009991', 'lymphocyte antigen 6 complex locus protein G5c', 74, 'β-tubulin'), ('GO_0042571', 'immunoglobulin complex, circulating', 84, 'antibodies')]
PMC4099383	7/2014	S153-PMC4099383	['Plasma is generated from parental and child Blood samples and analyzed at a central laboratory for the presence of Antibodies to allergens.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('UBERON_0000178', 'blood', 44, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 115, 'antibodies')]
PMC4099383	7/2014	S210-PMC4099383	['moreover, the Sera of the children taken at 12\xa0months of age were tested for Ige Antibodies specific for Cow’s Milk and Egg white by using the phadia immmunocap system (phadia diagnostics, uppsala, sweden).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 14, 'sera'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 77, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibodies'), ('NCBITaxon_33208', 'Metazoa', 105, 'cow'), ('UBERON_0001913', 'milk', 111, 'milk'), ('UBERON_0007379', 'shelled egg', 120, 'egg')]
PMC4099383	7/2014	S211-PMC4099383	['if the doctor believed that another Food Allergen was causing Food allergy, Antibodies against that Food Allergen were measured.']	N/A	N/A	[('CHEBI_73772', 'K antigen', 36, 'food allergen'), ('CHEBI_33290', 'food', 62, 'food'), ('GO_0042571', 'immunoglobulin complex, circulating', 76, 'antibodies'), ('CHEBI_33290', 'food', 100, 'food'), ('CHEBI_50904', 'allergen', 105, 'allergen')]
PMC4106226	7/2014	S61-PMC4106226	['concordance between anti-transglutaminase Iga Antibodies (attg) and anti-endomysial Antibodies (ema) was near 100%.']	N/A	N/A	[('GO_0071746', 'IgA immunoglobulin complex, circulating', 42, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 84, 'antibodies')]
PMC4113768	7/2014	S1550-PMC4113768	['Cmv Antibody titre was determined on a subset ( n = 902) of these Serum samples, via an in-house anti-Cmv Igg elisa which reports semi-quantitative units.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'CMV'), ('GO_0042571', 'immunoglobulin complex, circulating', 4, 'antibody'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('NCBITaxon_10088', 'Mus <genus>', 102, 'CMV'), ('GO_0071735', 'IgG immunoglobulin complex', 106, 'IgG')]
PMC4129499	8/2014	S181-PMC4129499	['Antibodies in patients with autism are found to cells in the Caudate Nucleus (131), Cerebellum (132,133), Hypothalamus and Thalamus (121), the Cingulate Gyrus (134), and to Cerebral Folate receptors (135).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('UBERON_0002866', 'caudal part of spinal trigeminal nucleus', 61, 'caudate nucleus'), ('UBERON_0002037', 'cerebellum', 84, 'cerebellum'), ('UBERON_0001898', 'hypothalamus', 106, 'hypothalamus'), ('UBERON_0001897', 'dorsal plus ventral thalamus', 123, 'thalamus'), ('UBERON_0007841', 'furcula', 143, 'cingulate'), ('UBERON_0000200', 'gyrus', 153, 'gyrus'), ('UBERON_0001893', 'telencephalon', 173, 'cerebral'), ('CHEBI_30863', '5-azaorotic acid', 182, 'folate')]
PMC4129499	8/2014	S182-PMC4129499	['children with Cerebellar Autoantibodies had lower Adaptive and Cognitive function as well as increased aberrant behaviors compared to children without these Antibodies (132).']	N/A	N/A	[('UBERON_0002037', 'cerebellum', 14, 'cerebellar'), ('GO_0044308', 'axonal spine', 25, 'autoantibodies'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 50, 'adaptive'), ('GO_0050890', 'cognition', 63, 'cognitive'), ('GO_0042571', 'immunoglobulin complex, circulating', 157, 'antibodies')]
PMC4129499	8/2014	S184-PMC4129499	['maternal Antibodies cross the underdeveloped Blood Brain Barrier of the fetus (138) leading to impaired fetal Neurodevelopment and long-term neurodegeneration, Neurobehavioral, and Cognitive difficulties (139).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 9, 'antibodies'), ('UBERON_0000120', 'blood brain barrier', 45, 'blood brain barrier'), ('GO_0007399', 'nervous system development', 110, 'neurodevelopment'), ('GO_0007399', 'nervous system development', 160, 'neurobehavioral'), ('GO_0050890', 'cognition', 181, 'cognitive')]
PMC4129499	8/2014	S195-PMC4129499	['markers under consideration include circulating Antibodies against Tight Junction proteins, Lps, actomyosin (145) calprotectin (146), and Lactoferrin (147).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 48, 'antibodies'), ('GO_0044292', 'dendrite terminus', 67, 'tight junction'), ('CHEBI_16412', 'lipopolysaccharide', 92, 'LPS'), ('PR_000002198', 'catenin beta-1', 138, 'lactoferrin')]
PMC4132016	8/2014	S87-PMC4132016	['the membranes were then incubated overnight at 4°c with the primary Antibody diluted 1/1000e in 5% bsa containing tbs-t: anti-coxiv (molecular probes #a21348), anti-porin (biovision #3594-100), anti-Ucp2 (biolegend #615901), anti-Β-Actin (santa cruz biotechnology #sc-47778).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 68, 'antibody'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 199, 'UCP2'), ('PR_000003676', 'actin, cytoplasmic 1', 230, 'β-Actin')]
PMC4132016	8/2014	S88-PMC4132016	['after washing in tbs-T, membranes were incubated for 1 hour at room temperature with the secondary Antibody diluted 1/5000e in 5% fat-free milk tbs-T (santa cruz: goat anti-Mouse Igg-hrp sc-2031 for anti-Coxiv and anti-Β-Actin and goat anti-Rabbit Igg-hrp sc-2030 for anti-porin and anti-Ucp2).']	N/A	N/A	[('CHEBI_53424', 'polysorbate 20', 21, 'T'), ('GO_0042571', 'immunoglobulin complex, circulating', 99, 'antibody'), ('CHEBI_53424', 'polysorbate 20', 148, 'T'), ('NCBITaxon_10088', 'Mus <genus>', 173, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 179, 'IgG'), ('PR_000005793', 'cytochrome c oxidase subunit 8C, mitochondrial', 204, 'CoxIV'), ('PR_000003676', 'actin, cytoplasmic 1', 219, 'β-Actin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 241, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 248, 'IgG'), ('PR_000017025', 'ubiquitin carboxyl-terminal hydrolase isozyme L3', 288, 'UCP2')]
PMC4141279	8/2014	S72-PMC4141279	['Membranes were blocked in 5% non-fat dry milk for 1 h and incubated with primary Antibody for 1 h. Membranes were washed with tbs/0.1% Tween-20 three times and incubated with secondary Antibody for 1 h, then washed with tbs/0.1% Tween-20 three times and reactivity was detected by the enhanced chemiluminescence kit (pierce).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibody'), ('GO_0016020', 'membrane', 99, 'Membranes'), ('CHEBI_53424', 'polysorbate 20', 135, 'Tween-20'), ('GO_0042571', 'immunoglobulin complex, circulating', 185, 'antibody'), ('CHEBI_53424', 'polysorbate 20', 229, 'Tween-20')]
PMC4141279	8/2014	S74-PMC4141279	['Mouse monoclonal Adiponectin and actin Antibodies were from abcam, inc. (cambridge, ma).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Mouse'), ('PR_000004104', 'AP-3 complex subunit beta-1', 17, 'adiponectin'), ('GO_0042571', 'immunoglobulin complex, circulating', 39, 'antibodies')]
PMC4143239	8/2014	S172-PMC4143239	['Acquired Immunity\nacquired Immunity is characterized by specialized Cellular and Antibody-Mediated Immune Responses, generated by T- and B-Lymphocytes reacting with high specificity towards pathogens and creating long-Lasting Immunological Memory.']	N/A	N/A	[('GO_0006914', 'autophagy', 0, 'Acquired'), ('GO_0007566', 'embryo implantation', 9, 'immunity'), ('GO_0007566', 'embryo implantation', 27, 'immunity'), ('GO_0000911', 'cytokinesis by cell plate formation', 68, 'cellular ... -mediated immune responses'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibody'), ('UBERON_0002405', 'immune system', 99, 'immune'), ('CL_0000918', 'Tc2 cell', 130, 'T- ...'), ('CL_0000236', 'B cell', 137, 'B-lymphocytes'), ('GO_0007568', 'aging', 217, '-lasting'), ('GO_0007566', 'embryo implantation', 226, 'immunological'), ('GO_0007613', 'memory', 240, 'memory')]
PMC4143239	8/2014	S388-PMC4143239	['caption (supplementary-material): table s12\n\narticles describing Antibody levels in children with malnutrition.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 65, 'antibody')]
PMC4152245	9/2014	S87-PMC4152245	['a purified fraction of anti-Rat cytokines were used as the capture Antibodies in conjunction with biotinylated anti-Rat cytokines.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 28, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 116, 'rat')]
PMC4152245	9/2014	S104-PMC4152245	['the Tissue sections were quenched in normal goat Serum for 30 min and incubated overnight at 4°c with the primary Antibody (diluted 1∶75.']	N/A	N/A	[('UBERON_0000479', 'tissue', 4, 'tissue'), ('UBERON_0001977', 'blood serum', 49, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 114, 'antibody')]
PMC4152245	9/2014	S105-PMC4152245	['secondary Antibody was applied followed by the streptavidin conjugated to horseradish Peroxides.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibody'), ('CHEBI_25895', 'pentaric acid anion', 86, 'peroxides')]
PMC4152245	9/2014	S115-PMC4152245	['after transfer, membranes were blocked for 1 h at room temperature in tbst (10 mmol/l Tris-Hcl, ph 8.0, 150 mmol/l Nacl, 0.2% Tween-20) containing 5% non-fat Milk powder, and incubated overnight at 4°c with diluted primary Antibody (nrf2) (1∶500 dilution).']	N/A	N/A	[('CHEBI_9754', 'tris', 86, 'Tris'), ('CHEBI_17883', 'hydrogen chloride', 91, 'HCl'), ('CHEBI_26710', 'sodium chloride', 115, 'NaCl'), ('CHEBI_53424', 'polysorbate 20', 126, 'Tween-20'), ('UBERON_0001913', 'milk', 158, 'milk'), ('GO_0042571', 'immunoglobulin complex, circulating', 223, 'antibody')]
PMC4152245	9/2014	S117-PMC4152245	['the second Antibodies (1∶2000 dilution) labeled by horseradish peroxydase (nrf2) were added, with incubation for 2 h at 37°c and washing the membrane for three times.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 11, 'antibodies')]
PMC4152245	9/2014	S118-PMC4152245	['to demonstrate equal loading, membranes were stripped and reprobed with a specific Antibody recognizing Β-Actin.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 83, 'antibody'), ('PR_000003676', 'actin, cytoplasmic 1', 104, 'β-actin')]
PMC4155824	8/2014	S272-PMC4155824	['lgg in Milk (1010cfu daily, 1 week before vaccination, 4 weeks after) was also shown to increase the poliovirus neutralizing Antibody titer with a fourfold increase in poliovirus-specific Iga in Adults receiving an Oral vaccine against Polio 1, 2 and 3 [132].']	N/A	N/A	[('UBERON_0001913', 'milk', 7, 'milk'), ('GO_0042571', 'immunoglobulin complex, circulating', 125, 'antibody'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 188, 'IgA'), ('UBERON_0007023', 'adult organism', 195, 'adults'), ('UBERON_0000165', 'mouth', 215, 'oral'), ('PR_000012725', 'phosphatidylinositol 3-kinase regulatory subunit beta', 236, 'polio 1'), ('PR_000010222', 'muscleblind-like protein 2', 245, '2')]
PMC4161853	8/2014	S110-PMC4161853	['when only the bcr is stimulated, mz B Cells migrate to the T Cell zone to develop a T Cell-dependent Antibody response.']	N/A	N/A	[('CL_0000236', 'B cell', 36, 'B cells'), ('CL_0000084', 'T cell', 59, 'T cell'), ('CL_0000084', 'T cell', 84, 'T cell'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody')]
PMC4161853	8/2014	S137-PMC4161853	['additionally, salmonella -specific Antibodies facilitate specific T Cell Responses via augmentation of bacterial uptake and induction of Apoptosis in Macrophages [97].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibodies'), ('CL_0000084', 'T cell', 66, 'T cell'), ('GO_0001783', 'B cell apoptotic process', 66, 'T cell responses'), ('GO_0006915', 'apoptotic process', 137, 'apoptosis'), ('CL_0000235', 'macrophage', 150, 'macrophages')]
PMC4161853	8/2014	S138-PMC4161853	['moreover, transferred low- and high-affinity Igg2C, and with less efficiency Igm, were shown to impede salmonella Colonization of Splenic Macrophages, markedly reducing bacteraemia by Antibodies induced during the infection in Mice [98].']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 45, 'IgG2c'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 77, 'IgM'), ('GO_0000746', 'conjugation', 114, 'colonization'), ('CL_0000871', 'splenic macrophage', 130, 'splenic macrophages'), ('UBERON_0002106', 'spleen', 130, 'splenic'), ('GO_0042571', 'immunoglobulin complex, circulating', 184, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 227, 'mice')]
PMC4169453	9/2014	S66-PMC4169453	['Antibody specificities were 100%, 104%, 40%, 17%, and 0% for 25(Oh)D2, 25(Oh)D3, 1,25(Oh)2D2, 1,25(Oh)2D3, and 3-Epi-25-Ohd3, respectively.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody'), ('CHEBI_77765', '2,4,6-trihydroxybenzophenone(1-)', 61, '25(OH)D2'), ('CHEBI_62946', 'ammonium sulfate', 71, '25(OH)D3'), ('CHEBI_33992', '(-)-catechin', 85, '(OH)2D2'), ('CHEBI_73394', 'Ala-Ser', 96, '25(OH)2D3'), ('CHEBI_73965', 'prostaglandin E2-UM', 111, '3-epi-25-OHD3')]
PMC4169551	9/2014	S76-PMC4169551	['Immunoglobulin assay\nSerum samples from sows and Piglets as well as samples of sow Colostrum and Milk were evaluated for Igg and Iga Antibody levels.']	N/A	N/A	[('GO_0019815', 'B cell receptor complex', 0, 'Immunoglobulin'), ('UBERON_0001977', 'blood serum', 21, 'Serum'), ('NCBITaxon_33208', 'Metazoa', 49, 'piglets'), ('UBERON_0001914', 'colostrum', 83, 'colostrum'), ('UBERON_0001913', 'milk', 97, 'milk'), ('GO_0071735', 'IgG immunoglobulin complex', 121, 'IgG'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 129, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 133, 'antibody')]
PMC4169551	9/2014	S82-PMC4169551	['only the Bioactive form is immunoreactive and detectable by Tgfβ1 Antibody.']	N/A	N/A	[('CHEBI_51870', 'boryl group', 9, 'bioactive'), ('PR_000000046', 'TGF-beta', 60, 'TGFβ1'), ('GO_0042571', 'immunoglobulin complex, circulating', 66, 'antibody')]
PMC4169551	9/2014	S103-PMC4169551	['flow cytometry analysis\nflow cytometry analysis was performed on ileal Pp using specific monoclonal Antibodies (mabs) or isotype-matched mab (as controls) (table s2) .']	N/A	N/A	[('UBERON_0004302', 'proximal phalanx', 71, 'PP'), ('GO_0042571', 'immunoglobulin complex, circulating', 100, 'antibodies')]
PMC4169551	9/2014	S105-PMC4169551	['Mabs against Mhc Class Ii, Cd4Α, cd14, Cd172Α and Tcr1 γ chain specific were from washington state university (monoclonal Antibody center, pullman, usa) and Cd21 was purchased from clinisciences (nanterre, france).']	N/A	N/A	[('GO_0015627', 'type II protein secretion system complex', 0, 'MAbs'), ('GO_0042613', 'MHC class II protein complex', 13, 'MHC class II'), ('PR_000001993', 'C-C motif chemokine 21', 13, 'MHC class II'), ('PR_000001200', 'C-C chemokine receptor type 4', 27, 'CD4α'), ('PR_000001304', 'CD300 molecule-like protein', 39, 'CD172α'), ('PR_000016190', 'trichohyalin-like protein 1', 50, 'TCR1'), ('GO_0042571', 'immunoglobulin complex, circulating', 122, 'Antibody'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 157, 'CD21')]
PMC4169551	9/2014	S106-PMC4169551	['Ileal pp cells were finally incubated with Fluorochrome anti-Mouse/Rat Ig isotype Antibodies (20 min, 4°c) except for labelling of Pig Cd8Α (bd biosciences, le pont de claix, france) and Mouse/Rat Foxp3 (ebiosciences, paris, france) that were directly conjugated.']	N/A	N/A	[('UBERON_0001705', 'nail', 0, 'Ileal'), ('CHEBI_51217', 'fluorochrome', 43, 'fluorochrome'), ('NCBITaxon_10088', 'Mus <genus>', 61, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 67, 'rat'), ('GO_0071735', 'IgG immunoglobulin complex', 71, 'Ig'), ('GO_0042571', 'immunoglobulin complex, circulating', 82, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 131, 'pig'), ('PR_000001200', 'C-C chemokine receptor type 4', 135, 'CD8α'), ('NCBITaxon_10088', 'Mus <genus>', 187, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 193, 'rat'), ('PR_000017653', 'zinc finger protein ZFPM2', 197, 'FoxP3')]
PMC4169551	9/2014	S241-PMC4169551	['caption (supplementary-material): table s2\n\nlist of Antibodies and the corresponding cell types recognized.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 52, 'antibodies')]
PMC4208652	6/2014	S113-PMC4208652	['(2003)‡ Hmga2 High Mobility Group At‐Hook 2Reeves and beckerbauer (2001)‡ ihh Indian Hedgehog lbh Limb Bud and Heart Development Homolog Lcorl ligand‐dependent Nuclear Receptor Corepressor‐Like Protein Lin28B Lin 28 Homolog B Lyar ly1 Antibody Reactive Homolog Lyn v‐yes‐1 Yamaguchi Sarcoma Viral Related Oncogene Homolog Mos v‐Mos moloney murine Sarcoma Viral Oncogene Homologscholz et al.']	N/A	N/A	[('PR_000008608', 'hexokinase-1', 8, 'HMGA2'), ('PR_000008479', 'polyamine deacetylase HDAC10', 14, 'High mobility group AT‐hook 2Reeves'), ('PR_000000035', 'BMP receptor type-1A', 78, 'Indian hedgehog'), ('UBERON_0004347', 'limb bud', 98, 'Limb bud'), ('GO_0007507', 'heart development', 111, 'heart development'), ('UBERON_0000948', 'heart', 111, 'heart'), ('SO_0000853', 'homologous_region', 129, 'homolog'), ('PR_000009709', 'late cornified envelope protein 3A', 137, 'LCORL'), ('GO_0005634', 'nucleus', 160, 'nuclear'), ('PR_000011509', 'nuclear pore complex protein Nup155', 160, 'nuclear receptor corepressor‐like protein'), ('PR_000009800', 'DNA ligase 1', 202, 'LIN28B'), ('PR_000009801', 'DNA ligase 3', 209, 'Lin 28 homolog B'), ('SO_0000853', 'homologous_region', 216, 'homolog'), ('PR_000009890', 'lysophosphatidylcholine acyltransferase 1', 226, 'LYAR'), ('GO_0042571', 'immunoglobulin complex, circulating', 235, 'antibody'), ('PR_000014040', 'E3 ubiquitin-protein transferase RMND5B', 244, 'reactive homolog'), ('SO_0000853', 'homologous_region', 253, 'homolog'), ('PR_000010000', 'lysozyme g-like protein 2', 261, 'LYN'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 271, '1'), ('PR_000017516', 'xylosyltransferase 2', 273, 'Yamaguchi sarcoma viral related oncogene homolog'), ('SO_0000898', 'epigenetically_modified_gene', 291, 'viral related oncogene'), ('SO_0000853', 'homologous_region', 314, 'homolog'), ('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 322, 'MOS'), ('NCBITaxon_10088', 'Mus <genus>', 328, 'mos'), ('PR_000014418', 'protein S100-A9', 347, 'sarcoma'), ('SO_0000467', 'post_translationally_regulated_by_protein_stability', 355, 'viral oncogene'), ('SO_0000853', 'homologous_region', 370, 'homologScholz')]
PMC4210519	10/2014	S58-PMC4210519	['chemicals and Antibodies\nanalytical grade biochemicals, Glycerol assay kits and hormones/agonists were obtained from sigma-aldrich inc. (st. louis, mo) and medium from invitrogen (carlsbad, ca) unless otherwise specified.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibodies'), ('CHEBI_17754', 'glycerol', 56, 'glycerol')]
PMC4210519	10/2014	S60-PMC4210519	['primary Antibodies for western blotting were obtained from cell signaling technology (danvers, ma; Mammalian Target Of Rapamycin (mtor), Hormone-Sensitive Lipase (Hsl)), santa cruz biotechnology (santa cruz, ca; Insulin Receptor Beta Subunit (Insrβ), Phosphatidylinositol-3-kinase (pi3k) and Protein Kinase C Zeta (Pkcζ)) and chemicon international inc. (temecula, ca; perilipin).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 8, 'antibodies'), ('NCBITaxon_40674', 'Mammalia', 99, 'mammalian'), ('PR_000016297', 'protein-glutamine gamma-glutamyltransferase 6', 109, 'target of rapamycin'), ('PR_000008560', 'histone H4 transcription factor', 137, 'hormone-sensitive lipase'), ('PR_000008794', 'heat shock factor protein 5', 163, 'HSL'), ('PR_000002050', 'interferon regulatory factor 8', 212, 'insulin receptor beta subunit'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 243, 'InsRβ'), ('CHEBI_28874', 'phosphatidylinositol', 251, 'phosphatidylinositol'), ('PR_000012524', 'pyridoxal kinase', 292, 'protein kinase C zeta'), ('PR_000003059', 'protein kinase C beta type', 315, 'PKCζ')]
PMC4210519	10/2014	S86-PMC4210519	['Membranes were incubated overnight at 4°c with Rat-specific primary Antibodies at the given concentrations: Insrβ, 1:50; Pi3K, 1:200; Pkcζ 1:200; mtor 1:200; Hsl 1:1000; perilipin 1:10000.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 47, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 68, 'antibodies'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 108, 'InsRβ'), ('PR_000014702', 'plasminogen activator inhibitor 1', 121, 'PI3K'), ('PR_000003059', 'protein kinase C beta type', 134, 'PKCζ'), ('PR_000008794', 'heat shock factor protein 5', 158, 'HSL')]
PMC4210519	10/2014	S87-PMC4210519	['detection of the primary Antibodies was performed using secondary anti-Rabbit-hrp Antibodies: for either 1 h (Pi3K 1:2000, Pkcζ 1:2000 Hsl 1:2000, perilipin 1:2000), 1.5 h (Insrβ 1:25000), or 2 h (mtor 1:25000) at rt.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 25, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 71, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 82, 'antibodies'), ('PR_000014702', 'plasminogen activator inhibitor 1', 110, 'PI3K'), ('PR_000003059', 'protein kinase C beta type', 123, 'PKCζ'), ('PR_000008794', 'heat shock factor protein 5', 135, 'HSL'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 173, 'InsRβ')]
PMC4210914	10/2014	S63-PMC4210914	['cells were incubated with Antibodies directed against Dcx (1:200 Rabbit polyclonal, abcam, cambridge, uk), Gfap (1:5000 Rabbit polyclonal, dako, agilent technologies, santa clara, ca, usa), Proliferating Cell Nuclear Antigen (Pcna) (1:200 Mouse monoclonal, santa cruz biotechnology, dallas, tx, usa) or Map2 (1:100 Rabbit polyclonal, cell signaling technology, danvers, ma, usa) overnight at 4 °c in pbs containing 3% bsa and 0.1% Triton.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 26, 'antibodies'), ('CHEBI_4450', 'desmopressin', 54, 'DCX'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 65, 'rabbit'), ('PR_000007939', 'glial fibrillary acidic protein', 107, 'GFAP'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 120, 'rabbit'), ('GO_0008283', 'cell proliferation', 190, 'proliferating'), ('PR_000014700', 'serpin B9', 190, 'proliferating cell nuclear antigen'), ('CHEBI_59132', 'antigen', 217, 'antigen'), ('PR_000012421', 'proliferating cell nuclear antigen', 226, 'PCNA'), ('NCBITaxon_10088', 'Mus <genus>', 239, 'mouse'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 303, 'MAP2'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 315, 'rabbit'), ('CHEBI_29234', 'triton', 431, 'triton')]
PMC4210914	10/2014	S64-PMC4210914	['cells were washed 4 times with pbs and incubated for 90 min at 37 °c with appropriate secondary Antibodies: Alexa Fluor goat anti-Mouse Igg 488 and Alexa Fluor goat anti-Rabbit 488 (all 1:500, molecular probes, life technologies, carlsbad, ca, usa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 96, 'antibodies'), ('CHEBI_82170', 'Allidochlor', 108, 'Alexa Fluor'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 136, 'IgG'), ('CHEBI_75698', 'dG15', 140, '488'), ('CHEBI_82170', 'Allidochlor', 148, 'Alexa Fluor'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 170, 'rabbit'), ('CHEBI_75698', 'dG15', 177, '488')]
PMC4213680	12/2014	S85-PMC4213680	['a Mouse monoclonal Antibody against 5-Methyl Cytidine (no.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 2, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 19, 'antibody'), ('CHEBI_20607', '5-methylcytidine', 36, '5-methyl cytidine')]
PMC4233040	11/2014	S65-PMC4233040	['Membranes were incubated with a primary Antibody against Et-1 (ab2786, abcam, 1:300 in Antibody diluent) overnight at 4°c and with a peroxidase-conjugated secondary Antibody for 60\xa0min.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibody'), ('PR_000007222', 'protein C-ets-2', 57, 'ET-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 87, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 165, 'antibody')]
PMC4233040	11/2014	S71-PMC4233040	['sections were then rinsed with pbs, and blocked with blocking Serum before incubation with a primary Antibody against Et-1 (ab2786, abcam, 1:250 in Antibody diluent) overnight.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody'), ('PR_000007222', 'protein C-ets-2', 118, 'ET-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 148, 'antibody')]
PMC4233040	11/2014	S72-PMC4233040	['control sections were incubated with pbs instead of the primary Antibody.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 64, 'antibody')]
PMC4233040	11/2014	S98-PMC4233040	['aliquots were incubated overnight at 4°c with one of the following Antibodies: 5\xa0μl anti-acetylaled Histone H3 (06–599, millipore), 5\xa0μl anti-acetylated Histone H3 (lys9) (H3K9, 07–352, millipore), or 5\xa0μl anti-acetylaled Histone H4 (06–866, millipore).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies'), ('CHEBI_15358', 'histone', 100, 'Histone'), ('PR_000008608', 'hexokinase-1', 100, 'Histone H3'), ('CHEBI_15358', 'histone', 153, 'Histone'), ('PR_000008608', 'hexokinase-1', 153, 'Histone H3'), ('SO_0001735', 'H3K79_methylation_site', 172, 'H3K9'), ('CHEBI_15358', 'histone', 222, 'Histone'), ('PR_000008608', 'hexokinase-1', 222, 'Histone H4')]
PMC4243771	8/2014	S151-PMC4243771	['immunostaining of Slow Myosin (myhc) was determined using anti-slow myosin Pig specific myhc Antibody (sigma-aldrich co.']	N/A	N/A	[('PR_000015609', 'steroid 5-alpha-reductase 2-like 2 protein', 18, 'slow myosin'), ('NCBITaxon_10088', 'Mus <genus>', 75, 'pig'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibody')]
PMC4243771	8/2014	S154-PMC4243771	['briefly, slides were stained as follows: 15\xa0minutes with primary Antibody, 8\xa0minutes with secondary Antibodies, 10\xa0minutes with 3,3 diaminobenzine and counterstained with Hematoxylin.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 65, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 100, 'antibodies'), ('CHEBI_37987', 'Cy3 dye', 128, '3,3'), ('CHEBI_51686', 'haematoxylin', 171, 'hematoxylin')]
PMC4243771	8/2014	S155-PMC4243771	['a negative control slide in which the primary Antibody stage was excluded was included with each batch.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibody')]
PMC4251881	11/2014	S70-PMC4251881	['complement leads to Chemotaxis of Eosinophils to the site of the ag-Ab Complex on the bmz, where they Degranulate and damage the dermal-Epidermal junction and cause blisters [5].']	N/A	N/A	[('GO_0006935', 'chemotaxis', 20, 'chemotaxis'), ('CL_0000771', 'eosinophil', 34, 'eosinophils'), ('GO_0042571', 'immunoglobulin complex, circulating', 68, 'Ab'), ('GO_0032991', 'protein-containing complex', 71, 'complex'), ('GO_0030324', 'lung development', 102, 'degranulate'), ('UBERON_0007376', 'outer epithelium', 136, 'epidermal')]
PMC4251881	11/2014	S79-PMC4251881	['Progesterone, which is elevated in the last few weeks of Pregnancy, depresses Antibody production, while Estrogen enhances Antibody production.']	N/A	N/A	[('CHEBI_17026', 'progesterone', 0, 'Progesterone'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0042571', 'immunoglobulin complex, circulating', 78, 'antibody'), ('CHEBI_50114', 'estrogen', 105, 'estrogen'), ('GO_0042571', 'immunoglobulin complex, circulating', 123, 'antibody')]
PMC4251881	11/2014	S99-PMC4251881	['they also had widespread cutaneous eruption and Mucosal involvement as well as Igg deposits on dif and circulating Serum Antibodies iif.']	N/A	N/A	[('UBERON_0000344', 'mucosa', 48, 'mucosal'), ('GO_0071735', 'IgG immunoglobulin complex', 79, 'IgG'), ('UBERON_0001977', 'blood serum', 115, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 121, 'antibodies')]
PMC4258799	11/2014	S324-PMC4258799	['in men with asthenozoospermia, Intake of Zinc Sulphate (500\xa0mg for 3\xa0months) improved Spermatozoa quality (count, progressive motility and Fertilizing capacity) and reduced the incidence of antisperm Antibodies [160].']	N/A	N/A	[('GO_0007631', 'feeding behavior', 31, 'intake'), ('CHEBI_32313', 'Zinc undecylenate', 41, 'zinc sulphate'), ('CL_0000019', 'sperm', 86, 'spermatozoa'), ('GO_0009566', 'fertilization', 139, 'fertilizing'), ('GO_0042571', 'immunoglobulin complex, circulating', 200, 'antibodies')]
PMC4263713	12/2014	S13-PMC4263713	['ra also enhances the Expression of Polymeric Immunoglobulin receptor (pigr)[4]and the Differentiation Of Iga Antibody-Secreting Cells (iga-asc) in Mice and Humans as well as stimulates the migration of T and B Cells to the Gut[5]–[9].']	N/A	N/A	[('GO_0010467', 'gene expression', 21, 'expression'), ('CHEBI_33839', 'macromolecule', 35, 'polymeric'), ('CHEBI_38709', '1,2-dicarboxyethanethiolate', 45, 'immunoglobulin'), ('GO_0019814', 'immunoglobulin complex', 45, 'immunoglobulin'), ('GO_0030154', 'cell differentiation', 86, 'differentiation of ... -secreting cells'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 105, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 109, 'antibody'), ('CL_0002200', 'oxyphil cell of thyroid', 128, '... cells'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 156, 'humans'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 202, 'T ...'), ('CL_0000236', 'B cell', 208, 'B cells'), ('UBERON_0001555', 'digestive tract', 223, 'gut')]
PMC4263713	12/2014	S78-PMC4263713	['flow cytometry\nthe monoclonal Antibodies pecy5-anti-Cd45, apc-anti-cd3, pe-anti-Cd4, Fitc-anti-Cd8 and Fitc-anti-Cd25 were used to label the T Lymphocytes, and pecy5-anti-Cd45 and Fitc-anti-Cd45R (bd pharmingen, san diego, ca) were used to label the B Lymphocytes.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 30, 'antibodies'), ('PR_000001309', 'CD70 molecule', 52, 'CD45'), ('PR_000001204', 'C-C chemokine receptor type 8', 80, 'CD4'), ('CHEBI_37926', 'fluorescein isothiocyanate', 85, 'FITC'), ('PR_000005170', 'CD37 molecule', 95, 'CD8'), ('CHEBI_37926', 'fluorescein isothiocyanate', 103, 'FITC'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 113, 'CD25'), ('CL_0000084', 'T cell', 141, 'T lymphocytes'), ('PR_000001309', 'CD70 molecule', 171, 'CD45'), ('CHEBI_37926', 'fluorescein isothiocyanate', 180, 'FITC'), ('PR_000001200', 'C-C chemokine receptor type 4', 190, 'CD45R'), ('CL_0000236', 'B cell', 250, 'B lymphocytes')]
PMC4263713	12/2014	S80-PMC4263713	['individual cell populations were identified according to the presence of specific fluorescence-labeled Antibodies, and isotype-matched monoclonal Antibodies were used as negative controls.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 103, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 146, 'antibodies')]
PMC4271720	12/2014	S134-PMC4271720	['the disease is characterized by Synovial hyperplasia, production of selected Autoantibodies such as rheumatoid factor and anti-citrullinated protein Antibody, and systemic inflammation involving multiple Organs outside the Joints (mcinnes and schett, 2011;choy, 2012).']	N/A	N/A	[('UBERON_0007616', 'layer of synovial tissue', 32, 'synovial'), ('GO_0044308', 'axonal spine', 77, 'autoantibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 149, 'antibody'), ('UBERON_0000062', 'organ', 204, 'organs'), ('UBERON_0004905', 'articulation', 223, 'joints')]
PMC4292443	1/2015	S79-PMC4292443	['briefly, we incubated separate one-in-five series of Forebrain sections from each Animal in primary Antibody overnight at 4°c (Iba-1, 1:1000; Rabbit; wako chemicals usa inc., richmond, va, usa or Fos, 1:10,000; Rabbit; santa cruz biotechnology, santa cruz, ca, usa).']	N/A	N/A	[('UBERON_0001890', 'forebrain', 53, 'forebrain'), ('NCBITaxon_33208', 'Metazoa', 82, 'animal'), ('GO_0042571', 'immunoglobulin complex, circulating', 100, 'antibody'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 127, 'Iba-1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 142, 'rabbit'), ('PR_000007705', 'galactoside alpha-(1,2)-fucosyltransferase 2', 196, 'Fos'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 211, 'rabbit')]
PMC4292443	1/2015	S80-PMC4292443	['this was followed by secondary Antibody (1.5 h; 1:200, Iba-1, 1:500, Fos; biotinylated anti-Rabbit; vector laboratories, burlingame, ca, usa) and an avidin-Biotin horseradish peroxidase (hrp) Complex (abc; 45 min; vector elite kit; vector).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 31, 'antibody'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 55, 'Iba-1'), ('PR_000007705', 'galactoside alpha-(1,2)-fucosyltransferase 2', 69, 'Fos'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 92, 'rabbit'), ('CHEBI_15956', 'biotin', 156, 'biotin'), ('GO_0032991', 'protein-containing complex', 192, 'complex')]
PMC4302429	1/2015	S73-PMC4302429	['single cells were stained with the following Antibodies: Cd45 (30-f11), Cd4 (rm4-5), Cd27 (lg.3a10), Cd11B (m1/70), and ly6c (Hk1.4) purchased from biolegend (san diego, ca, usa), cd3 (145-2c11), Cd25 (pc61.5), Cd19 (ebio1d3) Nk1.1 (pk136), and Foxp3 (fjk-16\xa0s) provided by ebioscience (san diego, ca, usa), and ly6g (1a8, bd pharmigen, franklin lakes, nj, usa) and Ccr2 (fab5538a, r&d systems, minneapolis, mn, usa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 45, 'antibodies'), ('PR_000001309', 'CD70 molecule', 57, 'CD45'), ('PR_000001204', 'C-C chemokine receptor type 8', 72, 'CD4'), ('PR_000001309', 'CD70 molecule', 85, 'CD27'), ('PR_000001309', 'CD70 molecule', 101, 'CD11b'), ('PR_000008608', 'hexokinase-1', 126, 'HK1'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 196, 'CD25'), ('PR_000001309', 'CD70 molecule', 211, 'CD19'), ('PR_000001242', 'neuromedin-K receptor', 226, 'NK1.1'), ('PR_000017653', 'zinc finger protein ZFPM2', 245, 'FoxP3'), ('PR_000001204', 'C-C chemokine receptor type 8', 366, 'CCR2')]
PMC4314531	11/2014	S32-PMC4314531	['the following Antibodies were used for analysis: cd3, Cd4, Cd5, B220, Gr-1, ter119, C-Kit/Cd117, mac-1, Cd45.2 (bd, franklin lakes, nj), Cd45.1, Sca-1, aa4.1/Cd93, f4/80 (ebioscience, san diego, ca).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibodies'), ('PR_000001204', 'C-C chemokine receptor type 8', 54, 'CD4'), ('PR_000001204', 'C-C chemokine receptor type 8', 59, 'CD5'), ('PR_000004691', 'B-cell lymphoma/leukemia 11B', 64, 'B220'), ('PR_000008224', 'growth factor receptor-bound protein 2', 70, 'Gr-1'), ('PR_000002319', 'catenin beta-1 isoform 1', 84, 'c-Kit'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 90, 'CD117'), ('PR_000001309', 'CD70 molecule', 104, 'CD45'), ('PR_000001309', 'CD70 molecule', 137, 'CD45'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 142, '1'), ('PR_000014662', 'selenoprotein W', 145, 'Sca-1'), ('PR_000001309', 'CD70 molecule', 158, 'CD93')]
PMC4314531	11/2014	S35-PMC4314531	['quantitative real-time pcr\nfor qrt-pcr, hfd or control fetal Liver cells were immunomagnetically enriched using the Sca-1 Antibody conjugated to pe (clone e13-161.7; bd, franklin lakes, nj) and the easysep pe positive selection kit (stemcell technologies, vancouver, bc)[15].']	N/A	N/A	[('UBERON_0002107', 'liver', 61, 'liver'), ('PR_000014662', 'selenoprotein W', 116, 'Sca-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 122, 'antibody')]
PMC4314531	11/2014	S65-PMC4314531	['retroorbital Blood draws were performed at 4 and 14 weeks post-transplant and peripheral Blood was stained with Antibodies against Cd45.1 and Cd45.2 for analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 13, 'blood'), ('UBERON_0000178', 'blood', 89, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 112, 'antibodies'), ('PR_000001304', 'CD300 molecule-like protein', 131, 'CD45.1'), ('PR_000001304', 'CD300 molecule-like protein', 142, 'CD45.2')]
PMC4314535	10/2014	S67-PMC4314535	['briefly, after pretreatment overnight in a Mixture of 0.3% Triton x-100 and 2% normal goat Serum, sections were incubated for 48\xa0h at 4\xa0c in a Rabbit primary Antiserum directed against the n-terminal Domain of Fos (Ab-5, oncogene; 1:2,000).']	N/A	N/A	[('CHEBI_60004', 'mixture', 43, 'mixture'), ('CHEBI_29236', 'protium atom', 59, 'Triton'), ('UBERON_0001977', 'blood serum', 91, 'serum'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 143, 'rabbit'), ('UBERON_0002462', 'erector spinae muscle group', 158, 'antiserum'), ('SO_0000417', 'polypeptide_domain', 200, 'domain'), ('PR_000007705', 'galactoside alpha-(1,2)-fucosyltransferase 2', 210, 'Fos'), ('GO_0042571', 'immunoglobulin complex, circulating', 215, 'Ab')]
PMC4314535	10/2014	S68-PMC4314535	['the primary Antibody was localized with Alexa Fluor 488 Goat anti-Rabbit Igg (invitrogen; 1:200).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibody'), ('CHEBI_52661', 'Alexa Fluor 488', 40, 'Alexa Fluor 488'), ('NCBITaxon_10088', 'Mus <genus>', 56, 'Goat'), ('NCBITaxon_10088', 'Mus <genus>', 66, 'Rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 73, 'IgG')]
PMC4314535	10/2014	S75-PMC4314535	['the primary Antibodies used for these studies were a Rat anti-Pecam (1:200, generous gift from dr. britta engelhardt, theodor kocher institut, bern, switzerland) and a rabit anti-Gfap (dako cytomation; 1:2,000).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 53, 'rat'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 62, 'PECAM'), ('PR_000007939', 'glial fibrillary acidic protein', 179, 'GFAP')]
PMC4314535	10/2014	S80-PMC4314535	['the primary Antibodies used for western blotting were anti-Ghrelin (abcam, 1:500) and anti-Erk (cell signaling, 1:1,000).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibodies'), ('PR_000007988', 'gastric inhibitory polypeptide receptor', 59, 'ghrelin'), ('GO_0005783', 'endoplasmic reticulum', 91, 'ERK'), ('PR_000007120', 'ephrin type-A receptor 1', 91, 'ERK')]
PMC4329404	10/2014	S59-PMC4329404	['cytokines were analysed in Lung homogenate supernatants and Antibodies in Serum.']	N/A	N/A	[('UBERON_0002048', 'lung', 27, 'lung'), ('GO_0042571', 'immunoglobulin complex, circulating', 60, 'antibodies'), ('UBERON_0001977', 'blood serum', 74, 'serum')]
PMC4329404	10/2014	S60-PMC4329404	["paired Antibodies for Murine Ige, Interleukin (Il)-4, Il-5, Ifn-Γ (bd biosciences), Il-33, Il-10 (r&d systems, abingdon, uk), and Il-13 and Il-25 (ebioscience) were used in standardized sandwich elisas according to the manufacturer's protocol."]	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 7, 'antibodies'), ('NCBITaxon_39107', 'Murinae', 22, 'murine'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 29, 'IgE'), ('PR_000001470', 'interleukin-28B', 34, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 47, 'IL)-4'), ('PR_000001470', 'interleukin-28B', 54, 'IL-5'), ('PR_000008920', 'interferon alpha-7', 60, 'IFN-γ'), ('PR_000001470', 'interleukin-28B', 84, 'IL-33'), ('PR_000001470', 'interleukin-28B', 91, 'IL-10'), ('PR_000001470', 'interleukin-28B', 130, 'IL-13'), ('PR_000001470', 'interleukin-28B', 140, 'IL-25')]
PMC4329404	10/2014	S109-PMC4329404	['total Ige and hdm-specific Ige (a) Antibodies were measured in the Serum of pups by elisa.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 6, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 27, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibodies'), ('UBERON_0001977', 'blood serum', 67, 'serum')]
PMC4334594	2/2015	S2-PMC4334594	['case presentation\nwe report a case of an 18\xa0year old female who presented in early Pregnancy with acute hemolytic anemia and a positive donath-landsteiner Antibody test.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('GO_0042571', 'immunoglobulin complex, circulating', 155, 'antibody')]
PMC4334594	2/2015	S24-PMC4334594	['donath landsteiner Antibody testing was performed using a Blood sample that was immediately immersed into an insulated container filled with Water at 37°c, and directly delivered to the testing laboratory.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 19, 'antibody'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_15377', 'water', 141, 'water')]
PMC4334594	2/2015	S25-PMC4334594	['a donath landsteiner Antibody test was positive (figure\xa01), confirming the diagnosis of pch.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 21, 'antibody')]
PMC4334594	2/2015	S33-PMC4334594	['caption (fig): figure 1\n\ndonath-landsteiner Antibody test.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 44, 'antibody')]
PMC4334594	2/2015	S48-PMC4334594	['in contrast to Autoimmune hemolytic anemia mediated by Igm cold agglutinins, most cases of pch are caused by non-agglutinating Igg Antibodies with anti-p specificity [2,3,8].']	N/A	N/A	[('UBERON_0001442', 'skeleton of manus', 15, 'autoimmune'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 55, 'IgM'), ('GO_0071735', 'IgG immunoglobulin complex', 127, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 131, 'antibodies')]
PMC4334594	2/2015	S51-PMC4334594	['this prevents Adsorption Of anti-p Antibodies Onto autologous Red Blood Cells at low temperatures.']	N/A	N/A	[('GO_0030154', 'cell differentiation', 14, 'adsorption of ... onto ... cells'), ('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibodies'), ('CL_0000232', 'erythrocyte', 62, 'red blood cells'), ('UBERON_0000178', 'blood', 66, 'blood')]
PMC4334594	2/2015	S58-PMC4334594	['donath-landsteiner Antibody testing became negative at 3\xa0months and her hemoglobin improved to near baseline levels.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 19, 'antibody')]
PMC4352208	2/2015	S86-PMC4352208	['protein was transferred to Pvdf membranes (li-cor biosciences, lincoln, ne), which were blocked for one hour with blocking buffer (li-cor) and then probed for one hour with primary Antibodies, including goat anti-Gpx1 (r&d systems, minneapolis, mn), Rabbit anti-Selp [22], and Mouse monoclonal Igg anti-Β-Actin (sigma).']	N/A	N/A	[('CHEBI_53250', 'poly(vinylene fluoride)', 27, 'PVDF'), ('GO_0042571', 'immunoglobulin complex, circulating', 181, 'antibodies'), ('PR_000008210', 'glutathione peroxidase 1', 213, 'GPx1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 250, 'rabbit'), ('PR_000014622', 'semaphorin-4A', 262, 'SelP'), ('NCBITaxon_10088', 'Mus <genus>', 277, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 294, 'IgG'), ('PR_000003676', 'actin, cytoplasmic 1', 303, 'β-actin')]
PMC4352208	2/2015	S87-PMC4352208	['appropriate secondary Antibodies (li-cor) were incubated with the membranes for one hour and the bands were detected and quantified using a li-cor odyssey infrared imaging system and image studio software (li-cor).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 22, 'antibodies')]
PMC4354412	3/2015	S78-PMC4354412	['cells were counted microscopically in a neubauer chamber, and 106cells were stained in a two step-protocol using non-conjugated Antibodies against cd14, Cd45, mhcii, and Cd172A (listed in table1) followed by secondary Antibodies labeled with Fluorescein Isothiocyanate (Fitc) or Phycoerythrin (pe).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 128, 'antibodies'), ('PR_000001309', 'CD70 molecule', 153, 'CD45'), ('PR_000001309', 'CD70 molecule', 170, 'CD172a'), ('GO_0042571', 'immunoglobulin complex, circulating', 218, 'antibodies'), ('CHEBI_37926', 'fluorescein isothiocyanate', 242, 'fluorescein isothiocyanate'), ('CHEBI_37926', 'fluorescein isothiocyanate', 270, 'FITC'), ('CHEBI_36311', 'corphinoid', 279, 'phycoerythrin')]
PMC4354412	3/2015	S81-PMC4354412	['caption (table-wrap): table 1\n\nAntibodies used for flow cytometry .specificitycloneisotypefluorochromedistributorcd2msa4igg2anonevmrdacd4α74-12-4igg2bfitcbiozolbcd59g12igg1nonevmrdbcd8α76-2-11igg2apebiozolcd8βpg164aigg2anonevmrdtcr1-n4 (δ)pglbl22aigg1nonevmrdcd14mil-2igg2bnoneabd serotecccd16g7igg1noneacrisdcd25k231.3b2igg1noneacriscd45 (allotypic)mac323igg2anonebiozol(Sirpα, Cd172A)74-22-15igg1nonevmrdigmk521c3igg1nonebiozolmhciimsa3igg2anonevmrd\navmrd (pullman, wa, usa) .']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 31, 'Antibodies'), ('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 372, 'SIRPα'), ('PR_000001309', 'CD70 molecule', 379, 'CD172a')]
PMC4354412	3/2015	S85-PMC4354412	['for fluorescence microscopy, cells were labeled using Antibodies against cd14 and Cd45.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 54, 'antibodies'), ('PR_000001309', 'CD70 molecule', 82, 'CD45')]
PMC4354412	3/2015	S86-PMC4354412	['the secondary Antibody against Cd45 was labeled with Alexa Fluor 647.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibody'), ('PR_000001309', 'CD70 molecule', 31, 'CD45'), ('CHEBI_52661', 'Alexa Fluor 488', 53, 'Alexa Fluor 647')]
PMC4354412	3/2015	S90-PMC4354412	['Antibodies used for flow cytometry are listed in table1.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies')]
PMC4354412	3/2015	S115-PMC4354412	['blocking the staining of mcd14 on Blood Monocytes using Milk supernatant\nthe same monoclonal Antibody used to stain the milk cells (Mil-2) was also used for the Monocyte staining.']	N/A	N/A	[('CL_0000081', 'blood cell', 34, 'blood monocytes'), ('UBERON_0000178', 'blood', 34, 'blood'), ('UBERON_0001913', 'milk', 56, 'milk'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibody'), ('PR_000010450', 'protein AF-10', 132, 'MIL-2'), ('CL_0000576', 'monocyte', 161, 'monocyte')]
PMC4354412	3/2015	S116-PMC4354412	['before addition of the Antibody to the Monocytes (106cells in 30\u2009μl of pbs), the Antibody (0.5\u2009μl) was incubated either in 70\u2009μl of either pure Milk supernatant, or 50 or 10% dilutions of Milk supernatant in pbs.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 23, 'antibody'), ('CL_0000576', 'monocyte', 39, 'monocytes'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibody'), ('UBERON_0001913', 'milk', 144, 'milk'), ('UBERON_0001913', 'milk', 188, 'milk')]
PMC4354412	3/2015	S152-PMC4354412	['caption (fig): figure 4\n\nmilk cells marked with Antibodies (anti-cd14 with Fitc and anti Cd45 with pe) visualized natively (a), using a 530-nm band pass filter for Fitc (b), and using a 585-nm band pass filter for pe (c) .']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 48, 'antibodies'), ('CHEBI_37926', 'fluorescein isothiocyanate', 75, 'FITC'), ('PR_000001309', 'CD70 molecule', 89, 'CD45'), ('CHEBI_37926', 'fluorescein isothiocyanate', 164, 'FITC')]
PMC4368185	3/2015	S62-PMC4368185	['western blotting\nconcentration of 11β-Hds2 was determined by western blot using a primary anti-Rat 11Β-hydroxysteroid dehydrogenase type ii polyclonal Antibody (millipore, ca) diluted 1:1000.']	N/A	N/A	[('PR_000008474', 'hematopoietic lineage cell-specific protein', 38, 'HDS2'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 95, 'rat'), ('CHEBI_37983', 'sulfur-35 atom', 99, '11β'), ('GO_0042571', 'immunoglobulin complex, circulating', 151, 'antibody')]
PMC4368185	3/2015	S63-PMC4368185	['for Β-Actin, we used a Mouse primary Antibody anti Rat (santa cruz, ca, usa) diluted 1:2000.']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 4, 'β-actin'), ('NCBITaxon_10088', 'Mus <genus>', 23, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 37, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 51, 'rat')]
PMC4368185	3/2015	S64-PMC4368185	['an anti-Sheep Igg—peroxidase secondary Antibody in a 1:10.000 dilution was used as secondary Antibody (sigma-aldrich, st. louis, mo, usa).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 8, 'sheep'), ('GO_0071735', 'IgG immunoglobulin complex', 14, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 39, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibody')]
PMC4372177	2/2015	S235-PMC4372177	['total Abdominal Fat, Visceral Fat (Vf), and subcutaneous fat (subqf) were measured by computed tomography scans of the Fourth Lumbar Spine [116] in Adults and by magnetic resonance imaging at the same level in children and adolescents; circulating levels of adiponectin and leptin were measured by a double Antibody equilibrium radioimmunoassay (ria) (millipore corporation, billerica, ma) and Tnf-Alpha, Interleukin-1Beta (Il-1Β), and Interleukin-6 (Il-6) levels that were measured as previously described [117].']	N/A	N/A	[('UBERON_0007808', 'adipose tissue of abdominal region', 6, 'abdominal fat'), ('UBERON_0004754', 'foramen ovale of heart', 21, 'visceral fat'), ('UBERON_0002824', 'vestibular ganglion', 35, 'VF'), ('UBERON_0013496', 'unbarbed keratin-coated spine', 119, 'fourth lumbar spine'), ('UBERON_0007023', 'adult organism', 148, 'adults'), ('GO_0042571', 'immunoglobulin complex, circulating', 307, 'antibody'), ('PR_000000134', 'tumor necrosis factor alpha', 394, 'TNF-alpha'), ('PR_000001365', 'interleukin-10 receptor subunit alpha', 405, 'interleukin-1beta'), ('PR_000001383', 'interleukin-22', 424, 'IL-1β'), ('PR_000001381', 'interleukin-2 receptor subunit beta', 436, 'interleukin-6'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 451, 'IL')]
PMC4383226	2/2015	S198-PMC4383226	["viral Antibodies were detected using the enzyme-linked immunosorbent assay (elisa)-based assay vironostikaò hiv uni-form ii plus o (biomériux, marcy l'etoile, france)."]	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 6, 'antibodies')]
PMC4383546	4/2015	S51-PMC4383546	['briefly, samples were incubated overnight in primary Antibodies, washed, and incubated in secondary Antibodies.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 100, 'antibodies')]
PMC4383546	4/2015	S53-PMC4383546	['primary Antibodies used were Rat anti-F4/80 for cls (1:1000; abcam), Rat anti-perilipin (1:1000; sigma) for Adipocyte sizing, armenian hamster anti-Cd11C to visualize M1 (1:500; abd serotec), and conjugated Cd301-Alexa647 (1:200; abd serotec) to visualize M2 Macrophages.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 8, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 29, 'rat'), ('PR_000001900', 'neuropilin-1', 38, 'F4/80'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 69, 'rat'), ('CL_0000136', 'fat cell', 108, 'adipocyte'), ('PR_000001309', 'CD70 molecule', 148, 'CD11c'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 167, 'M1'), ('PR_000005169', 'CMRF35-like molecule 9', 207, 'CD301'), ('CHEBI_52661', 'Alexa Fluor 488', 213, 'Alexa647'), ('CL_0000235', 'macrophage', 256, 'M2 macrophages')]
PMC4383546	4/2015	S54-PMC4383546	['secondary Antibodies were goat anti-Rat Alexa 568, anti-Rabbit Alexa 488, and anti-hamster Alexa 647 (1:200; invitrogen).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 36, 'rat'), ('CHEBI_51766', 'Alexa Fluor 568', 40, 'Alexa 568'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 56, 'rabbit'), ('CHEBI_52661', 'Alexa Fluor 488', 63, 'Alexa 488'), ('CHEBI_52661', 'Alexa Fluor 488', 91, 'Alexa 647')]
PMC4383546	4/2015	S64-PMC4383546	['a minimum of 1x105cells were aliquoted into single-stain controls, fluorescence minus one controls, and sample tubes, then incubated in fc block (Rat anti-Mouse cd16/cd32) followed by conjugated Antibodies.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 146, 'rat'), ('NCBITaxon_10088', 'Mus <genus>', 155, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 195, 'antibodies')]
PMC4383546	4/2015	S68-PMC4383546	['the following commercially available Fluorochrome conjugated Antibodies were used: Cd45 Apc-Cy7 for Leukocytes, Cd64 percp-Cy5.5 for Macrophages, Cd11C pe-Cy7 for M1 Macrophages (biolegend, san diego, ca), and Cd301 Alexa 647 for M2 Macrophages (abd serotec, raleigh, nc).']	N/A	N/A	[('CHEBI_51217', 'fluorochrome', 37, 'fluorochrome'), ('GO_0042571', 'immunoglobulin complex, circulating', 61, 'antibodies'), ('PR_000001309', 'CD70 molecule', 83, 'CD45'), ('PR_000004122', 'adenomatous polyposis coli protein', 88, 'Apc'), ('CHEBI_37989', 'Cy5 dye', 92, 'Cy7'), ('CL_0000738', 'leukocyte', 100, 'leukocytes'), ('PR_000001309', 'CD70 molecule', 112, 'CD64'), ('CHEBI_37989', 'Cy5 dye', 123, 'Cy5'), ('CL_0000235', 'macrophage', 133, 'macrophages'), ('PR_000001309', 'CD70 molecule', 146, 'CD11c'), ('CHEBI_37989', 'Cy5 dye', 155, 'Cy7'), ('CL_0000235', 'macrophage', 163, 'M1 macrophages'), ('PR_000005169', 'CMRF35-like molecule 9', 210, 'CD301'), ('CHEBI_52661', 'Alexa Fluor 488', 216, 'Alexa 647'), ('CL_0000235', 'macrophage', 230, 'M2 macrophages')]
PMC4383546	4/2015	S156-PMC4383546	['e : histological illustration of Antibodies used for flow cytometry.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 33, 'antibodies')]
PMC4386645	3/2015	S204-PMC4386645	['when evaluating Iga, Igg, and Igm specific Antibodies, autistic children had significantly higher Serum levels of Iga Antibodies, high levels of Igm Antibodies specific for lactalbumin, and Igg and Igm levels for casein [159,160].']	N/A	N/A	[('GO_0071746', 'IgA immunoglobulin complex, circulating', 16, 'IgA'), ('GO_0071735', 'IgG immunoglobulin complex', 21, 'IgG'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 30, 'IgM'), ('GO_0042571', 'immunoglobulin complex, circulating', 43, 'antibodies'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 114, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 118, 'antibodies'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 145, 'IgM'), ('GO_0042571', 'immunoglobulin complex, circulating', 149, 'antibodies'), ('GO_0071735', 'IgG immunoglobulin complex', 190, 'IgG'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 198, 'IgM')]
PMC4388824	4/2015	S74-PMC4388824	['the 250–100 kd section was probed with Rabbit polyclonal anti-Ire1Α (1:1000 dilution; cell signalling technology, danvers, ma, usa); the 100–65 kd section was probed with Rabbit polyclonal anti-Grp78 (1:1000 dilution; genetex, irvine, ca) and the 20–65 kd section was probed with Mouse monoclonal anti-xbp-1S (1 μg/ml; biolegend, san diego, ca) Antibodies.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 39, 'rabbit'), ('PR_000029559', 'interleukin-36 beta', 62, 'IRE1α'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 171, 'rabbit'), ('PR_000008210', 'glutathione peroxidase 1', 194, 'GRP78'), ('NCBITaxon_10088', 'Mus <genus>', 280, 'mouse'), ('PR_000000034', 'BMP', 305, '-1s'), ('GO_0042571', 'immunoglobulin complex, circulating', 345, 'antibodies')]
PMC4418750	6/2015	S77-PMC4418750	['non-specific binding was blocked with 2% bsa in pbs containing 0.1% Triton-X100 for 30\u200amin at room temperature before overnight incubation at 4\u200a°c with a primary Antibody for α-Tubulin (1:2000; cell signaling, danvers, ma, usa) in pbs with 1% bsa and 0.1% Triton-X100.']	N/A	N/A	[('CHEBI_9750', 'Triton X-100', 68, 'Triton-X100'), ('GO_0042571', 'immunoglobulin complex, circulating', 162, 'antibody'), ('PR_000028799', 'tubulin', 177, 'tubulin'), ('CHEBI_9750', 'Triton X-100', 256, 'Triton-X100')]
PMC4418750	6/2015	S78-PMC4418750	['following washing in pbs with 0.1% Triton-X100, outgrowths were incubated with the appropriate Alexa Fluor conjugated secondary Antibody (1:10\u200a000; molecular probes, life technologies, paisley, uk) for 1\u200ah at room temperature and counterstained for Nuclei using Dapi (sigma–aldrich) for 10\u200amin before mounting on slides in dpx (fisher, loughborough, uk).']	N/A	N/A	[('CHEBI_9750', 'Triton X-100', 35, 'Triton-X100'), ('CHEBI_82170', 'Allidochlor', 95, 'Alexa Fluor'), ('GO_0042571', 'immunoglobulin complex, circulating', 128, 'antibody'), ('GO_0005634', 'nucleus', 249, 'nuclei'), ('CHEBI_51231', 'DAPI', 262, 'DAPI')]
PMC4418750	6/2015	S92-PMC4418750	['proteins were transferred onto Nitrocellulose membranes overnight, blocked in 5% milk in tbs-Tween (0.1% Tween 20; sigma–aldrich) before incubation overnight at 4\u200a°c with primary Antibodies (cell signaling) for total 4E-Bp1 (1:1000), Phospho- (thr37/46) 4e-bp1 (1:1000), total S6 Ribosomal Protein (1:2000), Phospho- (ser235/236) S6 Ribosomal Protein (1:2000) and α-Tubulin (1:10\u200a000), all diluted in 5% bsa in tbs-Tween.']	N/A	N/A	[('CHEBI_53325', 'nitrocellulose', 31, 'nitrocellulose'), ('CHEBI_53422', 'polysorbate', 93, 'Tween'), ('CHEBI_53424', 'polysorbate 20', 105, 'Tween 20'), ('GO_0042571', 'immunoglobulin complex, circulating', 179, 'antibodies'), ('PR_000006897', 'endothelin-1', 217, '4E-BP1'), ('CHEBI_32958', 'phosphate group', 234, 'phospho'), ('PR_000014774', 'pulmonary surfactant-associated protein C', 277, 'S6 ribosomal protein'), ('GO_0005840', 'ribosome', 280, 'ribosomal'), ('CHEBI_32958', 'phosphate group', 308, 'phospho'), ('PR_000014774', 'pulmonary surfactant-associated protein C', 330, 'S6 ribosomal protein'), ('GO_0005840', 'ribosome', 333, 'ribosomal'), ('PR_000028799', 'tubulin', 366, 'tubulin'), ('CHEBI_53422', 'polysorbate', 415, 'Tween')]
PMC4418750	6/2015	S93-PMC4418750	['after overnight incubation, membranes were washed in tbs-Tween before 1\u200ah of incubation with appropriate species-specific, irdye-conjugated secondary Antibodies (rockland, limerick, pa, usa) in 5% milk in tbs-Tween20 at room temperature.']	N/A	N/A	[('CHEBI_53422', 'polysorbate', 57, 'Tween'), ('GO_0042571', 'immunoglobulin complex, circulating', 150, 'antibodies'), ('CHEBI_53424', 'polysorbate 20', 209, 'Tween20')]
PMC4425955	4/2015	S71-PMC4425955	['the amersham ecl plex western blotting system using low-fluorescent Pvdf membrane (ge healthcare, buckinghamshire, uk) and two cydyes (ge healthcare), the Cy3 and Cy5 coupled to secondary Antibodies, were used for all analyses.']	N/A	N/A	[('CHEBI_53250', 'poly(vinylene fluoride)', 68, 'PVDF'), ('CHEBI_37987', 'Cy3 dye', 155, 'Cy3'), ('CHEBI_37989', 'Cy5 dye', 163, 'Cy5'), ('GO_0042571', 'immunoglobulin complex, circulating', 188, 'antibodies')]
PMC4425955	4/2015	S77-PMC4425955	['anti-Histone H2B (ab52484) primary Antibody at 1:40,000 dilution incubation with membrane for 1\xa0h at rt was followed by washing and then incubation with secondary Antibody.']	N/A	N/A	[('CHEBI_15358', 'histone', 5, 'Histone'), ('PR_000008590', 'histone H2B type 1-J', 5, 'Histone H2B'), ('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 163, 'antibody')]
PMC4425955	4/2015	S78-PMC4425955	['incubation with secondary Antibody diluted in wash buffer (Cy3 anti-Mouse, 1:4000 and Cy5 anti-Rabbit, 1:3000) was carried out in the dark at rt.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 26, 'antibody'), ('CHEBI_37987', 'Cy3 dye', 59, 'Cy3'), ('NCBITaxon_10088', 'Mus <genus>', 68, 'mouse'), ('CHEBI_37989', 'Cy5 dye', 86, 'Cy5'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 95, 'rabbit')]
PMC4425955	4/2015	S80-PMC4425955	['the secondary Antibody signal was detected by scanning the membrane using a fluorescent laser scanner, typhoon (ge healthcare).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibody')]
PMC4425955	4/2015	S82-PMC4425955	['the optimal primary and secondary Antibody concentrations were determined by performing a test on the different protein amount and different dilutions.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antibody')]
PMC4425955	4/2015	S84-PMC4425955	['specificity of Agtr2 Antibody was confirmed by blocking peptide: Agtr2-ab91522 (abcam), figure1.']	N/A	N/A	[('PR_000001180', 'opsin-5', 15, 'AGTR2'), ('GO_0042571', 'immunoglobulin complex, circulating', 21, 'antibody'), ('PR_000001180', 'opsin-5', 65, 'AGTR2')]
PMC4425955	4/2015	S85-PMC4425955	['caption (fig): figure 1\n\nrepresentative western blot for At2R to demonstrate Antibody specificity.']	N/A	N/A	[('PR_000004441', 'protein ATP1B4', 57, 'AT2R'), ('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibody')]
PMC4425955	4/2015	S86-PMC4425955	['the incubation of the Membrane with Antibody neutralized by blocking peptide resulted in absence of band corresponding to the Agtr2 receptor.']	N/A	N/A	[('GO_0016020', 'membrane', 22, 'membrane'), ('GO_0042571', 'immunoglobulin complex, circulating', 36, 'antibody'), ('PR_000001180', 'opsin-5', 126, 'AGTR2')]
PMC4425955	4/2015	S87-PMC4425955	['from the left: marker, 30 and 60\xa0 μ g protein sample incubated with blocking peptide/primary anti-Agtr2 Antibody, then 30 and 60\xa0 μ g protein sample incubated with primary anti-Agtr2 Antibody.']	N/A	N/A	[('PR_000001180', 'opsin-5', 98, 'AGTR2'), ('GO_0042571', 'immunoglobulin complex, circulating', 104, 'antibody'), ('PR_000001180', 'opsin-5', 177, 'AGTR2'), ('GO_0042571', 'immunoglobulin complex, circulating', 183, 'antibody')]
PMC4425955	4/2015	S90-PMC4425955	['Macrophages were stained with an Antibody to Ed1 as described (attia et\xa0al.2002).']	N/A	N/A	[('CL_0000235', 'macrophage', 0, 'Macrophages'), ('GO_0042571', 'immunoglobulin complex, circulating', 33, 'antibody'), ('PR_000006880', 'extracellular matrix protein 2', 45, 'ED1')]
PMC4425955	4/2015	S91-PMC4425955	['Lymphocytes were stained with an Antibody to cd3 as described (bongartz et\xa0al.2012).']	N/A	N/A	[('CL_0000849', 'crypt olfactory receptor neuron', 0, 'Lymphocytes'), ('GO_0042571', 'immunoglobulin complex, circulating', 33, 'antibody')]
PMC4425955	4/2015	S92-PMC4425955	['brightvision-hrp was used as secondary Antibody (immunologic, tilburg, the netherlands).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 39, 'antibody')]
PMC4438573	5/2015	S4-PMC4438573	['overall, after adjustment for covariates, the type of supplementation did not influence Antibody levels at 36 Gestation weeks or the rate of change in Antibody levels from enrolment to 36 weeks.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 88, 'antibody'), ('GO_0007565', 'female pregnancy', 110, 'gestation'), ('GO_0042571', 'immunoglobulin complex, circulating', 151, 'antibody')]
PMC4438573	5/2015	S17-PMC4438573	['in endemic regions, Pregnant women naturally acquire Antibodies to malaria with repeated exposure to infectious mosquito bites prior to and during Pregnancy.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibodies'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
PMC4438573	5/2015	S27-PMC4438573	['to investigate this, Antibody immunity was measured to Antigens Expressed by Placental-binding and non-Placental-binding parasite isolates, Merozoite Antigens and schizont extract in Pregnant women from mangochi, malawi enrolled in a randomized controlled trial receiving daily lns, multiple Micronutrients (mmn - multi Vitamin and Minerals combined supplement) or iron and Folic Acid supplements (ifa – 60 mg of iron and 400 μg of Folic Acid).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 21, 'antibody'), ('CHEBI_59132', 'antigen', 55, 'antigens'), ('GO_0010467', 'gene expression', 64, 'expressed'), ('UBERON_0001987', 'placenta', 77, 'placental'), ('UBERON_0001987', 'placenta', 103, 'placental'), ('CL_0000764', 'erythroid lineage cell', 140, 'merozoite'), ('GO_0070090', 'metaphase plate', 140, 'merozoite'), ('CHEBI_59132', 'antigen', 150, 'antigens'), ('GO_0007565', 'female pregnancy', 183, 'pregnant'), ('CHEBI_33839', 'macromolecule', 292, 'micronutrients'), ('CHEBI_33229', 'vitamin (role)', 320, 'vitamin'), ('CHEBI_46751', 'quinolizidine', 332, 'minerals'), ('CHEBI_30751', 'formic acid', 374, 'folic acid'), ('CHEBI_30751', 'formic acid', 432, 'folic acid')]
PMC4438573	5/2015	S50-PMC4438573	['measuring Igg and Igg subclass Antibodies to Merozoite and schizont Antigens, and quantitating total Plasma Igg\nin brief, 0.5-2 μg/ml of each recombinant Antigen was coated on to 384 well high protein binding black optiplates (perkinelmer inc., massachusetts, usa).']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 10, 'IgG'), ('GO_0071735', 'IgG immunoglobulin complex', 18, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 31, 'antibodies'), ('GO_0070090', 'metaphase plate', 45, 'merozoite'), ('CHEBI_59132', 'antigen', 68, 'antigens'), ('UBERON_0001969', 'blood plasma', 101, 'plasma'), ('GO_0071735', 'IgG immunoglobulin complex', 108, 'IgG'), ('CHEBI_59132', 'antigen', 154, 'antigen')]
PMC4438573	5/2015	S56-PMC4438573	['these samples were used to measure Igg subclass Antibodies to the above Antigens.']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 35, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 48, 'antibodies'), ('CHEBI_59132', 'antigen', 72, 'antigens')]
PMC4438573	5/2015	S58-PMC4438573	['following incubation the plates were washed and incubated with respective Mouse anti-Human secondary Antibodies (Igg1 clone hp6069, Igg2 clone hp6002, Igg3 hp6047 [life technologies, australia] and Igg4 clone hp6023 (merck millipore, darmstadt, germany) at 1:1,000 dilution.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 74, 'mouse'), ('NCBITaxon_9606', 'Homo sapiens', 85, 'human'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibodies'), ('GO_0071735', 'IgG immunoglobulin complex', 113, 'IgG1'), ('GO_0071735', 'IgG immunoglobulin complex', 132, 'IgG2'), ('GO_0071735', 'IgG immunoglobulin complex', 151, 'IgG3'), ('GO_0071735', 'IgG immunoglobulin complex', 198, 'IgG4')]
PMC4438573	5/2015	S59-PMC4438573	['tertiary Antibody horseradish peroxidase-conjugated goat anti-Mouse Igg was added at 1:2,500 dilution followed by development of the assay using abts (2,2′-Azino-Bis(3-Ethylbenzothiazoline-6-Sulfonic Acid); sigma-aldrich).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 9, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 62, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 68, 'IgG'), ('CHEBI_34264', '2-bromophenol', 153, '2′-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid')]
PMC4438573	5/2015	S62-PMC4438573	['gamma-chain specific anti-Human Igg capture Antibody (sigma-aldrich) was coated on to the plates at 0.5 μg/ml concentration and incubated with participants’ Plasma diluted at 1:50,000.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 26, 'human'), ('GO_0071735', 'IgG immunoglobulin complex', 32, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 44, 'antibody'), ('UBERON_0001969', 'blood plasma', 157, 'plasma')]
PMC4438573	5/2015	S70-PMC4438573	['opsonic Phagocytosis assay for measuring functional Antibodies to Placental-binding and non-Placental-binding malaria variant Surface Antigens\nin order to measure Antibodies that opsonize prbcs for Phagocytic Clearance a high throughput assay previously established in the current laboratory was used [33], with minor modifications [34], as described [32].']	N/A	N/A	[('GO_0006909', 'phagocytosis', 8, 'phagocytosis'), ('GO_0042571', 'immunoglobulin complex, circulating', 52, 'antibodies'), ('UBERON_0001987', 'placenta', 66, 'placental'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('GO_0009986', 'cell surface', 126, 'surface'), ('CHEBI_59132', 'antigen', 134, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 163, 'antibodies'), ('GO_0006909', 'phagocytosis', 198, 'phagocytic clearance')]
PMC4438573	5/2015	S72-PMC4438573	['a participant was considered seropositive for opsonizing Antibodies if the percentage Phagocytosis of the samples was greater than the sum of the average and three standard deviations of the percentage Phagocytosis of the negative controls.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibodies'), ('GO_0006909', 'phagocytosis', 86, 'phagocytosis'), ('GO_0006909', 'phagocytosis', 202, 'phagocytosis')]
PMC4438573	5/2015	S74-PMC4438573	['Alexa Fluor® 647-conjugated Donkey anti-Rabbit Antibody (life technologies) was used as the tertiary Antibody at 4 μg/ml concentration in contrast to the previous methods.']	N/A	N/A	[('CHEBI_82170', 'Allidochlor', 0, 'Alexa Fluor'), ('CHEBI_75698', 'dG15', 13, '647'), ('NCBITaxon_33208', 'Metazoa', 28, 'donkey'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 40, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody')]
PMC4438573	5/2015	S81-PMC4438573	['Antibody levels were compared between supplementation groups lns versus ifa and lns versus mmn using mann whitney u test.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody')]
PMC4438573	5/2015	S82-PMC4438573	['differences between Antibody levels at the two time points were determined using wilcoxon matched-pair test.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 20, 'antibody')]
PMC4438573	5/2015	S83-PMC4438573	['the rate of change in Antibody levels was calculated as difference between Antibody levels at 36 gw and Antibody levels at enrolment divided by the number of weeks of the study.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 22, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 75, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 104, 'antibody')]
PMC4438573	5/2015	S85-PMC4438573	['the rate of change in Antibody levels was compared between Lns and ifa, and Lns and mmn, where ifa and mmn were the respective reference groups, by performing linear regression analysis.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 22, 'antibody'), ('UBERON_0000029', 'lymph node', 59, 'LNS'), ('UBERON_0000029', 'lymph node', 76, 'LNS')]
PMC4438573	5/2015	S86-PMC4438573	['levels of Antibody of each Igg subclass to merozoite and schizont Antigens were compared between supplementation groups Lns versus ifa and Lns versus mmn using mann whitney u test.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibody'), ('GO_0071735', 'IgG immunoglobulin complex', 27, 'IgG'), ('CHEBI_59132', 'antigen', 66, 'antigens'), ('UBERON_0000029', 'lymph node', 120, 'LNS'), ('UBERON_0000029', 'lymph node', 139, 'LNS')]
PMC4438573	5/2015	S87-PMC4438573	['comparisons were also made between Antibody levels at enrolment and at 36 weeks using wilcoxon matched-pair test.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibody')]
PMC4438573	5/2015	S88-PMC4438573	['the covariates of the association between supplementation type and malaria Antibody immunity were determined based on their biological relevance.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 75, 'antibody')]
PMC4438573	5/2015	S89-PMC4438573	['covariates chosen were gravidity, maternal age, hiv infection, malaria infection, residence, socioeconomic status (ses), body mass index (bmi) and Antibody levels at enrolment.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 147, 'antibody')]
PMC4438573	5/2015	S94-PMC4438573	['all the variables were treated as categorical except for Antibody levels at enrolment which was treated as a continuous variable.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody')]
PMC4438573	5/2015	S95-PMC4438573	['likelihood ratio test was used to test whether the association between supplementation type and Antibody levels at 36 weeks varied with covariates chosen for the study.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 96, 'antibody')]
PMC4438573	5/2015	S97-PMC4438573	['multivariate linear regression analyses for continuous outcomes (Antibody levels at 36 weeks and the rate of change in Antibody levels) and multivariate logistic regression analyses for categorical outcomes (seropositivity to malaria Antigens).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 65, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 119, 'antibody'), ('CHEBI_59132', 'antigen', 234, 'antigens')]
PMC4438573	5/2015	S98-PMC4438573	['differences in Antibody levels among women with different bmi and ses groups were determined following multivariate linear regression analysis, adjusting for covariates including supplementation group, as detailed in the table footnotes.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody')]
PMC4438573	5/2015	S112-PMC4438573	['changes in Antibody levels between enrolment and 36 weeks\nopsonizing Antibodies that promote Phagocytic clearance and Igg against the vsa Expressed by Placental-binding isolate were significantly higher at 36 weeks compared to the levels at enrolment; median relative Antibody levels, 49.7% compared to 32.7% at enrolment (p\u2009<\u20090.0001) and 42.3% compared to 15.0% at enrolment (p\u2009<\u20090.0001), respectively (figure\xa01a).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 11, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 69, 'antibodies'), ('GO_0006909', 'phagocytosis', 93, 'phagocytic'), ('GO_0071735', 'IgG immunoglobulin complex', 118, 'IgG'), ('GO_0010467', 'gene expression', 138, 'expressed'), ('UBERON_0001987', 'placenta', 151, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 268, 'antibody')]
PMC4438573	5/2015	S114-PMC4438573	['Antibody levels to Msp-1 19kd, Msp-2, Msp-3, eba-175 and schizont extract were significantly reduced from enrolment to 36 weeks; median difference in relative Antibody levels, 0.7% (p\u2009=\u20090.0006), 3.9% (p\u2009<\u20090.001), 0.2% (p\u2009=\u20090.019), 1.3% (p\u2009<\u20090.0001) and 6.5% (p\u2009<\u20090.0001), respectively (figure\xa01b).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody'), ('PR_000010697', 'metallothionein-1E', 19, 'MSP-1'), ('PR_000010697', 'metallothionein-1E', 31, 'MSP-2'), ('PR_000010697', 'metallothionein-1E', 38, 'MSP-3'), ('GO_0042571', 'immunoglobulin complex, circulating', 159, 'antibody')]
PMC4438573	5/2015	S116-PMC4438573	['caption (fig): figure 1\n\nAntibodies to malaria Antigens at enrolment and at 36 Gestation weeks.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 25, 'Antibodies'), ('CHEBI_59132', 'antigen', 47, 'antigens'), ('GO_0007565', 'female pregnancy', 79, 'gestation')]
PMC4438573	5/2015	S117-PMC4438573	['(a) Antibodies to variant Surface Antigens Expressed by Placental-binding and non-Placental-binding parasite isolates.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'Antibodies'), ('GO_0009986', 'cell surface', 26, 'surface'), ('CHEBI_59132', 'antigen', 34, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antigens'), ('GO_0010467', 'gene expression', 43, 'expressed'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('UBERON_0001987', 'placenta', 82, 'placental')]
PMC4438573	5/2015	S118-PMC4438573	['(b) Antibodies to Merozoite Antigens and schizont extract.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'Antibodies'), ('CL_0000764', 'erythroid lineage cell', 18, 'merozoite'), ('GO_0070090', 'metaphase plate', 18, 'merozoite'), ('CHEBI_59132', 'antigen', 28, 'antigens')]
PMC4438573	5/2015	S119-PMC4438573	['data presented as box plots with the y axis representing Antibody levels as a percentage of the positive control.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody')]
PMC4438573	5/2015	S121-PMC4438573	['wilcoxon matched pairs test performed for Antibody comparisons between enrolment and 36 Gestation weeks.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 42, 'antibody'), ('GO_0007565', 'female pregnancy', 88, 'gestation')]
PMC4438573	5/2015	S123-PMC4438573	['effect of Nutrient supplementation on Antibody Immune Responses to malaria\nwhen categorized by the supplementation groups, no significant differences in the levels of Antibody to Placental-binding or non-Placental-binding isolates were observed at 36 weeks (figure\xa02a).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 10, 'nutrient'), ('GO_0007601', 'visual perception', 38, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibody'), ('GO_0006955', 'immune response', 47, 'immune responses'), ('GO_0042571', 'immunoglobulin complex, circulating', 167, 'antibody'), ('UBERON_0001987', 'placenta', 179, 'placental'), ('UBERON_0001987', 'placenta', 204, 'placental')]
PMC4438573	5/2015	S124-PMC4438573	['there were also no significant differences in Antibodies to merozoite or schizont Antigens, when stratified by supplementation type (figure\xa02b).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies'), ('CHEBI_59132', 'antigen', 82, 'antigens')]
PMC4438573	5/2015	S126-PMC4438573	['caption (fig): figure 2\n\nAntibodies to malaria Antigens at 36 weeks categorized by supplementation type.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 25, 'Antibodies'), ('CHEBI_59132', 'antigen', 47, 'antigens')]
PMC4438573	5/2015	S127-PMC4438573	['(a) Antibodies to variant Surface Antigens Expressed by Placental-binding and non-Placental-binding parasite isolates.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'Antibodies'), ('GO_0009986', 'cell surface', 26, 'surface'), ('CHEBI_59132', 'antigen', 34, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antigens'), ('GO_0010467', 'gene expression', 43, 'expressed'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('UBERON_0001987', 'placenta', 82, 'placental')]
PMC4438573	5/2015	S128-PMC4438573	['(b) Antibodies to Merozoite Antigens and schizont extract.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'Antibodies'), ('CL_0000764', 'erythroid lineage cell', 18, 'merozoite'), ('GO_0070090', 'metaphase plate', 18, 'merozoite'), ('CHEBI_59132', 'antigen', 28, 'antigens')]
PMC4438573	5/2015	S129-PMC4438573	['data presented as box plots with the y axis representing Antibodies as a percentage of the positive control.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibodies')]
PMC4438573	5/2015	S131-PMC4438573	['mann whitney u test performed for Antibody comparisons between supplementation groups lns versus ifa and Lns versus mmn.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antibody'), ('UBERON_0000029', 'lymph node', 105, 'LNS')]
PMC4438573	5/2015	S133-PMC4438573	['there were no differences in the prevalence of detectable Antibody responses at 36 weeks by supplementation group (see additional file3).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 58, 'antibody')]
PMC4438573	5/2015	S134-PMC4438573	['more than 85% of the Pregnant women had Antibodies to Placental-binding vsa.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 21, 'pregnant'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibodies'), ('UBERON_0001987', 'placenta', 54, 'placental')]
PMC4438573	5/2015	S135-PMC4438573	['effect of supplementation on the rate of change in Antibodies to malaria Antigens\nsignificant differences in the rate of change in Antibodies to parasite isolate vsa were not found between supplementation groups (table\xa02), except for Msp-2.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibodies'), ('CHEBI_59132', 'antigen', 73, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 131, 'antibodies'), ('PR_000010697', 'metallothionein-1E', 234, 'MSP-2')]
PMC4438573	5/2015	S137-PMC4438573	['caption (table-wrap): table 2\n\nassociation between Nutrient supplementation and the rate of change in Antibody levelsrate of change in Antibody levels (percentage Antibody level change per Gestation week, arbitrary units)Lns (n\u2009=\u2009337) compared to ifa (n\u2009=\u2009325)Lns (n\u2009=\u2009337) compared to mmn (n\u2009=\u2009347)unadjustedadjustedadjusted p-valueunadjustedadjustedadjusted p-value Igg to Placental-binding isolate vsa−0.12 (−0.34, 0.11)−0.08 (−0.38, 0.22)0.5990.13 (−0.09, 0.36)0.26 (−0.04, 0.55)0.089opsonizing Antibodies to Placental-binding solate vsa−0.02 (−0.24, 0.19)−0.11 (−0.41, 0.19)0.4690.06 (−0.14, 0.27)0.02 (−0.26, 0.30)0.864opsonizing Antibodies to non-Placental-binding isolate vsa−0.002 (−0.12, 0.12)0.01 (−0.16, 0.18)0.888−0.08 (−0.19, 0.03)0.02 (−0.13, 0.18)0.756Msp-1 19kd−0.02 (−0.17, 0.12)0.006 (−0.18, 0.19)0.953−0.06 (−0.19, 0.08)0.04 (−0.14, 0.21)0.693Msp-2−0.12 (−0.27, 0.03)−0.20 (−0.40, 0.02)0.069−0.15 (−0.32, 0.01)−0.25 (−0.46, −0.04)*0.021*Msp-3−0.18 (−0.36, −0.01)*−0.21 (−0.44, 0.03)0.080−0.05 (−0.24, 0.14)−0.01 (−0.28, 0.27)0.970pfrh20.07 (−0.13, 0.27)0.10 (−0.17, 0.37)0.461−0.21 (−0.40, −0.02)*−0.25 (−0.51, 0.02)0.073eba-175−0.06 (−0.18, 0.06)−0.04 (−0.20, 0.13)0.639−0.07 (−0.20, 0.05)−0.05 (−0.24, 0.14)0.603schizont extract−0.03 (−0.28, 0.23)0.13 (−0.21, 0.48)0.4500.003 (−0.26, 0.27)0.10 (−0.26, 0.47)0.583\nresults presented as regression coefficients (95% confidence interval) calculated by comparing the percentage rate of change in Antibody levels in lns group compared to ifa (reference group) and lns group compared to mmn (reference group).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 51, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 102, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 163, 'antibody'), ('GO_0007565', 'female pregnancy', 189, 'gestation'), ('UBERON_0000029', 'lymph node', 221, 'LNS'), ('UBERON_0000029', 'lymph node', 260, 'LNS'), ('GO_0071735', 'IgG immunoglobulin complex', 368, 'IgG'), ('UBERON_0001987', 'placenta', 375, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 499, 'antibodies'), ('UBERON_0001987', 'placenta', 513, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 636, 'antibodies'), ('UBERON_0001987', 'placenta', 654, 'placental'), ('PR_000008759', 'heparan sulfate glucosamine 3-O-sulfotransferase 2', 765, '756MSP-1'), ('PR_000008759', 'heparan sulfate glucosamine 3-O-sulfotransferase 2', 860, '693MSP-2'), ('PR_000010697', 'metallothionein-1E', 957, 'MSP-3'), ('GO_0042571', 'immunoglobulin complex, circulating', 1463, 'antibody')]
PMC4438573	5/2015	S138-PMC4438573	['the percentage rate of change in Antibody levels from enrolment to 36 gw were adjusted for gravidity, maternal age, hiv, malaria infection at enrolment, malaria infection at 36 weeks, bed net use, body mass index at enrolment, socioeconomic status and location of residence.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 33, 'antibody')]
PMC4438573	5/2015	S150-PMC4438573	['this difference was significant for opsonic Antibodies to both Placental-binding; median (p-value), 52.8% (p\u2009=\u20090.005) and non-Placental-binding isolates 41.0% (p\u2009=\u20090.001) (figure\xa03b-c), and was not affected by the supplementation type.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 44, 'antibodies'), ('UBERON_0001987', 'placenta', 63, 'placental'), ('UBERON_0001987', 'placenta', 126, 'placental')]
PMC4438573	5/2015	S152-PMC4438573	['caption (fig): figure 3\n\nAntibodies at 36 weeks stratified by maternal body mass index and socioeconomic status.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 25, 'Antibodies')]
PMC4438573	5/2015	S153-PMC4438573	['(a-c) Antibodies to variant Surface Antigens of Placental-binding and non-Placental-binding parasite isolates stratified by body mass index (bmi) groups and supplementation groups, (d-f) stratified by socioeconomic status (ses) and supplementation groups.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 6, 'Antibodies'), ('GO_0009986', 'cell surface', 28, 'surface'), ('CHEBI_59132', 'antigen', 36, 'antigens'), ('GO_0042571', 'immunoglobulin complex, circulating', 36, 'antigens'), ('UBERON_0001987', 'placenta', 48, 'placental'), ('UBERON_0001987', 'placenta', 74, 'placental')]
PMC4438573	5/2015	S157-PMC4438573	['caption (table-wrap): table 3\n\nrelationship of maternal nutritional status and socioeconomic status to malaria Antibody immunity at 36 weeksbody mass index at enrolment (kg/m2)socioeconomic status (high/low)unadjustedadjustedaadjusted p-valueaunadjustedadjustedbadjusted p-valuebigg to Placental-binding isolate vsa−0.88 (−1.66, −0.10)*−0.72 (−1.57, 0.12)0.095−13.9 (−18.25, −9.58)*−9.54 (−14.74, −4.35)*<0.001*opsonizing Antibodies to Placental-binding isolate vsa−0.86 (−1.65, −0.06)*−1.04 (−1.84, −0.24)*0.011*−14.7 (−19.18, −10.27)*−5.47 (−10.43, −0.50)*0.031*opsonizing Antibodies to non-Placental-binding isolate vsa−0.53 (−1.11, 0.06)0.25 (−0.20, 0.70)0.272−4.07 (−7.42, −0 .70)*−0.59 (−3.38, 2.20)0.678Msp-1 19kd−0.08 (−0.53, 0.37)0.45 (−0.02, 0.92)0.060−1.62 (−4.19, 0.96)−1.39 (−4.36, 1.57)0.355Msp-2−0.40 (−0.88, 0.08)0.14 (−0.37, 0.65)0.595−2.41 (−5.12, 0.30)−0.26 (−3.46, 2.94)0.874Msp-3−0.01 (−0.47, 0.44)0.06 (−0.57, 0.69)0.856−0.83 (−3.43, 1.77)0.38 (−3.55, 4.31)0.849pfrh2−0.30 (−0.77, 0.17)−0.66 (−1.32, −0.004)*0.051*−0.49 (−3.17, 2.18)0.49 (−3.64, 4.61)0.817eba-175−0.15 (−0.46, 0.16)0.11 (−0.28, 0.50)0.573−1.12 (−2.89, 0.65)−0.22 (−2.66, 2.22)0.858schizont extract−0.64 (−1.35, 0.07)−1.22 ( −2.08, −0.37)*0.005*−5.17 (−9.24, −1.10)*−0.55 (−6.12, 5.01)0.845\ndata presented as regression coefficient (95% confidence interval).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 111, 'antibody'), ('UBERON_0001987', 'placenta', 286, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 422, 'antibodies'), ('UBERON_0001987', 'placenta', 436, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 575, 'antibodies'), ('UBERON_0001987', 'placenta', 593, 'placental'), ('PR_000014709', 'neuroserpin', 707, '678MSP-1'), ('PR_000008758', 'heparan sulfate glucosamine 3-O-sulfotransferase 1', 802, '355MSP-2'), ('PR_000011509', 'nuclear pore complex protein Nup155', 892, '874MSP-3')]
PMC4438573	5/2015	S158-PMC4438573	['apercentage Antibody levels at 36 Gestation week adjusted for gravidity, maternal age, hiv, malaria infection at enrolment, bed net use, location of residence, Antibody levels at enrolment, socioeconomic status, supplementation group.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibody'), ('GO_0007565', 'female pregnancy', 34, 'gestation'), ('GO_0042571', 'immunoglobulin complex, circulating', 160, 'antibody')]
PMC4438573	5/2015	S159-PMC4438573	['bpercentage Antibody levels at 36 Gestation week adjusted for gravidity, maternal age, hiv, malaria infection at enrolment, bed net use, location of residence, Antibody levels at enrolment, body mass index at enrolment, supplementation group.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibody'), ('GO_0007565', 'female pregnancy', 34, 'gestation'), ('GO_0042571', 'immunoglobulin complex, circulating', 160, 'antibody')]
PMC4438573	5/2015	S166-PMC4438573	['ingestion of Lns was not associated with significant increases in malaria Antibody levels, a faster rate of change of Antibody levels from enrolment to 36 weeks, or likelihood of seropositivity to malaria Antigens.']	N/A	N/A	[('UBERON_0000029', 'lymph node', 13, 'LNS'), ('GO_0042571', 'immunoglobulin complex, circulating', 74, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 118, 'antibody'), ('CHEBI_59132', 'antigen', 205, 'antigens')]
PMC4438573	5/2015	S168-PMC4438573	['Antibodies were measured against vsa Expressed by a Placental-binding and non-Placental-binding parasite isolate, Merozoite Antigens and schizont extract.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('GO_0010467', 'gene expression', 37, 'expressed'), ('UBERON_0001987', 'placenta', 52, 'placental'), ('UBERON_0001987', 'placenta', 78, 'placental'), ('CL_0000764', 'erythroid lineage cell', 114, 'merozoite'), ('GO_0070090', 'metaphase plate', 114, 'merozoite'), ('CHEBI_59132', 'antigen', 124, 'antigens')]
PMC4438573	5/2015	S169-PMC4438573	['Antibodies to Placental-binding vsa reduced the risk of Placental malaria by inhibiting cytoadhesion to receptors [37], and by promoting their Phagocytic clearance [39].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('UBERON_0001987', 'placenta', 14, 'placental'), ('UBERON_0001987', 'placenta', 56, 'placental'), ('GO_0006909', 'phagocytosis', 143, 'phagocytic')]
PMC4438573	5/2015	S170-PMC4438573	['Antibodies to Merozoite Antigens can prevent invasion of prbcs [29] inhibit Intra-Erythrocytic development and Opsonize merozoites for Phagocytic Clearance [40,41] contributing to the protection against clinical malaria.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('GO_0070090', 'metaphase plate', 14, 'merozoite'), ('CHEBI_59132', 'antigen', 24, 'antigens'), ('GO_0005622', 'intracellular anatomical structure', 76, 'intra'), ('CL_0000232', 'erythrocyte', 82, 'erythrocytic'), ('GO_0042275', 'error-free postreplication DNA repair', 82, 'erythrocytic'), ('GO_0007608', 'sensory perception of smell', 111, 'opsonize'), ('GO_0006909', 'phagocytosis', 135, 'phagocytic clearance')]
PMC4438573	5/2015	S171-PMC4438573	['a strong increase in both total and opsonizing Antibodies to Placental-binding vsa from study entry to 36 weeks was observed while Antibodies to merozoite anti6gens and non-Placental-binding isolates declined.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibodies'), ('UBERON_0001987', 'placenta', 61, 'placental'), ('GO_0042571', 'immunoglobulin complex, circulating', 131, 'antibodies'), ('UBERON_0001987', 'placenta', 173, 'placental')]
PMC4438573	5/2015	S186-PMC4438573	['overall, women with a low bmi at study entry had higher Antibody levels to vsa than did women with normal or increased bmi.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 56, 'antibody')]
PMC4438573	5/2015	S187-PMC4438573	['supplementation type did not influence the relationship between Antibody responses and bmi.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 64, 'antibody')]
PMC4448820	5/2015	S761-PMC4448820	['● a decreased anti-tetanus Antibody response after tetanus vaccination was observed in obese compared with healthy-weight children (446).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 27, 'antibody')]
PMC4453242	5/2015	S43-PMC4453242	['caption (table-Wrap): table 1\n\nprimary Antibodies used for immunocytochemistry, immunohistochemistry and ultrastructural immunohistochemistrytarget phenotypestarget proteins/epitopeshostdilutionvendorhuman cell markershuman Nuclei protein Antibody (hnu)Mouse1:1,000millipore, billerica, ma, usahuman Cytoplasm-specific Antibody (sc121)Mouse1:3,000stemcells, inc., ca, usaneuron ( in vivo )type Iii-Tubulin epitope j1 (tuj1)Rabbit1:400covance, berkeley, ca, usaneuron ( in vitro )type Iii-Tubulin epitope j1 (tuj1)Mouse1:100sigma, saint louis, mo, usamitotic markerki67 Antigen (ncl-ki67p)Rabbit1:400novocastra labs, newcastle, ukaxonneurofilament heavy chainrabbit1:200sigma, saint louis, mo, usaprogenitor/early Oligodendrocyteolig2Goat1:50santa cruz, santa cruz, ca, usaplatelet-Derived Growth Factor Receptor Α (Pdgfrα)Rabbit1:100santa cruz, santa cruz, ca, usaa2b5mouse1:200millipore, billerica, ma, usang2rabbit1:100millipore, billerica, ma, usao4mouse1:100millipore, billerica, ma, usalate Oligodendrocytemyelin Basic protein (Mbp)rabbit1:200abcam, cambridge, ma, usaadenomatous polyposis coli protein (Apc)Rabbit1:200novus biologicals, littleton, co, usaastrocyte ( in vivo )Glial Fibrillary Acidic Protein (Gfap)Rabbit1:400dako, carpinteria, ca, usaastrocyte ( in vitro )Glial Fibrillary Acidic Protein (Gfap)Rabbit1:100millipore, billerica, ma, usamesodermal markerbone Morphogenetic Protein-4 (Bmp4)Mouse1:300millipore, billerica, ma, usa\n\nAnimals and surgical procedures\nten-week old male nude Rats (crl:nih- Foxn1Rnu; charles river, wilmington, ma, usa) were used for hopc transplantation.']	N/A	N/A	[('PR_000017453', 'protein Wnt-9b', 15, 'WRAP'), ('GO_0042571', 'immunoglobulin complex, circulating', 39, 'antibodies'), ('GO_0005634', 'nucleus', 224, 'Nuclei'), ('GO_0042571', 'immunoglobulin complex, circulating', 239, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 253, 'Mouse1'), ('GO_0005737', 'cytoplasm', 300, 'cytoplasm'), ('GO_0042571', 'immunoglobulin complex, circulating', 319, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 335, 'Mouse1'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 394, 'III'), ('PR_000028799', 'tubulin', 398, 'tubulin'), ('NCBITaxon_10088', 'Mus <genus>', 423, 'Rabbit1'), ('PR_000008959', 'immunoglobulin heavy constant gamma 1', 484, 'III'), ('PR_000028799', 'tubulin', 488, 'tubulin'), ('NCBITaxon_10088', 'Mus <genus>', 513, 'Mouse1'), ('CHEBI_59132', 'antigen', 569, 'antigen'), ('NCBITaxon_10088', 'Mus <genus>', 588, 'Rabbit1'), ('CL_0000128', 'oligodendrocyte', 713, 'oligodendrocyteOlig2Goat1'), ('PR_000002067', 'poliovirus receptor', 780, '-derived growth factor receptor α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 815, 'PDGFRα'), ('NCBITaxon_10088', 'Mus <genus>', 822, 'Rabbit1'), ('CL_0000128', 'oligodendrocyte', 996, 'oligodendrocyteMyelin'), ('CHEBI_22695', 'base', 1018, 'basic'), ('PR_000010220', 'mannose-binding protein C', 1033, 'MBP'), ('PR_000004122', 'adenomatous polyposis coli protein', 1109, 'APC'), ('NCBITaxon_10088', 'Mus <genus>', 1113, 'Rabbit1'), ('CL_0000125', 'glial cell', 1182, 'Glial'), ('PR_000007897', 'glutamate--cysteine ligase catalytic subunit', 1182, 'Glial fibrillary acidic protein'), ('CHEBI_37527', 'acid', 1199, 'acidic'), ('PR_000007939', 'glial fibrillary acidic protein', 1215, 'GFAP'), ('NCBITaxon_10088', 'Mus <genus>', 1220, 'Rabbit1'), ('CL_0000125', 'glial cell', 1279, 'Glial'), ('PR_000007897', 'glutamate--cysteine ligase catalytic subunit', 1279, 'Glial fibrillary acidic protein'), ('CHEBI_37527', 'acid', 1296, 'acidic'), ('PR_000007939', 'glial fibrillary acidic protein', 1312, 'GFAP'), ('NCBITaxon_10088', 'Mus <genus>', 1317, 'Rabbit1'), ('GO_0009653', 'anatomical structure morphogenesis', 1379, 'morphogenetic'), ('PR_000001883', 'lysosome-associated membrane protein', 1379, 'morphogenetic protein-4'), ('PR_000000165', 'BMP4', 1404, 'BMP4'), ('NCBITaxon_10088', 'Mus <genus>', 1409, 'Mouse1'), ('NCBITaxon_33208', 'Metazoa', 1450, 'Animals'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 1505, 'rats'), ('PR_000029959', 'smad9 isoform 3 (human)', 1520, 'Foxn1rnu')]
PMC4453242	5/2015	S55-PMC4453242	['Axonal injury was studied with well-established tai markers, including an Antibody against the Amyloid Precursor Protein (App), the monoclonal Antibody Rmo14 binding to the Rod Domain of Neurofilaments h and M, and a monoclonal Antibody against the 68-kda light Chain Neurofilament protein.']	N/A	N/A	[('GO_0030424', 'axon', 0, 'Axonal'), ('GO_0042571', 'immunoglobulin complex, circulating', 74, 'antibody'), ('PR_000004155', 'apolipoprotein E', 95, 'amyloid precursor protein'), ('PR_000004168', 'amyloid-beta precursor protein', 122, 'APP'), ('GO_0042571', 'immunoglobulin complex, circulating', 143, 'antibody'), ('PR_000014050', 'ribonuclease 7', 152, 'RMO14'), ('CL_0000604', 'retinal rod cell', 173, 'rod'), ('SO_0000417', 'polypeptide_domain', 177, 'domain'), ('GO_0005883', 'neurofilament', 187, 'neurofilaments'), ('PR_000010788', 'interferon-induced GTP-binding protein Mx1', 208, 'M'), ('GO_0042571', 'immunoglobulin complex, circulating', 228, 'antibody'), ('PR_000005448', 'chondroitin sulfate synthase 2', 262, 'chain'), ('GO_0005883', 'neurofilament', 268, 'neurofilament')]
PMC4453242	5/2015	S56-PMC4453242	['hopc survival was studied with Human-specific Nuclei (hnu) or Human-specific Cytoplasm (sc121) Antibody using immunoperoxidase or immunofluorescence labeling.']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 31, 'human'), ('GO_0005634', 'nucleus', 46, 'nuclei'), ('NCBITaxon_9606', 'Homo sapiens', 62, 'human'), ('GO_0005737', 'cytoplasm', 77, 'cytoplasm'), ('GO_0042571', 'immunoglobulin complex, circulating', 95, 'antibody')]
PMC4453242	5/2015	S58-PMC4453242	['appositions between Axons and transplant-derived Oligodendrocytes were visualized with the combination of Antibodies against the Heavy Neurofilament Subunit (Nf-H) and the sc121 epitope as generic Axonal and transplant-derived cell markers, respectively.']	N/A	N/A	[('GO_0030424', 'axon', 20, 'axons'), ('CL_0000128', 'oligodendrocyte', 49, 'oligodendrocytes'), ('GO_0042571', 'immunoglobulin complex, circulating', 106, 'antibodies'), ('PR_000008450', 'hyaluronan synthase 2', 129, 'heavy neurofilament subunit'), ('GO_0005883', 'neurofilament', 135, 'neurofilament'), ('GO_0005883', 'neurofilament', 158, 'NF'), ('PR_000011241', 'homeobox protein Nkx-2.1', 158, 'NF-H'), ('GO_0030424', 'axon', 197, 'axonal')]
PMC4453242	5/2015	S60-PMC4453242	['all Antibody information is listed in table\xa01.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'antibody')]
PMC4453242	5/2015	S93-PMC4453242	['induction of tai was studied with ihc strategies routinely used in tbi studies - that is, Antibodies against App, the monoclonal Antibody Rmo14 binding to the Rod Domain of Neurofilament heavy and medium chains that are exposed after lesion-induced sidearm proteolysis, and a monoclonal Antibody against the 68-Kda Light Chain Neurofilament Protein (nf68).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibodies'), ('PR_000004168', 'amyloid-beta precursor protein', 109, 'APP'), ('GO_0042571', 'immunoglobulin complex, circulating', 129, 'antibody'), ('PR_000014050', 'ribonuclease 7', 138, 'RMO14'), ('CL_0000604', 'retinal rod cell', 159, 'rod'), ('SO_0000417', 'polypeptide_domain', 163, 'domain'), ('GO_0005883', 'neurofilament', 173, 'neurofilament'), ('GO_0042571', 'immunoglobulin complex, circulating', 287, 'antibody'), ('PR_000000794', 'voltage-gated potassium channel KCNH5', 311, 'kDa'), ('PR_000009893', 'acyl-CoA:lysophosphatidylglycerol acyltransferase 1', 315, 'light chain neurofilament protein'), ('GO_0005883', 'neurofilament', 327, 'neurofilament')]
PMC4473145	12/2014	S75-PMC4473145	['immunological detection\nprotein extraction from M. Quadriceps , Sds-page and incubation of different Antibodies, as well as chemiluminescence detection and quantification of protein bands were performed as described before(24).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 48, 'M.'), ('UBERON_0001377', 'quadriceps femoris', 51, 'quadriceps'), ('CHEBI_8984', 'sodium dodecyl sulfate', 64, 'SDS'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibodies')]
PMC4473145	12/2014	S76-PMC4473145	['Cd36 (r&d systems) and α-Tubulin (sigma-aldrich) were used as primary Antibodies and either anti-Rat (r&d systems) or anti-Mouse Igg (cell signaling technology) horseradish peroxidase-conjugated secondary Antibodies were used.']	N/A	N/A	[('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 0, 'CD36'), ('PR_000028799', 'tubulin', 25, 'tubulin'), ('GO_0042571', 'immunoglobulin complex, circulating', 70, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 97, 'rat'), ('NCBITaxon_10088', 'Mus <genus>', 123, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 129, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 205, 'antibodies')]
PMC4483650	6/2015	S261-PMC4483650	['Membranes were blocked in 5% (w/v) nonfat milk in Tris-buffered saline containing 0.05% (v/v) Tween (tbst) for 2 h, then incubated first with primary Antibodies (1:1000 dilution) followed by redetection with secondary Antibodies (1:1000 dilution) in tbst-5% (w/v) Milk overnight at 4 °c.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_9754', 'tris', 50, 'Tris'), ('CHEBI_53422', 'polysorbate', 94, 'Tween'), ('GO_0042571', 'immunoglobulin complex, circulating', 150, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 218, 'antibodies'), ('UBERON_0001913', 'milk', 264, 'milk')]
PMC4483650	6/2015	S262-PMC4483650	['detection of specific binding was performed by incubation with Horse radish peroxidase-conjugated secondary Antibodies (1:3000; santa cruz biotechnology inc., santa cruz, ca, usa) for 2 h at room temperature.']	N/A	N/A	[('NCBITaxon_1', 'root', 63, 'horse'), ('GO_0042571', 'immunoglobulin complex, circulating', 108, 'antibodies')]
PMC4516109	5/2015	S35-PMC4516109	['its concentration in the Umbilical Cord is about 4-7% of the concentration detected in the maternal Blood.1certolizumab Pegol is a humanized anti-Tnf Antibody fab fragment with high affinity to Tnf,conjugated with 2 Polyethylene Glycol Molecules.']	N/A	N/A	[('UBERON_0002331', 'umbilical cord', 25, 'umbilical cord'), ('UBERON_0000178', 'blood', 100, 'blood'), ('CHEBI_63618', 'pravastatin', 120, 'pegol'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 146, 'TNF'), ('GO_0042571', 'immunoglobulin complex, circulating', 150, 'antibody'), ('PR_000016482', 'tumor necrosis factor receptor superfamily member 18', 194, 'TNF'), ('CHEBI_46793', 'poly(ethylene glycol)', 216, 'polyethylene glycol'), ('CHEBI_36357', 'polyatomic entity', 236, 'molecules')]
PMC4516488	9/2009	S2-PMC4516488	['we employed arrays with Antibodies directed against more than 600 structural and signalling proteins, including Phospho-variants.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 24, 'antibodies'), ('CHEBI_32958', 'phosphate group', 112, 'phospho')]
PMC4516488	9/2009	S24-PMC4516488	['we first employed Antibody microarrays (featuring over 600 different Antibodies) to detect proteins that were changed in their Expression and/or activation upon treatment with Vitamin D3.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 69, 'antibodies'), ('GO_0010467', 'gene expression', 127, 'expression'), ('CHEBI_33279', 'vitamin D5', 176, 'vitamin D3')]
PMC4516488	9/2009	S39-PMC4516488	['Antibody protein arrays\nover 600 Antibodies (≥350 pan- and ≥280 Phospho-site-specific, specification available upon request) were deposited in adjacent, duplicate spots on the glass slides (kinexus bioinformatics proprietary methodology).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 33, 'antibodies'), ('CHEBI_32958', 'phosphate group', 64, 'phospho')]
PMC4516488	9/2009	S43-PMC4516488	['caption (table-wrap): table 3\n\nselected protein targets for validation by conventional western blot*protein name%cfccdk2101.83egfr50.89Gsk3A/b−61.19Gsk3A/b (s21/s9)−59.81Gsk3A/b (y279/ y216)−43.04Mapk14−18.77p38a mapk (t180 + y182)−62.98pea-15 (ped15) (s116)953.61pi3k P110 Delta75.96pka49.52pkbg (Akt3)60.60pkca59.75\nin cases where the Antibodies were directed against the phosphorylated form of the protein, the site of phosphorylation is given in parentheses after the protein name.']	N/A	N/A	[('PR_000011040', 'nuclear receptor coactivator 1', 133, '89GSK3a'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 146, '19GSK3a'), ('PR_000008840', 'huntingtin', 168, '81GSK3a'), ('PR_000005411', 'chromodomain-helicase-DNA-binding protein 5', 194, '04MAPK14'), ('PR_000009025', 'immortalization up-regulated protein', 269, 'p110 delta75'), ('PR_000003910', 'aflatoxin B1 aldehyde reductase member 4', 298, 'Akt3'), ('GO_0042571', 'immunoglobulin complex, circulating', 337, 'antibodies')]
PMC4516488	9/2009	S46-PMC4516488	['first, proteins were separated by conventional gel electrophoresis based on their molecular weights, followed by detection with highly validated panel of Human Antibodies (the same as applied on the Kam1.1 chip).']	N/A	N/A	[('NCBITaxon_9606', 'Homo sapiens', 154, 'human'), ('GO_0042571', 'immunoglobulin complex, circulating', 160, 'antibodies'), ('PR_000009209', 'juxtaposed with another zinc finger protein 1', 199, 'KAM1')]
PMC4516488	9/2009	S55-PMC4516488	['Membranes were blocked for 1 hr with 5% non-fat dry milk in tbs containing 0.05% Tween-20 incubated with primary Antibodies (directed against: total Akt, pakt (s473), total pea-15, ppea-15 (s116) and Β-Actin as indicated in the figures) and visualized by chemiluminescence [28].']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('CHEBI_53424', 'polysorbate 20', 81, 'Tween-20'), ('GO_0042571', 'immunoglobulin complex, circulating', 113, 'antibodies'), ('PR_000003888', 'A-kinase anchor protein 14', 149, 'AKT'), ('PR_000003676', 'actin, cytoplasmic 1', 200, 'β-actin')]
PMC4516488	9/2009	S67-PMC4516488	['panel below (b), verification of the efficacy of the Sirna directed against Pea-15 by western blot using an Antibody detecting total Pea-15.']	N/A	N/A	[('SO_0000646', 'siRNA', 53, 'siRNA'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 76, 'PEA-15'), ('GO_0042571', 'immunoglobulin complex, circulating', 108, 'antibody'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 133, 'PEA-15')]
PMC4516488	9/2009	S87-PMC4516488	['Gene ontology sorting\nthe Gene ontology data annotation (version 161)http://www.geneontology.org;http://www.ebi.ac.uk/goa/) was used to classify and characterize the Genes that resulted from the Antibody microarray analysis.']	N/A	N/A	[('SO_0000704', 'gene', 0, 'Gene'), ('SO_0000704', 'gene', 26, 'Gene'), ('SO_0000704', 'gene', 166, 'genes'), ('GO_0042571', 'immunoglobulin complex, circulating', 195, 'antibody')]
PMC4516488	9/2009	S97-PMC4516488	['the Antibody array used in our study (kinexus) features more than 600 Antibodies (≥350 pan-specific and ≥250 Phospho-site-specific) deposited in duplicate spots.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 70, 'antibodies'), ('CHEBI_32958', 'phosphate group', 109, 'phospho')]
PMC4516488	9/2009	S103-PMC4516488	['lysates of treated and untreated cells were then applied to the Antibody array (fig.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 64, 'antibody')]
PMC4516488	9/2009	S104-PMC4516488	['1b, complete list of Antibody target proteins are referenced in supplementary table 1).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 21, 'antibody')]
PMC4516488	9/2009	S113-PMC4516488	['caption (table-wrap): table 1\n\nlist of Vitamin D3-Regulated proteins*protein name%cfcprotein name%cfcprotein name%cfcprotein name%cfcabl (y412)48.39jik [tao3]−53.38Pkba (Akt1) (s473)−56.65rb (t821)−47.07ack1[Ack]49.40jnk−60.27pkba (Akt1) (s473)1.37rb (t826)−48.51aif58.18jun (s63)−64.43Pkba (Akt1) (s473)47.91rb (s780)−61.39alk59.02mapkapk2 (t222)−48.57Pkba (Akt1) (t308)44.07ret (s696)−50.89ankrd352.82Mek1[Map2K1] (t385)160.80pkbg (Akt3)60.60ripk−54.19Arrestin B1 (s412)49.79Mek7[Map2K7]39.93pkbg (Akt3)104.38rb (t356)−39.08ask1[Map3K5]42.07mekk1[Map3K1]42.01pkca59.75roka[Rock2]−52.16bad (s99)76.14Mkp1−37.80pkca/b2 (t638/t641)−54.75Ror2−41.76bak69.32mnk1 (t209 + t214)−52.98pkcb274.40Rsk2−43.86bcl-Xs/l62.51Mnk2−65.50pkcd (s664)70.96Rsk1/2 (s380/s386)78.34bid68.12mos−44.47pkcd (y313)87.09rsk1/2 (s221/s227)−59.42btk115.73Mrlc2 (s18)−49.26pkce (s729)111.75Rsk1/2 (s363/s369)−41.89cas69.55msk1 (s376)−69.50pkce (s729)55.77Rsk1/2 (s380/s386)−44.83catenin b55.47Mst1−57.57pkcg87.89s6ka [P70 S6Ka]−42.53cdk2101.83Mst1−46.41pkcg (t514)76.71sirpa1−42.01Cdk1/2 (y15)104.61Mypt1 (t696)−48.44pkcg (t674)79.58Stat1 (s727)−53.87cdk1092.90nek2−53.10pkcq (s676)68.89Stat1 (y701)−51.38chk168.90nek2−62.32pkcq (s695)116.97Stat3 (s727)−45.76crystallin ab (s19)49.62Nek2−50.27pkd (Pkcm)52.85sti141.78crystallin ab (s45)60.01nek7−49.49pkd (pkcm) (s910)−63.08stk3385.79dnapk56.89Nfkappab P50−44.64pkm262.55Syk102.15Dok2 (y142)96.20Nfkb P65 (Rel A) (s276)−47.40pkn45.04synapsin 1 (S9)79.19egfr50.89nip1−46.25plk172.54tak125.86Egfr53.24nme6−48.11Pp1/ca (t320)56.56tau (s738)59.37egfr (y1068)53.23nme7−53.78pp2cab45.78tau (s518)25.20eif2a (s51)66.64nr1 (s896)−68.80pp5c94.37tau (s530)58.44eif2be (s540)61.39p16 Ink4−50.85pp6c49.63tau (s578)93.33erk4−48.65p18 Ink4C−45.99pras40 (t246)41.71tau (s712)−50.11erk6[P38G]54.02p35−41.17Prk1/2[Pkn1/2] (t774)−53.59tau (t547)64.83fak (y576)54.89P38A mapk−48.49prkwnk4−53.20tbk1127.12fak (y577)−56.74P38A mapk (t180 + y182)−62.98progesterone receptor (s294)−50.71tlk1130.92gck52.03p53 (s392)−45.00pten−51.11tradd95.57Gfap (s8)−49.22Pak1/2/3 (s144/s141/s154)−52.47pten (s370)−41.89trka81.99Grk3[Bark2]−35.17Parp1−48.38pten (s380 + s382 + s385)−57.24ttk105.00gsk3a/b (s21/s9)−59.81pax2 (s394)−41.20ptp1b−58.39tyk278.70Gsk3A/b (y279/ y216)−43.04paxillin 1 (y118)−61.03ptp1c−55.86th (s19)122.06hhr23b−52.41paxillin 1 (y118)56.45ptp1d−57.37th (s71)73.38histone H2A.x (s139)−75.10paxillin 1 (y31)−47.29pkr−43.59vegfr2[Kdr] (y1054)62.03hpk158.84Pctk1[Pctaire1]−44.85ptp-pest−98.46vimentin (s33)87.10hsp27 (s78)177.00Pdk1 (s244)−41.46Pyk2 (y579)−43.64vrk1117.51hsp60133.04pea-15 (ped15) (s116)953.61rad17 (s645)−53.78wee144.52ikka/b (s180)−50.72pi3k P110 Delta75.96raf1−51.29xiap55.94ikkb−56.26pka49.52rb (s612)−50.50zap70 (y315+y319)48.60Irak4−50.42pka cb (s338)55.65rb (s807)−58.72zap70 (y319)51.94Jak2−62.42Pkba (Akt1) (t308)75.72rb (s807 + s811)−67.14zipk44.78\nlisted are the results of Antibody microarray analysis (duplicate spots, complete list).']	N/A	N/A	[('CHEBI_33279', 'vitamin D5', 39, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 39, 'vitamin D3'), ('GO_0065007', 'biological regulation', 50, 'regulated'), ('PR_000006060', 'CWF19-like protein 1', 162, '38PKBa'), ('PR_000003920', 'retinal dehydrogenase 1', 170, 'Akt1'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 208, 'ACK'), ('PR_000003920', 'retinal dehydrogenase 1', 232, 'Akt1'), ('PR_000001245', 'rhodopsin', 284, '43PKBa'), ('PR_000003920', 'retinal dehydrogenase 1', 292, 'Akt1'), ('PR_000001103', '5-hydroxytryptamine receptor 7', 351, '57PKBa'), ('PR_000003920', 'retinal dehydrogenase 1', 359, 'Akt1'), ('PR_000011040', 'nuclear receptor coactivator 1', 401, '82MEK1'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 408, 'MAP2K1'), ('PR_000003910', 'aflatoxin B1 aldehyde reductase member 4', 434, 'Akt3'), ('PR_000009980', 'protein LTV1', 452, '19Arrestin b1'), ('PR_000017509', 'X-ray repair cross-complementing protein 6', 475, '79MEK7'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 482, 'MAP2K7'), ('PR_000003910', 'aflatoxin B1 aldehyde reductase member 4', 500, 'Akt3'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 531, 'MAP3K5'), ('PR_000010129', 'mitogen-activated protein kinase kinase kinase 10', 549, 'MAP3K1'), ('PR_000014339', 'radial spoke head 14 homolog', 575, 'ROCK2'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 599, '14MKP1'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 634, '75ROR2'), ('PR_000014739', 'splicing factor 3B subunit 5', 686, '40RSK2'), ('PR_000004770', 'Polycomb complex protein BMI-1', 701, '-xS'), ('PR_000011579', 'ornithine decarboxylase antizyme', 709, '51Mnk2'), ('PR_000017515', 'xylosyltransferase 1', 735, '96RSK1'), ('PR_000016980', 'ubiquitin-conjugating enzyme E2 K', 824, '73MRLC2'), ('PR_000017524', 'tyrosine--tRNA ligase, mitochondrial', 858, '75RSK1'), ('PR_000017509', 'X-ray repair cross-complementing protein 6', 923, '77RSK1'), ('PR_000014689', 'leukocyte elastase inhibitor', 961, '47MST1'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 988, 'p70 S6Ka'), ('PR_000008758', 'heparan sulfate glucosamine 3-O-sulfotransferase 1', 1011, '83MST1'), ('PR_000004255', 'Rho guanine nucleotide exchange factor 2', 1049, '01CDK1'), ('PR_000017550', '14-3-3 protein gamma', 1067, '61MYPT1'), ('PR_000008758', 'heparan sulfate glucosamine 3-O-sulfotransferase 1', 1101, '58STAT1'), ('PR_000009999', 'lysozyme g-like protein 1', 1155, '89STAT1'), ('PR_000017509', 'X-ray repair cross-complementing protein 6', 1209, '97STAT3'), ('PR_000017535', 'protein YIPF5', 1251, '62Nek2'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 1268, 'PKCm'), ('PR_000009329', 'killer cell immunoglobulin-like receptor 2DL3', 1362, '89NFkappaB p50'), ('PR_000030888', 'coiled-coil domain-containing protein 28A', 1389, '55Syk102'), ('PR_000007318', 'acyl-CoA 6-desaturase', 1398, '15Dok2'), ('PR_000007353', 'protocadherin Fat 4', 1414, '20NFkB'), ('PR_000001245', 'rhodopsin', 1421, 'p65'), ('PR_000014290', '40S ribosomal protein S7', 1426, 'Rel A'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 1462, '1'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 1465, 'S9'), ('PR_000008250', 'glutamate receptor ionotropic, NMDA 3A', 1508, '86EGFR53'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1527, '11PP1'), ('PR_000009071', 'integrator complex subunit 4', 1693, 'INK4'), ('PR_000009020', "Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase", 1741, 'INK4c'), ('PR_000003035', 'cellular tumor antigen p53', 1791, 'p38g'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1808, '17PRK1'), ('PR_000012774', 'polycystic kidney disease 2-like 1 protein', 1817, 'PKN1'), ('PR_000036800', 'histone H3.3 acetylated and methylated 1 (human)', 1865, '89p38a'), ('PR_000017539', 'synaptobrevin homolog YKT6', 1919, '74p38a'), ('PR_000008430', 'E3 ubiquitin-protein ligase HACE1', 2036, '57GFAP'), ('PR_000010877', 'myogenin', 2051, '22PAK1'), ('PR_000016880', '5,6-dihydroxyindole-2-carboxylic acid oxidase', 2108, '99GRK3'), ('PR_000004692', 'Bcl-2-related protein A1', 2115, 'BARK2'), ('PR_000013270', 'pyridoxal phosphate homeostasis protein PLPBP', 2125, '17PARP1'), ('PR_000008529', 'hairy/enhancer-of-split related with YRPW motif protein 2', 2235, '70GSK3a'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 2272, '1'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 2332, '1'), ('PR_000027547', 'histone H2A', 2377, 'H2A.'), ('PR_000003770', 'all-trans-retinol dehydrogenase [NAD(+)] ADH4', 2404, '1'), ('PR_000009225', 'junctophilin-4', 2433, 'KDR'), ('PR_000011011', 'neurobeachin-like protein 1', 2457, '84PCTK1'), ('PR_000012493', 'pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial', 2465, 'PCTAIRE1'), ('PR_000004270', 'AT-rich interactive domain-containing protein 5B', 2528, '00PDK1'), ('PR_000013649', 'Rab9 effector protein with Kelch motifs', 2545, '46Pyk2'), ('PR_000009025', 'immortalization up-regulated protein', 2663, 'p110 delta75'), ('PR_000001245', 'rhodopsin', 2750, '60IRAK4'), ('PR_000017516', 'xylosyltransferase 2', 2811, '94JAK2'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 2821, '42PKBa'), ('PR_000003920', 'retinal dehydrogenase 1', 2829, 'Akt1'), ('GO_0042571', 'immunoglobulin complex, circulating', 2904, 'antibody')]
PMC4516488	9/2009	S114-PMC4516488	['in cases where the Antibodies were directed against the phosphorylated form of the protein, the site of phosphorylation is given in parentheses after the protein name.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 19, 'antibodies')]
PMC4516488	9/2009	S116-PMC4516488	['caption (table-wrap): table 2\n\nGene ontology data sorting*Gene ontology classes of Vitamin D3Targetspercentage of Regulated proteins per go classcell Cycle36.6cell differentiation44.2cellular development42.8cellular communication38.8general Regulation Of Biological Processes38.6intracellular signalling Cascade40.1mapkkk cascade37.9ns development41.9phosphorylation40.2primary Metabolic Processes38.5programmed cell death38.7protein modification42.0regulation of Programmed Cell Death32.9response to stimulus42.5signal transduction38.0intracellular transport61.9neurogenesis58.3neurological processes75.0neuron Development55.5organelle organization and biogenesis51.1\nresults of the Antibody array were sorted using Gene ontology (http://www.geneontology.org,http://www.ebi.ac.uk/goa/).']	N/A	N/A	[('SO_0000704', 'gene', 31, 'Gene'), ('SO_0000704', 'gene', 58, 'Gene'), ('CHEBI_51160', 'carbonyl ylide', 83, 'vitamin D3targetsPercentage'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 83, 'vitamin D3targetsPercentage'), ('GO_0065007', 'biological regulation', 114, 'regulated'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 150, 'cycle36'), ('GO_0010089', 'xylem development', 241, 'regulation of biological processes38'), ('GO_0050909', 'sensory perception of taste', 304, 'cascade40'), ('GO_0008152', 'metabolic process', 378, 'metabolic processes38'), ('GO_0006412', 'translation', 464, 'programmed cell death32'), ('GO_0044838', 'cell quiescence', 612, 'development55'), ('GO_0042571', 'immunoglobulin complex, circulating', 684, 'antibody'), ('SO_0000704', 'gene', 717, 'Gene')]
PMC4516488	9/2009	S119-PMC4516488	['Membranes were probed with Antibodies identical to those used on the protein array (kinexus), visualized with the ecl detection system and quantified by using iris identification software (fig.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 27, 'antibodies')]
PMC4516488	9/2009	S138-PMC4516488	['using an Antibody that recognizes Pea-15 irrespective of its phosphorylation status we also detected an up-regulation of the total amount of Pea protein after 12 hrs (fig.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 9, 'antibody'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 34, 'PEA-15'), ('PR_000001904', 'platelet endothelial cell adhesion molecule', 141, 'PEA')]
PMC4516488	9/2009	S170-PMC4516488	['several Expression changes indicated by the Antibody array paralleled the ones described previously by other authors.']	N/A	N/A	[('GO_0010467', 'gene expression', 8, 'expression'), ('GO_0042571', 'immunoglobulin complex, circulating', 44, 'antibody')]
PMC4516488	9/2009	S175-PMC4516488	['up-regulation of Pea-15 was the most prominent feature on the Antibody array.']	N/A	N/A	[('PR_000001904', 'platelet endothelial cell adhesion molecule', 17, 'PEA-15'), ('GO_0042571', 'immunoglobulin complex, circulating', 62, 'antibody')]
PMC4516488	9/2009	S181-PMC4516488	['on the microarray, five Antibodies were directed against activated ( i.e.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 24, 'antibodies')]
PMC4528901	9/2014	S37-PMC4528901	['anti-Nuclear Antibody screen and anti-Double-Stranded dna Antibody were negative.']	N/A	N/A	[('GO_0005634', 'nucleus', 5, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 13, 'antibody'), ('SO_0000985', 'double', 38, 'double-stranded'), ('GO_0042571', 'immunoglobulin complex, circulating', 58, 'antibody')]
PMC4528901	9/2014	S56-PMC4528901	['the Liver specimen shown infigure 1was fixed and labeled with anti-Hsv-2 Antibody.']	N/A	N/A	[('UBERON_0002107', 'liver', 4, 'liver'), ('NCBITaxon_10088', 'Mus <genus>', 67, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 67, 'HSV-2'), ('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibody')]
PMC4636015	9/2015	S62-PMC4636015	['Tissues were incubated in primary Antibody Mouse anti-Th (1:1,000, millipore mab318) for 48 hours at 4°c.']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissues'), ('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 43, 'mouse'), ('PR_000016310', 'THO complex subunit 1', 54, 'TH')]
PMC4636015	9/2015	S65-PMC4636015	['after incubation, Tissues were incubated for 1 hour in Donkey anti-Mouse/Alexa 568 secondary Antibody (1:1,000 dilution, life technologies a10037, carlsbad,ca).']	N/A	N/A	[('UBERON_0000479', 'tissue', 18, 'tissues'), ('NCBITaxon_33208', 'Metazoa', 55, 'donkey'), ('NCBITaxon_10088', 'Mus <genus>', 67, 'mouse'), ('CHEBI_51766', 'Alexa Fluor 568', 73, 'Alexa 568'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibody')]
PMC4636015	9/2015	S67-PMC4636015	['for d1, Tissues were incubated in primary Antibody Rat anti-d1 (1:1,000, sigma aldrich d2944) for 48 hours at 4°c.']	N/A	N/A	[('UBERON_0000479', 'tissue', 8, 'tissues'), ('GO_0042571', 'immunoglobulin complex, circulating', 42, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 51, 'rat')]
PMC4636015	9/2015	S70-PMC4636015	['for d2, Tissues underwent Antigen retrieval for 30 minutes in 10 mm Sodium Citrate buffer (ph 8.5) to unmask immunosignal and were incubated in primary Antibody Mouse anti-D2 (1:200, santa cruz sc-5303) for 48 hours at 4°c.']	N/A	N/A	[('UBERON_0000479', 'tissue', 8, 'tissues'), ('CHEBI_59132', 'antigen', 26, 'antigen'), ('CHEBI_53258', 'sodium citrate', 68, 'sodium citrate'), ('GO_0042571', 'immunoglobulin complex, circulating', 152, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 161, 'mouse'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 172, 'D2')]
PMC4661500	11/2014	S458-PMC4661500	['patients with Thyroid diseases can have anti-myoglobin Antibodies in Blood[128],[130].']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 14, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 55, 'antibodies'), ('UBERON_0000178', 'blood', 69, 'blood')]
PMC4661500	11/2014	S604-PMC4661500	['these historical experiments aimed at the induction of thyroglobulin Antibodies using Organ extracts from different species together with Adjuvants such as Toluene, heat-killed acid fast bacteria (dr. jules freund, ny), melted lanolin, Mineral oil (bayol f2, esso refining co.), and a monooleate of Manitol (arlacel, atlas powder co. ®)[243].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 69, 'antibodies'), ('UBERON_0000062', 'organ', 86, 'organ'), ('CHEBI_65445', 'AS-186c', 138, 'adjuvants'), ('CHEBI_17578', 'toluene', 156, 'toluene'), ('CHEBI_46662', 'mineral', 236, 'mineral'), ('CHEBI_25175', 'mannuronates', 299, 'manitol')]
PMC4673623	11/2015	S54-PMC4673623	['holotranscobalamin: Plasma holotranscobalamin was measured by the monoclonal Antibody capture assay (ulleland et\xa0al.2002).']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 20, 'Plasma'), ('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibody')]
PMC4692114	1/2016	S2-PMC4692114	['edta-treated Cord Blood samples were analyzed by flow cytometry and the software kaluza1.2 using Cd45 and Cd34-specific fluorescent Antibodies to identify the hspc population (Cd34+cells within the cd45dimblast gate).']	N/A	N/A	[('UBERON_0002240', 'spinal cord', 13, 'cord'), ('UBERON_0000178', 'blood', 18, 'blood'), ('PR_000001309', 'CD70 molecule', 97, 'CD45'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 106, 'CD34'), ('GO_0042571', 'immunoglobulin complex, circulating', 132, 'antibodies'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 176, 'CD34')]
PMC4692114	1/2016	S23-PMC4692114	['Cell Surface Cd45 (label: Fitc, isotype: Igg1, κ, clone: hi30) and Cd34 (label: Pe-Cy7, isotype: Igg1, κ, clone: 581) were stained with specific fluorescent Antibodies (biolegend, san diego, ca).']	N/A	N/A	[('GO_0009986', 'cell surface', 0, 'Cell surface'), ('PR_000001309', 'CD70 molecule', 13, 'CD45'), ('CHEBI_37926', 'fluorescein isothiocyanate', 26, 'FITC'), ('GO_0071735', 'IgG immunoglobulin complex', 41, 'IgG1'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 67, 'CD34'), ('CHEBI_51383', 'hydridocarbon(3.)', 80, 'PE'), ('CHEBI_37989', 'Cy5 dye', 83, 'Cy7'), ('GO_0071735', 'IgG immunoglobulin complex', 97, 'IgG1'), ('GO_0042571', 'immunoglobulin complex, circulating', 157, 'antibodies')]
PMC4703052	1/2016	S95-PMC4703052	['for example, infants receiving a vaccine against bacterial meningitis mounted a primary response which included, on average, the production of 11 Memory B Cells per 106total Lymphocytes and 19.8 μg/ml Igg Antibodies, both specific to the Antigen in the vaccine [46].']	N/A	N/A	[('CL_0000313', 'serous secreting cell', 146, 'memory'), ('GO_0007613', 'memory', 146, 'memory B cells'), ('CL_0000236', 'B cell', 153, 'B cells'), ('CL_0000542', 'lymphocyte', 174, 'lymphocytes'), ('GO_0071735', 'IgG immunoglobulin complex', 201, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 205, 'antibodies'), ('CHEBI_59132', 'antigen', 238, 'antigen')]
PMC4703052	1/2016	S96-PMC4703052	['more than 7 months later, after being challenged with the same vaccine, the infants mounted a secondary response that resulted in the production of 40 per 106memory b cells and 46.2 μg/ml Igg Antibodies against the Antigen.']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 188, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 192, 'antibodies'), ('CHEBI_59132', 'antigen', 215, 'antigen')]
PMC4703052	1/2016	S97-PMC4703052	['a rapid and robust response is a defining feature of Immunological Memory, and in this case the production of key Effectors—Antigen-specific Antibodies and B Lymphocytes—was 2.3–3.6 times greater following secondary exposure.']	N/A	N/A	[('GO_0007566', 'embryo implantation', 53, 'immunological'), ('GO_0007613', 'memory', 67, 'memory'), ('CHEBI_35224', 'effector', 114, 'effectors'), ('CHEBI_59132', 'antigen', 124, 'antigen'), ('GO_0042571', 'immunoglobulin complex, circulating', 141, 'antibodies'), ('CL_0000236', 'B cell', 156, 'B lymphocytes')]
PMC4703068	8/2015	S118-PMC4703068	['in addition, gf Mice have extensive defects in the Development Of Gut-associated lymphoid Tissues and in Antibody Production (round and mazmanian2009; olszak et\xa0al.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 16, 'mice'), ('GO_0009794', 'regulation of mitotic cell cycle, embryonic', 51, 'development of ... tissues'), ('UBERON_0001555', 'digestive tract', 66, 'gut'), ('UBERON_0000479', 'tissue', 90, 'tissues'), ('GO_0002376', 'immune system process', 105, 'antibody production'), ('GO_0042571', 'immunoglobulin complex, circulating', 105, 'antibody')]
PMC4732175	3/2016	S63-PMC4732175	['areas of the Cremaster Muscle (∼1\u200amm2) were then cut from either side of the main Cremaster Artery and blocked in 5% (v/v) goat Serum, 1% bsa (v/v) 0.3\u200amol/l glycine, 2% Triton x-100 in 1x pbs (sigma aldrich) for 1\u200ah. the Cremaster samples were incubated with an ikcaantibody (apc-051 alomone labs, jerusalem, israel; 1\u200a:\u200a200) and Cd31 Antibody (abcam, cambridge uk; 1\u200a:\u200a100) overnight at 4°c.']	N/A	N/A	[('UBERON_0008488', 'cremaster muscle', 13, 'cremaster muscle'), ('UBERON_0034693', 'cremasteric artery', 82, 'cremaster artery'), ('UBERON_0001977', 'blood serum', 128, 'serum'), ('CHEBI_29236', 'protium atom', 170, 'Triton'), ('UBERON_0008488', 'cremaster muscle', 222, 'cremaster'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 331, 'CD31'), ('GO_0042571', 'immunoglobulin complex, circulating', 336, 'antibody')]
PMC4732175	3/2016	S65-PMC4732175	['samples were probed with Alexa Fluor goat antimouse Igm 568 secondary Antibody (invitrogen; 1\u200a:\u200a100) and Alexa Fluor goat antirabbit Igg 633 secondary Antibody (invitrogen; 1\u200a:\u200a100) for 1\u200ah followed by three washes in pbst and incubation with 4,6-Diamidino-2-Phenylindole (Dapi) for 30\u200amin.']	N/A	N/A	[('CHEBI_82170', 'Allidochlor', 25, 'Alexa Fluor'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 52, 'IgM'), ('GO_0042571', 'immunoglobulin complex, circulating', 70, 'antibody'), ('CHEBI_82170', 'Allidochlor', 105, 'Alexa Fluor'), ('GO_0071735', 'IgG immunoglobulin complex', 133, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 151, 'antibody'), ('CHEBI_51231', 'DAPI', 243, '4,6-diamidino-2-phenylindole'), ('CHEBI_51231', 'DAPI', 273, 'DAPI')]
PMC4732175	3/2016	S69-PMC4732175	['sections were mounted with the Endothelium uppermost and blocked in 5% (v/v) goat Serum, 1% bsa (v/v) 0.3\u200amol/l glycine, 0.2% Triton x-100 in 1\u200a×\u200apbs for 1\u200ah followed by incubation with the ikcaantibody (apc-051 alomone labs; 1\u200a:\u200a100) or skcaantibody (apc-025 alomone; 1\u200a:\u200a50) for 2\u200ah. samples were washed three times in pbst then probed with Alexa Fluor 568 goat antimouse Igm secondary Antibody followed by a further three washes in pbst.']	N/A	N/A	[('UBERON_0001986', 'endothelium', 31, 'endothelium'), ('UBERON_0001977', 'blood serum', 82, 'serum'), ('CHEBI_29236', 'protium atom', 126, 'Triton'), ('CHEBI_51766', 'Alexa Fluor 568', 343, 'Alexa Fluor 568'), ('GO_0071754', 'IgM immunoglobulin complex, circulating', 374, 'IgM'), ('GO_0042571', 'immunoglobulin complex, circulating', 388, 'antibody')]
PMC4732175	3/2016	S71-PMC4732175	['negatives for all Tissues and secondary Antibodies were generated.']	N/A	N/A	[('UBERON_0000479', 'tissue', 18, 'tissues'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibodies')]
PMC4738402	11/2015	S35-PMC4738402	['immunohistochemistry and confocal microscopy were performed as previously described (belinson and michaelson2009) utilizing anti‐Vacht Antibodies (synaptic systems, dilution 1\xa0:\xa0200).']	N/A	N/A	[('PR_000014970', 'thiamine transporter 1', 129, 'VAChT'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibodies')]
PMC4739392	2/2016	S33-PMC4739392	['exclusion criteria were: primary and secondary immune deficiency; specific immune therapy within the past 2\xa0years; treatment with anti-Ige-Antibodies; regular intake of systemic Steroid Medication; intolerance against dairy products; obesity (bmi ≥30\xa0kg/m2); participation in another study.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 135, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 139, 'antibodies'), ('CHEBI_50325', 'proteinogenic amino-acid side-chain group', 178, 'steroid medication')]
PMC4778858	3/2016	S45-PMC4778858	['this is a solid phase, two-site Fluoro-immunometric assay based on the direct sandwich technique in which two monoclonal Antibodies are directed against separate Antigenic determinants on the c-peptide Molecule.']	N/A	N/A	[('CHEBI_42645', 'fluoro group', 32, 'fluoro'), ('GO_0042571', 'immunoglobulin complex, circulating', 121, 'antibodies'), ('CHEBI_59132', 'antigen', 162, 'antigenic'), ('CHEBI_36357', 'polyatomic entity', 202, 'molecule')]
PMC4820621	3/2016	S14-PMC4820621	['introduction\nimmune (idiopathic) thrombocytopenic purpura (itp) is an Autoimmune disorder characterized by persistent thrombocytopenia due to Antibody binding to Platelet Antigen(s) and causing their premature destruction by the Reticuloendothelial System, particularly in the Spleen.']	N/A	N/A	[('UBERON_0001442', 'skeleton of manus', 70, 'autoimmune'), ('GO_0042571', 'immunoglobulin complex, circulating', 142, 'antibody'), ('CL_0000233', 'platelet', 162, 'platelet'), ('CHEBI_59132', 'antigen', 171, 'antigen'), ('UBERON_0004864', 'vasculature of retina', 229, 'reticuloendothelial system'), ('UBERON_0002106', 'spleen', 277, 'spleen')]
PMC4825101	10/2015	S109-PMC4825101	['the primary outcome measures of the enid trial are Thymic Development during infancy, and Antibody response to vaccination.']	N/A	N/A	[('GO_0048538', 'thymus development', 51, 'thymic development'), ('UBERON_0002370', 'thymus', 51, 'thymic'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibody')]
PMC4835505	4/2016	S79-PMC4835505	['after transferring proteins with an iblot apparatus (life technologies), membranes were blocked with li-cor blocking buffer (li-cor biosciences, lincoln, ne) for 1 h at room temperature and subsequently probed with anti-fmrp Antibody (sigma, st. louis, mo; 1:700 dilution), anti-Shank3 Antibody (santa cruz biotechnologies, dallas, tx; 1:500 dilution), anti-ccoiv Antibody (cell signaling, danvers, ma, 1:1000 dilution), anti Atpb (bd biosciences, san jose, ca, 1:3000 dilution) overnight at 4°c, and with anti-β-actin (sigma, st. louis, mo; 1:20,000 dilution) for 1 hour at room temperature.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 225, 'antibody'), ('PR_000014662', 'selenoprotein W', 279, 'Shank3'), ('GO_0042571', 'immunoglobulin complex, circulating', 286, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 364, 'antibody'), ('PR_000004372', 'agouti-signaling protein', 426, 'ATPB')]
PMC4835505	4/2016	S81-PMC4835505	['secondary Antibodies were from li-cor (lincoln, ne; 1:10,000 dilution).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibodies')]
PMC4848989	4/2016	S151-PMC4848989	['the following Antibodies were used: ampk (goat anti-Rat Antibody (1:1000, overnight incubation; santa cruz biotechnology, santa cruz, ca, usa); phospho-ampk Antibody (Rabbit anti-Rat Antibody (1:1000, overnight incubation; santa cruz biotechnology) and phospho-Akt (ser 473) Antibody (Rabbit anti-Rat Antibody (1:1000, overnight incubation; cell signaling technology, danvers, ma, usa)).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 52, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 56, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 157, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 167, 'rabbit'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 179, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 183, 'antibody'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 261, 'Akt'), ('GO_0042571', 'immunoglobulin complex, circulating', 275, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 285, 'rabbit'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 297, 'rat'), ('GO_0042571', 'immunoglobulin complex, circulating', 301, 'antibody')]
PMC4873529	3/2016	S44-PMC4873529	['the Membranes were incubated in blocking buffer followed by overnight incubation with primary Antibodies at 4\xa0°c (table1); the Membranes were then incubated with the secondary Antibodies (table1).']	N/A	N/A	[('GO_0016020', 'membrane', 4, 'membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 94, 'antibodies'), ('GO_0016020', 'membrane', 127, 'membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 176, 'antibodies')]
PMC4873529	3/2016	S48-PMC4873529	['caption (table-wrap): table 1\n\nwestern blot Antibodiesab.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 44, 'antibodiesAb')]
PMC4892663	5/2016	S153-PMC4892663	['western blots using an Antibody specific to the n-terminal region of Tet1 detected bands approximating the predicted molecular weights in Tissue samples from both 3h1 wild-type and tuft Mice homozygous for the Tet1 mutation (fig.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 23, 'antibody'), ('PR_000016211', 'tectonic-3', 69, 'TET1'), ('UBERON_0000479', 'tissue', 138, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 186, 'mice'), ('PR_000016192', 'V-type proton ATPase 116 kDa subunit a3', 210, 'Tet1')]
PMC4892663	5/2016	S207-PMC4892663	['cells Transfected with the control Plasmid Expressing just the poly-his tag were positive for histidine immunostaining generally throughout the cell but negative for the Tet1 Antibody (fig.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 6, 'transfected'), ('SO_0000155', 'plasmid', 35, 'plasmid'), ('GO_0010467', 'gene expression', 43, 'expressing'), ('PR_000016211', 'tectonic-3', 170, 'TET1'), ('GO_0042571', 'immunoglobulin complex, circulating', 175, 'antibody')]
PMC4892663	5/2016	S209-PMC4892663	['Transfected cells incubated with just the secondary Antibodies were also negative (fig.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 0, 'Transfected'), ('GO_0042571', 'immunoglobulin complex, circulating', 52, 'antibodies')]
PMC4892663	5/2016	S218-PMC4892663	['(j) his-tet1tuft - Transfected cells incubated with just secondary Antibodies stained for all three colors.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 19, 'transfected'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies')]
PMC4892663	5/2016	S382-PMC4892663	['cells were washed and fixed in 4% paraformaldehyde and permeabilized in 0.1% Triton x-100 (sigma-aldrich) prior to incubations with Antibodies.']	N/A	N/A	[('CHEBI_29236', 'protium atom', 77, 'Triton'), ('GO_0042571', 'immunoglobulin complex, circulating', 132, 'antibodies')]
PMC4892663	5/2016	S388-PMC4892663	['bands were detected with secondary Antibodies conjugated with irdye (li-cor biosciences, lincoln, ne) diluted 1:10,000 and scanned with the li-cor digital imager (li-cor biosciences).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibodies')]
PMC4892663	5/2016	S389-PMC4892663	['immunolocalizations were detected using goat anti-Rabbit or Mouse secondary Antibodies conjugated with dylight diluted 1:800 in pbs (rockland immunochemicals inc., limerick, pa) and counterstained with Dapi (life technologies) for Nuclei.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 50, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 60, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 76, 'antibodies'), ('CHEBI_51231', 'DAPI', 202, 'DAPI'), ('GO_0005634', 'nucleus', 231, 'nuclei')]
PMC4892913	10/2015	S4-PMC4892913	['methods:\nSerum Thyroid hormones and anti-Thyroid Antibodies and Urinary Perchlorate, Thiocyanate, Nitrate, and Iodide concentrations were measured in 1,880 Pregnant women from san diego county, california, during 2000–2003, a period when much of the area’s Water supply was contaminated from an industrial plant with Perchlorate at levels near the 2007 california Regulatory standard of 6 μg/l.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 9, 'Serum'), ('UBERON_0002046', 'thyroid gland', 15, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 41, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibodies'), ('UBERON_0001088', 'urine', 64, 'urinary'), ('CHEBI_49706', 'perchlorate', 72, 'perchlorate'), ('CHEBI_18022', 'thiocyanate', 85, 'thiocyanate'), ('CHEBI_17137', 'hydrogensulfite', 98, 'nitrate'), ('CHEBI_16382', 'iodide', 111, 'iodide'), ('GO_0007565', 'female pregnancy', 156, 'pregnant'), ('CHEBI_15377', 'water', 257, 'water'), ('CHEBI_49706', 'perchlorate', 317, 'perchlorate'), ('GO_0065007', 'biological regulation', 364, 'regulatory')]
PMC4892913	10/2015	S62-PMC4892913	['after overnight shipping on dry ice, Serum samples were measured for total t4, ft4, tsh, and thyroperoxidase (tpo) and thyroglobulin (tg) Antibody concentrations at university of washington, seattle, using a beckman automated immunoassay chemiluminescence platform (beckman coulter) and microparticle enzyme immunoassay (abbott laboratories).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 37, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 138, 'antibody')]
PMC4892913	10/2015	S64-PMC4892913	['manufacturers’ values for tpo and tg Antibody positivity are > 9 and > 4 iu/ml, respectively.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 37, 'antibody')]
PMC4892913	10/2015	S95-PMC4892913	['caption (table-wrap): table 1\n\ndistributions of maternal Urinary analytes and Serum Thyroid hormones.analyte n mean ± sdminimumpercentilemaximum25th50th75thurine Perchlorate (μg/l)1,8808.49 ± 9.860.233.956.509.96177.00urine Thiocyanate (μg/l)1,8801,353 ± 1,553204598981,59016,200urine Nitrate (mg/l)1,87666.5 ± 57.00.732.955.584.3796.0urine Iodide (μg/l)1,818214.9 ± 247.30.877.0154.5270.03,000urine creatinine (mg/dl)1,878131.5± 75.77.973.3120.9175.0472.5serum total t4 (μg/dl)b1,88012.31 ± 1.890.5611.2112.2613.4019.99serum Tsh (μiu/ml)b1,8791.36 ± 0.860.0030.801.201.698.39serum ft4 (ng/dl)b1,8800.86 ± 0.190.110.770.850.935.44tg Antibody (iu/ml)1,8793.11 ± 24.130.000.000.000.60565.90tpo Antibody (iu/ml)1,87612.90 ± 59.730.100.500.801.50704.90urine collection (week)1,8788.6 ± 5.20.15.77.110.042.9serum collection (week)1,88017.1 ± 1.59.116.117.018.026.0urine-Serum difference (weeks)a1,8789.2 ± 3.80.07.09.911.626.7abbreviations: ft4, free thyroxine; t4, total thyroxine; tg, thyroglobulin; tpo, thyroperoxidase; tsh, Thyroid-Stimulating Hormone.aabsolute difference between Urine and Serum collection times.']	N/A	N/A	[('UBERON_0001088', 'urine', 57, 'urinary'), ('UBERON_0001977', 'blood serum', 78, 'serum'), ('CHEBI_9437', 'temoporfin', 84, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 84, 'thyroid'), ('CHEBI_49706', 'perchlorate', 162, 'perchlorate'), ('CHEBI_18022', 'thiocyanate', 224, 'thiocyanate'), ('CHEBI_17137', 'hydrogensulfite', 285, 'nitrate'), ('CHEBI_16382', 'iodide', 341, 'iodide'), ('CHEBI_17855', 'triglyceride', 526, 'TSH'), ('GO_0042571', 'immunoglobulin complex, circulating', 633, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 692, 'antibody'), ('UBERON_0001977', 'blood serum', 865, 'serum'), ('CHEBI_9437', 'temoporfin', 1024, 'thyroid'), ('PR_000016293', 'protein-glutamine gamma-glutamyltransferase 2', 1024, 'thyroid-stimulating hormone'), ('UBERON_0002046', 'thyroid gland', 1024, 'thyroid'), ('CHEBI_66524', 'streptokordin', 1032, 'stimulating hormone'), ('UBERON_0001088', 'urine', 1081, 'urine'), ('UBERON_0001977', 'blood serum', 1091, 'serum')]
PMC4892913	10/2015	S106-PMC4892913	['caption (table-wrap): table 2\n\nmaternal Thyroid Hormone concentrations stratified by various demographic factors.category n (%)T4 (μg/dl)ft4 (ng/dl)Tsh (μiu/ml)amedianmean ± sd p -valuebmedianmean ± sd p -valuebmedianmean ± sd p -valuebmother’s age (years)< 21435 (23.1)12.4312.50 ± 1.870.870.87 ± 0.141.261.36 ± 0.7721–25563 (29.9)12.3612.45 ± 1.910.860.87 ± 0.231.161.35 ± 0.8826–30414 (22.0)12.2612.38 ± 1.880.840.85 ± 0.241.161.36 ± 0.98> 30468 (24.9)11.9111.90 ± 1.830.830.83 ± 0.131.231.38 ± 0.80 r –0.12< 0.001–0.14< 0.0010.010.78mother’s education (highest grade)< 9509 (27.6)12.4212.57 ± 1.960.840.86 ± 0.301.121.33 ± 0.909–11308 (16.7)12.3112.35 ± 2.080.850.86 ± 0.151.221.41 ± 0.8712568 (30.8)12.2312.22 ± 1.810.850.86 ± 0.131.211.32 ± 0.82> 12460 (24.9)12.0512.07 ± 1.730.850.85 ± 0.121.261.44 ± 0.86 r –0.10< 0.0010.020.310.070.003mother’s weight (lbs)< 121469 (24.9)12.3812.49 ± 1.770.870.89 ± 0.251.151.32 ± 0.85122–145471 (25.1)12.1012.09 ± 1.800.850.86 ± 0.121.171.31 ± 0.82146–171466 (24.8)12.3112.39 ± 1.810.850.86 ± 0.231.231.38 ± 0.87> 171474 (25.2)12.2512.27 ± 2.130.830.83 ± 0.141.271.44 ± 0.90 r –0.010.54–0.14< 0.0010.060.01serum collection (weeks Gestation)< 16467 (24.8)12.4812.56 ± 1.750.880.89 ± 0.141.151.29 ± 0.8617512 (27.2)12.2012.32 ± 1.840.850.86 ± 0.211.251.37 ± 0.7718448 (23.8)12.1512.16 ± 1.820.820.84 ± 0.121.161.36 ± 0.87> 18453 (24.1)12.2512.19 ± 2.110.830.84 ± 0.251.241.43 ± 0.94 r –0.070.004–0.19< 0.0010.040.08tg (iu/ml)≤ 41,719 (91.4)12.2212.25 ± 1.830.850.86 ± 0.201.201.36 ± 0.82> 4161 (8.6)12.9712.97 ± 2.30< 0.0010.830.84 ± 0.130.051.171.43 ± 1.250.16Tpo (iu/ml)≤ 91,715 (91.2)12.2612.33 ± 1.870.850.86 ± 0.201.161.28 ± 0.71> 9165 (8.8)12.2312.10 ± 2.070.470.820.82 ± 0.130.0061.652.21 ± 1.54< 0.001ethnicityhispanic1,303 (69.3)12.3812.47 ± 1.90ref0.850.86 ± 0.21ref1.171.34 ± 0.86refwhite391 (20.8)11.8811.87 ± 1.72< 0.0010.840.84 ± 0.120.171.311.52 ± 0.91< 0.001asian72 (3.8)12.3012.17 ± 2.270.540.840.83 ± 0.140.481.201.23 ± 0.660.53black24 (1.3)11.9211.37 ± 1.840.010.900.90 ± 0.130.101.191.44 ± 0.830.55other90 (4.8)12.0112.32 ± 1.740.160.870.90 ± 0.190.060.941.04 ± 0.69< 0.001mother’s birthplaceusa854 (45.4)12.1012.16 ± 1.81ref0.850.85 ± 0.13ref1.251.42 ± 0.86refmexico889 (47.3)12.3812.45 ± 1.970.0010.840.86 ± 0.240.651.161.32 ± 0.870.002other137 (7.3)12.2812.35 ± 1.790.200.880.90 ± 0.14< 0.0011.131.24 ± 0.730.02abbreviations: ft4, free Thyroxine; r , spearman correlation coefficient; ref, reference category; t4, total thyroxine; tg, thyroglobulin Antibody; tpo, thyroperoxidase Antibody; tsh, Thyroid stimulating hormone.aone subject was missing a Serum Tsh value.bwhen the variables are continuous, p -values are provided for the spearman correlation coefficient between the two continuous variables.']	N/A	N/A	[('CHEBI_60311', 'thyroid hormone', 40, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 40, 'thyroid'), ('PR_000016190', 'trichohyalin-like protein 1', 127, 'T4'), ('CHEBI_17855', 'triglyceride', 148, 'TSH'), ('GO_0007565', 'female pregnancy', 1173, 'gestation'), ('CHEBI_63016', 'nonyl phenoxypolyethoxylethanol', 1600, '16TPO'), ('CHEBI_17842', 'trypanothione', 2400, 'thyroxine'), ('GO_0042571', 'immunoglobulin complex, circulating', 2513, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 2544, 'antibody'), ('UBERON_0002046', 'thyroid gland', 2559, 'thyroid'), ('UBERON_0001977', 'blood serum', 2614, 'serum'), ('CHEBI_17855', 'triglyceride', 2620, 'TSH')]
PMC4892913	10/2015	S116-PMC4892913	['agroup n t4 [βb(95% ci)]ft4 [βb(95% ci)]log10tsh [βb(95% ci)]all subjects1,476–0.70 (–1.06, –0.34)–0.053 (–0.092, –0.013)0.071 (0.008, 0.133)Iodide< 100 μg/l452–0.57 (–1.20, 0.07)–0.022 (–0.100, 0.056)0.034 (–0.081, 0.148)100–300 μg/l698–0.44 (–0.95, 0.08)–0.031 (–0.067, 0.005)0.094 (0.002, 0.189)> 300 μg/l326–1.77 (–2.73, –0.81)–0.172 (–0.305, –0.039)0.089 (–0.058, 0.236)Thiocyanate< 519 μg/l360–0.41 (–1.05, 0.24)–0.034 (–0.074, 0.006)0.039 (–0.092, 0.170)519–1,620 μg/l741–0.74 (–1.27, –0.21)–0.082 (–0.154, –0.010)0.086 (0.005, 0.166)> 1,620 μg/l375–1.28 (–2.04, –0.51)–0.041 (–0.098, 0.016)0.115 (–0.021, 0.252)Nitrate< 36.3 mg/l366–0.20 (–0.88, 0.48)–0.040 (–0.133, 0.054)0.053 (–0.071, 0.178)36.3–81.9 mg/l737–0.72 (–1.32, –0.12)–0.062 (–0.130, 0.006)0.093 (–0.014, 0.200)> 81.9 mg/l369–1.04 (–1.70, –0.38)–0.057 (–0.101, –0.013)0.099 (0.000, 0.199)ethnicityhispanic1,035–0.78 (–1.21, –0.36)–0.073 (–1.124, –0.023)0.037 (–0.032, 0.106)non-hispanic441–0.59 (–1.27, 0.09)–0.002 (–0.054, 0.050)0.184 (0.052, 0.317)sample collectionc≤ 8 weeks apart470–1.05 (–1.73, –0.38)–0.052 (–0.136, 0.033)0.001 (–0.121, 0.122)> 8 weeks apart1,006–0.55 (–0.98, –0.13)–0.050 (–0.092, –0.008)0.107 (0.036, 0.178)anti-Thyroid Antibodiespositived203–1.55 (–2.75, –0.34)–0.093 (–0.159, –0.027)0.153 (–0.060, 0.365)negative1,273–0.52 (–0.89, –0.15)–0.047 (–0.091, –0.002)0.060 (–0.004, 0.123)abbreviations: β, regression coefficient; ft4, free Thyroxine; t4, total thyroxine; Tsh, Thyroid-stimulating Hormone.aonly includes participants with Urinary creatinine concentrations between the 10th and 90th percentiles (i.e., 41–233 mg/dl).badjusted for Urinary creatinine, maternal age, maternal education, ethnicity (hispanic vs. non-hispanic), Gestational age at Serum collection, and Urinary Thiocyanate.cweeks between Urine and Serum sample collection.dincludes participants with thyroperoxidase or thyroglobulin Antibody concentrations above 9 and 4 iu/ml, respectively.']	N/A	N/A	[('CHEBI_5859', 'Icacine', 141, 'Iodide'), ('CHEBI_18022', 'thiocyanate', 375, 'Thiocyanate'), ('CHEBI_17120', 'hexanoate', 619, 'Nitrate'), ('UBERON_0002046', 'thyroid gland', 1208, 'thyroid'), ('GO_0033096', 'amyloplast envelope', 1216, 'antibodiesPositived203'), ('CHEBI_17842', 'trypanothione', 1431, 'thyroxine'), ('CHEBI_17855', 'triglyceride', 1463, 'TSH'), ('CHEBI_9437', 'temoporfin', 1468, 'thyroid'), ('UBERON_0002046', 'thyroid gland', 1468, 'thyroid'), ('CHEBI_33280', 'molecular messenger', 1488, 'hormone'), ('UBERON_0001088', 'urine', 1529, 'urinary'), ('UBERON_0001088', 'urine', 1636, 'urinary'), ('GO_0007565', 'female pregnancy', 1729, 'gestational'), ('UBERON_0001977', 'blood serum', 1748, 'serum'), ('UBERON_0001088', 'urine', 1770, 'urinary'), ('CHEBI_18022', 'thiocyanate', 1778, 'thiocyanate'), ('UBERON_0001088', 'urine', 1805, 'urine'), ('UBERON_0001977', 'blood serum', 1815, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 1900, 'antibody')]
PMC4896250	4/2016	S127-PMC4896250	['Serum test was thoroughly negative in scc, Cyfra, progrp, nse, igg4, Pr3- and mpo-anca, aspergillus , (1,3→) βd-Glucan, ana, ds-dna-Igg, anti-rnp, anti-sm, and anti-gbm Antibodies.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('PR_000006100', 'aromatase', 43, 'CYFRA'), ('PR_000013255', 'protein arginine N-methyltransferase 5', 69, 'PR3'), ('CHEBI_37163', 'glucan', 112, 'glucan'), ('GO_0071735', 'IgG immunoglobulin complex', 132, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 169, 'antibodies')]
PMC4896250	4/2016	S229-PMC4896250	['in one case, Ige Antibody against paper wasp was positive without an obvious former sting by it.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 13, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 17, 'antibody')]
PMC4896250	4/2016	S409-PMC4896250	['the dynamics of immunoregulatory substances Il-2,-4,-5,-10,-13, Tgf-Β1 and Allergen-specific Ige and Igg Antibodies to Cow milk protein, Α-Lactalbumin, Β-Lactglobulin, casein, Soy and goat Milk were measured by immunoenzime method.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 44, 'IL-2'), ('PR_000017527', 'YEATS domain-containing protein 4', 50, '4'), ('PR_000000183', 'TGF-beta 2', 64, 'TGF-β1'), ('CHEBI_50904', 'allergen', 75, 'allergen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 93, 'IgE'), ('GO_0071735', 'IgG immunoglobulin complex', 101, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 105, 'antibodies'), ('NCBITaxon_33208', 'Metazoa', 119, 'cow'), ('PR_000004103', 'AP-2 complex subunit sigma', 137, 'α-lactalbumin'), ('PR_000003676', 'actin, cytoplasmic 1', 152, 'β-lactglobulin'), ('CHEBI_29922', 'sulfo group', 176, 'soy'), ('UBERON_0001913', 'milk', 189, 'milk')]
PMC4896250	4/2016	S426-PMC4896250	['subsamples of 854 children (419 from guangzhou, 435 from conghua) were recruited for case-control study including detail questionnaire for natural and family history, environmental exposure and Eating behaviors, Histamine Airway provocation, Allergen skin prick test, and Serum Antibody analysis.']	N/A	N/A	[('GO_0051318', 'G1 phase', 194, 'eating'), ('CHEBI_18295', 'histamine', 212, 'histamine'), ('UBERON_0001005', 'respiratory airway', 222, 'airway'), ('CHEBI_50904', 'allergen', 242, 'allergen'), ('UBERON_0001977', 'blood serum', 272, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 278, 'antibody')]
PMC4896250	4/2016	S515-PMC4896250	['anti Nuclear Antibody, hepatitis markers, hiv and rheumatoid factor were negative in patient.']	N/A	N/A	[('GO_0005634', 'nucleus', 5, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 13, 'antibody')]
PMC4896250	4/2016	S832-PMC4896250	['the symptoms are more in autoreactive urticaria (au) where auto-Antibodies in Blood flares-up the condition.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 64, 'antibodies'), ('UBERON_0000178', 'blood', 78, 'blood')]
PMC4896250	4/2016	S880-PMC4896250	['Serum levels of chitinase, Il-18, Mpo and specific Ige/Igg Antibodies to wheat flour extracts were measured by elisa.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('PR_000001470', 'interleukin-28B', 27, 'IL-18'), ('PR_000010550', '3-mercaptopyruvate sulfurtransferase', 34, 'MPO'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 51, 'IgE'), ('GO_0071735', 'IgG immunoglobulin complex', 55, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 59, 'antibodies')]
PMC4896250	4/2016	S938-PMC4896250	['Blood, Spleen and Small Intestine were collected for Antibody, cytokine, Gene Expression and histological analysis.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('UBERON_0002106', 'spleen', 7, 'spleen'), ('UBERON_0002108', 'small intestine', 18, 'small intestine'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibody'), ('GO_0010467', 'gene expression', 73, 'gene expression'), ('SO_0000704', 'gene', 73, 'gene')]
PMC4896250	4/2016	S943-PMC4896250	['the protection offered by both vaccines included higher levels of specific Igg2A Antibodies that possess both in vitro and in vivo blocking abilities, as well as higher Splenic levels of th1-linked cytokines (Il-12 and Ifn-Γ).']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 75, 'IgG2a'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibodies'), ('UBERON_0002106', 'spleen', 169, 'splenic'), ('PR_000001470', 'interleukin-28B', 209, 'IL-12'), ('PR_000008920', 'interferon alpha-7', 219, 'IFN-γ')]
PMC4896250	4/2016	S945-PMC4896250	['conclusions: hypoallergen-based dna vaccines could effectively protect against tropomyosin sensitization in Mice via the Establishment Of Th1-Oriented Responses, Recruitment Of Regulatory T Cells, and induction of blocking Igg Antibodies.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 108, 'mice'), ('GO_0007455', 'eye-antennal disc morphogenesis', 121, 'establishment of Th1-oriented responses'), ('GO_0045453', 'bone resorption', 162, 'recruitment of'), ('CL_0000815', 'regulatory T cell', 177, 'regulatory T cells'), ('GO_0043277', 'apoptotic cell clearance', 177, 'regulatory T cells'), ('GO_0071735', 'IgG immunoglobulin complex', 223, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 227, 'antibodies')]
PMC4896250	4/2016	S964-PMC4896250	['d.farinae-specific Ige, Iga, Igg and secretory Iga Antibodies were measured by elisa.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 19, 'IgE'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 24, 'IgA'), ('GO_0071735', 'IgG immunoglobulin complex', 29, 'IgG'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 47, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibodies')]
PMC4896250	4/2016	S975-PMC4896250	['when we measured specific Serum Antibodies to Ofloxacin-Human Serum Albumin (hsa) conjugate using elisa, a high level of specific Serum Igg4 was detected, but Serum specific Ige was not detectable.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 32, 'antibodies'), ('CHEBI_7731', 'ofloxacin', 46, 'ofloxacin'), ('NCBITaxon_9606', 'Homo sapiens', 56, 'human'), ('PR_000003918', 'albumin', 62, 'serum albumin'), ('UBERON_0001977', 'blood serum', 62, 'serum'), ('UBERON_0001977', 'blood serum', 130, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 136, 'IgG4'), ('UBERON_0001977', 'blood serum', 159, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 174, 'IgE')]
PMC4896250	4/2016	S976-PMC4896250	['moreover, a Basophil Activation test showed a significant up-regulation of Cd203C with addition of Ofloxacin and anti-Igg4 Antibody in the patient with no significant changes in 3 non atopic healthy controls.']	N/A	N/A	[('CL_0000767', 'basophil', 12, 'basophil'), ('GO_0045148', 'tripeptide aminopeptidase activity', 21, 'activation'), ('PR_000001309', 'CD70 molecule', 75, 'CD203c'), ('CHEBI_7731', 'ofloxacin', 99, 'ofloxacin'), ('GO_0071735', 'IgG immunoglobulin complex', 118, 'IgG4'), ('GO_0042571', 'immunoglobulin complex, circulating', 123, 'antibody')]
PMC4896250	4/2016	S1403-PMC4896250	['85% patients of the study group showed allergen specific Ige Antibodies against house dust and dermatophagoides mites.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 57, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 61, 'antibodies')]
PMC4896250	4/2016	S1412-PMC4896250	['for Platelet Removal, Mice were injected with anti-Cd42B Antibody.']	N/A	N/A	[('CL_0000233', 'platelet', 4, 'platelet'), ('GO_0008219', 'cell death', 4, 'platelet removal'), ('NCBITaxon_10088', 'Mus <genus>', 22, 'mice'), ('PR_000001309', 'CD70 molecule', 51, 'CD42b'), ('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody')]
PMC4896250	4/2016	S1423-PMC4896250	['further, Serum Antibodies to thyroglobulin (atg) and Thyroid peroxidase (atpo), ana, and total Ige were measured.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibodies'), ('UBERON_0002046', 'thyroid gland', 53, 'thyroid'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 95, 'IgE')]
PMC4896250	4/2016	S1555-PMC4896250	['injection of anti-Fcγriii/ii monoclonal Antibody, and Cd200R3 Expression on peripheral Basophils was analyzed.']	N/A	N/A	[('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 18, 'FcγRIII'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibody'), ('PR_000005166', 'CMRF35-like molecule 7', 54, 'CD200R3'), ('GO_0010467', 'gene expression', 62, 'expression'), ('CL_0000767', 'basophil', 87, 'basophils')]
PMC4896250	4/2016	S2015-PMC4896250	['b) methods : ics of several Food proteins in Human Exocrine Fluids were determined with sandwich elisas constructed with anti-individual protein and anti-Human Iga Antibodies.']	N/A	N/A	[('CHEBI_33290', 'food', 28, 'food'), ('NCBITaxon_9606', 'Homo sapiens', 45, 'human'), ('UBERON_0003214', 'mammary gland alveolus', 51, 'exocrine fluids'), ('NCBITaxon_9606', 'Homo sapiens', 154, 'human'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 160, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 164, 'antibodies')]
PMC4896250	4/2016	S2226-PMC4896250	['we tested Ige Antibodies against ascaris in children with total Ige level over 20 ku/ at 6 and 12 months and over 200 ku/l at 2, 5, 10/12 and 16/18 years of Life.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 10, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibodies'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 64, 'IgE'), ('UBERON_0000104', 'life cycle', 157, 'life')]
PMC4896250	4/2016	S2227-PMC4896250	['Antibodies against ascaris were found in 29 of 50 preschool children and in 31 of 56 teenagers.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies')]
PMC4896250	4/2016	S2246-PMC4896250	['in order to identify the infectious triggers, Blood samples were used to evaluate the level of Antibodies for toxocara cannis , toxoplasma gondii , herpes simplex virus, Epstein–Barr Virus, cytomegalovirus and measles virus.']	N/A	N/A	[('UBERON_0000178', 'blood', 46, 'blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 95, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'Epstein'), ('NCBITaxon_10088', 'Mus <genus>', 178, 'Barr virus')]
PMC4896250	4/2016	S2252-PMC4896250	['all patients had negative results for cytomegalovirus Igm Antibodies.']	N/A	N/A	[('GO_0071754', 'IgM immunoglobulin complex, circulating', 54, 'IgM'), ('GO_0042571', 'immunoglobulin complex, circulating', 58, 'antibodies')]
PMC4896250	4/2016	S2337-PMC4896250	['also receptors presenting on the Cell Surface was evaluated via monoclonal Antibodies by flow cytometry.']	N/A	N/A	[('GO_0009986', 'cell surface', 33, 'cell surface'), ('GO_0042571', 'immunoglobulin complex, circulating', 75, 'antibodies')]
PMC4896250	4/2016	S2717-PMC4896250	['characteristics of asthma sub-phenotypes were analyzed by disease severity, Pulmonary function, Blood Eosinophil counts, total Ige levels in Serum, and specific Ige Antibody to environmental Allergens.']	N/A	N/A	[('UBERON_0002048', 'lung', 76, 'pulmonary'), ('UBERON_0000178', 'blood', 96, 'blood'), ('CL_0000771', 'eosinophil', 102, 'eosinophil'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 127, 'IgE'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 161, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 165, 'antibody'), ('CHEBI_33663', 'cyclic hydrocarbon', 191, 'allergens')]
PMC4896250	4/2016	S2720-PMC4896250	['in na, 37 patients (68.5%) had specific Ige Antibody to environmental Allergens whereas 42 patients (64.6%) in nna.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 40, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 44, 'antibody'), ('CHEBI_33663', 'cyclic hydrocarbon', 70, 'allergens')]
PMC4896250	4/2016	S2811-PMC4896250	['the Serum concentrations of total Ige and specific Ige Antibodies to wheat, gluten and ω-5 gliadin were measured.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 4, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 34, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 51, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 55, 'antibodies')]
PMC4896250	4/2016	S2812-PMC4896250	['the diagnostic values of each specific Antibody were analyzed and compared using the mann-whitney test and receiver operating characteristic curves.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 39, 'antibody')]
PMC4896250	4/2016	S2813-PMC4896250	['c) results : the median values of specific Ige Antibodies to Wheat, gluten and ω-5 Gliadin were significantly higher in wa compared to those in non-wa, and the optimal cutoff points were 0.90 kua/l, 0.43 kua/l and 0.19 kua/l respectively.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 43, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 61, 'wheat'), ('PR_000001295', 'CAMPATH-1 antigen', 80, '-5 gliadin')]
PMC4896250	4/2016	S2814-PMC4896250	['the positive decision points (specificity of 95%) of specific Ige Antibodies to wheat, gluten and ω-5 Gliadin were 3.12 kua/l, 2.61 kua/l and 0.21 kua/l respectively, and the accuracies at these levels were 91.8%, 92.9% and 93.4% correspondingly.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 62, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 66, 'antibodies'), ('PR_000001295', 'CAMPATH-1 antigen', 99, '-5 gliadin')]
PMC4896250	4/2016	S2815-PMC4896250	['the combination of specific Ige Antibodies to wheat and Ω-5 Gliadin resulted in the highest accuracy of 93.9% in diagnosing wheat allergy.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 28, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 32, 'antibodies'), ('PR_000001245', 'rhodopsin', 56, 'ω-5 gliadin')]
PMC4896250	4/2016	S3033-PMC4896250	['a211 clinical features of adverse Drug reactions of monoclonal Antibodies in korea\n\nda woon sim1,2, kyung hee park1, kyung hee park2, hye jung park1, hye jung park2, jung-won park1, jung-won park2, jae-hyun lee1, jae-hyun lee2\n\n1yonsei university college of medicine;2severance hospital regional Pharmacovigilance centre, south korea\n\ncorrespondence: da woon sim – yonsei university college of medicine\nbackground: recently monoclonal Antibodies (mabs) are widely used in various clinical fields.']	N/A	N/A	[('CHEBI_23888', 'drug', 34, 'Drug'), ('GO_0042571', 'immunoglobulin complex, circulating', 63, 'Antibodies'), ('CHEBI_8038', 'Phaeantharine', 296, 'Pharmacovigilance'), ('GO_0042571', 'immunoglobulin complex, circulating', 435, 'antibodies')]
PMC4896250	4/2016	S3468-PMC4896250	['Lte4 was collected with an anti-Lte4 Antibody and the concentrations were determined by elisa.']	N/A	N/A	[('PR_000009871', 'LIM homeobox transcription factor 1-beta', 0, 'LTE4'), ('PR_000009871', 'LIM homeobox transcription factor 1-beta', 32, 'LTE4'), ('GO_0042571', 'immunoglobulin complex, circulating', 37, 'antibody')]
PMC4896250	4/2016	S3483-PMC4896250	['allergen-specific Antibodies and St2 were measured in Serum.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibodies'), ('PR_000015770', 'storkhead-box protein 2', 33, 'ST2'), ('UBERON_0001977', 'blood serum', 54, 'serum')]
PMC4896250	4/2016	S3967-PMC4896250	['conclusions: repeated intramuscular injections of autologous Immunoglobulin significantly decreased Serum concentrations of total Ige and Allergen-specific Ige Antibodies in patients with severe ad.']	N/A	N/A	[('GO_0019814', 'immunoglobulin complex', 61, 'immunoglobulin'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 130, 'IgE'), ('CHEBI_50904', 'allergen', 138, 'allergen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 156, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 160, 'antibodies')]
PMC4896250	4/2016	S4100-PMC4896250	['b) methods: sixty ar patients already diagnosed to have hdm allergy were analyzed for the presence Ige Antibodies against Nder P 1, rder P 2, rder P 10 and native dermatophagoides pteronyssinus (dp).']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 99, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 103, 'antibodies'), ('PR_000011433', 'nurim', 122, 'nDer p 1'), ('PR_000012570', 'platelet factor 4 variant', 137, 'p 2'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 147, 'p 10')]
PMC4896250	4/2016	S4154-PMC4896250	['laboratory tests included Serum 25-Hydroxyvitamin D3, total Immunoglobulin e (Ige), and specific Ige Antibody titer against dermatophagoides (d.) farinae and d. pteronyssinus.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 26, 'serum'), ('CHEBI_63991', '15-epi-lipoxin B4', 32, '25-hydroxyvitamin D3'), ('GO_0019814', 'immunoglobulin complex', 60, 'immunoglobulin'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 78, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 97, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody')]
PMC4896250	4/2016	S4255-PMC4896250	['anti-Il-5 Antibody treatment significantly reduced Eosinophil counts and Il-5 levels in Bal Fluid, as well as Lc3 Expression in the Lung Tissue homogenate.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 5, 'IL-5'), ('GO_0042571', 'immunoglobulin complex, circulating', 10, 'antibody'), ('CL_0000771', 'eosinophil', 51, 'eosinophil'), ('PR_000001470', 'interleukin-28B', 73, 'IL-5'), ('UBERON_0006310', 'vitelline venous plexus', 88, 'BAL fluid'), ('PR_000009691', 'protein LBH', 110, 'LC3'), ('GO_0010467', 'gene expression', 114, 'expression'), ('UBERON_0002048', 'lung', 132, 'lung'), ('UBERON_0000479', 'tissue', 137, 'tissue')]
PMC4896250	4/2016	S4373-PMC4896250	['Mbl binds to N-Acetylglucosamineand Mannan structures on thesurface of bacteria, Fungi, Viruses and Protozoa, leading to opsonization, Phagocytosis and activation ofcomplement system through lectin pathway, independent of an Antibody.']	N/A	N/A	[('PR_000010220', 'mannose-binding protein C', 0, 'MBL'), ('CHEBI_21662', 'N-acylneuraminic acid phosphate', 13, 'N-acetylglucosamineand'), ('CHEBI_28808', 'mannan', 36, 'mannan'), ('NCBITaxon_10088', 'Mus <genus>', 81, 'fungi'), ('NCBITaxon_1', 'root', 88, 'viruses'), ('NCBITaxon_10088', 'Mus <genus>', 100, 'protozoa'), ('GO_0006909', 'phagocytosis', 135, 'phagocytosis'), ('GO_0042571', 'immunoglobulin complex, circulating', 225, 'antibody')]
PMC4896250	4/2016	S4383-PMC4896250	['we were analyzed for Mbl level in Serum by using double-Antibody sandwich elisa method.']	N/A	N/A	[('PR_000010220', 'mannose-binding protein C', 21, 'MBL'), ('UBERON_0001977', 'blood serum', 34, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 56, 'antibody')]
PMC4896250	4/2016	S4417-PMC4896250	['Mbl binds to N Acetylglucosamine and Mannan structures on the Surface of bacteria, Fungi, Viruses and Protozoa, leading to opsonization, Phagocytosis and activation of complement system through lectin pathway, independent of an Antibody.']	N/A	N/A	[('PR_000010220', 'mannose-binding protein C', 0, 'MBL'), ('CHEBI_28704', 'glycogen (amylose chain)n-[(1->6)-amylose chain]4', 13, 'N acetylglucosamine'), ('CHEBI_28808', 'mannan', 37, 'mannan'), ('GO_0009986', 'cell surface', 62, 'surface'), ('NCBITaxon_10088', 'Mus <genus>', 83, 'fungi'), ('NCBITaxon_1', 'root', 90, 'viruses'), ('NCBITaxon_10088', 'Mus <genus>', 102, 'protozoa'), ('GO_0006909', 'phagocytosis', 137, 'phagocytosis'), ('GO_0042571', 'immunoglobulin complex, circulating', 228, 'antibody')]
PMC4896250	4/2016	S4425-PMC4896250	['we were analyzed for Mbl level in Serum by using double-Antibody sandwich elisa method.']	N/A	N/A	[('PR_000010220', 'mannose-binding protein C', 21, 'MBL'), ('UBERON_0001977', 'blood serum', 34, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 56, 'antibody')]
PMC4896250	4/2016	S4573-PMC4896250	['then, Serum Igg Antibody against major bacteria derived Evs in dust were measured in 90 healthy control subjects, and 294 asthma, 242 copd, and 325 Lung cancer patients.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 6, 'Serum'), ('GO_0071735', 'IgG immunoglobulin complex', 12, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 16, 'antibody'), ('GO_0005793', 'endoplasmic reticulum-Golgi intermediate compartment', 56, 'EVs'), ('UBERON_0002048', 'lung', 148, 'lung')]
PMC4896250	4/2016	S4619-PMC4896250	['methods: six-week-old female balb/c Mice divided into 4 groups: control group, allergic rhinitis (ar) group, immunotherapy (it) group, and it with anti-Il-9 Antibody (anti-Il-9 Ab) group.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 36, 'mice'), ('PR_000001470', 'interleukin-28B', 152, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 157, 'antibody'), ('PR_000001470', 'interleukin-28B', 172, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'Ab')]
PMC4896250	4/2016	S4622-PMC4896250	['during the immunotherapy, Mice in anti-Il-9 Ab group were injected with purified anti-Mouse Il-9 Antibody.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 26, 'mice'), ('PR_000001470', 'interleukin-28B', 39, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 44, 'Ab'), ('NCBITaxon_10088', 'Mus <genus>', 86, 'mouse'), ('PR_000001470', 'interleukin-28B', 92, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 97, 'Antibody')]
PMC4896250	4/2016	S4625-PMC4896250	['results: Serum ova-specific Ige and Eosinophil counts were significantly decreased in anti-Il-9 Ab group compared with it group (p<0.05).']	N/A	N/A	[('UBERON_0001977', 'blood serum', 9, 'Serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 28, 'IgE'), ('CL_0000771', 'eosinophil', 36, 'Eosinophil'), ('PR_000001470', 'interleukin-28B', 91, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 96, 'Ab')]
PMC4896250	4/2016	S4626-PMC4896250	['the levels of mrna Expression of Il-4 were significantly decreased in anti-Il-9 Ab group compared with it group (p<0.05).']	N/A	N/A	[('GO_0010467', 'gene expression', 19, 'expression'), ('PR_000001470', 'interleukin-28B', 33, 'IL-4'), ('PR_000001470', 'interleukin-28B', 75, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 80, 'Ab')]
PMC4896250	4/2016	S4627-PMC4896250	['the levels of mrna Expression of Il-10 and Foxp3 were significantly increased in in anti-Il-9 Ab group compared with it group (p<0.05).']	N/A	N/A	[('GO_0010467', 'gene expression', 19, 'expression'), ('PR_000001470', 'interleukin-28B', 33, 'IL-10'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 43, 'Foxp3'), ('PR_000001470', 'interleukin-28B', 89, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 94, 'Ab')]
PMC4896250	4/2016	S4628-PMC4896250	['the levels of mrna Expression of Il-10 and Foxp3 were significantly increased in in anti-Il-9 Ab group compared with it group (p<0.05).']	N/A	N/A	[('GO_0010467', 'gene expression', 19, 'expression'), ('PR_000001470', 'interleukin-28B', 33, 'IL-10'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 43, 'Foxp3'), ('PR_000001470', 'interleukin-28B', 89, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 94, 'Ab')]
PMC4896250	4/2016	S4629-PMC4896250	['conclusion: administration of anti-Il-9 Antibody increased the induction of tolerance in a Mouse model of allergic rhinitis.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 35, 'IL-9'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 91, 'mouse')]
PMC4896250	4/2016	S4814-PMC4896250	['this method is advantageous over the conventional phage-displayed libraries by allowing the use of polyclonal Antibodies or even untreated Serum samples.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 110, 'antibodies'), ('UBERON_0001977', 'blood serum', 139, 'serum')]
PMC4896250	4/2016	S4975-PMC4896250	['laboratory investigations revealed positive anti-Nuclear Antibody in 26% (12/47; none with anti-Thyroid Antibodies), circulating Eosinophilia in 24% (14/59), increased Serum total Ige in 68% (40/59) and low Plasma C3 and/or c4 levels in 30% (16/53).']	N/A	N/A	[('GO_0005634', 'nucleus', 49, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody'), ('UBERON_0002046', 'thyroid gland', 96, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 104, 'antibodies'), ('CL_0000771', 'eosinophil', 129, 'eosinophilia'), ('UBERON_0001977', 'blood serum', 168, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 180, 'IgE'), ('UBERON_0001969', 'blood plasma', 207, 'plasma'), ('PR_000004904', 'complement C5', 214, 'C3')]
PMC4896250	4/2016	S5049-PMC4896250	['cell suspension was stained with Fluorophore labeled Antibodies to determine Il-33 Intracellular Expression in Cd45+3+T Cells, Cd45+19+B Cells, Cd45+cd3-Cd19-ly-6G-cells, Cd45-324+Epithelial Cells by flow cytometry.']	N/A	N/A	[('CHEBI_51217', 'fluorochrome', 33, 'fluorophore'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibodies'), ('PR_000001470', 'interleukin-28B', 77, 'IL-33'), ('GO_0005622', 'intracellular anatomical structure', 83, 'intracellular'), ('GO_0010467', 'gene expression', 97, 'expression'), ('PR_000001309', 'CD70 molecule', 111, 'CD45'), ('CL_0000084', 'T cell', 118, 'T cells'), ('PR_000001309', 'CD70 molecule', 127, 'CD45'), ('CL_0000236', 'B cell', 135, 'B cells'), ('PR_000001309', 'CD70 molecule', 144, 'CD45'), ('PR_000001309', 'CD70 molecule', 153, 'CD19'), ('PR_000007090', 'glycerophosphocholine cholinephosphodiesterase ENPP6', 161, '6G'), ('PR_000001309', 'CD70 molecule', 171, 'CD45'), ('CL_0000066', 'epithelial cell', 180, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 180, 'epithelial')]
PMC4896250	4/2016	S5117-PMC4896250	['results: the highest level of Serum Der P -specific Ige Antibodies was observed in group 2.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 30, 'serum'), ('PR_000006266', 'dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1', 36, 'Der p'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 52, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 56, 'antibodies')]
PMC4896250	4/2016	S5129-PMC4896250	['the mycoplasma pneumonia was confirmed by positive Igm and also rising titers of Igg Antibody of m. pneumoniae or cold agglutinin more than four times later.']	N/A	N/A	[('GO_0071754', 'IgM immunoglobulin complex, circulating', 51, 'IgM'), ('GO_0071735', 'IgG immunoglobulin complex', 81, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 85, 'antibody')]
PMC4896250	4/2016	S5307-PMC4896250	['methods\nusing elisa to detect 90 kinds of sigg Antibody of 291 patients with allergic diseases in the first affiliated hospital of guangzhou medical university for diagnosis and differential diagnosis, data were analyzed by spss19.0 statistical software.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibody')]
PMC4896250	4/2016	S5308-PMC4896250	['results\nthe positive rates of ten kinds of Food sigg Antibody from high to low are Milks and dairy products (33.03%), crustaceans (27.89%), meats and egg (19.31%), legumes (16.3%), fishes (15.56%), others (8.18%), vegetables (7.63%), nuts and oilseeds (6.70%), cereals (5.31%), the lowest is fruits (4.34%); the highest positive rate of Food is egg (64.60%), followed by the white soft cheese (56.70%), Cow’s Milk (54.30%).']	N/A	N/A	[('CHEBI_33290', 'food', 43, 'food'), ('GO_0042571', 'immunoglobulin complex, circulating', 53, 'antibody'), ('UBERON_0001913', 'milk', 83, 'milks'), ('CHEBI_33290', 'food', 337, 'food'), ('NCBITaxon_33208', 'Metazoa', 403, 'cow'), ('UBERON_0001913', 'milk', 409, 'milk')]
PMC4896250	4/2016	S5314-PMC4896250	['in 0~3 and 45~59 years old group, the positive rate of sigg Antibody of different categories of Food were not statistically different in gender, in 4~6 years old group, the positive rate of cereals, fruits, vegetables of male are higher than female (x2=7.068, p=.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 60, 'antibody'), ('CHEBI_33290', 'food', 96, 'food')]
PMC4896250	4/2016	S5386-PMC4896250	['definition of possible abpa were, (1) positive skin test or specific Ige for aspergillus, and (2) either a) positive precipitation or Igg Antibody for aspergillus or b) Mucoid impaction or bronchiectasis in Chest computed tomography.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 69, 'IgE'), ('GO_0071735', 'IgG immunoglobulin complex', 134, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 138, 'antibody'), ('UBERON_0000912', 'mucus', 169, 'mucoid'), ('UBERON_0001443', 'chest', 207, 'chest')]
PMC4896250	4/2016	S5699-PMC4896250	['he developed pollinosis in spring and autumn, and had increased levels of specific Ige Antibodies against many different kinds of Allergens such as Food and pollens, including, celery, white Birch, and mugwort.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 83, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 87, 'antibodies'), ('CHEBI_33663', 'cyclic hydrocarbon', 130, 'allergens'), ('CHEBI_33290', 'food', 148, 'food'), ('NCBITaxon_33208', 'Metazoa', 191, 'birch')]
PMC4896250	4/2016	S6212-PMC4896250	['methods: 40 children(4.6±2.6yr) from 209 patients with allergic Respiratory diseases(jun to august) in 2013 and 2014 as the experimental group, detecting 11 kinds of Serum specific Ige and total Ige Antibody.']	N/A	N/A	[('UBERON_0001004', 'respiratory system', 64, 'respiratory'), ('UBERON_0001977', 'blood serum', 166, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 181, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 195, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 199, 'antibody')]
PMC4896250	4/2016	S6314-PMC4896250	['no Virus-specific Antibodies, bacteria, and Fungi were detected in Csf, Blood, and Urine.']	N/A	N/A	[('NCBITaxon_1', 'root', 3, 'virus'), ('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'fungi'), ('UBERON_0001359', 'cerebrospinal fluid', 67, 'CSF'), ('UBERON_0000178', 'blood', 72, 'blood'), ('UBERON_0001088', 'urine', 83, 'urine')]
PMC4896250	4/2016	S6327-PMC4896250	['there was no increase of Igg mycoplasma pneumoniae Antibody titer in 3 serial tests between 7 days interval.']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 25, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibody')]
PMC4896250	4/2016	S6375-PMC4896250	['anti-Il-23P19 Antibody was given during hdm sensitization period.']	N/A	N/A	[('PR_000001379', 'interleukin-2', 5, 'IL-23p19'), ('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibody')]
PMC4896250	4/2016	S6379-PMC4896250	['in Bronchoalveolar Lavage Fluid, Il-4, Il-5, and Il-17A cytokine levels were significantly reduced in anti-Il-23 Antibody treated Mice.']	N/A	N/A	[('UBERON_0004212', 'glomerular capillary', 3, 'bronchoalveolar lavage fluid'), ('PR_000001470', 'interleukin-28B', 33, 'IL-4'), ('PR_000001470', 'interleukin-28B', 39, 'IL-5'), ('PR_000001139', 'interleukin-17B', 49, 'IL-17A'), ('PR_000001470', 'interleukin-28B', 107, 'IL-23'), ('GO_0042571', 'immunoglobulin complex, circulating', 113, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'mice')]
PMC4896250	4/2016	S6767-PMC4896250	['anti-Il-23P19 Antibody was given during the sensitization period.']	N/A	N/A	[('PR_000001379', 'interleukin-2', 5, 'IL-23p19'), ('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibody')]
PMC4896250	4/2016	S6772-PMC4896250	['anti-Il-23 Antibody treatment during Allergen sensitization period significantly diminished several phenotypes of allergic asthma.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 5, 'IL-23'), ('GO_0042571', 'immunoglobulin complex, circulating', 11, 'antibody'), ('CHEBI_50904', 'allergen', 37, 'allergen')]
PMC4896250	4/2016	S6883-PMC4896250	['by iuis grouping, Antibody deficiencies was most common (14 patients, 58.3%), comprising common variable immunodeficiency [cvid] (8), selective Iga deficiency alone (3), selective Iga with Igg2 and g4 deficiency (1), selective Igg2 and g4 deficiency alone (1) and hypogammaglobulinaemia (1, who had ring chromosome 18).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibody'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 144, 'IgA'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 180, 'IgA'), ('GO_0071735', 'IgG immunoglobulin complex', 189, 'IgG2'), ('GO_0071735', 'IgG immunoglobulin complex', 227, 'IgG2')]
PMC4896250	4/2016	S7053-PMC4896250	['the 25(Oh)D and dna from their Cord Blood are measured and specific Ige Antibodies against Egg and Milk were performed at 1, 3yr of age.']	N/A	N/A	[('CHEBI_71657', 'versiconol acetate', 4, '25(OH)D'), ('UBERON_0002240', 'spinal cord', 31, 'cord'), ('UBERON_0000178', 'blood', 36, 'blood'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 68, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 72, 'antibodies'), ('CL_0000025', 'egg cell', 91, 'egg'), ('UBERON_0001913', 'milk', 99, 'milk')]
PMC4896250	4/2016	S7175-PMC4896250	['it works by helping to re-balance an Individual’s Immune Response to Allergens and the ability to drive an Antibody titre response is greatly improved by the use of Adjuvants, the most common being Aluminium Hydroxide.']	N/A	N/A	[('NCBITaxon_1', 'root', 37, 'individual'), ('GO_0006955', 'immune response', 50, 'immune response'), ('UBERON_0002405', 'immune system', 50, 'immune'), ('CHEBI_33663', 'cyclic hydrocarbon', 69, 'allergens'), ('GO_0042571', 'immunoglobulin complex, circulating', 107, 'antibody'), ('CHEBI_65445', 'AS-186c', 165, 'adjuvants'), ('CHEBI_33130', 'aluminium hydroxide', 198, 'aluminium hydroxide')]
PMC4896250	4/2016	S7260-PMC4896250	['170 patients with allergic rhinitis/asthma and eczema were recruited in the study to investigate the pattern of 94 Allergen prevalence using immunocap Allergen specific Ige Antibody assay.']	N/A	N/A	[('CHEBI_50904', 'allergen', 115, 'allergen'), ('CHEBI_50904', 'allergen', 151, 'allergen'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 169, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 173, 'antibody')]
PMC4896250	4/2016	S7294-PMC4896250	['the obtained Sera were analysed for ova-specific Antibodies, while Spleen Cells were tested for T-Cell Responses including cytokine secretion after re-stimulation of the cells in vitro with ovalbumin.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 13, 'sera'), ('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibodies'), ('CL_0002240', 'marrow fibroblast', 67, 'spleen cells'), ('UBERON_0002106', 'spleen', 67, 'spleen'), ('CL_0000084', 'T cell', 96, 'T-cell'), ('GO_0001914', 'regulation of T cell mediated cytotoxicity', 96, 'T-cell responses')]
PMC4896250	4/2016	S7332-PMC4896250	['we evaluated Airway hyperresponsiveness (ahr), the proportion of Eosinophils in Bronchoalveolar Lavage Fluid (Balf), Lung histology, Serum total and ova-specific Antibody, cytokine profile of Balf and Lung draining Lymph Nodes (Lln), and T Cell population of lln.']	N/A	N/A	[('UBERON_0001005', 'respiratory airway', 13, 'airway'), ('CL_0000771', 'eosinophil', 65, 'eosinophils'), ('UBERON_0004212', 'glomerular capillary', 80, 'bronchoalveolar lavage fluid'), ('UBERON_0001348', 'brown adipose tissue', 110, 'BALF'), ('UBERON_0002048', 'lung', 117, 'lung'), ('UBERON_0001977', 'blood serum', 133, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 162, 'antibody'), ('UBERON_0001348', 'brown adipose tissue', 192, 'BALF'), ('UBERON_0002048', 'lung', 201, 'lung'), ('UBERON_0000029', 'lymph node', 215, 'lymph nodes'), ('UBERON_2000120', 'lateral line ganglion', 228, 'LLN'), ('CL_0000084', 'T cell', 238, 'T cell')]
PMC4896250	4/2016	S7346-PMC4896250	['bleeding diatheses were excluded by laboratory testing, and anti Nuclear Antibody(ana) and p-anca were positive.']	N/A	N/A	[('GO_0005634', 'nucleus', 65, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibody')]
PMC4896250	4/2016	S7348-PMC4896250	['Antiglomerular basement membrane Antibodies(anti-Gbm) was negative.']	N/A	N/A	[('GO_0043679', 'axon terminus', 0, 'Antiglomerular'), ('GO_0042571', 'immunoglobulin complex, circulating', 33, 'antibodies'), ('PR_000007896', 'glucokinase regulatory protein', 49, 'GBM')]
PMC4896250	4/2016	S7430-PMC4896250	['Blood examination were performed and hemolytic anemia, positive anti Nuclear Antibody (ana) and anti dsdna, as well as proteinuria were observed.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0005634', 'nucleus', 69, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibody')]
PMC4896250	4/2016	S7480-PMC4896250	['Antinuclear Antibodies (ana), rheumatoid factor (rf) and anti-ds-dna were negative.']	N/A	N/A	[('GO_0043679', 'axon terminus', 0, 'Antinuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibodies')]
PMC4896250	4/2016	S7626-PMC4896250	['targeting and localization of nanocarriers with perl’s (iron), Peg (anti-Peg Antibodies), immunofluorescence (spio nanocarriers with Fitc labelled Antibody) confirmed their localization with anti-Il-4R+ Lung Inflammatory Cells.']	N/A	N/A	[('CHEBI_61022', 'naproxol', 63, 'PEG'), ('CHEBI_61022', 'naproxol', 73, 'PEG'), ('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibodies'), ('CHEBI_37926', 'fluorescein isothiocyanate', 133, 'FITC'), ('GO_0042571', 'immunoglobulin complex, circulating', 147, 'antibody'), ('PR_000001470', 'interleukin-28B', 196, 'IL-4R'), ('CL_0011006', 'Lugaro cell', 203, 'lung inflammatory cells'), ('UBERON_0002048', 'lung', 203, 'lung')]
PMC4896250	4/2016	S7747-PMC4896250	['the study covered the following allegro-diagnostic stages:\ni stage - for precise verification of the Allergen, patient’s Blood Serum was examined on a particular specific-Ige Antibodies by modern automated system - "immuno cap 100" (phadia, switzerland).']	N/A	N/A	[('CHEBI_50904', 'allergen', 101, 'allergen'), ('UBERON_0000178', 'blood', 121, 'blood'), ('UBERON_0001977', 'blood serum', 127, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 171, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 175, 'antibodies')]
PMC4896250	4/2016	S7771-PMC4896250	['intra-Nasal administration of anti-S100A9 Antibody restored the increase of the numbers of Inflammatory Cells and ahr in cfa/ova Mice to those of sham Mice.']	N/A	N/A	[('UBERON_0000004', 'nose', 6, 'nasal'), ('PR_000014414', 'protein S100-A7', 35, 'S100A9'), ('GO_0042571', 'immunoglobulin complex, circulating', 42, 'antibody'), ('CL_0000902', 'induced T-regulatory cell', 91, 'inflammatory cells'), ('NCBITaxon_10088', 'Mus <genus>', 129, 'mice'), ('NCBITaxon_10088', 'Mus <genus>', 151, 'mice')]
PMC4896250	4/2016	S7819-PMC4896250	['anti-Fcεri Antibody was administered to the Mice Intraperitoneally for 4 consecutive days before the end of study.']	N/A	N/A	[('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 5, 'FcεRI'), ('GO_0042571', 'immunoglobulin complex, circulating', 11, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'mice'), ('UBERON_0000007', 'pituitary gland', 49, 'intraperitoneally')]
PMC4896250	4/2016	S7821-PMC4896250	['results: anti-Fcεri Antibody treated am Mice had significantly decreased phenotypes (e.g., clinical score, Airway hyperresponsiveness, and pathology) of ad and allergic asthma.']	N/A	N/A	[('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 14, 'FcεRI'), ('GO_0042571', 'immunoglobulin complex, circulating', 20, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('UBERON_0001005', 'respiratory airway', 107, 'airway')]
PMC4896250	4/2016	S7822-PMC4896250	['in addition, the levels of total Ige, ova-specific Igg1 and Il-13 in Serum were significantly lower in am Mice treated with anti-Fcεri Antibody.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 33, 'IgE'), ('GO_0071735', 'IgG immunoglobulin complex', 51, 'IgG1'), ('PR_000001470', 'interleukin-28B', 60, 'IL-13'), ('UBERON_0001977', 'blood serum', 69, 'serum'), ('NCBITaxon_10088', 'Mus <genus>', 106, 'mice'), ('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 129, 'FcεRI'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibody')]
PMC4896250	4/2016	S7823-PMC4896250	['the level of Prostaglandin D2 and the number of Mast Cells in skin were also decreased in the anti-Fcεri Antibody treated with am Mice.']	N/A	N/A	[('CHEBI_15555', 'prostaglandin D2', 13, 'prostaglandin D2'), ('CL_0000097', 'mast cell', 48, 'mast cells'), ('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 99, 'FcεRI'), ('GO_0042571', 'immunoglobulin complex, circulating', 105, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 130, 'mice')]
PMC4896250	4/2016	S7824-PMC4896250	['furthermore, the skin and Lung Expressions of Il-17 were reduced after the treatment of anti-Fcεri Antibody.']	N/A	N/A	[('UBERON_0002048', 'lung', 26, 'lung'), ('GO_0010467', 'gene expression', 31, 'expressions'), ('PR_000001470', 'interleukin-28B', 46, 'IL-17'), ('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 93, 'FcεRI'), ('GO_0042571', 'immunoglobulin complex, circulating', 99, 'antibody')]
PMC4896250	4/2016	S7825-PMC4896250	['conclusion: Ige-Fcεri blockade by anti-Fcεri Antibody can suppress the Ige-mediated phenotypes and inflammatory responses in am.']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 12, 'IgE'), ('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 16, 'FcεRI'), ('PR_000001480', 'low affinity immunoglobulin gamma Fc region receptor II-a', 39, 'FcεRI'), ('GO_0042571', 'immunoglobulin complex, circulating', 45, 'antibody'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 71, 'IgE')]
PMC4896250	4/2016	S7949-PMC4896250	['Pge2 Inhibitor and Tgf-Β neutralizing Antibodies were injected Intraperitoneally on four consecutive days at the approximate time of Ascs injection.']	N/A	N/A	[('CHEBI_7998', 'Peptide(-Leu)', 0, 'PGE2'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 0, 'PGE2'), ('CHEBI_35222', 'inhibitor', 5, 'inhibitor'), ('PR_000000046', 'TGF-beta', 19, 'TGF-β'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibodies'), ('UBERON_0000007', 'pituitary gland', 63, 'intraperitoneally'), ('CL_0002561', 'outer root sheath cell', 133, 'ASCs')]
PMC4896250	4/2016	S8378-PMC4896250	['a592 higher Ige Antibody levels mediate anti-cancer immunity in transgenic kn1 hyper-Ige Mice\n\nerika jensen-jarolim1,2, judit fazekas1,2, josef singer1,2, anna lukschal1,2, reinhard horvat3, gertrude achatz-straussberger4, gernot achatz4\n\n1messerli research institute of the university of veterinary medicine vienna, medical university vienna and university vienna, austria;2institute of pathophysiology and allergy research, center of pathophysiology, infectiology and immunology, medical university of vienna, austria;3medical university of vienna;4university of salzburg\n\ncorrespondence: erika jensen-jarolim – messerli research institute of the university of veterinary medicine vienna, medical university vienna and university vienna, austria\nbackground\nthe introduction of monoclonal Antibodies into clinical oncology yielded survival benefits for cancer patients by selectively targeting tumor-associated Antigens (taas).']	N/A	N/A	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 12, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 16, 'Antibody'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 85, 'IgE'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'Mice'), ('GO_0042571', 'immunoglobulin complex, circulating', 790, 'antibodies'), ('CHEBI_59132', 'antigen', 912, 'antigens')]
PMC4896250	4/2016	S8383-PMC4896250	['each strain was divided into groups 1-4 (n=8): groups 1. were immunized against Her-2 prior to tumor grafting, 2. against irrelevant Antigen bsa, 3. passively received the anti-Her-2 Igg Mouse monoclonal Antibody 4d5, 4. remained naïve.']	N/A	N/A	[('PR_000008440', 'heart- and neural crest derivatives-expressed protein 2', 80, 'HER-2'), ('CHEBI_59132', 'antigen', 133, 'antigen'), ('PR_000008440', 'heart- and neural crest derivatives-expressed protein 2', 177, 'HER-2'), ('GO_0071735', 'IgG immunoglobulin complex', 183, 'IgG'), ('NCBITaxon_10088', 'Mus <genus>', 187, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 204, 'antibody')]
PMC4896250	4/2016	S8391-PMC4896250	['references\n(1) Migration Of Antibody secreting Cells towards Cxcl12 depends on the isotype that forms the bcr.']	N/A	N/A	[('GO_0016477', 'cell migration', 15, 'Migration of ... cells'), ('GO_0042571', 'immunoglobulin complex, circulating', 28, 'antibody'), ('PR_000006069', 'C-X-C motif chemokine 2', 61, 'CXCL12')]
PMC4896250	4/2016	S8712-PMC4896250	['<methods> allergen samples were incubated in the wells coated with a primary Antibody for 2 hours at 37°c.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibody')]
PMC4896250	4/2016	S8713-PMC4896250	['after washing, a biotinylated secondary Antibody against the Allergen was incubated for 1 hour at 37°c.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibody'), ('CHEBI_50904', 'allergen', 61, 'allergen')]
PMC4896250	4/2016	S8959-PMC4896250	['methods: house dust samples were collected in sterile alk filters (alk laboratory, denmark) and analyzed for various indoor Allergenic factors including Der P 1, der f 1, Bla G 1, Per A 1 and Fel D 1 using Antibodies and elisa technique.']	N/A	N/A	[('CHEBI_77514', '6-phenylundecane', 124, 'allergenic'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 153, 'Der p 1'), ('PR_000004759', 'Bloom syndrome protein', 171, 'Bla g 1'), ('PR_000001658', 'prostaglandin E2 receptor EP2 subtype', 180, 'Per a 1'), ('PR_000007319', 'fatty acid desaturase 3', 192, 'Fel d'), ('GO_0042571', 'immunoglobulin complex, circulating', 206, 'antibodies')]
PMC4896250	4/2016	S8962-PMC4896250	['these samples were extracted individually and Allergens were quantitated using specific Antibodies from indoor biotechnologies (u.s.a) and alk laboratories (denmark) by elisa procedure.']	N/A	N/A	[('CHEBI_33663', 'cyclic hydrocarbon', 46, 'allergens'), ('GO_0042571', 'immunoglobulin complex, circulating', 88, 'antibodies')]
PMC4896250	4/2016	S9027-PMC4896250	['the analytes in the test can be immobilized to the Nitrocellulose membrane which was coated with specific Antibody or Antigen and visualized by specific ag or Ab conjugated with gold Nanoparticles.']	N/A	N/A	[('CHEBI_53325', 'nitrocellulose', 51, 'nitrocellulose'), ('GO_0042571', 'immunoglobulin complex, circulating', 106, 'antibody'), ('CHEBI_59132', 'antigen', 118, 'antigen'), ('GO_0042571', 'immunoglobulin complex, circulating', 159, 'Ab'), ('CHEBI_51029', 'nedocromil(2-)', 183, 'nanoparticles')]
PMC4896250	4/2016	S9033-PMC4896250	['Goat anti-Human Igg Antibody and Mouse Igg conjugated with gold nanoparticles were prepared in our laboratory and placed in the conjugate pad for further test.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Goat'), ('NCBITaxon_9606', 'Homo sapiens', 10, 'human'), ('GO_0071735', 'IgG immunoglobulin complex', 16, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 20, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 33, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 39, 'IgG')]
PMC4896250	4/2016	S9127-PMC4896250	['Serum Antibodies were measured by elisa, and cells in Balf were analyzed by facs.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 6, 'antibodies'), ('UBERON_0001348', 'brown adipose tissue', 54, 'BALF')]
PMC4908484	6/2016	S66-PMC4908484	['they were incubated overnight at 4°c with specific primary Antibody: anti‐ferritin (1:250, santa‐cruz), anti‐Vdr (d‐6) (1:200, santa‐cruz), anti‐P53 (1:500, santa‐cruz), anti‐cmyc (1:200, millipore s.p.a., milan, italy), anti‐ki67 (1:500, santa‐cruz), anti‐phospho‐P44/42 mapk (thr202/tyr204, 1:1000 cell‐signaling).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 59, 'antibody'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 109, 'VDR'), ('PR_000003035', 'cellular tumor antigen p53', 145, 'p53'), ('PR_000001245', 'rhodopsin', 265, 'p44')]
PMC4908484	6/2016	S70-PMC4908484	['the slides were incubated overnight at 4°c with specific primary Antibody: 1:50 C‐Myc, 1:50 ki67.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 65, 'antibody'), ('PR_000005009', 'calpain-1 catalytic subunit', 80, 'c‐Myc')]
PMC4908484	6/2016	S71-PMC4908484	['all Antibodies were diluted in pbs 1× in a humidified chamber and then incubated for 20\xa0min with diluted biotinylated secondary Antibody Solution (dako italia, milan, italy) and then for 20\xa0min with vectastain®abc Reagent (dako italia, milan, italy).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 128, 'antibody'), ('CHEBI_75958', 'solution', 137, 'solution'), ('CHEBI_33893', 'reagent', 214, 'Reagent')]
PMC4908484	6/2016	S75-PMC4908484	['P53 immunofluorescence\ncells, fixed as described above, were washed with cold pbs 1x, permeabilized with cold pbs 1× with 0.5% Triton x‐100 for 20\xa0min at 4°c, incubated in blocking Solution (1% bsa and 5% fbs in pbs 1x) for 30\xa0min at rt and then treated with P53 specific Antibody (1:50, santa‐ cruz) in pbs 1× overnight at 4°c.']	N/A	N/A	[('PR_000003035', 'cellular tumor antigen p53', 0, 'p53'), ('CHEBI_29236', 'protium atom', 127, 'Triton'), ('CHEBI_75958', 'solution', 181, 'solution'), ('PR_000003035', 'cellular tumor antigen p53', 259, 'p53'), ('GO_0042571', 'immunoglobulin complex, circulating', 272, 'antibody')]
PMC4908484	6/2016	S76-PMC4908484	['the slides were then incubated with fitch‐secondary Antibodies (1:200, sigma‐aldrich) in pbs 1× for 1\xa0h in the dark, counterstained with Dapi (1\xa0 μ g/ml; sigma‐ aldrich) diluted in pbs 1× for 5\xa0min in the dark at room temperature and finally mounted in vectashield (d.b.a.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 52, 'antibodies'), ('CHEBI_51231', 'DAPI', 137, 'DAPI')]
PMC4908484	6/2016	S129-PMC4908484	['protein extracts were analyzed by immunoblotting with specific Antibodies against the indicated proteins; results are expressed as means\xa0±\xa0sd(%) normalized to control values of four technical replicates; b, c, d, f, g, h p\xa0<\xa0 0.05 versus a; f p\xa0<\xa0 0.05 versus b; d, g p\xa0<\xa0 0.05 versus c; f, g, h p\xa0<\xa0 0.05 versus e; g p\xa0<\xa0 0.05 versus f.\n\nstudy of the Intracellular pathways activated by Calcitriol\nthe presence of Vdr receptors in neuroblastoma cells was studied by western blot and densitometric analysis (fig.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 63, 'antibodies'), ('GO_0005622', 'intracellular anatomical structure', 352, 'intracellular'), ('CHEBI_17823', 'calcitriol', 388, 'calcitriol'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 415, 'VDR')]
PMC4908484	6/2016	S140-PMC4908484	['(a) shows western blot of protein extracts analyzed by immunoblotting with a specific Antibody againstvdrand densitometric analysis ofvdr.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 86, 'antibody')]
PMC4908484	6/2016	S141-PMC4908484	['d, e, f, g, h p\xa0<\xa0 0.05 versus a; f p\xa0<\xa0 0.05 versus b; g p\xa0<\xa0 0.05 versus e; f, h p\xa0<\xa0 0.05 versus g; h p\xa0<\xa0 0.05 versus d; g p\xa0<\xa0 0.05 versus c. (b) shows western blot of protein extracts analyzed by immunoblotting with a specific Antibody against p‐Erkand densitometric analysis of p‐erk.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 233, 'antibody'), ('PR_000006910', 'elongation factor 2 kinase', 252, 'ERKand')]
PMC4908484	6/2016	S152-PMC4908484	['the results are expressed as means\xa0±\xa0sd(%) normalized to control values of four technical replicates (a) shows western blot of protein extracts analyzed by immunoblotting with a specific Antibody against P53 and densitometric analysis of P53.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 187, 'antibody'), ('PR_000003035', 'cellular tumor antigen p53', 204, 'p53'), ('PR_000003035', 'cellular tumor antigen p53', 238, 'p53')]
PMC4908484	6/2016	S153-PMC4908484	['b, c, d, f, h p\xa0<\xa0 0.05 versus a; c, d, f p\xa0<\xa0 0.05 versus b; d, g p\xa0<\xa0 0.05 versus c; h p\xa0<\xa0 0.05 versus d; f, g, h p\xa0<\xa0 0.05 versus e; g, h p\xa0<\xa0 0.05 versus f; h p\xa0<\xa0 0.05 versus g. (b) shows western blot of protein extracts analyzed by immunoblotting with a specific Antibody against Ki67 and densitometric analysis of Ki67.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 270, 'antibody'), ('PR_000009205', 'lysine-specific demethylase 5B', 287, 'ki67'), ('PR_000009205', 'lysine-specific demethylase 5B', 322, 'ki67')]
PMC4908484	6/2016	S154-PMC4908484	['b, c, d, f, g, h p\xa0<\xa0 0.05 versus a; f, g, h p\xa0<\xa0 0.05 versus e; c, d, f p\xa0<\xa0 0.05 versus b; d, g p\xa0<\xa0 0.05 versus c; h p\xa0<\xa0 0.05 versus d; g, h p\xa0<\xa0 0.05 versus f; h p\xa0<\xa0 0.05 versus g. (c) shows western blot of protein extracts analyzed by immunoblotting with a specific Antibody against C‐Myc and densitometric analysis of C‐Myc.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 273, 'antibody'), ('PR_000005009', 'calpain-1 catalytic subunit', 290, 'c‐Myc'), ('PR_000005009', 'calpain-1 catalytic subunit', 326, 'c‐Myc')]
PMC4912994	6/2016	S61-PMC4912994	['antiphospholipid Antibodies were normal when tested Postpartum.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 17, 'antibodies'), ('GO_0007565', 'female pregnancy', 52, 'postpartum')]
PMC4919621	6/2016	S187-PMC4919621	['Membranes were incubated with the specific primary Antibodies (for Antibody specifications and dilutions seetable s10) at 4\u2009°c overnight.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibody')]
PMC4919621	6/2016	S188-PMC4919621	['after several washes, the membranes were incubated with horseradish peroxidase (hrp)-conjugated secondary Antibody at room temperature for 1\u2009h. membranes were developed using the chemiluminescent hrp Antibody detection Reagent (denville scientific inc., usa), and exposed to kodak autoradiography films.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 106, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 200, 'antibody'), ('CHEBI_33893', 'reagent', 219, 'reagent')]
PMC4919621	6/2016	S195-PMC4919621	['Tissue sections were incubated with the specific primary Antibody (seetable s6for Antibody specifications and dilutions used).']	N/A	N/A	[('UBERON_0000479', 'tissue', 0, 'Tissue'), ('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 82, 'antibody')]
PMC4919621	6/2016	S196-PMC4919621	['after several washes, sections were treated with secondary Antibody (anti-Rabbit) and developed using the dako envision+ dual link system-hrp, dab+(k4065) as instructed by the manufacturer.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 59, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 74, 'rabbit')]
PMC4933715	7/2016	S210-PMC4933715	['four children of the apls mothers, of them the 3 asd children had persistent anti-Β2Gp1 Igg Antibodies.']	N/A	N/A	[('PR_000010000', 'lysozyme g-like protein 2', 82, 'β2GP1'), ('GO_0071735', 'IgG immunoglobulin complex', 88, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 92, 'antibodies')]
PMC4933715	7/2016	S211-PMC4933715	['none of the offspring of the sle mothers had either Neurodevelopmental disorders or anti-Β2Gp1 Igg Antibodies.']	N/A	N/A	[('GO_0007399', 'nervous system development', 52, 'neurodevelopmental'), ('PR_000010000', 'lysozyme g-like protein 2', 89, 'β2GP1'), ('GO_0071735', 'IgG immunoglobulin complex', 95, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 99, 'antibodies')]
PMC4934568	10/2014	S158-PMC4934568	['v. t. ramaekers et al ., belgium 2013 [35]case control study cases: 75 childrenwith infantile autismcontrols:non-autistic children with developmentaldelaydiagnosis establishedby dsm iv criteriaserum fr blockingautoimmune Antibodiesblocking fr Antibodies in caseshad significantly higherprevalence (57%) than innon-autistic developmentally delayed children (33%)mean Serum Folic Acid levels11.3 ng/ml) were significantly higher in cases than controls (9.30 ng/ml) p. suren et al ., norway, 2013 [8]population based prospective study.']	N/A	N/A	[('GO_0043079', 'antipodal cell nucleus', 221, 'antibodiesBlocking'), ('GO_0042571', 'immunoglobulin complex, circulating', 243, 'antibodies'), ('UBERON_0001977', 'blood serum', 366, 'serum'), ('CHEBI_30751', 'formic acid', 372, 'folic acid')]
PMC4937150	2/2016	S47-PMC4937150	['after protein transfer, Nitrocellulose membranes (biotrace, pall co., ann arbor, mi, u.s.a.) were blocked with 4% bsa and incubated respectively with anti-Gr (sc-1004, santa cruz biotechnology, dallas, tx, u.s.a., 1:500) and anti-Actb (ap0060, bioworld, atlanta, ga, u.s.a., 1:10,000) Antibodies overnight at 4°c.']	N/A	N/A	[('CHEBI_53325', 'nitrocellulose', 24, 'nitrocellulose'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 155, 'GR'), ('PR_000003666', 'acyl-coenzyme A synthetase ACSM2B, mitochondrial', 230, 'ACTB'), ('GO_0042571', 'immunoglobulin complex, circulating', 285, 'antibodies')]
PMC4937150	2/2016	S51-PMC4937150	['two μ g of sonicated dna were denatured and incubated with the Antibody against 5-Methyl cytosine (ab10805, abcam, cambridge, ma, u.s.a.) to immunoprecipitate the methylated dna fragments.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 63, 'antibody'), ('CHEBI_44700', 'L-ornithyl group', 80, '5-methyl')]
PMC4944979	7/2016	S70-PMC4944979	['in-cell elisa (ice)\n\nAntibody selection and optimization\nwe quantified Adipogenic differentiation response by measuring protein content of Pparγ (cell signaling technology, inc., danvers, ma, usa) and Fabp4 (cell signaling).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 21, 'Antibody'), ('GO_0060612', 'adipose tissue development', 71, 'adipogenic'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 139, 'PPARγ'), ('PR_000007380', 'putative F-box/LRR-repeat protein 21', 201, 'FABP4')]
PMC4944979	7/2016	S73-PMC4944979	['primary Antibodies for these proteins were selected based on their successful application by the manufacturer to either immunohistochemistry or in-cell elisa platforms.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 8, 'antibodies')]
PMC4944979	7/2016	S74-PMC4944979	['Goat anti-Rabbit horseradish peroxidase (hrp)-conjugated secondary Antibody (Goat≠Rabbit; abcam, cambridge, ma, usa) was also selected based on this criterion.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Goat'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 10, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 77, 'Goat'), ('NCBITaxon_10088', 'Mus <genus>', 82, 'Rabbit')]
PMC4944979	7/2016	S75-PMC4944979	['Antibody optimization for the ice was performed on purchased Human Bone Marrow-derived Mesenchymal Stem Cells (hbm-Msc; lonza).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody'), ('NCBITaxon_9606', 'Homo sapiens', 61, 'human'), ('CL_0002092', 'bone marrow cell', 67, 'bone marrow'), ('UBERON_0002371', 'bone marrow', 67, 'bone marrow'), ('CL_0000134', 'mesenchymal stem cell', 87, 'mesenchymal stem cells'), ('UBERON_0003104', 'mesenchyme', 87, 'mesenchymal'), ('CL_0000186', 'myofibroblast cell', 115, 'MSC')]
PMC4944979	7/2016	S77-PMC4944979	['Antibody dilutions were optimized in-house, listed ins2 table.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody')]
PMC4944979	7/2016	S78-PMC4944979	['the slope profiles for each Antibody dilution were analyzed.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 28, 'antibody')]
PMC4944979	7/2016	S79-PMC4944979	['dilutions presenting with multiple stable slope values over 5 minute intervals within the 30-minute read time were chosen as optimal dilution factors for the respective Antibody.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 169, 'antibody')]
PMC4944979	7/2016	S82-PMC4944979	['primary Antibodies were diluted in Antibody buffer (0.1% fraction v bsa and 5% goat Serum in pbs) and added to all wells, except the no primary control (npc) wells.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 8, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibody'), ('UBERON_0001977', 'blood serum', 84, 'serum')]
PMC4944979	7/2016	S84-PMC4944979	['after primary Antibodies were removed, wells were rinsed at room temperature for 7x5 minutes with rotation using rinse buffer.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibodies')]
PMC4944979	7/2016	S85-PMC4944979	['Goat≠Rabbit secondary Antibody (s2 table) was added to all wells and plates were incubated at room temperature for1 hour with rotation.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Goat'), ('NCBITaxon_10088', 'Mus <genus>', 5, 'Rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 22, 'antibody')]
PMC4944979	7/2016	S99-PMC4944979	['briefly, a 1:50 dilution of Sirt1 Antibody (abcam) was added to each sample of cell supernatant and incubated overnight at 4°c with agitation.']	N/A	N/A	[('PR_000014888', 'NAD-dependent protein deacetylase sirtuin-1', 28, 'SIRT1'), ('GO_0042571', 'immunoglobulin complex, circulating', 34, 'antibody')]
PMC4944979	7/2016	S100-PMC4944979	['the Antibody-supernatant Mixture was added to a 50% slurry of protein a agrose bead (cell signaling) and incubated for 3 hours at 4°c with agitation.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 4, 'antibody'), ('CHEBI_60004', 'mixture', 25, 'mixture')]
PMC4944979	7/2016	S107-PMC4944979	['total acetylated protein was immunoprecipitated from cell supernatant using an Antibody to acetylated lysine as described above and the content of Pparγ and Β-Catenin in the immunoprecipitant was measured on wes, and expressed relative to total Pparɣ and Β-Catenin protein that was also measured on wes.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 79, 'antibody'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 147, 'PPARγ'), ('PR_000002198', 'catenin beta-1', 157, 'β-catenin'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 245, 'PPARɣ'), ('PR_000002198', 'catenin beta-1', 255, 'β-catenin')]
PMC4944979	7/2016	S108-PMC4944979	['Antibody specifics for wes are listed ins2 table.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody')]
PMC4944979	7/2016	S197-PMC4944979	['caption (supplementary-material): s2 table\nAntibodies and their dilutions for the differentprotein detection methods used in this study.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 43, 'Antibodies')]
PMC4979151	8/2016	S39-PMC4979151	['the non-adherent Lymphocytes, which consisted predominantly of 70–75\xa0% of T Lymphocyte (cd3), 20–23\xa0% of B Lymphocytes (Cd19) and 5–7\xa0% of Natural Killer Cells (cd16) were separated from adherent Monocytes (cd14) (10–15\xa0% in total cbmc), and cultured in presence of stimulants (T Cell Mitogen phytohemagglutinin (Pha) or agonistic Antibodies to T-Cell receptor).']	N/A	N/A	[('CL_0000542', 'lymphocyte', 17, 'lymphocytes'), ('CL_0000084', 'T cell', 74, 'T lymphocyte'), ('CL_0000236', 'B cell', 105, 'B lymphocytes'), ('PR_000001309', 'CD70 molecule', 120, 'CD19'), ('CL_0000623', 'natural killer cell', 139, 'Natural killer cells'), ('CL_0000576', 'monocyte', 196, 'monocytes'), ('CL_0000084', 'T cell', 278, 'T cell'), ('CHEBI_52290', 'mitogen', 285, 'mitogen'), ('CHEBI_34926', 'Pitrazepin', 313, 'PHA'), ('GO_0042571', 'immunoglobulin complex, circulating', 331, 'antibodies'), ('CL_0000084', 'T cell', 345, 'T-cell'), ('GO_0005622', 'intracellular anatomical structure', 346, '-cell')]
PMC4979151	8/2016	S40-PMC4979151	['Stimulation Of Lymphocytes\nstimulation with anti-cd3 and anti-Cd28 Antibodies predominantly activates T Lymphocytes.']	N/A	N/A	[('GO_0016445', 'somatic diversification of immunoglobulins', 0, 'Stimulation of lymphocytes'), ('CL_0000542', 'lymphocyte', 15, 'lymphocytes'), ('PR_000001309', 'CD70 molecule', 62, 'CD28'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies'), ('CL_0000084', 'T cell', 102, 'T lymphocytes')]
PMC4979151	8/2016	S124-PMC4979151	['active Vitamin D can inhibit in vitro Proliferation and Differentiation Of B Cells into Plasma Cells as well as Antibody Production [23,24].']	N/A	N/A	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 56, 'differentiation of ... cells ... cells'), ('CL_0000236', 'B cell', 75, 'B cells'), ('CL_0000786', 'plasma cell', 88, 'plasma cells'), ('GO_0002376', 'immune system process', 112, 'antibody production'), ('GO_0042571', 'immunoglobulin complex, circulating', 112, 'antibody')]
PMC4989298	8/2016	S512-PMC4989298	['these methods measure the levels of guanine and specific Allergens using polyclonal and monoclonal Antibodies.']	N/A	N/A	[('CHEBI_33663', 'cyclic hydrocarbon', 57, 'allergens'), ('GO_0042571', 'immunoglobulin complex, circulating', 99, 'antibodies')]
PMC4995778	8/2016	S17-PMC4995778	['natalizumab (tysabri®; biogen, cambridge, ma, usa) is a humanized monoclonal Antibody indicated for relapsing-remitting ms (rrms) [6] that prevents Leukocyte Migration Into the Brain and reduces inflammation in ms patients [7,8].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibody'), ('CL_0000738', 'leukocyte', 148, 'leukocyte'), ('GO_0055095', 'lipoprotein particle mediated signaling', 148, 'leukocyte migration into ... brain'), ('UBERON_0000955', 'brain', 177, 'brain')]
PMC4999234	8/2016	S66-PMC4999234	['the dried samples were blocked in blocking buffer (1% bsa, 5% Sucrose, 0.05% Sodium Azide, pbs) for 180 minutes, incubated with primary Antibodies of angiotensin ii receptors at1and At2.']	N/A	N/A	[('CHEBI_17992', 'sucrose', 62, 'sucrose'), ('CHEBI_28341', '2-hydroxyacetophenone', 77, 'sodium azide'), ('GO_0042571', 'immunoglobulin complex, circulating', 136, 'antibodies'), ('PR_000004409', 'autophagy-related protein 16-1', 182, 'AT2')]
PMC4999234	8/2016	S67-PMC4999234	['dilutions of the following Antibodies were used: anti-At1Receptor (1:30) (anti-Rabbit—santa cruz, sc 1173, dallas, texas, usa) and anti-At2Receptor (1:30) anti-Rabbit (santa cruz, sc-9040, dallas, texas, usa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 27, 'antibodies'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 54, 'AT1receptor'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 79, 'rabbit'), ('PR_000004455', 'ATP synthase subunit gamma, mitochondrial', 136, 'AT2receptor'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 160, 'rabbit')]
PMC4999234	8/2016	S69-PMC4999234	['the plate was washed three times for five minutes with gentle agitation in pbs (200 μl per well) and incubated with 100 μl of a secondary Antibody (anti-Rabbit Igg, produced in goat and bound to alkaline phosphatase, sigma-aldrich, a3687, st. louis, missouri, usa,) for two hours under gentle agitation.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 138, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 153, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 160, 'IgG')]
PMC4999868	8/2016	S75-PMC4999868	['protein Expression of Fr-Α, Rfc and Pcft was determined in total cell lysates and mvm preparations using commercial Antibodies (santa cruz biotechnology, tx).']	N/A	N/A	[('GO_0010467', 'gene expression', 8, 'expression'), ('PR_000007706', '3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3', 22, 'FR-α'), ('PR_000013939', 'Ral-GDS-related protein', 28, 'RFC'), ('PR_000012424', 'pecanex-like protein 1', 36, 'PCFT'), ('GO_0042571', 'immunoglobulin complex, circulating', 116, 'antibodies')]
PMC5013576	9/2016	S38-PMC5013576	['typically, immunocompetent Adult Hosts have very mild or asymptomatic disease, and are immune after Antibody response to primary infection.']	N/A	N/A	[('UBERON_0007023', 'adult organism', 27, 'adult'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 33, 'hosts'), ('GO_0042571', 'immunoglobulin complex, circulating', 100, 'antibody')]
PMC5013576	9/2016	S89-PMC5013576	['immunohistochemistry results on patient’s initial Renal biopsy (day 3 of presentation) using primary Antibody to Human Parvovirus B19 capsid proteins Vp1 and Vp2 and anti-Mouse-hrp secondary Antibody.']	N/A	N/A	[('UBERON_0002113', 'kidney', 50, 'renal'), ('GO_0042571', 'immunoglobulin complex, circulating', 101, 'antibody'), ('NCBITaxon_9606', 'Homo sapiens', 113, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 119, 'parvovirus'), ('PR_000012529', 'PDZK1-interacting protein 1', 119, 'parvovirus B19'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 150, 'VP1'), ('PR_000017318', 'vacuolar protein sorting-associated protein 11', 158, 'VP2'), ('NCBITaxon_10088', 'Mus <genus>', 171, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 191, 'antibody')]
PMC5013576	9/2016	S154-PMC5013576	['abbreviations\nana, Antinuclear Antibody; dsdna, Double-Stranded dna; esrd, end stage Renal disease; fsgs, focal segmental glomerulosclerosis; hiv, Human immunodeficiency Virus; hivan, hiv-associated nephropathy; qpcr, quantitative polymerase chain reaction; scr, Serum creatinine\n\npubmed central:']	N/A	N/A	[('GO_0005642', 'annulate lamellae', 19, 'antinuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 31, 'antibody'), ('SO_0000985', 'double', 48, 'double-stranded'), ('UBERON_0002113', 'kidney', 85, 'Renal'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'Human'), ('NCBITaxon_10088', 'Mus <genus>', 170, 'Virus'), ('UBERON_0001977', 'blood serum', 263, 'serum')]
PMC5021959	6/2016	S58-PMC5021959	['for Caspase-3 processing, sections were incubated 24–48\xa0h at 4\xa0°c with primary Antibody polyclonal Rabbit-anti-Caspase 3 in diluent of normal goat Serum, Triton x-100 and tbs.']	N/A	N/A	[('PR_000002319', 'catenin beta-1 isoform 1', 4, 'caspase-3'), ('GO_0042571', 'immunoglobulin complex, circulating', 79, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 99, 'rabbit'), ('PR_000002318', 'caspase-9', 111, 'caspase 3'), ('UBERON_0001977', 'blood serum', 147, 'serum'), ('CHEBI_29234', 'triton', 154, 'triton')]
PMC5025055	9/2016	S46-PMC5025055	['Pvdf membrane was probed with primary and secondary Antibodies before developing using the ecl plus western blotting substrate (pierce, 32132).']	N/A	N/A	[('CHEBI_53250', 'poly(vinylene fluoride)', 0, 'PVDF'), ('GO_0042571', 'immunoglobulin complex, circulating', 52, 'antibodies')]
PMC5025055	9/2016	S47-PMC5025055	['Antibodies used are as follows: anti-E2F1 (santa cruz, sc-193x), anti-Ddk (origene, ta50011), anti-Βactin (sigma, a1978), ecl anti-Rabbit Igg hrp linked whole Antibody (from Donkey) (amersham, na934v) and anti-Mouse Igg hrp linked whole Antibody (from Sheep) (amersham, na931v).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('PR_000006852', 'transcription factor E2F1', 37, 'E2F1'), ('PR_000006330', 'DCN1-like protein 1', 70, 'DDK'), ('PR_000003676', 'actin, cytoplasmic 1', 99, 'βactin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 131, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 138, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 159, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 174, 'donkey'), ('NCBITaxon_10088', 'Mus <genus>', 210, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 216, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 237, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 252, 'sheep')]
PMC5025055	9/2016	S73-PMC5025055	['fragmented Chromatin was first pre-cleared with protein a-sepharose 4b and Rabbit Igg for 2 hrs before immunoprecipitating with fresh protein a-sepharose 4b and Antibody at 4°c overnight.']	N/A	N/A	[('GO_0000785', 'chromatin', 11, 'chromatin'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 75, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 82, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 161, 'antibody')]
PMC5025055	9/2016	S76-PMC5025055	['Antibodies used include anti-E2F1 (santa cruz, sc-193x), normal Rabbit Igg (santa cruz, sc-2027), anti-h3k27ac (abcam, ab4729), anti-H3K4Me1 (abcam, ab8895), anti-H3K4Me3 (abcam, ab8580), anti-H3K36Me3 (abcam, ab9050) and anti-h3k27me3 (millipore, 07–449).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('PR_000006852', 'transcription factor E2F1', 29, 'E2F1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 64, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 71, 'IgG'), ('SO_0001724', 'H3K36_trimethylation_site', 133, 'H3K4me1'), ('SO_0001734', 'H3K4_methylation_site', 163, 'H3K4me3'), ('SO_0001733', 'H3K36_methylation_site', 193, 'H3K36me3')]
PMC5029041	9/2016	S75-PMC5029041	['in a different study, malawian women with a bmi of less than 18.5\xa0kg/m2at first Antenatal visit had higher Antibody levels to pf var2csa at 36 Gestational weeks than those with a normal or raised bmi [36].']	N/A	N/A	[('GO_0007567', 'parturition', 80, 'antenatal'), ('GO_0042571', 'immunoglobulin complex, circulating', 107, 'antibody'), ('GO_0007565', 'female pregnancy', 143, 'gestational')]
PMC5029041	9/2016	S77-PMC5029041	['in the same cohort, Lipid-based Nutrient supplementation (lns) during Pregnancy did not improve anti-malarial Antibody responses [36].']	N/A	N/A	[('CHEBI_18059', 'lipid', 20, 'lipid'), ('CHEBI_33284', 'nutrient', 32, 'nutrient'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('GO_0042571', 'immunoglobulin complex, circulating', 110, 'antibody')]
PMC5073052	3/2016	S42-PMC5073052	['Intestinal Tissue sections were immunostained using Antibodies against ki67 and Muc2 to detect Proliferation and differentiation, respectively.']	N/A	N/A	[('UBERON_0000160', 'intestine', 0, 'Intestinal'), ('UBERON_0000479', 'tissue', 11, 'tissue'), ('GO_0042571', 'immunoglobulin complex, circulating', 52, 'antibodies'), ('PR_000010768', 'mucin-4', 80, 'MUC2'), ('GO_0008283', 'cell proliferation', 95, 'proliferation')]
PMC5073052	3/2016	S142-PMC5073052	['96-well plates were coated with an anti-Mouse Iga Antibody (sigma-aldrich) in pbs at 4°c overnight.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 40, 'mouse'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 46, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody')]
PMC5073052	3/2016	S144-PMC5073052	['plates were then incubated with supernatants of the Fecal homogenates for 1 hr, followed by a Fitc-conjugated anti-Mouse Iga Antibody (sigma-aldrich) for 1 hr at room temperature.']	N/A	N/A	[('UBERON_0000922', 'embryo', 52, 'fecal'), ('CHEBI_37926', 'fluorescein isothiocyanate', 94, 'FITC'), ('NCBITaxon_10088', 'Mus <genus>', 115, 'mouse'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 121, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 125, 'antibody')]
PMC5094567	6/2016	S109-PMC5094567	['mcad Antibodies were obtained from sigma (st. louis, mo).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 5, 'antibodies')]
PMC5095257	11/2016	S24-PMC5095257	['in most patients, Autoimmune etiology was confirmed by the detection of 21-hydroxylase Antibodies, or antiadrenal Antibodies in cases with more longstanding diagnosis.']	N/A	N/A	[('UBERON_0001442', 'skeleton of manus', 18, 'autoimmune'), ('GO_0042571', 'immunoglobulin complex, circulating', 87, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 114, 'antibodies')]
PMC5118969	11/2016	S46-PMC5118969	['graves’ disease was ruled out with negative Thyroid-stimulating Immunoglobulin and anti-Thyroid peroxidase Antibodies (table 2).']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 44, 'thyroid'), ('GO_0019814', 'immunoglobulin complex', 64, 'immunoglobulin'), ('UBERON_0002046', 'thyroid gland', 88, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 107, 'antibodies')]
PMC5118969	11/2016	S73-PMC5118969	['gtt is characterized by an elevated Serum Thyroid Hormone level and low or undetectable Serum Tsh level in the absence of Tsh receptor Antibody.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 36, 'serum'), ('CHEBI_60311', 'thyroid hormone', 42, 'thyroid hormone'), ('UBERON_0002046', 'thyroid gland', 42, 'thyroid'), ('UBERON_0001977', 'blood serum', 88, 'serum'), ('CHEBI_17855', 'triglyceride', 94, 'TSH'), ('PR_000016711', 'TSC22 domain family protein 1', 122, 'TSH'), ('GO_0042571', 'immunoglobulin complex, circulating', 135, 'antibody')]
PMC5153572	11/2016	S138-PMC5153572	['the disease is characterized by the presence of high affinity and concentrations of Serum Thyroid Antibody.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 84, 'serum'), ('UBERON_0002046', 'thyroid gland', 90, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 98, 'antibody')]
PMC5153572	11/2016	S139-PMC5153572	['the most frequently detected Antibodies are Tpo Antibody and thyroglobulin Antibody (tgab).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 29, 'antibodies'), ('PR_000016585', 'tripeptidyl-peptidase 1', 44, 'TPO'), ('GO_0042571', 'immunoglobulin complex, circulating', 48, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 75, 'antibody')]
PMC5153572	11/2016	S149-PMC5153572	['nearly all the women with Postpartum thyroiditis have Tpo Antibody.']	N/A	N/A	[('GO_0007565', 'female pregnancy', 26, 'postpartum'), ('PR_000016585', 'tripeptidyl-peptidase 1', 54, 'TPO'), ('GO_0042571', 'immunoglobulin complex, circulating', 58, 'antibody')]
PMC5216338	1/2017	S231-PMC5216338	['the fragmented dna (2\u2009μg) was heat-denatured to produce Single-Stranded dna, and the immunoprecipitation was performed overnight at 4\u2009°c with 2\u2009μg Antibody against 5-Methyl Cytosine (ab10805, abcam, uk).']	N/A	N/A	[('SO_0000984', 'single', 56, 'single-stranded'), ('GO_0042571', 'immunoglobulin complex, circulating', 147, 'antibody'), ('CHEBI_20791', '7-hydroxyoxindole-3-acetic acid', 164, '5-methyl cytosine')]
PMC5216338	1/2017	S232-PMC5216338	['pretreated protein a/g Agarose beads (40\u2009μl, 50% slurry, sc-2003, santa cruz, usa) were used to capture the Antibody/Dna Complexes.']	N/A	N/A	[('CHEBI_2511', 'agarose', 23, 'agarose'), ('GO_0042571', 'immunoglobulin complex, circulating', 108, 'antibody'), ('GO_0031080', 'nuclear pore outer ring', 116, '/DNA complexes')]
PMC5216338	1/2017	S240-PMC5216338	['the Mixture of Precleared Chromatin was incubated with 2\u2009μg specific gr Antibody overnight at 4\u2009°c (sc-1002x, santa cruz).']	N/A	N/A	[('CHEBI_60004', 'mixture', 4, 'mixture'), ('GO_0044099', 'polar tube', 15, 'precleared'), ('GO_0000785', 'chromatin', 26, 'chromatin'), ('GO_0042571', 'immunoglobulin complex, circulating', 72, 'antibody')]
PMC5283658	1/2017	S48-PMC5283658	['Antibodies\nMouse anti-Rat Cd11B/C percp-efluor®710 (cat#46–0110) and its isotype control (cat#46–4724) for flow cytometry were purchased from ebioscience (san diego, ca).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 11, 'Mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 22, 'rat'), ('PR_000001309', 'CD70 molecule', 26, 'CD11b'), ('PR_000005000', 'calmodulin-binding transcription activator 1', 32, 'c')]
PMC5283658	1/2017	S50-PMC5283658	['anti-Rat Cd68 Fitc (cat#sm1550f) for flow cytometry was from acris-Antibodies (san diego, ca).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 5, 'rat'), ('PR_000001309', 'CD70 molecule', 9, 'CD68'), ('CHEBI_37926', 'fluorescein isothiocyanate', 14, 'FITC'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies')]
PMC5283658	1/2017	S51-PMC5283658	['Rabbit anti-Rat Cd206 (Mannose receptor Antibody) (cat#ab64693), Mouse anti-Rat Cd11C (cat#ab11029) and Mouse anti-Rat Cd68 (cat#ab53444) for immunohistochemical staining were from abcam (cambridge, ma).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rabbit'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 12, 'rat'), ('PR_000001309', 'CD70 molecule', 16, 'CD206'), ('CHEBI_31005', 'manninotriose', 23, 'Mannose'), ('GO_0042571', 'immunoglobulin complex, circulating', 40, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 65, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 76, 'rat'), ('PR_000001309', 'CD70 molecule', 80, 'CD11c'), ('NCBITaxon_10088', 'Mus <genus>', 104, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 115, 'rat'), ('PR_000001309', 'CD70 molecule', 119, 'CD68')]
PMC5283658	1/2017	S54-PMC5283658	['svcs were immunostained with primary Antibodies for 30 min at 4°c followed by incubation with fluorescent-bounded secondary Antibody for another 30 min at 4°c in dark.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 37, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 124, 'antibody')]
PMC5283658	1/2017	S60-PMC5283658	['Cd68 (acris-Antibodies, san diego, ca), Cd206 (abcam, cambridge, ma) and Cd11C (abcam, cambridge, ma) were immunostained using a vectastain elite avidin/Biotin-Complex (abc) kit for Mouse Igg or a vectastain elite abc kit for Rabbit Igg (vector laboratory).']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 0, 'CD68'), ('GO_0042571', 'immunoglobulin complex, circulating', 12, 'antibodies'), ('PR_000001309', 'CD70 molecule', 40, 'CD206'), ('PR_000001309', 'CD70 molecule', 73, 'CD11c'), ('CHEBI_15956', 'biotin', 153, 'Biotin'), ('GO_0032991', 'protein-containing complex', 160, 'Complex'), ('NCBITaxon_10088', 'Mus <genus>', 182, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 188, 'IgG'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 226, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 233, 'IgG')]
PMC5283658	1/2017	S69-PMC5283658	['then svcs were incubated with anti-Rat Cd68 Fitc (acris-Antibodies, san diego, ca) for 30 minutes at 4°c in dark and washed with magnetic cell separation (macs) buffer (miltenyi biotec inc., auburn, ca).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 35, 'rat'), ('PR_000001309', 'CD70 molecule', 39, 'CD68'), ('CHEBI_37926', 'fluorescein isothiocyanate', 44, 'FITC'), ('GO_0042571', 'immunoglobulin complex, circulating', 56, 'antibodies')]
PMC5283658	1/2017	S121-PMC5283658	['a-i) atms were stained with anti-Cd68 Antibody.']	N/A	N/A	[('PR_000001309', 'CD70 molecule', 33, 'CD68'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibody')]
PMC5295525	6/2015	S21-PMC5295525	['pertinent laboratory findings: hemoglobin 89 g/l, Platelets: 223 × 109/l, both anti-Nuclear Antibodies (ana) and double-strand dna Antibodies (anti ds-dna) testing were negative.']	N/A	N/A	[('CL_0000233', 'platelet', 50, 'platelets'), ('GO_0005634', 'nucleus', 84, 'nuclear'), ('GO_0042571', 'immunoglobulin complex, circulating', 92, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 131, 'antibodies')]
PMC5303734	2/2017	S43-PMC5303734	['protein samples (20 μg) were separated on nupage®novex®4%–12% Bis-Tris gels (life technologies, carlsbad, ca, usa), then transferred to Pvdf membranes (rockford, il, usa), which were blocked with non-fat milk and incubated with primary Antibodies (oxphos Complexes; 1:2500, abcam, cambridge, uk), Drp-1 (1:2000, novus biotechnology, littleton, co, usa), Opa-1 (1:2000, novus biotechnology, littleton, co, usa), Lc3A/b (1:2000, cell signaling technology, danvers, ma, usa), Tom-20 (1:2000, santa cruz biotechnology, dallas, tx, usa) and Mnsod (1:2000, millipore, billerica, ma, usa), Pink-1 (1:1000, biovision incorporated, milpitas, ca, usa), Fis-1 (1:500, santa cruz biotechnology, dallas, tx, usa) and Parkin (1:500, cell signaling technology, danvers, ma, usa) for overnight.']	N/A	N/A	[('CHEBI_22868', 'bile salt', 62, 'Bis'), ('CHEBI_9754', 'tris', 66, 'Tris'), ('CHEBI_53250', 'poly(vinylene fluoride)', 136, 'PVDF'), ('GO_0042571', 'immunoglobulin complex, circulating', 236, 'antibodies'), ('GO_0032991', 'protein-containing complex', 255, 'complexes'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 297, 'Drp-1'), ('PR_000012086', 'homeobox protein OTX2', 354, 'Opa-1'), ('PR_000009691', 'protein LBH', 411, 'LC3A'), ('PR_000016500', 'tenomodulin', 473, 'Tom-20'), ('PR_000010875', 'myoblast determination protein 1', 536, 'MnSOD'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 583, 'Pink-1'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 643, 'Fis-1'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 704, 'Parkin')]
PMC5303734	2/2017	S44-PMC5303734	['Membranes were then incubated in secondary Antibodies (goat anti-Rabbit or Rabbit anti-Mouse Igg horseradish peroxidase-conjugated secondary Antibodies, 1:5000 for opa-1, mnsod, Tom-20, oxphos Complexes; 1:2000 for Drp-1, Pink-1, Lc3A/b; 1:500 for Parkin; santa cruz biotechnology, dallas, tx, usa) for 1 h. protein Expression was detected by supersignal west pico chemiluminescent substrate (thermo, waltham, ma, usa) and fujifilm las-3000 (fujifilm, tokyo, japan).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 43, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 65, 'rabbit'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 75, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 87, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 93, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 141, 'antibodies'), ('PR_000000037', 'BMP receptor type-2', 167, '-1'), ('PR_000016500', 'tenomodulin', 178, 'Tom-20'), ('GO_0032991', 'protein-containing complex', 193, 'complexes'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 215, 'Drp-1'), ('PR_000013508', 'PX domain-containing protein kinase-like protein', 222, 'Pink-1'), ('PR_000009691', 'protein LBH', 230, 'LC3A'), ('PR_000012523', 'pancreas/duodenum homeobox protein 1', 248, 'Parkin'), ('GO_0010467', 'gene expression', 316, 'expression')]
PMC5303734	2/2017	S51-PMC5303734	['for Caspase-3 staining, the Tissues were blocked with 10% normal Horse Serum for 30 min then incubated with Caspase-3 Antibody (1:300, bd biosciences, macquarie park, nsw, australia) overnight, followed by secondary Antibodies (goat anti-Rabbit hrp, 1:200, vector laboratories, burlingame, ca, usa) for 45 min.']	N/A	N/A	[('PR_000002319', 'catenin beta-1 isoform 1', 4, 'Caspase-3'), ('UBERON_0000479', 'tissue', 28, 'tissues'), ('NCBITaxon_1', 'root', 65, 'horse'), ('UBERON_0001977', 'blood serum', 71, 'serum'), ('PR_000002319', 'catenin beta-1 isoform 1', 108, 'Caspase-3'), ('GO_0042571', 'immunoglobulin complex, circulating', 118, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 216, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 238, 'rabbit')]
PMC5307888	2/2017	S60-PMC5307888	['Plasma leptin (in singulate; hl-81\xa0k; millipore, st. charles, mo, usa) and Plasma adiponectin (in singulate; hadp-61hk; millipore, st. charles, mo, usa) were determined by double Antibody radioimmunoassay following the methods from the supplier.']	N/A	N/A	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('PR_000010000', 'lysozyme g-like protein 2', 31, '-81'), ('UBERON_0001969', 'blood plasma', 75, 'plasma'), ('GO_0042571', 'immunoglobulin complex, circulating', 179, 'antibody')]
PMC5325607	2/2017	S76-PMC5325607	['for western blotting, Oxidative Phosphorylation (oxphos) Antibody (mitosciences, ms604-300) was used.']	N/A	N/A	[('GO_0006119', 'oxidative phosphorylation', 22, 'oxidative phosphorylation'), ('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibody')]
PMC5332602	3/2017	S251-PMC5332602	['after heat-induced epitope retrieval (60°c, 10 to 15\xa0min), immunofluorescent staining to evaluate Villin Expression was conducted with an anti-Villin goat polyclonal primary Antibody (1:500; santa cruz, ca) and a Donkey anti-goat secondary Antibody (1:200; abcam, inc., ca).']	N/A	N/A	[('PR_000017299', 'VIP peptides', 98, 'villin'), ('GO_0010467', 'gene expression', 105, 'expression'), ('PR_000017299', 'VIP peptides', 143, 'villin'), ('GO_0042571', 'immunoglobulin complex, circulating', 174, 'antibody'), ('NCBITaxon_33208', 'Metazoa', 213, 'donkey'), ('GO_0042571', 'immunoglobulin complex, circulating', 240, 'antibody')]
PMC5332602	3/2017	S276-PMC5332602	['the levels of the cytokines Porcine Alpha Interferon, Il-6, tumor necrosis factor alpha, Il-12, and Il-10 in the collected supernatants were examined by enzyme-linked immunosorbent assay (elisa) with anti-Swine cytokine Antibodies as previously described (55,64).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 28, 'porcine'), ('PR_000004519', 'autism susceptibility gene 2 protein', 36, 'alpha interferon'), ('PR_000001470', 'interleukin-28B', 54, 'IL-6'), ('PR_000001470', 'interleukin-28B', 89, 'IL-12'), ('PR_000001470', 'interleukin-28B', 100, 'IL-10'), ('NCBITaxon_33208', 'Metazoa', 205, 'swine'), ('GO_0042571', 'immunoglobulin complex, circulating', 220, 'antibodies')]
PMC5337401	12/2016	S6-PMC5337401	['women with Thyroid Antibodies were excluded; data and samples were available for 191 women.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 11, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 19, 'antibodies')]
PMC5337401	12/2016	S40-PMC5337401	['Tsh, free T4 (ft4), and Thyroid peroxidase Antibodies (tpoab) were measured in Serum samples using a modular analytics e170 analyzer (roche diagnostics, mannheim, germany) at the department of clinical chemistry, máxima medical center (veldhoven, the netherlands).']	N/A	N/A	[('CHEBI_17855', 'triglyceride', 0, 'TSH'), ('CHEBI_37972', 'phosphorus-32 atom', 10, 'T4'), ('UBERON_0002046', 'thyroid gland', 24, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 43, 'antibodies'), ('UBERON_0001977', 'blood serum', 79, 'serum')]
PMC5337401	12/2016	S44-PMC5337401	['women were defined as Thyroid-Antibody positive if they were positive for tpoab and/or tgab.']	N/A	N/A	[('UBERON_0002046', 'thyroid gland', 22, 'thyroid'), ('GO_0042571', 'immunoglobulin complex, circulating', 30, 'antibody')]
PMC5337401	12/2016	S66-PMC5337401	['the study compared (log) tg concentration between Antibody-positive and Antibody-negative women, and between categories of Milk Consumption using t -tests and one-way analysis of variance, respectively.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 72, 'antibody'), ('GO_0007614', 'short-term memory', 123, 'milk'), ('UBERON_0001913', 'milk', 123, 'milk'), ('GO_0007631', 'feeding behavior', 128, 'consumption')]
PMC5338078	3/2017	S68-PMC5338078	['ltd., new delhi, india]), hepatitis b (erbalisa hepatitis b Surface Antibody test [erba mannheim, mannheim, germany]), and syphilis (rapid plasma reagin (rpr) [span diagnostics, surat, india]).']	N/A	N/A	[('GO_0009986', 'cell surface', 60, 'surface'), ('GO_0042571', 'immunoglobulin complex, circulating', 68, 'antibody')]
PMC5351212	3/2017	S139-PMC5351212	['in a sandwich elisa v-plex plus, 96-well plates were coated with primary Antibodies directed against Interleukin Il-1Β, Il-6, and Tnf-Α.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibodies'), ('PR_000001139', 'interleukin-17B', 101, 'interleukin IL-1β'), ('PR_000001470', 'interleukin-28B', 120, 'IL-6'), ('PR_000000134', 'tumor necrosis factor alpha', 130, 'TNF-α')]
PMC5351212	3/2017	S140-PMC5351212	['samples were added and cytokines were detected with corresponding detecting Antibodies, which were prelabeled with sulfo-Tag™ (msd, rockville, md, usa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 76, 'antibodies'), ('CHEBI_17855', 'triglyceride', 121, 'TAG'), ('CHEBI_24870', 'ion', 124, '™')]
PMC5385335	4/2017	S86-PMC5385335	['protein was probed with anti-Pcamkii Mouse polyclonal Antibody (diluted 1/2,000, pt286, thermo scientific) and anti-Camkii Rabbit monoclonal Antibody (diluted 1/1,000, abcam, france).']	N/A	N/A	[('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 29, 'pCaMKII'), ('NCBITaxon_10088', 'Mus <genus>', 37, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 54, 'antibody'), ('PR_000003199', 'calcium/calmodulin-dependent protein kinase type II subunit alpha', 116, 'CaMKII'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 123, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 141, 'antibody')]
PMC5385335	4/2017	S87-PMC5385335	['following de-hybridization, membrane was probed with Rabbit polyclonal anti-Perk and total Erk Antibodies (diluted 1/1,000, abcam).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 53, 'rabbit'), ('PR_000001882', 'lysosome-associated membrane glycoprotein 3', 76, 'pERK'), ('GO_0005783', 'endoplasmic reticulum', 91, 'ERK'), ('PR_000007120', 'ephrin type-A receptor 1', 91, 'ERK'), ('GO_0042571', 'immunoglobulin complex, circulating', 95, 'antibodies')]
PMC5385335	4/2017	S88-PMC5385335	['immunoreactive bands were visualized with dylight™680- and 800-conjugated Antibodies, respectively (kpl, eurobio, france).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 74, 'antibodies')]
PMC5385335	4/2017	S91-PMC5385335	['protein load was controlled with anti-actin Mouse monoclonal Antibody (diluted 1/2,000, sigma).']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 44, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 61, 'antibody')]
PMC5385335	4/2017	S93-PMC5385335	['sections were stained with a Rabbit polyclonal Antibody raised against Cck-1R diluted at 1/200 (santa cruz biotechnology, ca, usa).']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 29, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 47, 'antibody'), ('PR_000001202', 'C-C chemokine receptor type 6', 71, 'CCK-1R')]
PMC5385335	4/2017	S94-PMC5385335	['the secondary Antibody used at appropriate dilution (1/1,000) was a goat biotinylated anti-Rabbit polyclonal Antibody (vector laboratories, clinisciences, nanterre, france) followed by Alexa Fluor®488-conjugated streptavidin Antibody (molecular probes, life technologies).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 91, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 109, 'antibody'), ('CHEBI_82170', 'Allidochlor', 185, 'Alexa Fluor'), ('CHEBI_75698', 'dG15', 197, '488'), ('GO_0042571', 'immunoglobulin complex, circulating', 225, 'antibody')]
PMC5392925	4/2017	S133-PMC5392925	['adiponectin is measured by a commercially available radioimmunoassay (millipore) using 125I-labeled Murine adiponectin and a multispecies anti-adiponectin Antibody; measurements are performed in duplicate and results are reported as the mean.']	N/A	N/A	[('CHEBI_15883', "P(1),P(4)-bis(5'-guanosyl) tetraphosphate", 87, '125I'), ('NCBITaxon_39107', 'Murinae', 100, 'murine'), ('GO_0042571', 'immunoglobulin complex, circulating', 155, 'antibody')]
PMC5419021	2/2017	S28-PMC5419021	['Immunoglobulin g (Igg) is the only major class of Antibody that is transported across the Human Placenta.']	N/A	N/A	[('GO_0019815', 'B cell receptor complex', 0, 'Immunoglobulin'), ('GO_0071735', 'IgG immunoglobulin complex', 18, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody'), ('NCBITaxon_9606', 'Homo sapiens', 90, 'human'), ('UBERON_0001987', 'placenta', 96, 'placenta')]
PMC5424401	10/2015	S231-PMC5424401	['Blood type and Antibody screenactiongive Mtx (50\xa0mg/m2 of body surface area im)no actionβ-Hcg decline\u2009<15\xa0% from day 4 to day 7: mtx, return to day 1 of protocol.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('CHEBI_74130', 'N-[(15Z)-tetracosenoyl]sphinganine', 41, 'MTX'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 90, 'hCG'), ('PR_000006060', 'CWF19-like protein 1', 90, 'hCG')]
PMC5424401	10/2015	S243-PMC5424401	['Blood type and Antibody screenactiongive Mtx (50\xa0mg/m2 of body surface area im)give Mtx (50\xa0mg/m2 of body surface area im)Β-Hcg decline\u2009<15\xa0% from day 4 to day 7: give Mtxβ-hcg decline\u2009<15\xa0% from day 7 to day 11: give Mtxβ-hcg decline\u2009<15\xa0% from day 11 to day 14: refer for surgeryβ-hcg decline\u2009>15\xa0% from day 4 to day 7: check β-hcg at 1 week intervals until zero.β-hcg decline\u2009>15\xa0% from day 7 to day 11: check β-hcg at 1 week intervals until zero.β-hcg decline\u2009>15\xa0% from day 11 to day 14: check β-hcg at 1 week intervals until zero.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('CHEBI_74130', 'N-[(15Z)-tetracosenoyl]sphinganine', 41, 'MTX'), ('CHEBI_74130', 'N-[(15Z)-tetracosenoyl]sphinganine', 84, 'MTX'), ('PR_000000035', 'BMP receptor type-1A', 122, 'β-hCG'), ('PR_000010717', 'metal regulatory transcription factor 1', 168, 'MTXβ'), ('PR_000010717', 'metal regulatory transcription factor 1', 218, 'MTXβ')]
PMC5424401	10/2015	S250-PMC5424401	['Blood type and Antibody screenactionmtx (1\xa0mg/kg, im)leu (0.1\xa0mg/kg, im)Β-Hcg decline\u2009<15\xa0% from day 1 to day 3: give mtxleuβ-hcg decline\u2009<15\xa0% from day 3 to day 5: give mtxleuβ-hcg decline\u2009<15\xa0% from day 5 to day 7: give mtxleuβ-hcg decline\u2009>15\xa0% from day 1 to day 3: check β-hcg at one week intervals until zero.β-hcg decline\u2009>15\xa0% from day 3 to day 5: check β-hcg at one week intervals until zero.β-Hcg decline\u2009>15\xa0% from day 5 to day 7: check β-Hcg at one week intervals until zero.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('PR_000000035', 'BMP receptor type-1A', 72, 'β-hCG'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 74, 'hCG'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 402, 'hCG'), ('CHEBI_16568', '5,10-methylenetetrahydromethanopterin', 449, 'hCG')]
PMC5442804	9/2016	S77-PMC5442804	['details on the protocol and a list of Antibodies used can be found in the supplemental online data.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibodies')]
PMC5442804	9/2016	S78-PMC5442804	['cell counts\n\ncell characterization in vitro\nthe extent of Neuronal and Glial differentiation was assessed using Antibodies against lineage‐ and stage‐specific markers.']	N/A	N/A	[('CL_0000540', 'neuron', 58, 'neuronal ...'), ('CL_0000125', 'glial cell', 71, 'glial'), ('GO_0042571', 'immunoglobulin complex, circulating', 112, 'antibodies')]
PMC5442804	9/2016	S80-PMC5442804	['cell engraftment, differentiation, and Migration in vivo\nHuman cells were identified by using anti‐Human Antibodies.']	N/A	N/A	[('GO_0007601', 'visual perception', 39, 'Migration'), ('NCBITaxon_10088', 'Mus <genus>', 57, 'Human'), ('NCBITaxon_9606', 'Homo sapiens', 99, 'human'), ('GO_0042571', 'immunoglobulin complex, circulating', 105, 'antibodies')]
PMC5442804	9/2016	S84-PMC5442804	['the cell type composition of engrafted cells was assessed by using immunofluorescence followed by confocal microscopy analysis in coronal Brain sections (three fields per section; three slices per Mouse) using anti‐Hnuclei or anti‐Mitochondria Antibodies in combination with Antibodies against lineage‐specific markers and Nuclear counterstaining.']	N/A	N/A	[('UBERON_0000955', 'brain', 138, 'brain'), ('NCBITaxon_10088', 'Mus <genus>', 197, 'mouse'), ('GO_0005682', 'U5 snRNP', 215, 'hNuclei'), ('GO_0005739', 'mitochondrion', 231, 'mitochondria'), ('GO_0042571', 'immunoglobulin complex, circulating', 244, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 275, 'antibodies'), ('GO_0005634', 'nucleus', 323, 'nuclear')]
PMC5442804	9/2016	S319-PMC5442804	['Human cells engrafted in mld Brains were detected by means of Antibodies that specifically recognize Human Mitochondrial (hmito) and Nuclear (Hnuclei) proteins39(fig.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Human'), ('UBERON_0000955', 'brain', 29, 'brains'), ('GO_0042571', 'immunoglobulin complex, circulating', 62, 'antibodies'), ('NCBITaxon_9606', 'Homo sapiens', 101, 'human'), ('GO_0005739', 'mitochondrion', 107, 'mitochondrial'), ('GO_0005634', 'nucleus', 133, 'nuclear'), ('GO_0005682', 'U5 snRNP', 142, 'hNuclei')]
PMC5443512	5/2017	S85-PMC5443512	['the Membranes were blocked with 5% nonfat dry Milk in tris-buffered saline and incubated first with primary Antibodies that recognize Psd95 (1:2000, abcam), Synaptophysin (1:1000, dako) and Insulin Receptor (1:500 santa cruz biotechnology, san diego, ca, usa) overnight at 4°c, and then with their corresponding secondary hrp-conjugated Antibodies.']	N/A	N/A	[('GO_0016020', 'membrane', 4, 'membranes'), ('UBERON_0001913', 'milk', 46, 'milk'), ('GO_0042571', 'immunoglobulin complex, circulating', 108, 'antibodies'), ('GO_0014069', 'postsynaptic density', 134, 'PSD95'), ('PR_000013354', 'pregnancy-specific beta-1-glycoprotein 6', 134, 'PSD95'), ('PR_000015896', 'synaptotagmin-11', 157, 'synaptophysin'), ('PR_000001365', 'interleukin-10 receptor subunit alpha', 190, 'insulin receptor'), ('GO_0042571', 'immunoglobulin complex, circulating', 337, 'antibodies')]
PMC5472316	6/2017	S120-PMC5472316	['after blocking in normal Serum, sections were incubated with the first Antibody over night at 4°c.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('GO_0042571', 'immunoglobulin complex, circulating', 71, 'antibody')]
PMC5472316	6/2017	S121-PMC5472316	['Rabbit polyclonal to Osteoprotegerin (Opg) Antibodies (abcam, cambridge, uk, dilution 1:100) were used as first Antibodies.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 0, 'Rabbit'), ('PR_000011593', 'ovarian cancer-related protein 1', 21, 'osteoprotegerin'), ('PR_000011622', 'S-acyl fatty acid synthase thioesterase, medium chain', 38, 'OPG'), ('GO_0042571', 'immunoglobulin complex, circulating', 43, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 112, 'antibodies')]
PMC5472316	6/2017	S122-PMC5472316	['the sections were then incubated (30 min) with the second Antibody: biotinylated anti-Rabbit Immunoglobulin (abcam, cambridge, uk, dilution 1:200).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 58, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 86, 'rabbit'), ('GO_0019814', 'immunoglobulin complex', 93, 'immunoglobulin')]
PMC5472316	6/2017	S123-PMC5472316	['negative control sections for each Antibody were obtained by identical immunohistochemical staining excluding the primary Antibody.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 35, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 122, 'antibody')]
PMC5472316	6/2017	S210-PMC5472316	['* Antibody control in males; *,Antibody control in females.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 2, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 31, 'antibody')]
PMC5472316	6/2017	S219-PMC5472316	['* Antibody control in males; *,Antibody control in females.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 2, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 31, 'antibody')]
PMC5472316	6/2017	S224-PMC5472316	['* Antibody control in males; *,Antibody control in females.the Nucleus in the Chondrocyte with the negative Ocn signal is stained blue and indicated by blue arrows.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 2, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 31, 'antibody'), ('GO_0005634', 'nucleus', 63, 'nucleus'), ('CL_0000138', 'chondrocyte', 78, 'chondrocyte'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 108, 'OCN')]
PMC5482199	2/2017	S32-PMC5482199	['following blocking, the membrane was probed with Mouse monoclonal anti-Pkcζ Antibody (santa cruz biotechnology, dallas, tx, u.s.a.), washed and then incubated with hrp-conjugated Sheep anti-Mouse Antibody.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 49, 'mouse'), ('PR_000003059', 'protein kinase C beta type', 71, 'PKCζ'), ('GO_0042571', 'immunoglobulin complex, circulating', 76, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 179, 'sheep'), ('NCBITaxon_10088', 'Mus <genus>', 190, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 196, 'antibody')]
PMC5482199	2/2017	S35-PMC5482199	['under the same time and temperature conditions, Cbmcs were also cultured in the presence of either anti-Il-10 (Il-10 neutralizing) Antibody or Il-12 alone or with Lps.']	N/A	N/A	[('CL_0000979', 'IgG memory B cell', 48, 'CBMCs'), ('PR_000001470', 'interleukin-28B', 104, 'IL-10'), ('PR_000001470', 'interleukin-28B', 111, 'IL-10'), ('GO_0042571', 'immunoglobulin complex, circulating', 131, 'antibody'), ('PR_000001470', 'interleukin-28B', 143, 'IL-12'), ('CHEBI_16412', 'lipopolysaccharide', 163, 'LPS')]
PMC5482199	2/2017	S45-PMC5482199	['Maturation was gauged by flow cytometry, measuring the Expression of Cd45Ra and Cd45Ro using anti-Cd45Ra-apc, anti-Cd45Ro-pe, anti-cd3-Fitc or isotype control Mix (Igg2B-apc, igg2a-pe and Igg1-Fitc) Antibodies (all bd biosciences).']	N/A	N/A	[('GO_0046693', 'sperm storage', 0, 'Maturation'), ('GO_0010467', 'gene expression', 55, 'expression'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 69, 'CD45RA'), ('PR_000005170', 'CD37 molecule', 80, 'CD45RO'), ('PR_000005164', 'CD2 cytoplasmic tail-binding protein 2', 98, 'CD45RA'), ('PR_000005170', 'CD37 molecule', 115, 'CD45RO'), ('CHEBI_37926', 'fluorescein isothiocyanate', 135, 'FITC'), ('CHEBI_60004', 'mixture', 159, 'mix'), ('GO_0071735', 'IgG immunoglobulin complex', 164, 'IgG2b'), ('GO_0071735', 'IgG immunoglobulin complex', 188, 'IgG1'), ('CHEBI_37926', 'fluorescein isothiocyanate', 193, 'FITC'), ('GO_0042571', 'immunoglobulin complex, circulating', 199, 'antibodies')]
PMC5482199	2/2017	S65-PMC5482199	['culturing Lps-stimulated Cbmcs in the presence of an anti-Il-10 neutralizing Antibody resulted in an increase in Ifnγ Production (figure 1b).']	N/A	N/A	[('CHEBI_16412', 'lipopolysaccharide', 10, 'LPS'), ('CL_0000979', 'IgG memory B cell', 25, 'CBMCs'), ('PR_000001470', 'interleukin-28B', 58, 'IL-10'), ('GO_0042571', 'immunoglobulin complex, circulating', 77, 'antibody'), ('GO_0032608', 'interferon-beta production', 113, 'IFNγ production'), ('PR_000008920', 'interferon alpha-7', 113, 'IFNγ')]
PMC5482199	2/2017	S69-PMC5482199	['( b ) neutralization of Il-10 with an anti-Il-10 monoclonal Antibody (10 μg/ml) resulted in a significant increase in ifnγ Production by Lps-Stimulated (30 ng/ml) Cbmcs.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 24, 'IL-10'), ('PR_000001470', 'interleukin-28B', 43, 'IL-10'), ('GO_0042571', 'immunoglobulin complex, circulating', 60, 'antibody'), ('GO_0007128', 'meiotic prophase I', 123, 'production'), ('CHEBI_16412', 'lipopolysaccharide', 137, 'LPS'), ('GO_0042475', 'odontogenesis of dentin-containing tooth', 141, '... stimulated'), ('CL_0000979', 'IgG memory B cell', 163, 'CBMCs')]
PMC5482199	2/2017	S111-PMC5482199	['we now report that the addition of anti-Il-10 Antibody also increases the Production Of Ifnγ.']	N/A	N/A	[('PR_000001470', 'interleukin-28B', 40, 'IL-10'), ('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibody'), ('GO_0032508', 'DNA duplex unwinding', 74, 'production of IFNγ'), ('PR_000008920', 'interferon alpha-7', 88, 'IFNγ')]
PMC5485024	3/2017	S4-PMC5485024	['classification of asthma and rhinitis was based on questionnaires, and Serum Ige Antibodies were measured at 8 and 16 years.']	N/A	N/A	[('UBERON_0001977', 'blood serum', 71, 'serum'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 77, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 81, 'antibodies')]
PMC5485024	3/2017	S34-PMC5485024	['Blood samples were analysed for specific Ige Antibodies with immunocap (phadia ab, uppsala, sweden) to common inhalant Allergens using the phadiatop®‐Mix (cat, Dog, Horse, Birch, Timothy, mugwort, dermatophagoides pteronyssinus and cladosporium )9.']	N/A	N/A	[('UBERON_0000178', 'blood', 0, 'Blood'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 41, 'IgE'), ('GO_0042571', 'immunoglobulin complex, circulating', 45, 'antibodies'), ('CHEBI_33663', 'cyclic hydrocarbon', 119, 'allergens'), ('CHEBI_60004', 'mixture', 150, 'mix'), ('NCBITaxon_33208', 'Metazoa', 160, 'dog'), ('NCBITaxon_1', 'root', 165, 'horse'), ('NCBITaxon_33208', 'Metazoa', 172, 'birch'), ('NCBITaxon_10088', 'Mus <genus>', 179, 'timothy')]
PMC5486026	6/2017	S137-PMC5486026	['inhibitors and Antibodies\ninhibitors used for Cell Signaling studies included the pi3 kinase Inhibitor Ly294002 and the mek Inhibitor pd98059 (both from sigma aldrich, st. louis, mo, usa) at an optimal/non cytotoxic dose of 50 µm in Dmso.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 15, 'Antibodies'), ('GO_0007267', 'cell-cell signaling', 46, 'cell signaling'), ('CHEBI_35222', 'inhibitor', 93, 'inhibitor'), ('CHEBI_65329', 'LY294002', 103, 'LY294002'), ('CHEBI_35222', 'inhibitor', 124, 'inhibitor'), ('CHEBI_34018', '(S)-AMPA', 233, 'DMSO')]
PMC5486026	6/2017	S139-PMC5486026	['primary Antibodies used for western blotting were Mouse monoclonal Antibodies against Fatty Acid Transport Protein-4 (Fatp-4), a-Fabp, phospho-Ribosomal protein s6 Antibody (ser 235/236) (santa cruz biotechnology, dallas, tx, usa), fat and Lpl (abcam, cambridge, uk), and Rabbit polyclonal Antibodies to Fatp-1, phospho-Akt (ser473), phosphor-Erk (thr 202/tyr 204), phospho-Irs1/2 (tyr 612) (santa cruz, ca, usa), anti Igf-2Antibody, el (abcam) and Β-Actin (sigma aldrich, st. louis, mo, usa).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 8, 'antibodies'), ('NCBITaxon_10088', 'Mus <genus>', 50, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 67, 'antibodies'), ('CHEBI_35366', 'fatty acid', 86, 'Fatty acid'), ('GO_0015908', 'fatty acid transport', 86, 'Fatty acid transport'), ('PR_000015050', 'long-chain fatty acid transport protein 6', 86, 'Fatty acid transport protein-4'), ('PR_000007355', 'Fas-binding factor 1', 118, 'FATP-4'), ('PR_000004740', 'class E basic helix-loop-helix protein 40', 128, '-FABP'), ('GO_0005840', 'ribosome', 143, 'ribosomal'), ('GO_0042571', 'immunoglobulin complex, circulating', 164, 'antibody'), ('PR_000009880', 'Lon protease, mitochondrial', 240, 'LPL'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 272, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 290, 'antibodies'), ('PR_000007355', 'Fas-binding factor 1', 304, 'FATP-1'), ('PR_000003908', 'aflatoxin B1 aldehyde reductase member 2', 320, 'Akt'), ('PR_000007120', 'ephrin type-A receptor 1', 343, 'ERK'), ('PR_000009158', 'inositol 1,4,5-trisphosphate receptor type 1', 374, 'IRS1'), ('PR_000010222', 'muscleblind-like protein 2', 379, '2'), ('PR_000001377', 'interleukin-18 receptor 1', 419, 'IGF-2antibody'), ('PR_000003676', 'actin, cytoplasmic 1', 449, 'β-actin')]
PMC5486026	6/2017	S140-PMC5486026	['anti-Mouse and anti-Rabbit secondary Antibodies conjugated with horseradish peroxidase were obtained from santa cruz biotechnology.']	N/A	N/A	[('NCBITaxon_10088', 'Mus <genus>', 5, 'mouse'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 20, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 37, 'antibodies')]
PMC5486026	6/2017	S157-PMC5486026	['Membranes were incubated with primary Antibodies overnight at 4 °c.']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibodies')]
PMC5486026	6/2017	S158-PMC5486026	['blots were then probed with the corresponding secondary Antibody conjugated with horseradish peroxidase.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 56, 'antibody')]
PMC5487839	3/2016	S282-PMC5487839	['the presence of Antiphospholipid Antibodies at high titres predisposes to Arterial hypertension, pe, and to Thrombotic microangiopathy during Pregnancy.']	N/A	N/A	[('CHEBI_16240', 'hydrogen peroxide', 16, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 33, 'antibodies'), ('UBERON_0001637', 'artery', 74, 'arterial'), ('GO_0007596', 'blood coagulation', 108, 'thrombotic'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy')]
PMC5489519	6/2017	S53-PMC5489519	['Milk samples from Vitamin D sufficient and deficient mother groups containing an equal amount of protein (50\u2009µg) were subjected to western blot analysis for Trail Expression using a specific anti-Trail Antibody.']	N/A	N/A	[('UBERON_0001913', 'milk', 0, 'Milk'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 157, 'TRAIL'), ('GO_0010467', 'gene expression', 163, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 196, 'TRAIL'), ('GO_0042571', 'immunoglobulin complex, circulating', 202, 'antibody')]
PMC5489519	6/2017	S73-PMC5489519	['hme1 cells were treated with different concentrations of 1,25(Oh)2D at 0–20\u2009nm for 24\u2009h. ( a and b ) total cell lysates were subjected to western blot for Trail Expression using a specific anti-Trail Antibody.']	N/A	N/A	[('CHEBI_82784', 'PVP38-Ag NP', 57, '1,25(OH)2D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 155, 'TRAIL'), ('GO_0010467', 'gene expression', 161, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 194, 'TRAIL'), ('GO_0042571', 'immunoglobulin complex, circulating', 200, 'antibody')]
PMC5489519	6/2017	S130-PMC5489519	['the blots were then incubated for 1\u2009h with hrp-conjugated secondary Antibody and developed using ecl system.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 68, 'antibody')]
PMC5504744	7/2017	S46-PMC5504744	['a sectional cut of the entire muscle area was stained using anti-slow myosin heavy chain monoclonal Antibody (novocastra lyophilized Mouse monoclonal Antibody myosin heavy chain (ncl-Mhcs) diluted 1:20 in ultrapure Water; novocastra, newcastle, uk).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 100, 'antibody'), ('NCBITaxon_10088', 'Mus <genus>', 133, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 150, 'antibody'), ('CL_0000354', 'blastemal cell', 183, 'MHCs'), ('GO_0042611', 'MHC protein complex', 183, 'MHCs'), ('CHEBI_15377', 'water', 215, 'water')]
PMC5519748	7/2017	S78-PMC5519748	['caption (fig): figure 5\n\nchip-pcr analysis of H3 Acetylation at the Promoter of Ampk-Α1 with Antibody to Histone H3.']	N/A	N/A	[('GO_0043977', 'histone H2A-K5 acetylation', 46, 'H3 acetylation'), ('PR_000027594', 'histone H3', 46, 'H3'), ('SO_0000167', 'promoter', 68, 'promoter'), ('PR_000004512', 'ataxin-8', 80, 'AMPK-α1'), ('GO_0042571', 'immunoglobulin complex, circulating', 93, 'antibody'), ('CHEBI_15358', 'histone', 105, 'histone'), ('PR_000027594', 'histone H3', 105, 'histone H3')]
PMC5519748	7/2017	S139-PMC5519748	['after washing, the membrane was incubated overnight at 4\u2009°c with anti-Ampk-Α1 Antibodies (dilution 1:1000, catalog no.']	N/A	N/A	[('PR_000004512', 'ataxin-8', 70, 'AMPK-α1'), ('GO_0042571', 'immunoglobulin complex, circulating', 78, 'antibodies')]
PMC5519748	7/2017	S140-PMC5519748	['1596–1), anti-Srebp-1c Antibodies (dilution 1:3000, catalog no.']	N/A	N/A	[('PR_000015619', 'sorcin', 14, 'SREBP'), ('GO_0042571', 'immunoglobulin complex, circulating', 23, 'antibodies')]
PMC5519748	7/2017	S141-PMC5519748	['ab3259, abcam, new territories, hk) and anti-gpadh Antibodies (dilution 1:5000, catalog no.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibodies')]
PMC5519748	7/2017	S142-PMC5519748	['5174, cell signaling technology, boston, usa), and subsequently incubated with secondary Antibodies conjugated with horseradish peroxidase (beyotime biotechnology, hangzhou, china) for 2\u2009h at room temperature.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 89, 'antibodies')]
PMC5519748	7/2017	S160-PMC5519748	['the supernatant fractions were incubated with Antibodies against acetylated acelated Histone H3 (2\u2009ul, catalog no.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 46, 'antibodies'), ('CHEBI_15358', 'histone', 85, 'histone'), ('PR_000027594', 'histone H3', 85, 'histone H3')]
PMC5519748	7/2017	S170-PMC5519748	['for negative controls, we performed chip assays with an Igg Antibody (1ug) followed by amplification of the Promoter region (Forward: 5′-cgtagctcaggcctctgcgccctt-3′, reverse, 5′-ctggcactgcacaagaagatgcggctg-3′) of gapdh to show immunospecificity of the Antibodies for the Ampk-Α1 Promoter.']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 56, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 60, 'antibody'), ('SO_0000167', 'promoter', 108, 'promoter'), ('SO_0001030', 'forward', 125, 'Forward'), ('GO_0042571', 'immunoglobulin complex, circulating', 252, 'antibodies'), ('PR_000004512', 'ataxin-8', 271, 'AMPK-α1'), ('SO_0000167', 'promoter', 279, 'promoter')]
PMC5521778	7/2017	S52-PMC5521778	['Antibodies\nthe polyclonal Antibody to bco1 was characterized as described previously [34].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 26, 'antibody')]
PMC5521778	7/2017	S53-PMC5521778	['polyclonal Antibodies to Pparα (cat.# sc-9000), Pparβ (cat.# sc-7197), and Pparγ (cat.# sc-7196) were obtained from santa cruz biotechnology (santa cruz, ca).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 11, 'antibodies'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 25, 'PPARα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 48, 'PPARβ'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 75, 'PPARγ')]
PMC5521778	7/2017	S54-PMC5521778	['the monoclonal Antibody to Β-Actin (cat.# a1978) was from sigma.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 15, 'antibody'), ('PR_000003676', 'actin, cytoplasmic 1', 27, 'β-actin')]
PMC5521778	7/2017	S94-PMC5521778	['after electrophoresis, the separated proteins were transferred to immun-blot™Pvdf membranes (bio-rad) by semi-dry blotting and were probed with the appropriate Antibody followed by incubation with anti-Rabbit (cat.# rpn4301) or anti-Mouse Igg (cat.# rpn4201) conjugated to horseradish peroxidase (amersham biosciences, piscataway, nj).']	N/A	N/A	[('CHEBI_53250', 'poly(vinylene fluoride)', 77, 'PVDF'), ('GO_0042571', 'immunoglobulin complex, circulating', 160, 'antibody'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 202, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'mouse'), ('GO_0071735', 'IgG immunoglobulin complex', 239, 'IgG')]
PMC5521778	7/2017	S95-PMC5521778	['polyclonal Pparα, -β, and -Γ and Rxrα Antibodies were used at 1:500 to 1:1000 dilutions in pbs containing 5% non-fat dry Milk.']	N/A	N/A	[('PR_000013057', 'peroxisome proliferator-activated receptor delta', 11, 'PPARα'), ('PR_000006300', 'lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial', 27, 'γ'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 33, 'RXRα'), ('GO_0042571', 'immunoglobulin complex, circulating', 38, 'antibodies'), ('UBERON_0001913', 'milk', 121, 'milk')]
PMC5521778	7/2017	S127-PMC5521778	['Expression of Bco1 protein in the indicated Human cell lines: cell lysates were subjected to western blot analysis using anti-Rabbit Antibody against the Bco1 protein c-terminal peptide.']	N/A	N/A	[('GO_0010467', 'gene expression', 0, 'Expression'), ('PR_000004693', 'Bcl-2-like protein 10', 14, 'BCO1'), ('NCBITaxon_9606', 'Homo sapiens', 44, 'human'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 126, 'rabbit'), ('GO_0042571', 'immunoglobulin complex, circulating', 133, 'antibody'), ('PR_000004693', 'Bcl-2-like protein 10', 154, 'BCO1')]
PMC5521778	7/2017	S128-PMC5521778	['equal loading was confirmed by stripping and re-probing the same blot with Β-Actin Antibody.']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 75, 'β-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 83, 'antibody')]
PMC5521778	7/2017	S135-PMC5521778	['to verify the presence of Bco1 protein in these cells, we generated an affinity-purified Rabbit anti-Human Bco1 Antibody to a unique sequence in Human Bco1 [34] and performed western blot analyses of protein lysates from the cell lines shown infig 1b.']	N/A	N/A	[('PR_000004693', 'Bcl-2-like protein 10', 26, 'BCO1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 89, 'rabbit'), ('NCBITaxon_9606', 'Homo sapiens', 101, 'human'), ('PR_000004693', 'Bcl-2-like protein 10', 107, 'BCO1'), ('GO_0042571', 'immunoglobulin complex, circulating', 112, 'antibody'), ('NCBITaxon_9606', 'Homo sapiens', 145, 'human'), ('PR_000004693', 'Bcl-2-like protein 10', 151, 'BCO1')]
PMC5521778	7/2017	S154-PMC5521778	['Bco1 protein from each treatment was analyzed by western blot using Rabbit anti-Bco1 Antibody with Β-Actin serving as a loading control ( top panel ).']	N/A	N/A	[('PR_000004693', 'Bcl-2-like protein 10', 0, 'BCO1'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 68, 'rabbit'), ('PR_000004693', 'Bcl-2-like protein 10', 80, 'BCO1'), ('GO_0042571', 'immunoglobulin complex, circulating', 85, 'antibody'), ('PR_000003676', 'actin, cytoplasmic 1', 99, 'β-actin')]
PMC5521778	7/2017	S222-PMC5521778	['cell lysates were subjected to western blot analysis using the indicated Antibodies, Pparα ( left panel ), Pparβ ( middle ), and Pparγ ( right ), respectively.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibodies'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 85, 'PPARα'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 107, 'PPARβ'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 129, 'PPARγ')]
PMC5521778	7/2017	S223-PMC5521778	['equal loading was confirmed by stripping and reprobing the blots with Β-Actin Antibody.']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 70, 'β-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 78, 'antibody')]
PMC5521778	7/2017	S253-PMC5521778	['cell lysates were subjected to western blot analysis using the indicated Antibodies.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 73, 'antibodies')]
PMC5521778	7/2017	S254-PMC5521778	['equal loading was confirmed by stripping and reprobing with Β-Actin Antibody.']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 60, 'β-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 68, 'antibody')]
PMC5521778	7/2017	S257-PMC5521778	['after 48 h Transfection, cells were treated with vehicle, Dex, or Forskolin for 24 h. equal amounts of cell lysates from each treatment were subjected to western blot analysis using the indicated Antibodies.']	N/A	N/A	[('GO_0009294', 'DNA mediated transformation', 11, 'transfection'), ('CHEBI_4450', 'desmopressin', 58, 'DEX'), ('CHEBI_42471', 'forskolin', 66, 'forskolin'), ('GO_0042571', 'immunoglobulin complex, circulating', 196, 'antibodies')]
PMC5521778	7/2017	S258-PMC5521778	['equal loading was confirmed by stripping and reprobing blots with Β-Actin Antibody.']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 66, 'β-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 74, 'antibody')]
PMC5537884	7/2017	S51-PMC5537884	['at that time, the Antibodies anti Pla2R tested negative and Kidney function was normal.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 18, 'antibodies'), ('PR_000014698', 'serpin B7', 34, 'PlA2r'), ('UBERON_0002113', 'kidney', 60, 'kidney')]
PMC5580292	9/2017	S61-PMC5580292	['Membranes were then incubated overnight at 4\xa0°c in blocking buffer containing primary Antibodies (as shown in table3).']	N/A	N/A	[('GO_0016020', 'membrane', 0, 'Membranes'), ('GO_0042571', 'immunoglobulin complex, circulating', 86, 'antibodies')]
PMC5580292	9/2017	S62-PMC5580292	['a goat anti-Rabbit Igg (h\xa0+\xa0l) secondary Antibody (thermo pierce, code no.31210, usa) with 1/5000 dilution was used in the detection of specific proteins.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 12, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 19, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 41, 'antibody')]
PMC5580292	9/2017	S63-PMC5580292	['for loading control, Β-Actin Antibody was used as control.']	N/A	N/A	[('PR_000003676', 'actin, cytoplasmic 1', 21, 'β-actin'), ('GO_0042571', 'immunoglobulin complex, circulating', 29, 'antibody')]
PMC5580292	9/2017	S68-PMC5580292	['caption (table-wrap): table 3\n\nthe primary Antibodies for western blotprimary Antibodyorder numbersdilutionsize,\xa0kdaanti-Cardiac fabpabca ab459661:150015anti-fatp1abcam ab818751:200065anti-Cpt1Babcam ab1046621:200088anti-Phospho-ampkcell signaling technology25351:100062anti-ampkαcell signaling technology58321:100062β-actin (c4)santa cruz sc-477781:150043\nthe relative Expressions of target proteins\xa0=\xa0(the optical density of target proteins/the optical density of Β-Actin).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 43, 'antibodies'), ('GO_0031224', 'intrinsic component of membrane', 78, 'antibodyOrder'), ('UBERON_0000948', 'heart', 121, 'Cardiac'), ('PR_000005809', 'complexin-1', 189, 'CPT1Babcam'), ('CHEBI_32958', 'phosphate group', 221, 'Phospho'), ('GO_0010467', 'gene expression', 370, 'expressions'), ('PR_000003676', 'actin, cytoplasmic 1', 466, 'β-actin')]
PMC5593991	9/2017	S266-PMC5593991	['immunoprecipitation (ip) was carried out at 4\u2009°c overnight in diluted pi-Sds/Triton x-100 buffer using the Egr-1 Antibody (c-19) x (santa cruz biotechnology, tx, usa) bound to dynabeads m-280 sheep anti-Rabbit Igg (life technologies, ca,usa).']	N/A	N/A	[('CHEBI_8984', 'sodium dodecyl sulfate', 73, 'SDS'), ('CHEBI_29236', 'protium atom', 77, 'Triton'), ('PR_000006903', 'elongation factor 1-alpha 1', 107, 'Egr-1'), ('GO_0042571', 'immunoglobulin complex, circulating', 113, 'Antibody'), ('NCBITaxon_10088', 'Mus <genus>', 203, 'Rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 210, 'IgG')]
PMC5621970	7/2017	S23-PMC5621970	['the detection of maternal Antibodies against Hpa-1A confirmed nait.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 26, 'antibodies'), ('PR_000008793', 'heat shock factor protein 4', 45, 'HPA-1a')]
PMC5621970	7/2017	S72-PMC5621970	['risk reduction mechanisms involve increasing infusion time and decreasing the maximum daily dosage.6hemolytic anemia is caused by the transfer of anti-a and anti-b Antibodies.9risk factors include higher cumulative ivig dose, non-o recipient Blood type, and recipient female gender.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 164, 'antibodies'), ('UBERON_0000178', 'blood', 242, 'blood')]
PMC5626729	10/2017	S231-PMC5626729	['Sglt1 was identified by primary Antibodies against Human Sglt1 (1:1000, #5042, cell signaling, the netherlands), and Antibody against gapdh (1:1000, #8884, cell signaling) served as a loading control.']	N/A	N/A	[('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 0, 'SGLT1'), ('GO_0042571', 'immunoglobulin complex, circulating', 32, 'antibodies'), ('NCBITaxon_9606', 'Homo sapiens', 51, 'human'), ('PR_000015229', 'solute carrier organic anion transporter family member 4A1', 57, 'SGLT1'), ('GO_0042571', 'immunoglobulin complex, circulating', 117, 'antibody')]
PMC5626729	10/2017	S232-PMC5626729	['for detection, a secondary anti-Rabbit Igg Antibody conjugated with horseradish peroxidase (hrp) (1:2000, #7074, cell signaling) was used.']	N/A	N/A	[('NCBITaxon_9986', 'Oryctolagus cuniculus', 32, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 39, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 43, 'antibody')]
PMC5626729	10/2017	S239-PMC5626729	['following Antigen retrieval and washing steps in the Detergent-containing buffers, cryosections were incubated for 30\u2009min in 1% w/v Bovine Serum Albumin Solution (in pbs) to block nonspecific binding of the Antibodies, then incubated with a previously described40non-commercial, affinity purified, Rabbit-raised, anti-Mouse Sglt1 Antibody (msglt1-Ab; 1:100 in pbs) at 4\u2009°c overnight.']	N/A	N/A	[('CHEBI_59132', 'antigen', 10, 'antigen'), ('CHEBI_27780', 'detergent', 53, 'detergent'), ('NCBITaxon_33208', 'Metazoa', 132, 'bovine'), ('PR_000003918', 'albumin', 139, 'serum albumin'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_75958', 'solution', 153, 'solution'), ('GO_0042571', 'immunoglobulin complex, circulating', 207, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 298, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 318, 'mouse'), ('PR_000015239', 'SLIT and NTRK-like protein 3', 324, 'Sglt1'), ('GO_0042571', 'immunoglobulin complex, circulating', 330, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 347, 'Ab')]
PMC5626729	10/2017	S240-PMC5626729	['the samples were then rinsed, incubated in secondary Garcy3 Antibody (1.6\u2009μg/ml in pbs;Cy3-labeled goat anti-Rabbit Igg; # 111-165-003, jackson immunoresearch laboratories, usa) at room temperature for one hour, rinsed, overlayed with fluorescence fading retardant vectashield (vector laboratories, usa).']	N/A	N/A	[('PR_000007764', 'GA-binding protein subunit beta-1', 53, 'GARCY3'), ('GO_0042571', 'immunoglobulin complex, circulating', 60, 'antibody'), ('CHEBI_37987', 'Cy3 dye', 87, 'CY3'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 109, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 116, 'IgG')]
PMC5680205	11/2017	S266-PMC5680205	['in depth analysis of Labyrinth structure was performed using immunohistochemistry (ihc) as previously described72,73and details of Antibodies and dilutions used are provided in supplementary table\xa0s5.']	N/A	N/A	[('UBERON_0001731', 'cavity of pharynx', 21, 'labyrinth'), ('GO_0042571', 'immunoglobulin complex, circulating', 131, 'antibodies')]
PMC5716389	9/2017	S70-PMC5716389	['vaccines routinely used in the first year of Life.vaccinetypemechanism of action polio vaccine– live (Oral)– killed (inactivated)– induces the formation of Serum Igg, Mucosal Igg and Iga Antibodies– induces the formation of Serum and Mucosal Iggrotaviruslive attenuatedinduces the formation of Mucosal igabcglive mycobacteriumthe mechanisms of action of Bcg remains poorly understood.']	N/A	N/A	[('UBERON_0000104', 'life cycle', 45, 'life'), ('UBERON_0000165', 'mouth', 102, 'oral'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 162, 'IgG'), ('UBERON_0000344', 'mucosa', 167, 'mucosal'), ('GO_0071735', 'IgG immunoglobulin complex', 175, 'IgG'), ('GO_0071746', 'IgA immunoglobulin complex, circulating', 183, 'IgA'), ('GO_0042571', 'immunoglobulin complex, circulating', 187, 'antibodies'), ('UBERON_0001977', 'blood serum', 224, 'serum'), ('UBERON_0000344', 'mucosa', 234, 'mucosal'), ('GO_0071736', 'IgG immunoglobulin complex, circulating', 242, 'IgGRotavirusLive'), ('UBERON_0000344', 'mucosa', 294, 'mucosal'), ('CHEBI_33250', 'atom', 354, 'BCG')]
PMC5716389	9/2017	S81-PMC5716389	['measles vaccine is a live attenuated vaccine inducing Antibodies (Serum Igg) and cd8 cells, which protect against measles virus [29].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 54, 'antibodies'), ('UBERON_0001977', 'blood serum', 66, 'serum'), ('GO_0071735', 'IgG immunoglobulin complex', 72, 'IgG')]
PMC5716389	9/2017	S148-PMC5716389	['infants of zinc supplemented mothers had a higher Antibody response to the three routine vaccination doses of hepatitis b vaccine at the age of 6 months compared with peers whose mothers had Placebo supplements, but this finding was not statistically significant [63].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 50, 'antibody'), ('CHEBI_26130', 'biological pigment', 191, 'placebo')]
PMC5727393	12/2017	S394-PMC5727393	['sections were then incubated for 72\u2009h with primary Antibodies (Rabbit anti C-Fos 1:1000, santa cruz; Mouse anti-mcherry 1:1000, abcam), washed six times, and then incubated overnight with secondary Antibodies (Donkey anti-Rabbit Alexa Fluor 488 Igg 1:1000, life technologies; goat anti-Mouse Alexa Fluor 647 Igg 1:1000, abcam).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 51, 'antibodies'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 63, 'rabbit'), ('PR_000002318', 'caspase-9', 75, 'c-Fos'), ('NCBITaxon_10088', 'Mus <genus>', 101, 'mouse'), ('GO_0042571', 'immunoglobulin complex, circulating', 198, 'antibodies'), ('NCBITaxon_33208', 'Metazoa', 210, 'donkey'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 222, 'rabbit'), ('CHEBI_52661', 'Alexa Fluor 488', 229, 'Alexa Fluor 488'), ('GO_0071735', 'IgG immunoglobulin complex', 245, 'IgG'), ('NCBITaxon_10088', 'Mus <genus>', 286, 'mouse'), ('CHEBI_52661', 'Alexa Fluor 488', 292, 'Alexa Fluor 647'), ('GO_0071735', 'IgG immunoglobulin complex', 308, 'IgG')]
PMC5804088	2/2018	S5-PMC5804088	['the levels of Antibodies against Merozoite Surface Protein 1 (Msp1 19kd) and Msp2, Erythrocyte Binding Antigen 175 (Eba175), Reticulocyte Binding Protein Homologue 2A (Rh2A9), schizont extract and variant Antigens Expressed on the Surface of infected Erythrocytes were measured.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 14, 'antibodies'), ('GO_0070090', 'metaphase plate', 33, 'merozoite'), ('PR_000001883', 'lysosome-associated membrane protein', 33, 'merozoite surface protein 1'), ('PR_000010757', 'metaxin-3', 62, 'MSP1'), ('PR_000010697', 'metallothionein-1E', 77, 'MSP2'), ('CL_0000232', 'erythrocyte', 83, 'erythrocyte'), ('PR_000006910', 'elongation factor 2 kinase', 83, 'erythrocyte binding antigen 175'), ('CHEBI_59132', 'antigen', 103, 'antigen'), ('PR_000006881', 'proteasome adapter and scaffold protein ECM29', 116, 'EBA175'), ('CL_0000558', 'reticulocyte', 125, 'reticulocyte'), ('PR_000013799', 'RNA-binding protein 41', 125, 'reticulocyte binding protein homologue 2A'), ('SO_0000853', 'homologous_region', 154, 'homologue'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 168, 'Rh2A9'), ('CHEBI_59132', 'antigen', 205, 'antigens'), ('GO_0010467', 'gene expression', 214, 'expressed'), ('GO_0009986', 'cell surface', 231, 'surface'), ('CL_0000232', 'erythrocyte', 251, 'erythrocytes')]
PMC5804088	2/2018	S8-PMC5804088	['however, the supplementation type did not have any impact on the prevalence or levels of Antibodies at either 6 or 18\xa0months of age to any of the tested malaria Antigens in either univariate analysis or multivariate analysis after adjusting for covariates.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 89, 'antibodies'), ('CHEBI_59132', 'antigen', 161, 'antigens')]
PMC5804088	2/2018	S9-PMC5804088	['conclusions\npre- and Postnatal Lipid-based Nutrient supplementation did not alter malaria Antibody acquisition during infancy, compared to Prenatal supplementation with Iron and Folic Acid or pre- and Postnatal supplementation with multiple Micronutrients.']	N/A	N/A	[('GO_0007567', 'parturition', 21, 'postnatal'), ('CHEBI_18059', 'lipid', 31, 'lipid'), ('CHEBI_33284', 'nutrient', 43, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 90, 'antibody'), ('GO_0007565', 'female pregnancy', 139, 'prenatal'), ('CHEBI_24870', 'ion', 169, 'iron'), ('CHEBI_30751', 'formic acid', 178, 'folic acid'), ('GO_0007567', 'parturition', 201, 'postnatal'), ('CHEBI_33839', 'macromolecule', 241, 'micronutrients')]
PMC5804088	2/2018	S52-PMC5804088	['measurement of total Igg levels against vsa\ntotal Igg Antibody levels against vsas Expressed on the Surface Of Ies were measured by flow cytometry as previously described [32] with slight modifications.']	N/A	N/A	[('GO_0071735', 'IgG immunoglobulin complex', 21, 'IgG'), ('GO_0071735', 'IgG immunoglobulin complex', 50, 'IgG'), ('GO_0042571', 'immunoglobulin complex, circulating', 54, 'antibody'), ('GO_0010467', 'gene expression', 83, 'expressed'), ('GO_0009986', 'cell surface', 100, 'surface of'), ('GO_0005622', 'intracellular anatomical structure', 111, 'IEs')]
PMC5804088	2/2018	S62-PMC5804088	['measured Antibody levels (in optical density [od] for schizont and Merozoite Antigens and geometric mean fluorescence intensity [mfi] for vsa) were presented as a percentage of the positive control.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 9, 'antibody'), ('GO_0070090', 'metaphase plate', 67, 'merozoite'), ('CHEBI_59132', 'antigen', 77, 'antigens')]
PMC5804088	2/2018	S64-PMC5804088	['seroprevalence was defined as the percentage of the cohort having Antibody responses greater than the mean Antibody response plus three standard deviations for negative controls, which were malaria naïve samples from melbourne Blood donors.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 66, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 107, 'antibody'), ('UBERON_0000178', 'blood', 227, 'blood')]
PMC5804088	2/2018	S68-PMC5804088	['differences in the Antibody level and the seropositivity between 6 and 18\xa0months old children were determined by wilcoxon matched-pairs signed-ranks test and mcnemar’s test, respectively.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 19, 'antibody')]
PMC5804088	2/2018	S70-PMC5804088	['Antibody levels at 6 and 18\xa0months of age were reported as the median percentage of the positive control and the interquartile range (iqr).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody')]
PMC5804088	2/2018	S71-PMC5804088	['the kruskal–wallis test was performed to compare Antibody levels across supplementation groups.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibody')]
PMC5804088	2/2018	S72-PMC5804088	['regression analyses were carried out using natural logarithmically transformed Antibody levels which were back transformed for reporting descriptive results.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 79, 'antibody')]
PMC5804088	2/2018	S73-PMC5804088	['linear regression univariate analysis was performed between Lns versus ifa, Lns versus mmn and mmn versus ifa to determine the Antibody level differences between supplementation groups.']	N/A	N/A	[('UBERON_0000029', 'lymph node', 60, 'LNS'), ('UBERON_0000029', 'lymph node', 76, 'LNS'), ('GO_0042571', 'immunoglobulin complex, circulating', 127, 'antibody')]
PMC5804088	2/2018	S91-PMC5804088	['caption (table-wrap): table\xa02\n\ncomparative characteristics of the included and excluded participants at 6\xa0months of agecharacteristicsincluded (432)excluded (349)p valueaparasitaemia by microscopy22 (5.1)6 (1.7)0.01parasitaemia by rdtb31 (7.17)35 (10.0)0.15haemoglobin level, mean\xa0±\xa0sd, g/l103.4\xa0±\xa015.8101.4\xa0±\xa015.90.09anaemiac251 (58.1)250 (71.7)<\xa00.0001low socioeconomic status251 (58.1)215(61.6)0.32mother’s education below median225 (52.1)193 (55.3)0.37\nvalues are number (%) or mean\xa0±\xa0sd\nap \xa0value obtained by chi square test or mann–whitney test (continuous variables)\nbrapid diagnostic test\ncanaemia defined as haemoglobin level\xa0<\xa0110\xa0g/l (world health organization [1])\n\nthe magnitude and prevalence of Antibodies in different age groups\nthe levels of Antibodies and seroprevalence for the Antibodies against Merozoite Antigens, schizont extract and vsa for three different parasite lines were measured at 6\xa0months and 18\xa0months of age (table\xa03).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 710, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 759, 'antibodies'), ('GO_0042571', 'immunoglobulin complex, circulating', 797, 'antibodies'), ('GO_0070090', 'metaphase plate', 816, 'merozoite'), ('NCBITaxon_33208', 'Metazoa', 816, 'merozoite'), ('CHEBI_59132', 'antigen', 826, 'antigens')]
PMC5804088	2/2018	S99-PMC5804088	['association between Nutrient supplementation and Antibody seroprevalence in 6\xa0months old children\nseroprevalence of the malaria Antigens in 6\xa0months old children was not significantly different between any of the treatment arms for any of the tested Antigens except Rh2A9 (p\xa0=\xa00.044) (table\xa04).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 20, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 49, 'antibody'), ('CHEBI_59132', 'antigen', 128, 'antigens'), ('CHEBI_59132', 'antigen', 250, 'antigens'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 266, 'Rh2A9')]
PMC5804088	2/2018	S102-PMC5804088	['caption (table-wrap): table\xa04\n\nassociation between Nutrient supplementation and seroprevalence in 6\xa0months old childrenoutcomenumber of children seropositive/total number of childrencomparison between Lns and ifa groupcomparison between lns and mmn groupcomparison between mmn and ifa groupifaammnblnscp valuedor (95% ci)p valueeor (95% ci)p valueeor (95% ci)p valueemsp-1f19kd43/145(29.7%)44/140(31.4%)41/147(27.9%)0.8060.96 (0.74, 1.23)0.7390.84 (0.51, 1.40)0.5121.07 (0.64, 1.77)0.804adjusted modelg0.97 (0.73, 1.28)0.8080.86 (0.49, 1.49)0.5831.01 (0.57, 1.76)0.981msp-2h38/145(26.2%)40/140(28.6%)36/147(24.5%)0.7340.96 (0.73, 1.24)0.7360.81 (0.48, 1.37)0.4341.07 (0.63, 1.80)0.807adjusted modelg0.98 (0.74, 1.31)0.8930.80 (0.45, 1.42)0.4471.09 (0.62, 1.94)0.764eba-175i15/145(10.3%)20/140(14.3%)13/147(8.9%)0.3200.92 (0.62, 1.35)0.6630.58 (0.28, 1.22)0.1521.34 (0.65, 2.76)0.426adjusted modelg0.96 (0.63, 1.47)0.8570.54 (0.25, 1.18)0.1201.53 (0.70, 3.37)0.289rh2a9j9/145(6.21%)3/140(2.14%)2/147(1.4%) 0.044 0.46 (0.21, 0.99) 0.047 0.63 (0.10, 3.83)0.6160.33 (0.09, 1.23)0.098adjusted modelg0.48 (0.21, 1.06)0.0700.79 (0.12, 5.42)0.8140.34 (0.09, 1.30)0.114schizont extract68/145(46.9%)67/140(47.86%)67/147(45.6%)0.9270.97 (0.77, 1.23)0.8210.91 (0.57, 1.45)0.6991.07 (0.67, 1.71)0.774adjusted modelg0.91 (0.70, 1.18)0.4680.89 (0.53, 1.51)0.6770.97 (0.58, 1.63)0.923vsakof E8B parasite line31/145(21.4%)39/140(27.9%)35/147(23.8%)0.4371.09 (0.83, 1.43)0.5520.80 (0.47, 1.36)0.4021.52 (0.88, 2.64)0.134adjusted modelg1.01 (0.74, 1.37)0.9570.70 (0.38, 1.26)0.2331.55 (0.86, 2.80)0.146vsa of r29 parasite line14/145(9.7%)12/140(8.6%)11/147(7.5%)0.8030.86 (0.57, 1.30)0.4700.83 (0.35, 1.94)0.6590.88 (0.39, 1.98)0.756adjusted modelg0.76 (0.48, 1.20)0.2340.69 (0.27, 1.74)0.4270.91 (0.38, 2.14)0.822vsa of 3d7 parasite line27/145(18.6%)33/140(23.6%)34/147(23.1%)0.5301.16 (0.87, 1.54)0.3130.97 (0.56, 1.69)0.9241.35 (0.76, 2.41)0.301adjusted modelg1.04 (0.75, 1.43)0.8290.89 (0.48, 1.65)0.7211.24 (0.66, 2.31)0.501\nairon and Folic Acid\nbmultiple Micronutrients\nClipid based Nutrient supplements\ndp value calculated using the chi2test\nep value calculated using logistic regression reporting odds ratios (or) and 95% confidence intervals (ci)\nfmerozoite Surface Protein 1\ngp value calculated using multivariate logistic regression reporting odds ratios (or) while adjusting for maternal bmi at enrolment, duration of Gestation (from enrolment to Delivery), number of Pregnancies, sex of the child, maternal education, socioeconomic status, study site, maternal anaemic status at enrolment, maternal hiv status and bed net use by children\nhmerozoite Surface Protein 2\nIerythrocyte Binding Antigen 175\nJreticulocyte Binding Protein Homologue 2A\nkvariant Surface Antigens\nsignificant p values <0.05 are indicated in italics\n\nassociation between Nutrient supplementation and Antibody seroprevalence in 18\xa0months old children\nseroprevalence of the tested malaria Antigens in 18\xa0months old children was not significantly different between any of the treatment arms for any of the Antigens tested (table\xa05).']	N/A	N/A	[('CHEBI_33284', 'nutrient', 51, 'nutrient'), ('UBERON_0000029', 'lymph node', 201, 'LNS'), ('PR_000007140', 'epsin-3', 1375, 'E8B'), ('CHEBI_30751', 'formic acid', 2021, 'folic acid'), ('CHEBI_33839', 'macromolecule', 2042, 'micronutrients'), ('CHEBI_18245', 'carboxylato group', 2057, 'clipid'), ('CHEBI_33284', 'nutrient', 2070, 'nutrient'), ('GO_0009986', 'cell surface', 2248, 'surface'), ('PR_000015693', 'suppressor of tumorigenicity 7 protein', 2248, 'surface protein 1'), ('GO_0007565', 'female pregnancy', 2411, 'gestation'), ('GO_0007567', 'parturition', 2440, 'delivery'), ('GO_0007565', 'female pregnancy', 2461, 'pregnancies'), ('GO_0009986', 'cell surface', 2643, 'surface'), ('PR_000015619', 'sorcin', 2643, 'surface protein 2'), ('CL_0000836', 'promyelocyte', 2661, 'iErythrocyte'), ('PR_000017453', 'protein Wnt-9b', 2674, 'binding antigen 175'), ('CHEBI_59132', 'antigen', 2682, 'antigen'), ('PR_000009209', 'juxtaposed with another zinc finger protein 1', 2694, 'jReticulocyte binding protein homologue 2A'), ('SO_0000853', 'homologous_region', 2724, 'homologue'), ('GO_0009986', 'cell surface', 2746, 'surface'), ('CHEBI_59132', 'antigen', 2754, 'antigens'), ('CHEBI_33284', 'nutrient', 2836, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 2865, 'antibody'), ('CHEBI_59132', 'antigen', 2952, 'antigens'), ('CHEBI_59132', 'antigen', 3068, 'antigens')]
PMC5804088	2/2018	S103-PMC5804088	['adjustment of the analysis for the selected covariates did not significantly change the results of the analysis, and no significant differences in Antibody seroprevalence were observed between the different supplementation groups for any of tested Antigens.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 147, 'antibody'), ('CHEBI_59132', 'antigen', 248, 'antigens')]
PMC5804088	2/2018	S104-PMC5804088	['caption (table-wrap): table\xa05\n\nassociation between Nutrient supplementation and seroprevalence in 18\xa0months old childrenoutcomenumber of children seropositive/total number of childrencomparison between Lns and ifa groupcomparison between lns and mmn groupcomparison between mmn and ifa groupifaammnblnscp valuedor (95% ci)p valueeor (95% ci)p valueeor (95% ci)p valueemsp-1 19kdf82/145(56.5%)72/140(51.4%)82/147(55.7%)0.6460.98 (0.78, 1.24)0.8951.19 (0.75, 1.90)0.4600.83 (0.52, 1.33)0.444adjusted modelg0.98 (0.77, 1.25)0.8651.10 (0.67, 1.82)0.7080.80 (0.48, 1.34)0.398msp-2h42/145(28.9%)39/140(27.8%)36/147(24.4%)0.6690.88 (0.66, 1.16)0.3590.79 (0.45, 1.40)0.4280.95 (0.54, 1.66)0.851adjusted modelg0.82 (0.60, 1.13)0.2260.63 (0.34, 1.18)0.1490.96 (0.53, 1.76)0.906eba-175i19/145(13.1%)14/140(10.0%)18/147(12.2%)0.7050.99 (0.67, 1.43)0.9671.59 (0.69, 3.63)0.2730.61 (0.27, 1.40)0.242adjusted modelg0.91 (0.60, 1.37)0.6421.19 (0.48, 2.95)0.7100.65 (0.27, 1.58)0.342rh2a9j42/145(28.9%)40/140(28.5%)40/147(27.2%)0.9410.96 (0.74, 1.24)0.7390.93 (0.56, 1.57)0.7970.96 (0.57, 1.61)0.880adjusted modelg0.96 (0.73, 1.26)0.7630.84 (0.48, 1.47)0.5400.98 (0.56, 1.71)0.931schizont extract73/145(50.3%)78/140(55.7%)82/147(55.7%)0.5681.12 (0.89, 1.40)0.3521.003 (0.63, 1.60)0.9911.24 (0.78, 1.99)0.365adjusted modelg1.18 (0.90, 1.54)0.2230.87 (0.52, 1.46)0.6001.40 (0.83, 2.35)0.208vsakof e8b parasite line14/145(9.6%)11/140(7.9%)9/147(6.1%)0.5340.78 (0.51, 1.21)0.2660.76 (0.30, 1.89)0.5540.78 (0.33, 1.83)0.562adjusted modelg0.80 (0.50, 1.29)0.3600.72 (0.27, 1.89)0.5040.75 (0.29, 1.93)0.557vsa of r29 parasite line7/145(4.8%)5/140(3.5%)4/147(2.7%)0.6320.74 (0.40, 1.39)0.3510.76(0.20, 2.87)0.6800.72 (0.22, 2.32)0.582adjusted modelg0.79 (0.39, 1.60)0.5060.95 (0.22, 4.07)0.9460.85 (0.23, 3.14)0.808vsa of 3d7 parasite line15/145(10.3%)11/140(7.8%)10/147(6.8%)0.5320.80 (0.52, 1.21)0.2830.86 (0.35, 2.08)0.7320.85 (0.37, 1.97)0.710adjusted modelg0.74 (0.46, 1.22)0.2410.55 (0.20, 1.52)0.2501.11(0.43, 2.83)0.830\nairon and Folic Acid\nbmultiple Micronutrients\nClipid based Nutrient supplements\ndp-value calculated using the chi2test\nep-value calculated using logistic regression reporting odds ratios (or) and 95% confidence intervals (ci)\nfmerozoite Surface Protein 1\ngp-value calculated using multivariate logistic regression reporting odds ratios (or) while adjusting for maternal bmi at enrolment, duration of Gestation (from enrolment to Delivery), number of Pregnancies, sex of the child, maternal education, socioeconomic status, study site, maternal anaemic status at enrolment, maternal hiv status and bed net use by children\nhmerozoite Surface protein 2\nierythrocyte Binding Antigen 175\njreticulocyte Binding Protein Homologue 2A\nkvariant Surface Antigens\n\nassociation between Nutrient supplementation and Antibody levels in 6\xa0month old children\nthe level of Antibodies did not differ significantly according to different Nutrient supplementation groups for any of the tested Antigens at 6\xa0months of age.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 51, 'nutrient'), ('UBERON_0000029', 'lymph node', 202, 'LNS'), ('PR_000000037', 'BMP receptor type-2', 371, '-1'), ('CHEBI_30751', 'formic acid', 2013, 'folic acid'), ('CHEBI_33839', 'macromolecule', 2034, 'micronutrients'), ('CHEBI_18245', 'carboxylato group', 2049, 'clipid'), ('CHEBI_33284', 'nutrient', 2062, 'nutrient'), ('GO_0009986', 'cell surface', 2240, 'surface'), ('PR_000015693', 'suppressor of tumorigenicity 7 protein', 2240, 'surface protein 1'), ('GO_0007565', 'female pregnancy', 2403, 'gestation'), ('GO_0007567', 'parturition', 2432, 'delivery'), ('GO_0007565', 'female pregnancy', 2453, 'pregnancies'), ('GO_0009986', 'cell surface', 2635, 'surface'), ('PR_000017453', 'protein Wnt-9b', 2666, 'binding antigen 175'), ('CHEBI_59132', 'antigen', 2674, 'antigen'), ('PR_000004593', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3', 2700, 'binding protein homologue 2A'), ('SO_0000853', 'homologous_region', 2716, 'homologue'), ('GO_0009986', 'cell surface', 2738, 'surface'), ('CHEBI_59132', 'antigen', 2746, 'antigens'), ('CHEBI_33284', 'nutrient', 2776, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 2805, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 2858, 'antibodies'), ('CHEBI_33284', 'nutrient', 2921, 'nutrient'), ('CHEBI_59132', 'antigen', 2975, 'antigens')]
PMC5804088	2/2018	S105-PMC5804088	['moreover, multivariate linear regression showed no significant differences in the levels of Antibodies against any of the tested Antigens when they were categorized by different supplementation groups (table\xa06).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 92, 'antibodies'), ('CHEBI_59132', 'antigen', 129, 'antigens')]
PMC5804088	2/2018	S106-PMC5804088	['caption (table-wrap): table\xa06\n\nassociation between Nutrient supplementation and Antibody levels in 6\xa0months old childrenoutcomeantibody levels by study group, median (iqr)lns and ifalns and mmnmmn and ifaifaammnblnscp valuedcoeff (95% ci)p valueecoeff (95% ci)p valueecoeff (95% ci)p valueenumber of participantsn\xa0=\xa0145n\xa0=\xa0140n\xa0=\xa0147msp-1 19kdf0.81 (0.38, 2.45)1.13 (0.37, 3.02)1.03 (0.40, 0.72)0.4301.03 (0.85, 1.25)0.7730.88 (0.60, 1.28)0.4981.15 (0.78, 1.70)0.467adjusted modelg1.06 (0.87, 1.30)0.5420.94 (0.63, 1.39)0.7551.11 (0.75, 1.64)0.614msp-2h2.36 (1.43, 3.57)2.02 (1.33, 4.13)1.98 (1.19, 3.27)0.3130.99 (0.87, 1.12)0.8330.87 (0.66, 1.15)0.3341.08 (0.82, 1.42)0.592adjusted modelg0.99 (0.86, 1.13)0.8340.88 (0.66, 1.19)0.4171.06 (0.80, 1.40)0.703eba-175i2.37 (1.34, 3.85)2.60 (1.50, 4.50)2.50 (1.42, 4.02)0.3351.03 (0.92, 1.14)0.6100.91 (0.74, 1.13)0.3901.14 (0.91, 1.43)0.240adjusted modelg1.04 (0.93, 1.16)0.5020.86 (0.69, 1.08)0.1951.24 (0.99, 1.54)0.061rh2a9j4.93 (1.53,18.55)5.97 (2.12, 39.95)5.86 (2.45, 33.70)0.2451.11 (0.89, 1.38)0.3641.00 (0.66, 1.53)0.9861.23 (0.77, 1.95)0.382adjusted modelg1.08 (0.85, 1.37)0.5320.99 (0.63, 1.57)0.9901.16 (0.70, 1.93)0.559schizont extract1.85 (0.80, 4.93)2.11 (0.82, 8.08)2.06 (0.89, 7.23)0.5691.07 (0.89, 1.28)0.4650.97 (0.68, 1.40)0.8751.21 (0.85, 1.73)0.282adjusted modelg1.06 (0.89, 1.27)0.4810.88 (0.61, 1.26)0.4751.30 (0.91, 1.85)0.155vsakof e8b parasite line0.17 (0.03, 0.46)0.26 (0.06, 0.47)0.19 (0.02, 0.44)0.4531.04 (0.87, 1.24)0.6881.00 (0.70, 1.42)0.9951.07 (0.76, 1.51)0.709adjusted modelg1.00 (0.82, 1.21)0.9960.99 (0.68, 1.47)0.9871.02 (0.71, 1.47)0.925vsa of r29 parasite line0.16 (0, 0.59)0.25 (0, 0.81)0.12 (0, 0.55)0.4520.93 (0.75, 1.15)0.4960.70 (0.46, 1.07)0.0981.21 (0.80, 1.82)0.358adjusted modelg0.91 (0.73, 1.13)0.4070.63 (0.41, 0.97)0.0631.30 (0.88, 1.91)0.187vsa of 3d7 parasite line0.19 (0.01, 0.48)0.24 (0.02, 0.64)0.26 (0.01,0.59)0.5441.19 (0.98, 1.46)0.0811.06 (0.72, 1.55)0.7741.34 (0.91, 1.99)0.138adjustedg1.13 (0.92, 1.39)0.2451.05 (0.69, 1.61)0.8101.18 (0.81, 1.73)0.382\nairon and Folic Acid\nbmultiple Micronutrients\nClipid based Nutrient supplements\ndp value calculated using kruskal–wallis test\nep value calculated using linear regression of Antibody levels between supplementation groups reporting coefficient and 95% confidence intervals (ci)\nfmerozoite Surface Protein 1\ngp value calculated using multivariate regression adjusting for maternal bmi at enrolment, duration of Gestation (from enrolment to Delivery), number of Pregnancies, sex of the child, maternal education, socioeconomic status, study site, maternal anaemic status at enrolment, maternal hiv status and bed net use by children\nhmerozoite Surface Protein 2\nierythrocyte Binding Antigen 175\njreticulocyte Binding Protein Homologue 2A\nkvariant Surface Antigens\n\nassociation between Nutrient supplementation and Antibody levels in 18\xa0month old children\nthe level of Antibodies did not differ significantly between different Nutrient supplementation groups for any of the tested Antigens except for Igg against e8b parasite line (p\xa0=\xa00.043) in 18\xa0months old children.']	N/A	N/A	[('CHEBI_33284', 'nutrient', 51, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 80, 'antibody'), ('CHEBI_30751', 'formic acid', 2073, 'folic acid'), ('CHEBI_33839', 'macromolecule', 2094, 'micronutrients'), ('CHEBI_18245', 'carboxylato group', 2109, 'clipid'), ('CHEBI_33284', 'nutrient', 2122, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 2236, 'antibody'), ('GO_0009986', 'cell surface', 2350, 'surface'), ('PR_000015693', 'suppressor of tumorigenicity 7 protein', 2350, 'surface protein 1'), ('GO_0007565', 'female pregnancy', 2471, 'gestation'), ('GO_0007567', 'parturition', 2500, 'delivery'), ('GO_0007565', 'female pregnancy', 2521, 'pregnancies'), ('GO_0009986', 'cell surface', 2703, 'surface'), ('PR_000015619', 'sorcin', 2703, 'surface protein 2'), ('PR_000017453', 'protein Wnt-9b', 2734, 'binding antigen 175'), ('CHEBI_59132', 'antigen', 2742, 'antigen'), ('PR_000004593', 'N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3', 2768, 'binding protein homologue 2A'), ('SO_0000853', 'homologous_region', 2784, 'homologue'), ('GO_0009986', 'cell surface', 2806, 'surface'), ('CHEBI_59132', 'antigen', 2814, 'antigens'), ('CHEBI_33284', 'nutrient', 2844, 'nutrient'), ('GO_0042571', 'immunoglobulin complex, circulating', 2873, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 2927, 'antibodies'), ('CHEBI_33284', 'nutrient', 2985, 'nutrient'), ('CHEBI_59132', 'antigen', 3039, 'antigens'), ('GO_0071735', 'IgG immunoglobulin complex', 3059, 'IgG')]
PMC5804088	2/2018	S107-PMC5804088	['multivariate linear regression showed no significant differences in the levels of Antibodies against any of the tested Antigens between the different supplementation groups (table\xa07).']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 82, 'antibodies'), ('CHEBI_59132', 'antigen', 119, 'antigens')]
PMC5804088	2/2018	S112-PMC5804088	['in a higher transmission setting, the seroprevalence of Antibody to Msp1 reached a peak after 6\xa0months of age, whereas prevalence of Antibody to Msp2 peaked at 9\xa0months of age [39].']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 56, 'antibody'), ('PR_000010757', 'metaxin-3', 68, 'MSP1'), ('GO_0042571', 'immunoglobulin complex, circulating', 133, 'antibody'), ('PR_000010697', 'metallothionein-1E', 145, 'MSP2')]
PMC5804088	2/2018	S118-PMC5804088	['Antibody levels or seroprevalence of Antibodies to the tested Antigens did not differ between the supplementation groups in either unadjusted or adjusted analysis (p\xa0>\xa00.05) except for the seroprevalence in 6\xa0months old children for Rh2A9 (p\xa0=\xa00.044), and that significance was lost in the adjusted analysis.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 0, 'Antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 37, 'antibodies'), ('CHEBI_59132', 'antigen', 62, 'antigens'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 233, 'Rh2A9')]
PMC5906686	4/2018	S170-PMC5906686	['fixed samples were blocked with Antibody dilution buffer (adb) at 37\u2009°c for 30\u2009min and incubated with primary Antibodies (table\xa0s2) at 37\u2009°c for 8\u2009h in a 1:200 dilution.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 32, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 110, 'antibodies')]
PMC5906686	4/2018	S172-PMC5906686	['finally, the cells were incubated in dark with secondary Antibodies of Cy3 (anti-Rabbit, beyotime, a0562, nantong, china; anti-Mouse, beyotime, a0568) or Fluorescein Isothiocyanate (Fitc)-labeled goat Igg (anti-Rabbit, beyotime, a0516; anti-Mouse, beyotime, a0521) at 37\u2009°c for 1.5\u2009h and stained with Hoechst 33342 (beyotime, c1022) for 5\u2009min.']	N/A	N/A	[('GO_0042571', 'immunoglobulin complex, circulating', 57, 'antibodies'), ('CHEBI_37987', 'Cy3 dye', 71, 'CY3'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 81, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 127, 'mouse'), ('CHEBI_37926', 'fluorescein isothiocyanate', 154, 'fluorescein isothiocyanate'), ('CHEBI_37926', 'fluorescein isothiocyanate', 182, 'FITC'), ('GO_0071735', 'IgG immunoglobulin complex', 201, 'IgG'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 211, 'rabbit'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mouse'), ('CHEBI_79959', 'cis-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid', 301, 'Hoechst 33342')]
PMC5906686	4/2018	S177-PMC5906686	['sections were blocked and incubated with anti-Mvh protein Antibody as reported above for primary Antibodies, then Fitc (Cy3 in tunel assay)-labeled goat anti-Rabbit Igg and Nucleic acid was stained with Propidium Iodide (solaibio, p8080-10, beijing, china) or Hoechst 33342 (in tunel assay).']	N/A	N/A	[('PR_000010788', 'interferon-induced GTP-binding protein Mx1', 46, 'MVH'), ('GO_0042571', 'immunoglobulin complex, circulating', 58, 'antibody'), ('GO_0042571', 'immunoglobulin complex, circulating', 97, 'antibodies'), ('CHEBI_37926', 'fluorescein isothiocyanate', 114, 'FITC'), ('CHEBI_37987', 'Cy3 dye', 120, 'CY3'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 158, 'rabbit'), ('GO_0071735', 'IgG immunoglobulin complex', 165, 'IgG'), ('GO_0005634', 'nucleus', 173, 'nucleic'), ('CHEBI_51240', 'propidium iodide', 203, 'propidium iodide'), ('CHEBI_79959', 'cis-1,3,4,6,7,11b-Hexahydro-9-methoxy-2H-benzo[a]quinolizine-3-carboxylic acid', 260, 'Hoechst 33342')]
